Sentence,class,file
Jae-Seop	Oh	(E-mail:	ysrehab@inje.ac.kr) ©2013	The	Society	of	Physical	Therapy	Science This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/jpts-25-1537.PMC3885834.pdf
Mohammad Akbari (E-mail: ak - bari_mo@tums.ac.ir) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/0f/cf/jpts-25-1541.PMC3885835.pdf
Taro Matsuzaki (E-mail: tarosan- knz@umin.ac.jp) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/86/0d/jpts-25-1547.PMC3885836.pdf
Hae-yeon Kwon (E-mail: Red-fine@ hanmail.net) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/26/1b/jpts-25-1553.PMC3885837.pdf
http://inwa-nordicwalking.com/.,Non-OADS,/arxiv_data1/oa_pdf/26/1b/jpts-25-1553.PMC3885837.pdf
http://walking.about.com/ od/poles/tp/nordicpoles.htm (Accessed Apr.,Non-OADS,/arxiv_data1/oa_pdf/26/1b/jpts-25-1553.PMC3885837.pdf
http://www.nordicwalk - ing.co.uk.,Non-OADS,/arxiv_data1/oa_pdf/26/1b/jpts-25-1553.PMC3885837.pdf
Daehee Lee (E-mail: dhlee.yd.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/aa/01/jpts-25-1557.PMC3885838.pdf
Ferruh	Taspinar	(E-mail:	fztferruh@ hotmail.com) ©2013	The	Society	of	Physical	Therapy	Science This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/41/a7/jpts-25-1561.PMC3885839.pdf
Sami Saleh AlAbdulwahab (E-mail:  swahab@ksu.edu.sa) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/32/62/jpts-25-1565.PMC3885840.pdf
Clarice Tanaka (E-mail: cltanaka@ usp.br) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/9c/de/jpts-25-1569.PMC3885841.pdf
"[Medline]   [CrossRef] 38) SENIAM: Project 2005, http://www.seniam.org (Accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/9c/de/jpts-25-1569.PMC3885841.pdf
Se-hun Kim (E-mail: ptsehun@ gmail.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1f/02/jpts-25-1575.PMC3885842.pdf
Jooyeon Ko (E-mail: 7806218@ hanmail.net) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/bb/1a/jpts-25-1579.PMC3885843.pdf
Hae Yong Lee (E-mail: cyberlhy@ nate.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/47/31/jpts-25-1583.PMC3885844.pdf
Jae Shin Lee (E-mail: jaeshin@ konyang.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/94/f9/jpts-25-1587.PMC3885845.pdf
Sang-young Park (E-mail: sypark@ uu.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/91/b3/jpts-25-1591.PMC3885846.pdf
Gi Duck Park (E-mail: prescrip@ knu.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cf/f1/jpts-25-1595.PMC3885847.pdf
ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/7d/eb/jpts-25-1601.PMC3885848.pdf
Tackhoon Kim (E-mail: tack@ hanseo.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/02/59/jpts-25-1605.PMC3885849.pdf
Ji Won Park (E-mail: mylovept@ cu.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2f/9c/jpts-25-1609.PMC3885850.pdf
Jin	Hwan	Lee	(E-mail:	poohpt22@naver.com) ©2013	The	Society	of	Physical	Therapy	Science This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4c/4d/jpts-25-1613.PMC3885851.pdf
Junghwan Kim (E-mail: junghwan - kim3@yongin.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e8/bf/jpts-25-1617.PMC3885852.pdf
The data obtained were screened against rat databases downloaded from both  NCBI (http://www.ncbi.nlm.nih.gov) and the Swiss-Prot/ TrEMBL homepage (http://www.expasy.ch/sprot).,OADS,/arxiv_data1/oa_pdf/e8/bf/jpts-25-1617.PMC3885852.pdf
ac.jp) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ac/a0/jpts-25-1621.PMC3885853.pdf
2) Japanese Nursing Association: Promotion of postgraduate clinical training  system of a nursing http://www.nurse.or.jp/nursing/education/shinjin/ (in  Japanese) (Accessed Apr.,Non-OADS,/arxiv_data1/oa_pdf/ac/a0/jpts-25-1621.PMC3885853.pdf
Core curriculum in postgraduate clinical training http://www.mhlw.go.jp/shingi/2002/06/s0627-3f.html (in Japanese) (Accessed Apr.,Non-OADS,/arxiv_data1/oa_pdf/ac/a0/jpts-25-1621.PMC3885853.pdf
http://www.mhlw.go.jp/bunya/iryou/oshirase/dl/100210–3.pdf (in Japanese)   (Accessed Apr.,Non-OADS,/arxiv_data1/oa_pdf/ac/a0/jpts-25-1621.PMC3885853.pdf
http://www.ptcas.org/Professionalism.html (Accessed Apr.,Non-OADS,/arxiv_data1/oa_pdf/ac/a0/jpts-25-1621.PMC3885853.pdf
http://www.marquette.edu/physical-therapy/docu - ments/CoreValuesSelf-Assessment.pdf (Accessed Apr.,Non-OADS,/arxiv_data1/oa_pdf/ac/a0/jpts-25-1621.PMC3885853.pdf
Masayuki Soma (E-mail: souma@ tfu-mail.tfu.ac.jp) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/9a/34/jpts-25-1625.PMC3885854.pdf
Joong-Chul Lee (E-mail: chan - nel365@hanmail.net) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/18/1b/jpts-25-1629.PMC3885855.pdf
"2) National Scoliosis Foundation and DePuy Spine, Inc: Scoliosis media and community guide, from http://www.srs.org/professionals/policy/ scolime - diaguide.pdf, (Accessed MM DD 2009) 3) Mahaudens P, Banse X, Mousny M, et al.",Non-OADS,/arxiv_data1/oa_pdf/18/1b/jpts-25-1629.PMC3885855.pdf
Hye Young Lee (E-mail: happypt@ hanmail.net) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/73/c8/jpts-25-1633.PMC3885856.pdf
Hideaki Ishii (E-mail: 11dr01@g. seirei.ac.jp) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/99/f6/jpts-25-1637.PMC3885857.pdf
Myoung Hee Lee (E-mail:  mhlee0317@hanmail.net) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ed/af/jpts-25-1643.PMC3885858.pdf
Ki Seok Nam (E-mail: seokah@ hanmail.net) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d8/71/jpts-25-1647.PMC3885859.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/34/aa/srep03614.PMC3885878.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3614 | DOI: 10.1038/srep03614 8",Non-OADS,/arxiv_data1/oa_pdf/34/aa/srep03614.PMC3885878.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/05/fd/srep03612.PMC3885879.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3612 | DOI: 10.1038/srep03612 7",Non-OADS,/arxiv_data1/oa_pdf/05/fd/srep03612.PMC3885879.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6f/6d/srep03613.PMC3885880.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3613 | DOI: 10.1038/srep03613 5",Non-OADS,/arxiv_data1/oa_pdf/6f/6d/srep03613.PMC3885880.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3608 | DOI: 10.1038/srep03608 6",Non-OADS,/arxiv_data1/oa_pdf/51/f0/srep03608.PMC3885881.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3617 | DOI: 10.1038/srep03617 6",Non-OADS,/arxiv_data1/oa_pdf/87/bf/srep03617.PMC3885882.pdf
"Master Thesis, University of New Mexico, Albuquerque, 2010, http://repository.unm.edu/handle/1928/11135.",Non-OADS,/arxiv_data1/oa_pdf/57/57/srep03610.PMC3885883.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/57/srep03610.PMC3885883.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3610 | DOI: 10.1038/srep03610 7",Non-OADS,/arxiv_data1/oa_pdf/57/57/srep03610.PMC3885883.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7b/69/srep03615.PMC3885884.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3615 | DOI: 10.1038/srep03615 3",Non-OADS,/arxiv_data1/oa_pdf/7b/69/srep03615.PMC3885884.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3620 | DOI: 10.1038/srep03620 9",Non-OADS,/arxiv_data1/oa_pdf/b0/df/srep03620.PMC3885886.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.08.002☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/aa/3d/main.PMC3885920.pdf
http://dx.doi.org/10.1016/j.mmcr.2013.01.005 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/7f/1c/main.PMC3885935.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.09.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/8b/0a/main.PMC3885936.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.07.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/61/f0/main.PMC3885938.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.08.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/d2/c1/main.PMC3885939.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.05.002☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/4e/53/main.PMC3885942.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.10.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/f0/f1/main.PMC3885950.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.05.003☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/70/06/main.PMC3885951.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.06.004☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permitsnon-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/b9/80/main.PMC3885953.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.06.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/6a/ee/main.PMC3885955.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.10.002☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permitsnon-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/70/93/main.PMC3885961.pdf
"Resulting sequences were com- pared and aligned with those deposited in the NCBI GenBank database using the Basic Local Alignment Search Tool (BLAST) [9], CLUSTAL OMEGA ( http://www.ebi.ac.uk/Tools/msa/clustalo ), and EMBOSS Needle ( http://www.ebi.ac.uk/Tools/psa/emboss_needle/ nucleotide.html ).",OADS,/arxiv_data1/oa_pdf/70/93/main.PMC3885961.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.05.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/fc/90/main.PMC3885964.pdf
J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e3 URL: http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.pdf doi:10.5037/jomr.2010.1103 http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
"J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e3 URL: http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.pdf doi:10.5037/jomr.2010.1103 Copyright © Juodzbalys G, Wang HL, Sabalys G. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 22 December 2009.",Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be included.",Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/75/27/jomr-01-e3.PMC3886037.pdf
J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e6 URL: http://www.ejomr.org/JOMR/archives/2010/1/e6/e6ht.htm doi:10.5037/jomr.2010.1106   http://www.ejomr.org/JOMR/archives/2010/1/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/9a/jomr-01-e6.PMC3886038.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/9a/jomr-01-e6.PMC3886038.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/9a/jomr-01-e6.PMC3886038.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/9a/jomr-01-e6.PMC3886038.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/9a/jomr-01-e6.PMC3886038.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/9a/jomr-01-e6.PMC3886038.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/9a/jomr-01-e6.PMC3886038.pdf
"J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e6 URL: http://www.ejomr.org/JOMR/archives/2010/1/e6/e6ht.htm doi:10.5037/jomr.2010.1106 Copyright ©  Bassam H. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http:// www.ejomr.org/ ), 15 December 2009.",Non-OADS,/arxiv_data1/oa_pdf/b1/9a/jomr-01-e6.PMC3886038.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be included.",Non-OADS,/arxiv_data1/oa_pdf/b1/9a/jomr-01-e6.PMC3886038.pdf
"Accepted for publication: 29 December 2009  To cite this article: Papamanthos M, Matiakis A, Tsirevelou P, Kolokotronis A, Skoulakis H. Hereditary Angioedema: Three Cases Report,  Members of the Same Family J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e9 URL: http://www.ejomr.org/JOMR/archives/2010/1/e9/e9ht.pdf doi:10.5037/jomr.2010.1109   http://www.ejomr.org/JOMR/archives/2010/1/e9/e9ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.",Non-OADS,/arxiv_data1/oa_pdf/67/66/jomr-01-e9.PMC3886039.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e9/e9ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/67/66/jomr-01-e9.PMC3886039.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e9/e9ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/67/66/jomr-01-e9.PMC3886039.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e9/e9ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/67/66/jomr-01-e9.PMC3886039.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e9/e9ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/67/66/jomr-01-e9.PMC3886039.pdf
"[Medline: 15573358 ] [doi: 10.1016/j.joms.2004.07.010 ] ___ To cite this article: Papamanthos M, Matiakis A, Tsirevelou P, Kolokotronis A, Skoulakis H. Hereditary Angioedema: Three Cases Report,  Members of the Same Family J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e9 URL: http://www.ejomr.org/JOMR/archives/2010/1/e9/e9ht.htm doi:10.5037/jomr.2010.1109",Non-OADS,/arxiv_data1/oa_pdf/67/66/jomr-01-e9.PMC3886039.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e9/e9ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/67/66/jomr-01-e9.PMC3886039.pdf
"Copyright ©  Papamanthos M, Matiakis A, Tsirevelou P, Kolokotronis A, Skoulakis H. Accepted for publication in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org/ ), 29 December 2009.",Non-OADS,/arxiv_data1/oa_pdf/67/66/jomr-01-e9.PMC3886039.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/67/66/jomr-01-e9.PMC3886039.pdf
J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e2 URL: http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.pdf doi:10.5037/jomr.2010.1102   http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/12/jomr-01-e2.PMC3886040.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/12/jomr-01-e2.PMC3886040.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/12/jomr-01-e2.PMC3886040.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/12/jomr-01-e2.PMC3886040.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/12/jomr-01-e2.PMC3886040.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/12/jomr-01-e2.PMC3886040.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/12/jomr-01-e2.PMC3886040.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/12/jomr-01-e2.PMC3886040.pdf
"J Oral Maxillofac Res 2010;1(1):e2 URL: http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.pdf doi:10.5037/jomr.2010.1102 Copyright © Juodzbalys G, Wang HL, Sabalys G. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 31 December 2009.",Non-OADS,/arxiv_data1/oa_pdf/d0/12/jomr-01-e2.PMC3886040.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/d0/12/jomr-01-e2.PMC3886040.pdf
J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e5 URL: http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.pdf doi:10.5037/jomr.2010.1105 http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
"Furthermore,  the observers were asked to provide subjective  ratings of following periapical radiographs evaluation  parameters: lamina dura  delineation, trabecular pattern   depiction, contrast perception and crater and furcation  involvement visibility, using an ordinal scale from 0 to  http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.",Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e5 URL: http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.pdf doi:10.5037/jomr.2010.1105,Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
"1 | No 1 | e5 | p.8 (page number not for citation purposes)Copyright ©  Vandenberghe B, Jacobs R. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org/ ), 18 December 2009.",Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/59/28/jomr-01-e5.PMC3886041.pdf
J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e4 URL: http://www.ejomr.org/JOMR/archives/2010/1/e4/e4ht.pdf doi:10.5037/jomr.2010.1104 http://www.ejomr.org/JOMR/archives/2010/1/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/08/jomr-01-e4.PMC3886042.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/08/jomr-01-e4.PMC3886042.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/08/jomr-01-e4.PMC3886042.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/08/jomr-01-e4.PMC3886042.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/08/jomr-01-e4.PMC3886042.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/08/jomr-01-e4.PMC3886042.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/08/jomr-01-e4.PMC3886042.pdf
"J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e4 URL: http://www.ejomr.org/JOMR/archives/2010/1/e4/e4ht.pdf doi:10.5037/jomr.2010.1104 Copyright ©  Sollazzo V , Palmieri A, Girardi A, Farinella F, Carinci F. Accepted for publication in the JOURNAL OF ORAL  & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org/ ), 26 November 2009.",Non-OADS,/arxiv_data1/oa_pdf/86/08/jomr-01-e4.PMC3886042.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/86/08/jomr-01-e4.PMC3886042.pdf
Restoration-guided implant rehabilitation of the complex partial edentulism: a clinical report J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e8 URL: http://www.ejomr.org/JOMR/archives/2010/1/e8/e8ht.pdf doi:10.5037/jomr.2010.1108 http://www.ejomr.org/JOMR/archives/2010/1/e8/e8ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e8/e8ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e8/e8ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e8/e8ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e8/e8ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e8/e8ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e8/e8ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e8/e8ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
"Restoration-guided implant rehabilitation of the complex partial edentulism: a clinical report J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e8 URL: http://www.ejomr.org/JOMR/archives/2010/1/e8/e8ht.pdf doi:10.5037/jomr.2010.1108 Copyright ©  Tzerbos F, Sykaras N, Tzoras V .",Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org/ ), 24 November 2009.",Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/e2/d3/jomr-01-e8.PMC3886043.pdf
"JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                                               Juodzbalys G. Welcome to the Journal of Oral & Maxillofacial Research  first issue Gintaras Juodzbalys, DMD, PhD, Professor, Founder and Editor-in-Chief  http://www.ejomr.org/JOMR/archives/2010/1/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.",Non-OADS,/arxiv_data1/oa_pdf/f8/d2/jomr-01-e1.PMC3886044.pdf
Gintaras Juodzbalys   Accepted for publication: 31 December 2009 J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e1 URL: http://www.ejomr.org/JOMR/archives/2010/1/e1/e1ht.pdf doi:10.5037/jomr.2010.1101,Non-OADS,/arxiv_data1/oa_pdf/f8/d2/jomr-01-e1.PMC3886044.pdf
"Accepted for publication: 9 December 2009  To cite this article: Shahbazian M, Xue D, Hu Y , Cleynenbreuge J, Jacobs R. Spiral Computed Tomography Based Maxillary Sinus Imaging in  Relation to Tooth Loss, Implant Placement and Potential Grafting Procedure J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e7 URL: http://www.ejomr.org/JOMR/archives/2010/1/e7/e7ht.pdf doi:10.5037/jomr.2010.1107 http://www.ejomr.org/JOMR/archives/2010/1/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
[Medline: 9766541 ]   [doi: 10.1016/S0278-2391(98)90761-3 ] http://www.ejomr.org/JOMR/archives/2010/1/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
"[Epub ahead of print] [Medline: 19410409 ] [doi: 10.1016/j.ejrad.2009.03.042 ] To cite this article: Shahbazian M, Xue D, Hu Y , Cleynenbreuge J, Jacobs R. Spiral Computed Tomography Based Maxillary Sinus Imaging in  Relation to Tooth Loss, Implant Placement and Potential Grafting Procedure J Oral Maxillofac Res 2010 (Jan-Mar);1(1):e7 URL: http://www.ejomr.org/JOMR/archives/2010/1/e7/e7ht.pdf doi:10.5037/jomr.2010.1107",Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
http://www.ejomr.org/JOMR/archives/2010/1/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
"Copyright ©  Shahbazian M, Xue D, Hu Y , Cleynenbreuge J, Jacobs R. Accepted for publication in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 9 December 2009.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/jomr-01-e7.PMC3886045.pdf
J Oral Maxillofac Res 2010 (Apr- Jun);1(2):e5 URL: http://www.ejomr.org/JOMR/archives/2010/2/e5/e5ht.pdf doi:10.5037/jomr.2010.1205 http://www.ejomr.org/JOMR/archives/2010/2/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
Available from:   http://www.ispub.com/journal/the_internet_journal_of_dental_science/volume_7_number_2_20/article/psammomatoid- juvenile-ossifying-fibroma-of-the-mandible-a-histochemical-insight.html 18.,Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
"J Oral Maxillofac Res 2010;1(2):e5 URL: http://www.ejomr.org/JOMR/archives/2010/2/e5/e5ht.pdf doi:10.5037/jomr.2010.1205   Copyright © Keles B, Duran M, Uyar Y .",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
"Accepted for publication in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 7 March 2010.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jomr-01-e5.PMC3886046.pdf
J Oral Maxillofac Res 2010 (Apr- Jun);1(2):e3 URL: http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.pdf doi:10.5037/jomr.2010.1203 http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
[Medline: 19772941 ]  [doi: 10.1016/j.joms.2009.03.050 ] http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
"J Oral Maxillofac Res 2010;1(2):e3 URL: http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.pdf doi:10.5037/jomr.2010.1203 Copyright © Olutayo J, Agbaje JO, Jacobs R, Verhaeghe V , Velde FV , Vinckier F. Accepted for publication in the JOURNAL  OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 30 March 2010.",Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/dc/8a/jomr-01-e3.PMC3886047.pdf
J Oral Maxillofac Res 2010 (Apr- Jun);1(2):e2 URL: http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.pdf doi:10.5037/jomr.2010.1202 http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
"J Oral Maxillofac Res 2010;1(2):e2 URL: http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.pdf doi:10.5037/jomr.2010.1202 Copyright © Lima G de M, Almeida JD, Cabral LA.",Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 15 March 2010.",Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/9e/36/jomr-01-e2.PMC3886048.pdf
J Oral Maxillofac Res 2010 (Apr- Jun);1(2):e4 URL: http://www.ejomr.org/JOMR/archives/2010/2/e4/e4ht.pdf doi:10.5037/jomr.2010.1204 http://www.ejomr.org/JOMR/archives/2010/2/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/jomr-01-e4.PMC3886049.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/jomr-01-e4.PMC3886049.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/jomr-01-e4.PMC3886049.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/jomr-01-e4.PMC3886049.pdf
[Medline: 18929275 ] [doi: 10.1016/j.ajodo.2006.10.038 ] http://www.ejomr.org/JOMR/archives/2010/2/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/jomr-01-e4.PMC3886049.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/jomr-01-e4.PMC3886049.pdf
"J Oral Maxillofac Res 2010;1(2):e4 URL: http://www.ejomr.org/JOMR/archives/2010/2/e4/e4ht.pdf doi:10.5037/jomr.2010.1204 Copyright © Sullivan M, Rossitto R, Casey DM.",Non-OADS,/arxiv_data1/oa_pdf/2a/e6/jomr-01-e4.PMC3886049.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 4 April 2010.",Non-OADS,/arxiv_data1/oa_pdf/2a/e6/jomr-01-e4.PMC3886049.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/2a/e6/jomr-01-e4.PMC3886049.pdf
J Oral Maxillofac Res 2010 (Apr- Jun);1(2):e1 URL: http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.pdf doi:10.5037/jomr.2010.1201 http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  [doi: 10.5037/jomr.2010.1102 ] 8.,OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  [doi: 10.5037/jomr.2010.1103 ] 9.,OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
"J Oral Maxillofac Res 2010;1(2):e1 URL: http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.pdf doi:10.5037/jomr.2010.1201 Copyright © Juodzbalys G, Wang HL.",Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 17 March 2010.",Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/53/12/jomr-01-e1.PMC3886050.pdf
J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e5 URL: http://www.ejomr.org/JOMR/archives/2010/3/e5/e5ht.pdf doi: 10.5037/jomr.2010.1305 http://www.ejomr.org/JOMR/archives/2010/3/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e5/e5ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
"J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e5 URL: http://www.ejomr.org/JOMR/archives/2010/3/e5/e5ht.pdf doi: 10.5037/jomr.2010.1305 Copyright © Uehara M, Ikeda H, Nonaka M, Asahina I.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 16 July 2010.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/jomr-01-e5.PMC3886051.pdf
J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e3 URL: http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.pdf doi: 10.5037/jomr.2010.1303 http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/1/e4/e4ab.htm 33.,OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
"J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e3 URL: http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.pdf doi: 10.5037/jomr.2010.1303 Copyright © Jimbo R, Ivarsson M, Koskela A, Sul YT, Johansson CB.",Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
"Accepted for publication in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 18 May 2010.",Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/ac/8e/jomr-01-e3.PMC3886052.pdf
J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e2 URL: http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.pdf doi: 10.5037/jomr.2010.1302 http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e2 URL: http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.pdf doi: 10.5037/jomr.2010.1302 Copyright © Kolokythas A.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH  (http://www.ejomr.org ), 4 July 2010.",Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/86/a1/jomr-01-e2.PMC3886053.pdf
J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e4 URL: http://www.ejomr.org/JOMR/archives/2010/3/e4/e4ht.pdf doi: 10.5037/jomr.2010.1304 http://www.ejomr.org/JOMR/archives/2010/3/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/86/jomr-01-e4.PMC3886054.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/86/jomr-01-e4.PMC3886054.pdf
"As general practice registers  cover more than 99% of the population in England    (http://www.statistics.gov.uk ) and access to most health  service care is through the general medical practitioner,  the practice age-sex resister is a convenient frame for a  general population survey.",Non-OADS,/arxiv_data1/oa_pdf/3c/86/jomr-01-e4.PMC3886054.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/86/jomr-01-e4.PMC3886054.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/86/jomr-01-e4.PMC3886054.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/86/jomr-01-e4.PMC3886054.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e4/e4ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/86/jomr-01-e4.PMC3886054.pdf
"J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e4 URL: http://www.ejomr.org/JOMR/archives/2010/3/e4/e4ht.pdf doi: 10.5037/jomr.2010.1304 Copyright © Macfarlane TV , Blinkhorn AS, Stevenson LJ, Coulthard P. Accepted for publication in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 12 July 2010.",Non-OADS,/arxiv_data1/oa_pdf/3c/86/jomr-01-e4.PMC3886054.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/3c/86/jomr-01-e4.PMC3886054.pdf
J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e6 URL: http://www.ejomr.org/JOMR/archives/2010/3/e6/e6ht.pdf doi: 10.5037/jomr.2010.1306 http://www.ejomr.org/JOMR/archives/2010/3/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d4/14/jomr-01-e6.PMC3886055.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d4/14/jomr-01-e6.PMC3886055.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d4/14/jomr-01-e6.PMC3886055.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d4/14/jomr-01-e6.PMC3886055.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d4/14/jomr-01-e6.PMC3886055.pdf
J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e6 URL: http://www.ejomr.org/JOMR/archives/2010/3/e6/e6ht.pdf doi: 10.5037/jomr.2010.1306,OADS,/arxiv_data1/oa_pdf/d4/14/jomr-01-e6.PMC3886055.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e6/e6ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d4/14/jomr-01-e6.PMC3886055.pdf
"Accepted for publication in the JOURNAL  OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 7 July 2010.",Non-OADS,/arxiv_data1/oa_pdf/d4/14/jomr-01-e6.PMC3886055.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/d4/14/jomr-01-e6.PMC3886055.pdf
Part I. J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e1 URL: http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.pdf doi: 10.5037/jomr.2010.1301 http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
Part I. J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e1 URL: http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.pdf doi: 10.5037/jomr.2010.1301 Copyright © Kolokythas A.,Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH  (http://www.ejomr.org ), 4 July 2010.",Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/39/2c/jomr-01-e1.PMC3886056.pdf
J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e7 URL: http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.pdf doi: 10.5037/jomr.2010.1307 http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.htm  J Oral Maxillofac Res 2010 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
"J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e7 URL: http://www.ejomr.org/JOMR/archives/2010/3/e7/e7ht.pdf doi: 10.5037/jomr.2010.1307 Copyright © Yildirim G, Ataoglu H, Kalayci A, Özkan BT, Kucuk K, Esen A.",Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
"Accepted for publication in the JOURNAL  OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 12 June 2010.",Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/fd/a9/jomr-01-e7.PMC3886057.pdf
Part I. J Oral Maxillofac Res 2011 (Apr-Jun);2(2):e1 URL: http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.pdf doi: 10.5037/jomr.2011.2201 http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
"Part I. J Oral Maxillofac Res 2011;2(2):e1 URL: http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.pdf doi: 10.5037/jomr.2011.2201 Copyright © Kolokythas A, Miloro M, Zhou X.",Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org/ ), 13 April 2011.",Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e1/v2n2e1ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/80/11/jomr-02-e1.PMC3886058.pdf
J Oral Maxillofac Res 2011 (Apr-Jun);2(2):e4 URL: http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.pdf doi: 10.5037/jomr.2011.2204 http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
[URL: http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.pdf ] [doi: 10.5037/jomr.2010.1201 ] 13.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
"J Oral Maxillofac Res 2011;2(2):e4 URL: http://www.ejomr.org/JOMR/archives/2011/2/e4/v2n2e4ht.pdf doi: 10.5037/jomr.2011.2204 Copyright © Farronato G, Garagiola U, Carletti V , Cressoni P, Mortellaro C. Accepted for publication in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org/ ), 14 April 2011.",Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/98/60/jomr-02-e4.PMC3886059.pdf
J Oral Maxillofac Res 2011 (Apr-Jun);2(2):e3 URL: http://www.ejomr.org/JOMR/archives/2011/2/e3/v2n2e3ht.pdf doi: 10.5037/jomr.2011.2203 http://www.ejomr.org/JOMR/archives/2011/2/e3/v2n2e3ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/2d/jomr-02-e3.PMC3886060.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e3/v2n2e3ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/2d/jomr-02-e3.PMC3886060.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e3/v2n2e3ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/2d/jomr-02-e3.PMC3886060.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e3/v2n2e3ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/2d/jomr-02-e3.PMC3886060.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e3/v2n2e3ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/2d/jomr-02-e3.PMC3886060.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e3/v2n2e3ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/2d/jomr-02-e3.PMC3886060.pdf
"[URL: http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.htm ] [doi: 10.5037/jomr.2010.1403 ] To cite this article: dos Santos JA, Capella DL, Rozza RE, Ferreira SJ, Berti Couto SA, Sant’Ana Filho M, de Lima AA, Westphalen FH, Couto  Souza PH.",Non-OADS,/arxiv_data1/oa_pdf/94/2d/jomr-02-e3.PMC3886060.pdf
"J Oral Maxillofac Res 2011;2(2):e3 URL: http://www.ejomr.org/JOMR/archives/2011/2/e3/v2n2e3ht.pdf doi: 10.5037/jomr.2011.2203 Copyright © dos Santos JA, Capella DL, Rozza RE, Ferreira SJ, Berti Couto SA, Sant’Ana Filho M, de Lima AA,  Westphalen FH, Couto Souza PH.",Non-OADS,/arxiv_data1/oa_pdf/94/2d/jomr-02-e3.PMC3886060.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH   (http://www.ejomr.org/ ), 18 April 2011.",Non-OADS,/arxiv_data1/oa_pdf/94/2d/jomr-02-e3.PMC3886060.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/94/2d/jomr-02-e3.PMC3886060.pdf
J Oral Maxillofac Res 2011 (Apr-Jun);2(2):e2 URL: http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.pdf doi: 10.5037/jomr.2011.2202 http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
"J Oral Maxillofac Res 2011;2(2):e2 URL: http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.pdf doi: 10.5037/jomr.2011.2202 Copyright © Kolokythas A, Miloro M, Zhou X.",Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org/ ), 19 April 2011.",Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e2/v2n2e2ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/a7/jomr-02-e2.PMC3886061.pdf
J Oral Maxillofac Res 2011 (Apr-Jun);2(2):e5 URL: http://www.ejomr.org/JOMR/archives/2011/2/e5/v2n2e5ht.pdf doi: 10.5037/jomr.2011.2205 http://www.ejomr.org/JOMR/archives/2011/2/e5/v2n2e5ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a4/45/jomr-02-e5.PMC3886062.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e5/v2n2e5ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a4/45/jomr-02-e5.PMC3886062.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e5/v2n2e5ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a4/45/jomr-02-e5.PMC3886062.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e5/v2n2e5ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a4/45/jomr-02-e5.PMC3886062.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e5/v2n2e5ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a4/45/jomr-02-e5.PMC3886062.pdf
http://www.ejomr.org/JOMR/archives/2011/2/e5/v2n2e5ht.htm J Oral Maxillofac Res 2011 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a4/45/jomr-02-e5.PMC3886062.pdf
"J Oral Maxillofac Res 2011;2(2):e5 URL: http://www.ejomr.org/JOMR/archives/2011/2/e5/v2n2e5ht.pdf doi: 10.5037/jomr.2011.2205 Copyright © Rangare RA, Babu GS, Thomas PS, Shetty RS.",Non-OADS,/arxiv_data1/oa_pdf/a4/45/jomr-02-e5.PMC3886062.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org/ ), 30 March 2010.",Non-OADS,/arxiv_data1/oa_pdf/a4/45/jomr-02-e5.PMC3886062.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/a4/45/jomr-02-e5.PMC3886062.pdf
J Oral Maxillofac Res 2011 (Jan-Mar);2(1):e1 URL: http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.pdf doi: 10.5037/jomr.2011.2101 http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  [doi: 10.5037/jomr.2010.1102 ] http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/1/e3/e3ht.htm  [doi: 10.5037/jomr.2010.1103 ] 20.,OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  [doi: 10.5037/jomr.2010.1201 ] 21.,OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
"J Oral Maxillofac Res 2011;2(1):e1 URL: http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.pdf doi: 10.5037/jomr.2011.2101 Copyright © Juodzbalys G, Wang HL, Sabalys G. Accepted for publication in the JOURNAL OF ORAL &   MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 10 January 2011.",Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/d9/4e/jomr-02-e1.PMC3886063.pdf
J Oral Maxillofac Res 2011 (Jan-Mar);2(1):e4 URL: http://www.ejomr.org/JOMR/archives/2011/1/e4/v2n1e4ht.pdf doi: 10.5037/jomr.2011.2104 http://www.ejomr.org/JOMR/archives/2011/1/e4/v2n1e4ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/7f/jomr-02-e4.PMC3886064.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e4/v2n1e4ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/7f/jomr-02-e4.PMC3886064.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e4/v2n1e4ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/7f/jomr-02-e4.PMC3886064.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e4/v2n1e4ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/7f/jomr-02-e4.PMC3886064.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e4/v2n1e4ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/7f/jomr-02-e4.PMC3886064.pdf
"J Oral Maxillofac Res 2011;2(1):e4 URL: http://www.ejomr.org/JOMR/archives/2011/1/e4/v2n1e4ht.pdf doi: 10.5037/jomr.2011.2104 Copyright © Sperandio FF, Giudice FS, Pinto-Junior DD, de Sousa SC.",Non-OADS,/arxiv_data1/oa_pdf/1f/7f/jomr-02-e4.PMC3886064.pdf
"Accepted for publication in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 27 December 2010.",Non-OADS,/arxiv_data1/oa_pdf/1f/7f/jomr-02-e4.PMC3886064.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/1f/7f/jomr-02-e4.PMC3886064.pdf
J Oral Maxillofac Res 2011 (Jan-Mar);2(1):e3 URL: http://www.ejomr.org/JOMR/archives/2011/1/e3/v2n1e3ht.pdf doi: 10.5037/jomr.2011.2103 http://www.ejomr.org/JOMR/archives/2011/1/e3/v2n1e3ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/26/jomr-02-e3.PMC3886065.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e3/v2n1e3ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/26/jomr-02-e3.PMC3886065.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e3/v2n1e3ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/26/jomr-02-e3.PMC3886065.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e3/v2n1e3ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/26/jomr-02-e3.PMC3886065.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e3/v2n1e3ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/26/jomr-02-e3.PMC3886065.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e3/v2n1e3ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/26/jomr-02-e3.PMC3886065.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e3/v2n1e3ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3c/26/jomr-02-e3.PMC3886065.pdf
"J Oral Maxillofac Res 2011;2(1):e3 URL: http://www.ejomr.org/JOMR/archives/2011/1/e3/v2n1e3ht.pdf doi: 10.5037/jomr.2011.2103 Copyright © Deo V , Ansari S, Mandia S, Bhongade B.",Non-OADS,/arxiv_data1/oa_pdf/3c/26/jomr-02-e3.PMC3886065.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 20 December 2010.",Non-OADS,/arxiv_data1/oa_pdf/3c/26/jomr-02-e3.PMC3886065.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/3c/26/jomr-02-e3.PMC3886065.pdf
J Oral Maxillofac Res 2011 (Jan-Mar);2(1):e2 URL: http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.pdf doi: 10.5037/jomr.2011.2102 http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
"J Oral Maxillofac Res 2011;2(1):e2 URL: http://www.ejomr.org/JOMR/archives/2011/1/e2/v2n1e2ht.pdf doi: 10.5037/jomr.2011.2102 Copyright © Schuckert KH, Jopp S, Osadnik M. Accepted for publication in the JOURNAL OF ORAL &   MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 18 January 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/b7/ad/jomr-02-e2.PMC3886066.pdf
J Oral Maxillofac Res 2011 (Jan-Mar);2(1):e5 URL: http://www.ejomr.org/JOMR/archives/2011/1/e5/v2n1e5ht.pdf doi: 10.5037/jomr.2011.2105 http://www.ejomr.org/JOMR/archives/2011/1/e5/v2n1e5ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/64/85/jomr-02-e5.PMC3886067.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e5/v2n1e5ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/64/85/jomr-02-e5.PMC3886067.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e5/v2n1e5ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/64/85/jomr-02-e5.PMC3886067.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e5/v2n1e5ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/64/85/jomr-02-e5.PMC3886067.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e5/v2n1e5ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/64/85/jomr-02-e5.PMC3886067.pdf
URL: http://medind.nic.in/eaa/t01/i1/eaat01i1p24g.pdf 25.,OADS,/arxiv_data1/oa_pdf/64/85/jomr-02-e5.PMC3886067.pdf
URL: http://www.defence.gov.au/health/adf_nurses/Archive/Latex_Allergy.pdf,OADS,/arxiv_data1/oa_pdf/64/85/jomr-02-e5.PMC3886067.pdf
http://www.ejomr.org/JOMR/archives/2011/1/e5/v2n1e5ht.htm J Oral Maxillofac Res 2011 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/64/85/jomr-02-e5.PMC3886067.pdf
"J Oral Maxillofac Res 2011;2(1):e5 URL: http://www.ejomr.org/JOMR/archives/2011/1/e5/v2n1e5ht.pdf doi: 10.5037/jomr.2011.2105 Copyright © Shetty SR, Rangare A, Babu S, Rao P. Accepted for publication in the JOURNAL OF ORAL &   MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 23 January 2011.",Non-OADS,/arxiv_data1/oa_pdf/64/85/jomr-02-e5.PMC3886067.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/64/85/jomr-02-e5.PMC3886067.pdf
"Part I. J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e1 URL: http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.pdf doi: 10.5037/jomr.2010.1301Lateral Periodontal Cyst: a Case Report and Literature Review Luis Felipe das Chagas e Silva de Carvalho1, Celina Faig Lima2, Luiz Antonio Guimarães Cabral3,  Adriana Aigotti Haberbeck Brandão3, Janete Dias Almeida3 1Postgraduation Program in Oral Biopathology, São José dos Campos Dental School, São Paulo State University - UNESP,  São José dos Campos, São Paulo, Brazil and Postgraduation Program in Nanosciences and Advanced Materials, Federal  University of ABC, Santo André, São Paulo, Brazil 2Postgraduation Program in Oral Biopathology, São José dos Campos Dental School, São Paulo State University - UNESP,  São José dos Campos, São Paulo, Brasil 3Department of Biosciences and Oral Diagnosis, São José dos Campos Dental School, São Paulo State University - UNESP,  São José dos Campos, São Paulo, Brazil Corresponding Author: Janete Dias Almeida Faculdade de Odontologia de São José dos Campos – UNESP Departamento de Biociências e Diagnóstico Bucal Av.",Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
J Oral Maxillofac Res 2010 (Oct-Dec);1(4):e5 URL: http://www.ejomr.org/JOMR/archives/2010/4/e5/v1n4e5ht.pdf doi: 10.5037/jomr.2010.1405 http://www.ejomr.org/JOMR/archives/2010/4/e5/v1n4e5ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e5/v1n4e5ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e5/v1n4e5ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e5/v1n4e5ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e5/v1n4e5ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e5/v1n4e5ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e5/v1n4e5ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
"J Oral Maxillofac Res 2010;1(4):e5 URL: http://www.ejomr.org/JOMR/archives/2010/4/e5/v1n4e5ht.pdf doi: 10.5037/jomr.2010.1405 Copyright © de Carvalho LF, Lima CF, Cabral LA, Brandão AA, Almeida JD.",Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
"Accepted for publication in the JOURNAL  OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org/ ), 21 October 2010.",Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.31.",Non-OADS,/arxiv_data1/oa_pdf/60/59/jomr-01-e5.PMC3886068.pdf
"Part I. J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e1 URL: http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.pdf doi: 10.5037/jomr.2010.1301Granular Cell Ameloblastoma: an Unusual Histological Subtype  Report and Review of Literature Nikolaos G. Nikitakis1, Fotios Tzerbos2, Kyriaki Triantafyllou1, Christos Papadimas2, Alexandra  Sklavounou1 1Department of Oral Pathology and Medicine, School of Dentistry, National and Kapodistrian University of Athens, Greece  2Department of Oral and Maxillofacial Surgery, School of Dentistry, National and Kapodistrian University of Athens, Greece  Corresponding Author: Nikolaos G. Nikitakis Department of Oral Pathology and Medicine, School of Dentistry, University of Athens 2 Thivon St., Goudi 11527, Athens Greece Phone: +30 210 746 1003 Fax: +30 210 746 1220  E-mail: nnikitakis1@yahoo.com ABSTRACT Background:  Granular cell ameloblastoma is a rare histological subtype of ameloblastoma accounting for less than 5% of  the total.",Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
J Oral Maxillofac Res 2010 (Oct-Dec);1(4):e3 URL: http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.pdf doi: 10.5037/jomr.2010.1403 http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
[Medline: 8857640 ] http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
"J Oral Maxillofac Res 2010;1(4):e3 URL: http://www.ejomr.org/JOMR/archives/2010/4/e3/v1n4e3ht.pdf doi: 10.5037/jomr.2010.1403 Copyright © Nikitakis NG, Tzerbos F, Triantafyllou K, Papadimas C, Sklavounou A.",Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
"Accepted for publication in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org/ ), 29 September 2010.",Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/53/da/jomr-01-e3.PMC3886069.pdf
"Part I. J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e1 URL: http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.pdf doi: 10.5037/jomr.2010.1301Mouthwash Use in General Population: Results from Adult Dental  Health Survey in Grampian, Scotland Tatiana V .",Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
J Oral Maxillofac Res 2010 (Oct-Dec);1(4):e2 URL: http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.pdf doi: 10.5037/jomr.2010.1402 http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
"Age, gender  and area stratified random sample of 6,000 people aged  25 years and over was selected from the Community  Health Index (CHI) database ( http://www.shsc.scot.nhs.",OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
"NHS Grampian had  recently undertaken a youth and young people lifestyle  survey ( http://www.hi-netgrampian.org/hinet/file/4388/ GrampianYouthLifestyleSurveyreport2007final.doc ), and  therefore 16 - 24 year olds were not sampled.",Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
Deprivation was measured using the Scottish Index of  Multiple Deprivation (SIMD) ( http://www.scotland.gov.,OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
"All analysis was done using PASW Statistics 18  (Release 18.0.2, April 2, 2010, http://www.spss.com/ ).",OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
Available from:   http://www.australianprescriber.com/magazine/32/3/72/5/ 2.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
Available from:   http://www.australianprescriber.com/magazine/32/6/162/4/   [doi: 10.1111/j.1834-7819.2009.01116_4.x ] 6.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
[Medline: 14622444 ] [doi: 10.1186/1472-6963-3-21 ] [FREE Full Text ] http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
"J Oral Maxillofac Res 2010;1(4):e2 URL: http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.pdf doi: 10.5037/jomr.2010.1402 Copyright © Macfarlane TV , Kawecki MM, Cunningham C, Bovaird I, Morgan R, Rhodes K, Watkins R. Accepted for  publication in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org/ ), 22 October 2010.",Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/3a/b7/jomr-01-e2.PMC3886070.pdf
"Part I. J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e1 URL: http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.pdf doi: 10.5037/jomr.2010.1301Osteochondroma of the Temporomandibular Joint Treated by  Means of Condylectomy and Immediate Reconstruction with a  Total Stock Prosthesis Miguel-Angel Morey-Mas1, Jorge Caubet-Biayna2, José-Ignacio Iriarte-Ortabe1 1Department of Oral and Maxillofacial Surgery, Son Dureta University Hospital, Palma de Mallorca, Spain 2Bone regeneration and Oral and Maxillofacial Surgery Unit (GBCOM), Hospital Son Dureta, Insalud, Baleares, Spain  Corresponding Author: Miguel-Angel Morey-Mas Department of Oral and Maxillofacial Surgery Son Dureta University Hospital 55 Andrea Doria Street, 0701 Palma Mallorca Spain Phone: +34 971452131 E-mail: mmoreym@gmail.com ABSTRACT Background:  Osteochondromas are one of the most common benign tumours of bone, but they are rare in the craniofacial  region.",Non-OADS,/arxiv_data1/oa_pdf/34/0f/jomr-01-e4.PMC3886071.pdf
J Oral Maxillofac Res 2010 (Oct-Dec);1(4):e4 URL: http://www.ejomr.org/JOMR/archives/2010/4/e4/v1n4e4ht.pdf doi: 10.5037/jomr.2010.1404 http://www.ejomr.org/JOMR/archives/2010/4/e4/v1n4e4ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/34/0f/jomr-01-e4.PMC3886071.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e4/v1n4e4ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/34/0f/jomr-01-e4.PMC3886071.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e4/v1n4e4ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/34/0f/jomr-01-e4.PMC3886071.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e4/v1n4e4ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/34/0f/jomr-01-e4.PMC3886071.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e4/v1n4e4ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/34/0f/jomr-01-e4.PMC3886071.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e4/v1n4e4ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/34/0f/jomr-01-e4.PMC3886071.pdf
"J Oral Maxillofac Res 2010 (Oct-Dec);1(4):e4 URL: http://www.ejomr.org/JOMR/archives/2010/4/e4/v1n4e4ht.pdf doi: 10.5037/jomr.2010.1404 Copyright © Morey-Mas MA, Caubet-Biayna J, Iriarte-Ortabe JI.",Non-OADS,/arxiv_data1/oa_pdf/34/0f/jomr-01-e4.PMC3886071.pdf
"Accepted for publication in the JOURNAL OF ORAL  & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org/ ), 22 October 2010.",Non-OADS,/arxiv_data1/oa_pdf/34/0f/jomr-01-e4.PMC3886071.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/34/0f/jomr-01-e4.PMC3886071.pdf
Part I. J Oral Maxillofac Res 2010 (Jul- Sep);1(3):e1 URL: http://www.ejomr.org/JOMR/archives/2010/3/e1/e1ht.pdf doi: 10.5037/jomr.2010.1301The Effect of Locally Delivered Doxycycline in the Treatment  of Chronic Periodontitis.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
J Oral Maxillofac Res 2010 (Oct-Dec);1(4):e1 URL: http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e1ht.pdf doi: 10.5037/jomr.2010.1401 http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.htm J Oral Maxillofac Res 2010 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
"J Oral Maxillofac Res 2010;1(4):e1 URL: http://www.ejomr.org/JOMR/archives/2010/4/e1/v1n4e1ht.pdf doi: 10.5037/jomr.2010.1401 Copyright © Ioannou I, Dimitriadis N, Papadimitriou K, V ouros I, Sakellari D, Konstantinidis A.",Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
"Accepted for publication  in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org/ ), 31 July 2010.",Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org/ ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/76/76/jomr-01-e1.PMC3886072.pdf
J Oral Maxillofac Res 2011 (Jul-Sep);2(3):e1 URL: http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.pdf doi: 10.5037/jomr.2011.2301 http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
"J Oral Maxillofac Res 2011;2(3):e1 URL: http://www.ejomr.org/JOMR/archives/2011/3/e1/v2n3e1ht.pdf doi: 10.5037/jomr.2011.2301 Copyright © Vandeweghe S, Hattingh A, Wennerberg A, De Bruyn H.  Accepted for publication in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 4 August 2011.",Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/12/cb/jomr-02-e1.PMC3886073.pdf
J Oral Maxillofac Res 2011 (Jul-Sep);2(3):e4 URL: http://www.ejomr.org/JOMR/archives/2011/3/e4/v2n3e4ht.pdf doi: 10.5037/jomr.2011.2304 http://www.ejomr.org/JOMR/archives/2011/3/e4/v2n3e4ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8f/ee/jomr-02-e4.PMC3886074.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e4/v2n3e4ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8f/ee/jomr-02-e4.PMC3886074.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e4/v2n3e4ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8f/ee/jomr-02-e4.PMC3886074.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e4/v2n3e4ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8f/ee/jomr-02-e4.PMC3886074.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e4/v2n3e4ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8f/ee/jomr-02-e4.PMC3886074.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e4/v2n3e4ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8f/ee/jomr-02-e4.PMC3886074.pdf
"J Oral Maxillofac Res 2011;2(3):e4 URL: http://www.ejomr.org/JOMR/archives/2011/3/e4/v2n3e4ht.pdf doi: 10.5037/jomr.2011.2304 Copyright © Arvanitidou IE, Nikitakis NG, Sklavounou A.",Non-OADS,/arxiv_data1/oa_pdf/8f/ee/jomr-02-e4.PMC3886074.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 7 June 2011.",Non-OADS,/arxiv_data1/oa_pdf/8f/ee/jomr-02-e4.PMC3886074.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/8f/ee/jomr-02-e4.PMC3886074.pdf
J Oral Maxillofac Res 2011 (Jul-Sep);2(3):e3 URL: http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.pdf doi: 10.5037/jomr.2011.2303 http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
[Medline: 20580538 ] [doi: 10.1016/j.colsurfb.2010.05.032 ] http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
URL: http://www.freepatentsonline.com/EP1781568A1.html  [FREE Full Text ] 35.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/3/e3/e3ht.htm  [doi: 10.5037/jomr.2010.1303 ] 40.,OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
"J Oral Maxillofac Res 2011;2(3):e3 URL: http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.pdf doi: 10.5037/jomr.2011.2303 Copyright © Bougas K, Stenport VF, Currie F, Wennerberg A.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 19 July 2011.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/jomr-02-e3.PMC3886075.pdf
J Oral Maxillofac Res 2011 (Jul-Sep);2(3):e2 URL: http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.pdf doi: 10.5037/jomr.2011.2302 http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
J Oral Maxillofac Res 2011;2(3):e2 URL: http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.pdf doi: 10.5037/jomr.2011.2302,Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e2/v2n3e2ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 11 July 2011.",Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/af/e4/jomr-02-e2.PMC3886076.pdf
J Oral Maxillofac Res 2011 (Jul-Sep);2(3):e5 URL: http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.pdf doi:10.5037/jomr.2011.2305 http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/2/e5/e5ht.htm   [doi: 10.5037/jomr.2010.1205 ] 10.,OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.htm J Oral Maxillofac Res 2011 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
"J Oral Maxillofac Res 2011;2(3):e5 URL: http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.pdf doi: 10.5037/jomr.2011.2305 Copyright © Rao KA, Shetty SR, Babu SG, Castelino RL.",Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 14 April 2011.",Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/d1/c7/jomr-02-e5.PMC3886077.pdf
J Oral Maxillofac Res 2011 (Oct-Dec);2(4):e1 URL: http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.pdf doi: 10.5037/jomr.2011.2401 http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
[Medline: 16922928 ]  [doi: 10.1111/j.1399-302X.2006.00293.x ] http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
"J Oral Maxillofac Res 2011;2(4):e1 URL: http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.pdf doi: 10.5037/jomr.2011.2401 Copyright © Graunaite I, Lodiene G, Maciulskiene V .",Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 3 September 2011.",Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e1/v2n4e1ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/61/d7/jomr-02-e1.PMC3886078.pdf
J Oral Maxillofac Res 2011 (Oct-Dec);2(4):e4 URL: http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e4ht.pdf doi: 10.5037/jomr.2011.2404 http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e4ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/0b/jomr-02-e4.PMC3886079.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e4ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/0b/jomr-02-e4.PMC3886079.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e4ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/0b/jomr-02-e4.PMC3886079.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e4ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/0b/jomr-02-e4.PMC3886079.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e4ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/0b/jomr-02-e4.PMC3886079.pdf
J Oral Maxillofac Res 2011;2(4):e4 URL: http://www.ejomr.org/JOMR/archives/2011/4/e4/v2n4e4ht.pdf doi: 10.5037/jomr.2011.2404,Non-OADS,/arxiv_data1/oa_pdf/a6/0b/jomr-02-e4.PMC3886079.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e4ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/0b/jomr-02-e4.PMC3886079.pdf
"Copyright © Pandey PK, Umarani M, Kotrashetti S, Baliga S.  Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 29 November 2011.",Non-OADS,/arxiv_data1/oa_pdf/a6/0b/jomr-02-e4.PMC3886079.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/a6/0b/jomr-02-e4.PMC3886079.pdf
J Oral Maxillofac Res 2011 (Oct-Dec);2(4):e3 URL: http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e3ht.pdf doi: 10.5037/jomr.2011.2403 http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e3ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e3ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e3ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e3ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e3ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e3ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e3ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ht.htm ;  [doi: 10.5037/jomr.2010.1302 ] 2.,OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e3ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
"J Oral Maxillofac Res 2011;2(4):e3 URL: http://www.ejomr.org/JOMR/archives/2011/4/e3/v2n4e3ht.pdf doi: 10.5037/jomr.2011.2403 Copyright © Yasuda T, Chiba H, Satomi T, Matsuo A, Kaneko T, Chikazu D, Miyamatsu H.  Accepted for publication in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 28 November 2011.",Non-OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/a1/86/jomr-02-e3.PMC3886080.pdf
J Oral Maxillofac Res 2011 (Oct-Dec);2(4):e2 URL: http://www.ejomr.org/JOMR/archives/2011/4/e2/v2n4e2ht.pdf doi: 10.5037/jomr.2011.2402 http://www.ejomr.org/JOMR/archives/2011/4/e2/v2n4e2ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e2/v2n4e2ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e2/v2n4e2ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e2/v2n4e2ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e2/v2n4e2ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e2/v2n4e2ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e2/v2n4e2ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/3/e2/e2ab.htm ;  [doi: 10.5037/jomr.2010.1302 ] 2.,OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e2/v2n4e2ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
"J Oral Maxillofac Res 2011;2(4):e2 URL: http://www.ejomr.org/JOMR/archives/2011/4/e2/v2n4e2ht.pdf doi: 10.5037/jomr.2011.2402 Copyright © Wolff J, Agata H, Sándor GK, Haimi S.  Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 23 August 2011.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/jomr-02-e2.PMC3886081.pdf
J Oral Maxillofac Res 2011 (Oct-Dec);2(4):e5 URL: http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.pdf doi: 10.5037/jomr.2011.2405 http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
[Medline: 10221545 ] [doi: 10.1016/S8756-3282(98)00194-X ] http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
2008 Nov. URL: http://www.faqs.org/patents/app/20080220233 29.,OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
URL:  http://www.ejomr.org/JOMR/archives/2011/3/e3/v2n3e3ht.htm ; [doi: 10.5037/jomr.2011.230339 ] 39.,OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.htm J Oral Maxillofac Res 2011 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
"J Oral Maxillofac Res 2011;2(4):e5 URL: http://www.ejomr.org/JOMR/archives/2011/4/e5/v2n4e5ht.pdf doi: 10.5037/jomr.2011.2405 Copyright © Bougas K, Stenport VF, Tengvall P, Currie F, Wennerberg A.",Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
"Accepted for publication in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 16 September 2011.",Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/5c/64/jomr-02-e5.PMC3886082.pdf
J Oral Maxillofac Res 2012;3(3):e5 URL: http://www.ejomr.org/JOMR/archives/2012/3/e5/v3n3e5ht.pdf doi: 10.5037/jomr.2012.3305 http://www.ejomr.org/JOMR/archives/2012/3/e5/v3n3e5ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/jomr-03-e5.PMC3886083.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e5/v3n3e5ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/jomr-03-e5.PMC3886083.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e5/v3n3e5ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/jomr-03-e5.PMC3886083.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e5/v3n3e5ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/jomr-03-e5.PMC3886083.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e5/v3n3e5ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/jomr-03-e5.PMC3886083.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e5/v3n3e5ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7e/e5/jomr-03-e5.PMC3886083.pdf
"J Oral Maxillofac Res 2012;3(3):e5 URL: http://www.ejomr.org/JOMR/archives/2012/3/e5/v3n3e5ht.pdf doi: 10.5037/jomr.2012.3305 Copyright ©  Reenesh M, Munishwar S, Rath SK.",Non-OADS,/arxiv_data1/oa_pdf/7e/e5/jomr-03-e5.PMC3886083.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 25 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/7e/e5/jomr-03-e5.PMC3886083.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.REFERENCES 1. Cooper CL, Loewen R, Shore T. Gingival hyperplasia complicating acute myelomonocytic leukemia.",Non-OADS,/arxiv_data1/oa_pdf/7e/e5/jomr-03-e5.PMC3886083.pdf
URL: http://web.squ.edu.om/med-Lib/MED_CD/E_CDs/oral%20medicine/startme.pdf 3.,OADS,/arxiv_data1/oa_pdf/7e/e5/jomr-03-e5.PMC3886083.pdf
J Oral Maxillofac Res 2012;3(3):e4 URL: http://www.ejomr.org/JOMR/archives/2012/3/e4/v3n3e4ht.pdf doi: 10.5037/jomr.2012.3304 http://www.ejomr.org/JOMR/archives/2012/3/e4/v3n3e4ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e4/v3n3e4ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e4/v3n3e4ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e4/v3n3e4ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e4/v3n3e4ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e4/v3n3e4ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e4/v3n3e4ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e4/v3n3e4ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
"J Oral Maxillofac Res 2012;3(3):e4 URL: http://www.ejomr.org/JOMR/archives/2012/3/e4/v3n3e4ht.pdf doi: 10.5037/jomr.2012.3304 Copyright ©  Borges T, Lima T, Carvalho Á, Carvalho V .",Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 27 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/57/86/jomr-03-e4.PMC3886084.pdf
J Oral Maxillofac Res 2012;3(3):e2 URL: http://www.ejomr.org/JOMR/archives/2012/3/e2/v3n3e2ht.pdf doi: 10.5037/jomr.2012.3302 http://www.ejomr.org/JOMR/archives/2012/3/e2/v3n3e2ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/eb/jomr-03-e2.PMC3886085.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e2/v3n3e2ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/eb/jomr-03-e2.PMC3886085.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e2/v3n3e2ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/eb/jomr-03-e2.PMC3886085.pdf
0102030405060708090100Aberdeen City (2.1)Dyce (6.2)Balmedie (8.2)Banchory (18.7)Westhill (6.2)Aboyne (30.8)Stonehaven (15.5)Ellon (16.9)Peterhead (32.3)Banff (45.1)Inverurie (16.3)Insch (28)Turriff (29.4)Huntly (37.7)Keith (48.1)Elgin (64.9)Lossiemouth (68.4)Fife (89.5)Liverpool (353) Number of patientsPostcode region and distance from ARI (miles) http://www.ejomr.org/JOMR/archives/2012/3/e2/v3n3e2ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/eb/jomr-03-e2.PMC3886085.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e2/v3n3e2ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/eb/jomr-03-e2.PMC3886085.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e2/v3n3e2ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/eb/jomr-03-e2.PMC3886085.pdf
URL: http://www.aberdeenshire.gov.uk/statistics/ 7.,Non-OADS,/arxiv_data1/oa_pdf/5d/eb/jomr-03-e2.PMC3886085.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e2/v3n3e2ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/eb/jomr-03-e2.PMC3886085.pdf
"J Oral Maxillofac Res 2012;3(3):e2 URL: http://www.ejomr.org/JOMR/archives/2012/3/e2/v3n3e2ht.pdf doi: 10.5037/jomr.2012.3302 Copyright ©  Hutchison C, Morrison R. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 26 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/5d/eb/jomr-03-e2.PMC3886085.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.11.",Non-OADS,/arxiv_data1/oa_pdf/5d/eb/jomr-03-e2.PMC3886085.pdf
J Oral Maxillofac Res 2012;3(3):e1 URL: http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.pdf doi: 10.5037/jomr.2012.3301 http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
URL: http://www.australianprescriber.com/magazine/32/6/162/4/ 4.,Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
"J Oral Maxillofac Res 2012;3(3):e1 URL: http://www.ejomr.org/JOMR/archives/2012/3/e1/v3n3e1ht.pdf doi: 10.5037/jomr.2012.3301 Copyright ©  Wirth T, Kawecki MM, Reeve J, Cunningham C, Bovaird I, Macfarlane TV .",Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
"Accepted for publication in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 28 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.14.",Non-OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/4/e2/v1n4e2ht.htm  [doi: 10.5037/jomr.2010.1402 ] 18.,OADS,/arxiv_data1/oa_pdf/84/d7/jomr-03-e1.PMC3886086.pdf
J Oral Maxillofac Res 2012;3(3):e3 URL: http://www.ejomr.org/JOMR/archives/2012/3/e3/v3n3e3ht.pdf doi: 10.5037/jomr.2012.3303 http://www.ejomr.org/JOMR/archives/2012/3/e3/v3n3e3ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e3/v3n3e3ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e3/v3n3e3ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e3/v3n3e3ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e3/v3n3e3ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e3/v3n3e3ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
URL: http://www.idf.org/diabetesatlas 3.,Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e3/v3n3e3ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
J Oral Maxillofac Res 2012;3(3):e3 URL: http://www.ejomr.org/JOMR/archives/2012/3/e3/v3n3e3ht.pdf doi: 10.5037/jomr.2012.3303 Copyright ©  Panchbhai AS.,Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH  (http://www.ejomr.org ), 4 July 2012 This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed  under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License , which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/94/16/jomr-03-e3.PMC3886087.pdf
J Oral Maxillofac Res 2012;3(3):e6 URL: http://www.ejomr.org/JOMR/archives/2012/3/e6/v3n3e6ht.pdf doi: 10.5037/jomr.2012.3306 http://www.ejomr.org/JOMR/archives/2012/3/e6/v3n3e6ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e6/v3n3e6ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e6/v3n3e6ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e6/v3n3e6ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e6/v3n3e6ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
http://www.ejomr.org/JOMR/archives/2012/3/e6/v3n3e6ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
URL: http://old.materialise.com/materialise/view/fr/382317-Extra-oral+Implant+Placement.html?cat=115089 17.,Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
[doi: 10.4103/0970-0358.19796 ] http://www.ejomr.org/JOMR/archives/2012/3/e6/v3n3e6ht.htm J Oral Maxillofac Res 2012 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
"J Oral Maxillofac Res 2012;3(3):e6 URL: http://www.ejomr.org/JOMR/archives/2012/3/e6/v3n3e6ht.pdf doi: 10.5037/jomr.2012.3306 Copyright ©  El Charkawi HG, El Sharkawi AG.",Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 7 August 2012.",Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/07/00/jomr-03-e6.PMC3886088.pdf
J Oral Maxillofac Res 2012 (Jan-Mar);3(1):e5 URL: http://www.ejomr.org/JOMR/archives/2012/1/e5/v3n1e5ht.pdf doi: 10.5037/jomr.2012.3105 http://www.ejomr.org/JOMR/archives/2012/1/e5/v3n1e5ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/jomr-03-e5.PMC3886089.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e5/v3n1e5ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/jomr-03-e5.PMC3886089.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e5/v3n1e5ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/jomr-03-e5.PMC3886089.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e5/v3n1e5ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/jomr-03-e5.PMC3886089.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e5/v3n1e5ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/jomr-03-e5.PMC3886089.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e5/v3n1e5ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/jomr-03-e5.PMC3886089.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e5/v3n1e5ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/jomr-03-e5.PMC3886089.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e5/v3n1e5ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/jomr-03-e5.PMC3886089.pdf
"J Oral Maxillofac Res 2012;3(1):e5 URL: http://www.ejomr.org/JOMR/archives/2012/1/e5/v3n1e5ht.pdf doi: 10.5037/jomr.2012.3105 Copyright ©  Raunio A, Rauhala E, Kiviharju M, Lehmijoki O, Sándor GK, Oikarinen K. Accepted for publication in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 29 March 2012 This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed  under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License , which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/e9/jomr-03-e5.PMC3886089.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/bf/e9/jomr-03-e5.PMC3886089.pdf
J Oral Maxillofac Res 2012 (Jan-Mar);3(1):e4 URL: http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.pdf doi: 10.5037/jomr.2012.3104 http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
    Counts/10000 http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
[Medline: 12608667 ] http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
"J Oral Maxillofac Res 2012;3(1):e4 URL: http://www.ejomr.org/JOMR/archives/2012/1/e4/v3n1e4ht.pdf doi: 10.5037/jomr.2012.3104 Copyright ©  Mesquita P, Gomes PD, Sampaio P, Juodzbalys G, Afonso A, Fernandes MH.",Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
"Accepted for publication in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 29 March 2012 This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed  under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License , which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/62/12/jomr-03-e4.PMC3886090.pdf
J Oral Maxillofac Res 2012 (Jan-Mar);3(1):e2 URL: http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.pdf doi: 10.5037/jomr.2012.3102 http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
J Oral Maxillofac Res 2012;3(1):e2 URL: http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.pdf doi: 10.5037/jomr.2012.3102 http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e2/v3n1e2ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 17 March 2012 This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed  under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License , which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/15/01/jomr-03-e2.PMC3886091.pdf
J Oral Maxillofac Res 2012 (Jan-Mar);3(1):e1 URL: http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.pdf doi: 10.5037/jomr.2012.3101 http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
The journals Pain® http://www.elsevier.com/ wps/find/journaldescription.cws_home/506083/ description#description  and Head and Neck http:// eu.wiley.com/WileyCDA/WileyTitle/productCd-HED.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
Available from: http://www.cancer.gov.dictionary/ 2.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
Available from:   http://www.iarc.fr/en/publications/pdfs-online/wcr/index.php 3.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
Available from: http://www.iarc.fr/en/publications/pdfs-online/wcr/index.php 6.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
Available from: http://www.cochrane-handbook.org/ .,OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
[Medline: Cited 2010 Dec 3]; Available from: http://www.refworks.com/ .,OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
Available from: http://www.cochrane-handbook.org 96.,OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
Available from:   http://www.nlm.nih.gov/pubs/factsheets/medline.html 97.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
Available from: http://www.cochrane-handbook.org,OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
J Oral Maxillofac Res 2012;3(1):e1 URL: http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.pdf doi: 10.5037/jomr.2012.3101 http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
"Copyright ©  Macfarlane TV , Wirth T, Ranasinghe S, Ah-See KW, Renny N, Hurman D. Accepted for publication in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 23 February 2012.",Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
"The copyright, license information and link to the original publication on (http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/9e/jomr-03-e1.PMC3886092.pdf
J Oral Maxillofac Res 2012 (Jan-Mar);3(1):e3 URL: http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.pdf doi: 10.5037/jomr.2012.3103 http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.htm J Oral Maxillofac Res 2012 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
"J Oral Maxillofac Res 2012;3(1):e3 URL: http://www.ejomr.org/JOMR/archives/2012/1/e3/v3n1e3ht.pdf doi: 10.5037/jomr.2012.3103 Copyright ©  Gomes PD, Juodzbalys G, Fernandes MH, Guobis Z.",Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 20 March 2012 This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed  under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License , which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/86/9e/jomr-03-e3.PMC3886093.pdf
J Oral Maxillofac Res 2012;3(4):e5 URL: http://www.ejomr.org/JOMR/archives/2012/4/e5/v3n4e5ht.pdf doi: 10.5037/jomr.2012.3405 http://www.ejomr.org/JOMR/archives/2012/4/e5/v3n4e5ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e5/v3n4e5ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e5/v3n4e5ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e5/v3n4e5ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e5/v3n4e5ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e5/v3n4e5ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e5/v3n4e5ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e5/v3n4e5ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
"J Oral Maxillofac Res 2012;3(4):e5 URL: http://www.ejomr.org/JOMR/archives/2012/4/e5/v3n4e5ht.pdf doi: 10.5037/jomr.2012.3405 Copyright ©  Näpänkangas R, Raunio A, Sipilä K, Raustia A.",Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 4 December 2012.",Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.22.",Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jomr-03-e5.PMC3886094.pdf
J Oral Maxillofac Res 2012;3(4):e4 URL: http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.pdf doi: 10.5037/jomr.2012.3404 http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
URL: http://direct.bl.uk/bld/PlaceOrder.do?UIN=227265757&ETOC=RN&from=searchengine 34.,OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
[Medline: 16490395 ] [doi: 10.1016/j.clinph.2005.12.025 ]  http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
"J Oral Maxillofac Res 2012;3(4):e4 URL: http://www.ejomr.org/JOMR/archives/2012/4/e4/v3n4e4ht.pdf doi: 10.5037/jomr.2012.3404 Copyright ©  Armijo-Olivo S, Magee D. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 13 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.91.",Non-OADS,/arxiv_data1/oa_pdf/f9/ef/jomr-03-e4.PMC3886095.pdf
URL: http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.pdf doi: 10.5037/jomr.2012.3402 http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
URL: http://www.chlt.org/sandbox/dh/aretaeusEnglish/index.html 3.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
"J Oral Maxillofac Res 2012;3(4):e2 URL: http://www.ejomr.org/JOMR/archives/2012/4/e2/v3n4e2ht.pdf doi: 10.5037/jomr.2012.3402 Copyright ©  Sabalys G, Juodzbalys G, Wang HL.",Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 29 December 2012.",Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/e1/9c/jomr-03-e2.PMC3886096.pdf
URL: http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.pdf doi: 10.5037/jomr.2012.3401 http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm  J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm  J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm  J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
URL: http://www.cancer.gov/cancertopics/factsheet/Sites-Types/ head-and-neck 3.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
URL: http://www.cancerresearchuk.org/cancer-info/ cancerstats/types/oral/incidence/uk-oral-cancer-incidence-statistics 4.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
[doi: 10.5037/jomr.2012.3101 ]  URL: http://www.ejomr.org/JOMR/archives/2012/1/e1/v3n1e1ht.htm 25.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
URL: http://www.britishpainsociety.org/book_cancer_ pain.pdf 32.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
URL: http://www.mrc-bsu.cam.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
[Medline: 22676380 ] [doi: 10.1186/1472-684X-11-7 ] [FREE Full Text ] http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
"J Oral Maxillofac Res 2012;3(4):e1 URL: http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.pdf doi: 10.5037/jomr.2012.3401 Copyright ©  Trotter PB, Norton LA, Loo AS, Munn JI, V oge E, Ah-See KW, Macfarlane TV .",Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
"Accepted for publication in  the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 20 December 2012.",Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm  J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e1/v3n4e1ht.htm  J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6a/2a/jomr-03-e1.PMC3886097.pdf
J Oral Maxillofac Res 2012;3(4):e3 URL: http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.pdf doi: 10.5037/jomr.2012.3403 http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.htm J Oral Maxillofac Res 2012 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
"J Oral Maxillofac Res 2012;3(4):e3 URL: http://www.ejomr.org/JOMR/archives/2012/4/e3/v3n4e3ht.pdf doi: 10.5037/jomr.2012.3403 Copyright ©  Kallás MS, Crosato EM, Maria Biazevic MG, Mori M, Aggarwal VR.",Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
"Accepted for publication in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 21 August 2012.",Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.29.",Non-OADS,/arxiv_data1/oa_pdf/6f/aa/jomr-03-e3.PMC3886098.pdf
J Oral Maxillofac Res 2012 (Apr-Jun);3(2):e5 URL: http://www.ejomr.org/JOMR/archives/2012/2/e5/v3n2e5ht.pdf doi: 10.5037/jomr.2012.3205 http://www.ejomr.org/JOMR/archives/2012/2/e5/v3n2e5ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8b/ed/jomr-03-e5.PMC3886099.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e5/v3n2e5ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8b/ed/jomr-03-e5.PMC3886099.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e5/v3n2e5ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8b/ed/jomr-03-e5.PMC3886099.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e5/v3n2e5ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8b/ed/jomr-03-e5.PMC3886099.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e5/v3n2e5ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8b/ed/jomr-03-e5.PMC3886099.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e5/v3n2e5ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8b/ed/jomr-03-e5.PMC3886099.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e5/v3n2e5ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8b/ed/jomr-03-e5.PMC3886099.pdf
"J Oral Maxillofac Res 2012;3(2):e5 URL: http://www.ejomr.org/JOMR/archives/2012/2/e5/v3n2e5ht.pdf doi: 10.5037/jomr.2012.3205 Copyright ©  Patras M, Martin W, Sykaras N. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 22 May 2012 This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed  under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License , which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/ed/jomr-03-e5.PMC3886099.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/8b/ed/jomr-03-e5.PMC3886099.pdf
J Oral Maxillofac Res 2012;3(2):e4 URL: http://www.ejomr.org/JOMR/archives/2012/2/e4/v3n2e4ht.pdf doi: 10.5037/jomr.2012.3204 http://www.ejomr.org/JOMR/archives/2012/2/e4/v3n2e4ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/e3/jomr-03-e4.PMC3886100.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e4/v3n2e4ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/e3/jomr-03-e4.PMC3886100.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e4/v3n2e4ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/e3/jomr-03-e4.PMC3886100.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e4/v3n2e4ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/e3/jomr-03-e4.PMC3886100.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e4/v3n2e4ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/e3/jomr-03-e4.PMC3886100.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e4/v3n2e4ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/e3/jomr-03-e4.PMC3886100.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e4/v3n2e4ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/e3/jomr-03-e4.PMC3886100.pdf
"J Oral Maxillofac Res 2012;3(2):e4 URL: http://www.ejomr.org/JOMR/archives/2012/2/e4/v3n2e4ht.pdf doi: 10.5037/jomr.2012.3204 Copyright ©  Friedl CC, Bashutski J, Rashidi N. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 28 June 2012 This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed  under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License , which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/e3/jomr-03-e4.PMC3886100.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/c9/e3/jomr-03-e4.PMC3886100.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e4/v3n2e4ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c9/e3/jomr-03-e4.PMC3886100.pdf
J Oral Maxillofac Res 2012 (Apr-Jun);3(2):e2 URL: http://www.ejomr.org/JOMR/archives/2012/2/e2/v3n2e2ht.pdf doi: 10.5037/jomr.2012.3202 http://www.ejomr.org/JOMR/archives/2012/2/e2/v3n2e2ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/21/31/jomr-03-e2.PMC3886101.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e2/v3n2e2ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/21/31/jomr-03-e2.PMC3886101.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e2/v3n2e2ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/21/31/jomr-03-e2.PMC3886101.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e2/v3n2e2ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/21/31/jomr-03-e2.PMC3886101.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e2/v3n2e2ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/21/31/jomr-03-e2.PMC3886101.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e2/v3n2e2ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/21/31/jomr-03-e2.PMC3886101.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e2/v3n2e2ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/21/31/jomr-03-e2.PMC3886101.pdf
"J Oral Maxillofac Res 2012;3(2):e2 URL: http://www.ejomr.org/JOMR/archives/2012/2/e2/v3n2e2ht.pdf doi: 10.5037/jomr.2012.3202 Copyright ©  Benninger B, Rossb A, Delamarter T.  Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 14 June 2012 This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed  under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License , which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/31/jomr-03-e2.PMC3886101.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org)  must be  included.",Non-OADS,/arxiv_data1/oa_pdf/21/31/jomr-03-e2.PMC3886101.pdf
J Oral Maxillofac Res 2012 (Apr-Jun);3(2):e1 URL: http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.pdf doi: 10.5037/jomr.2012.3201 http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
"J Oral Maxillofac Res 2012;3(2):e1 URL: http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.pdf doi: 10.5037/jomr.2012.3201 Copyright ©  Gupta S, Deo V , Williams C. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 10 April 2012 This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed  under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License , which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e1/v3n2e1ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/d7/jomr-03-e1.PMC3886102.pdf
J Oral Maxillofac Res 2012 (Apr-Jun);3(2):e3 URL: http://www.ejomr.org/JOMR/archives/2012/2/e3/v3n2e3ht.pdf doi: 10.5037/jomr.2012.3203 http://www.ejomr.org/JOMR/archives/2012/2/e3/v3n2e3ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/fb/jomr-03-e3.PMC3886103.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e3/v3n2e3ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/fb/jomr-03-e3.PMC3886103.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e3/v3n2e3ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/fb/jomr-03-e3.PMC3886103.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e3/v3n2e3ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/fb/jomr-03-e3.PMC3886103.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e3/v3n2e3ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/fb/jomr-03-e3.PMC3886103.pdf
http://www.ejomr.org/JOMR/archives/2012/2/e3/v3n2e3ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/fb/jomr-03-e3.PMC3886103.pdf
[Medline: 10830646 ] [doi: 10.1034/j.1600-0528.2000.280305.x ] http://www.ejomr.org/JOMR/archives/2012/2/e3/v3n2e3ht.htm J Oral Maxillofac Res 2012 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/fb/jomr-03-e3.PMC3886103.pdf
"J Oral Maxillofac Res 2012;3(2):e3 URL: http://www.ejomr.org/JOMR/archives/2012/2/e3/v3n2e3ht.pdf doi: 10.5037/jomr.2012.3203 Copyright ©  Andersen K, Nørholt SE, Küseler A, Jensen J, Pedersen TK.",Non-OADS,/arxiv_data1/oa_pdf/d2/fb/jomr-03-e3.PMC3886103.pdf
"Accepted for publication in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 20 June 2012 This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed  under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License , which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/fb/jomr-03-e3.PMC3886103.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/d2/fb/jomr-03-e3.PMC3886103.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/1/e4/v4n1e4ht.pdf doi: 10.5037/jomr.2013.4104 http://www.ejomr.org/JOMR/archives/2013/1/e4/v4n1e4ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/4b/jomr-04-e4.PMC3886104.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e4/v4n1e4ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/4b/jomr-04-e4.PMC3886104.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e4/v4n1e4ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/4b/jomr-04-e4.PMC3886104.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e4/v4n1e4ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/4b/jomr-04-e4.PMC3886104.pdf
[Medline: 16880743 ] [doi: 10.4161/cc.5.15.3112 ] [FREE Full Text ] http://www.ejomr.org/JOMR/archives/2013/1/e4/v4n1e4ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/4b/jomr-04-e4.PMC3886104.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e4/v4n1e4ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/4b/jomr-04-e4.PMC3886104.pdf
"J Oral Maxillofac Res 2013;4(1):e4 URL: http://www.ejomr.org/JOMR/archives/2013/1/e4/v4n1e4ht.pdf doi: 10.5037/jomr.2013.4104 Copyright ©  Roy S, Garg V .",Non-OADS,/arxiv_data1/oa_pdf/74/4b/jomr-04-e4.PMC3886104.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH  (http://www.ejomr.org ), 26 February 2013.",Non-OADS,/arxiv_data1/oa_pdf/74/4b/jomr-04-e4.PMC3886104.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/74/4b/jomr-04-e4.PMC3886104.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/1/e5/v4n1e5ht.pdf doi: 10.5037/jomr.2013.4105 http://www.ejomr.org/JOMR/archives/2013/1/e5/v4n1e5ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6b/3d/jomr-04-e5.PMC3886105.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e5/v4n1e5ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6b/3d/jomr-04-e5.PMC3886105.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e5/v4n1e5ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6b/3d/jomr-04-e5.PMC3886105.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e5/v4n1e5ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6b/3d/jomr-04-e5.PMC3886105.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e5/v4n1e5ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6b/3d/jomr-04-e5.PMC3886105.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e5/v4n1e5ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6b/3d/jomr-04-e5.PMC3886105.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e5/v4n1e5ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6b/3d/jomr-04-e5.PMC3886105.pdf
"J Oral Maxillofac Res 2013;4(1):eX URL: http://www.ejomr.org/JOMR/archives/2013/1/e5/v4n1e5ht.pdf doi: 10.5037/jomr.2013.4105 Copyright ©  Nikitakis NG, Emmanouil D, Maroulakos MP, Angelopoulou MV .",Non-OADS,/arxiv_data1/oa_pdf/6b/3d/jomr-04-e5.PMC3886105.pdf
"Accepted for publication in the JOURNAL  OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 27 February 2013.",Non-OADS,/arxiv_data1/oa_pdf/6b/3d/jomr-04-e5.PMC3886105.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/6b/3d/jomr-04-e5.PMC3886105.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.pdf doi: 10.5037/jomr.2013.4102 http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
"J Oral Maxillofac Res 2013;4(1):e2 URL: http://www.ejomr.org/JOMR/archives/2013/1/e2/v4n1e2ht.pdf doi: 10.5037/jomr.2013.4102 Copyright ©  Chen D, Cabay RJ, Jin Y , Wang A, Luo Y , Shah-Khan M, Zhou X.",Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
"Accepted for publication in the JOURNAL  OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 4 March 2013.",Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.160.",Non-OADS,/arxiv_data1/oa_pdf/bd/11/jomr-04-e2.PMC3886106.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/1/e3/v4n1e3ht.pdf doi: 10.5037/jomr.2013.4103 http://www.ejomr.org/JOMR/archives/2013/1/e3/v4n1e3ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jomr-04-e3.PMC3886107.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e3/v4n1e3ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jomr-04-e3.PMC3886107.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e3/v4n1e3ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jomr-04-e3.PMC3886107.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e3/v4n1e3ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jomr-04-e3.PMC3886107.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e3/v4n1e3ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jomr-04-e3.PMC3886107.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e3/v4n1e3ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jomr-04-e3.PMC3886107.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e3/v4n1e3ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jomr-04-e3.PMC3886107.pdf
"J Oral Maxillofac Res 2013;4(1):e3 URL: http://www.ejomr.org/JOMR/archives/2013/1/e3/v4n1e3ht.pdf doi: 10.5037/jomr.2013.4103 Copyright ©  Epivatianos A, Andreadis D, Iordanidis S. Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 29 March 2013.",Non-OADS,/arxiv_data1/oa_pdf/cb/05/jomr-04-e3.PMC3886107.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.23.",Non-OADS,/arxiv_data1/oa_pdf/cb/05/jomr-04-e3.PMC3886107.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.pdf doi: 10.5037/jomr.2013.4101 http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
"This has allowed investigators to catalogue mutations  in over twenty malignancies, including brain, breast,  and prostate cancers (The Cancer Genome Atlas:    http://cancergenome.nih.gov/ ).",OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.htm J Oral Maxillofac Res 2013 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
"J Oral Maxillofac Res 2013;4(1):e1 URL: http://www.ejomr.org/JOMR/archives/2013/1/e1/v4n1e1ht.pdf doi: 10.5037/jomr.2013.4101 Copyright ©  Spiotto MT, Pytynia M, Liu GF, Ranck MC, Widau R. Accepted for publication in the JOURNAL OF ORAL  & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 23 January 2013.",Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/35/1d/jomr-04-e1.PMC3886108.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/2/e4/v4n2e4ht.pdf doi: 10.5037/jomr.2013.4204 http://www.ejomr.org/JOMR/archives/2013/2/e4/v4n2e4ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e3/ab/jomr-04-e4.PMC3886109.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e4/v4n2e4ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e3/ab/jomr-04-e4.PMC3886109.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e4/v4n2e4ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e3/ab/jomr-04-e4.PMC3886109.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e4/v4n2e4ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e3/ab/jomr-04-e4.PMC3886109.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e4/v4n2e4ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e3/ab/jomr-04-e4.PMC3886109.pdf
"J Oral Maxillofac Res 2013;4(2):e4 URL: http://www.ejomr.org/JOMR/archives/2013/2/e4/v4n2e4ht.pdf doi: 10.5037/jomr.2013.4204 Copyright ©  Kuoppala R, Näpänkangas R, Raustia A.",Non-OADS,/arxiv_data1/oa_pdf/e3/ab/jomr-04-e4.PMC3886109.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 19 June 2013.",Non-OADS,/arxiv_data1/oa_pdf/e3/ab/jomr-04-e4.PMC3886109.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.9.",Non-OADS,/arxiv_data1/oa_pdf/e3/ab/jomr-04-e4.PMC3886109.pdf
[Medline: 21726276 ]  [doi: 10.1111/j.1741-2358.2011.00531.x ] http://www.ejomr.org/JOMR/archives/2013/2/e4/v4n2e4ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e3/ab/jomr-04-e4.PMC3886109.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.pdf doi: 10.5037/jomr.2013.4205 http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
J Oral Maxillofac Res 2013;4(2):e5 URL: http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.pdf doi: 10.5037/jomr.2013.4205,Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e5/v4n2e5ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
"Accepted for publication in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 29 June 2013.",Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/18/97/jomr-04-e5.PMC3886110.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.pdf doi: 10.5037/jomr.2013.4202 http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  [doi: 10.5037/jomr.2010.1201 ] 41.,OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm  [doi: 10.5037/jomr.2010.1102 ] 49.,OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
URL: http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm   [doi: 10.5037/jomr.2011.2101 ] 87.,OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
"J Oral Maxillofac Res 2013;4(2):e2 URL: http://www.ejomr.org/JOMR/archives/2013/2/e2/v4n2e2ht.pdf doi: 10.5037/jomr.2013.4202 Copyright ©  Juodzbalys G, Kubilius M. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 12 June 2013.",Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/c5/0f/jomr-04-e2.PMC3886111.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.pdf doi: 10.5037/jomr.2013.4203 http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
Available from: http://globocan.iarc.fr/factsheets/ populations/factsheet.asp?uno=900#MEN 2.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
Available from: http://vdisk.univille.edu.br/community/depto_odontologia/get/ ODONTOLOGIA/RSBO/RSBO_v8_n3_julho-setembro2011/RSBO-v8n3-artigo01.pdf   31.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
Available from: http://www.who.int/substance_abuse/ terminology/who_lexicon/en/ .,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
J Oral Maxillofac Res 2013;4(2):e3 URL: http://www.ejomr.org/JOMR/archives/2013/2/e3/v4n2e3ht.pdf doi: 10.5037/jomr.2013.4203 Copyright ©  Ahmed GH.,Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
"Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH  (http://www.ejomr.org ), 22 April 2013.",Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.62.",Non-OADS,/arxiv_data1/oa_pdf/f4/86/jomr-04-e3.PMC3886112.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.pdf doi: 10.5037/jomr.2013.4201 http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/2/e1/e1ht.htm  [doi: 10.5037/jomr.2010.1201 ] 32.,OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
J Oral Maxillofac Res 2013;4(2):e1 URL: http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.pdf doi: 10.5037/jomr.2013.4201,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm J Oral Maxillofac Res 2013 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
"4 | No 2 | e1 | p.12 (page number not for citation purposes)JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                               Juodzbalys and Daugela  Copyright ©  Juodzbalys G, Daugela P. Accepted for publication in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 11 June 2013.",Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/92/33/jomr-04-e1.PMC3886113.pdf
"http://informahealthcare.com/iht ISSN: 0895-8378 (print), 1091-7691 (electronic) Inhal Toxicol, 2013; 25(13): 735–746 !2013 Informa Healthcare USA, Inc. DOI: 10.3109/08958378.2013.845629 RESEARCH ARTICLE Safe human exposure limits for airborne linear siloxanes during spaceflight Valerie E. Meyers1, Hector D. Garcı ´a2, Tami S. McMullin3, Joseph M. Tobin3, and John T. James1 1National Aeronautics and Space Administration Johnson Space Center, Houston, TX, USA,2Wyle Science, Technology & Engineering Group, Houston, TX, USA, and3Dow Corning Corporation, Health and Environmental Sciences, Midland, MI, USA Abstract Background : Low molecular weight siloxanes are used in industrial processes and consumer products, and their vapors have been detected in the atmospheres of the Space Shuttle andInternational Space Station.",Non-OADS,/arxiv_data1/oa_pdf/a9/db/IHT-25-735.PMC3886388.pdf
"Hexamethyl-disiloxane (L2) Octamethyl-trisiloxane (L3) Decamethyl-tetrasiloxane (L4) Dodecamethyl-pentasiloxane (L5) Structure Formula C 6–H18–O–Si 2 C8–H24–O2–Si 3 C10–H30–O3–Si 4 C12–H36–O4–Si 5 CAS Registry # 107-46-0 107-51-7 141-62-8 141-63-9 Molecular Weight 162.38 236.53 310.69 384.84Physical State Clear, colorless liquid Clear, colorless liquid Clear, colorless liquid Clear, colorless liquid Boiling Point ( /C14C) 99 152 194 232 Melting Point (/C14C) /C066 /C082 /C068 /C080 log K ow 4.2 4.8 5.4 6 Vapor pressure at 25/C14C (torr) 42 3.9 0.4 0.1 Saturated vapor concentration (ppm)a55 300 5131 530 130 Information obtained from NCBI PubChem: http://pubchem.ncbi.nlm.nih.gov/.",Non-OADS,/arxiv_data1/oa_pdf/a9/db/IHT-25-735.PMC3886388.pdf
Available from: http://toxnet.nlm.nih.gov/help/ hsdbnames.html [Last accessed: 21 Jan 2012].,OADS,/arxiv_data1/oa_pdf/a9/db/IHT-25-735.PMC3886388.pdf
Available from: http://www.nap.edu/openbook.php?record_id=9062 &page=R1.,Non-OADS,/arxiv_data1/oa_pdf/a9/db/IHT-25-735.PMC3886388.pdf
"http://informahealthcare.com/iht ISSN: 0895-8378 (print), 1091-7691 (electronic) Inhal Toxicol, 2013; 25(14): 802–812 !2013 Informa Healthcare USA, Inc. DOI: 10.3109/08958378.2013.850127 REVIEW ARTICLE Particulate matter beyond mass: recent health evidence on the role of fractions, chemical constituents and sources of emission Flemming R. Cassee1,2, Marie-Eve He ´roux3, Miriam E. Gerlofs-Nijland1, and Frank J. Kelly4 1Department for Environmental Health, National Institute for Public Health and the Environment, Bilthoven, The Netherlands,2Institute for Risk Assessment Studies, Utrecht University, Utrecht, The Netherlands,3WHO European Centre for Environment and Health, Bonn, Germany, and 4MRC-PHE Centre for Environment and Health, King’s College, London, UK Abstract Particulate matter (PM) is regulated in various parts of the world based on specific size cut offs, often expressed as 10 or 2.5 mm mass median aerodynamic diameter.",Non-OADS,/arxiv_data1/oa_pdf/05/05/IHT-25-802.PMC3886392.pdf
Review of evidence on health aspects of airpollution – REVIHAAP Project: Final technical report isavailable via http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/05/IHT-25-802.PMC3886392.pdf
Available from: http://cfpub.epa.gov/ncea/cfm/ recordisplay.cfm?deid ¼216546#Download.,OADS,/arxiv_data1/oa_pdf/05/05/IHT-25-802.PMC3886392.pdf
Available from: http://ec.europa.eu/environment/archives/cafe/pdf/working_groups/ 2nd_position_paper_pm.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/05/IHT-25-802.PMC3886392.pdf
Available from: http://pubs.healtheffect-s.org/getfile.php?u ¼553.,Non-OADS,/arxiv_data1/oa_pdf/05/05/IHT-25-802.PMC3886392.pdf
Available from: http://pubs.healtheffects.org/ getfile.php?u ¼893.,Non-OADS,/arxiv_data1/oa_pdf/05/05/IHT-25-802.PMC3886392.pdf
Availablefrom: http://www.euro.who.int/__data/assets/pdf_file/0005/78638/E90038.pdf.,OADS,/arxiv_data1/oa_pdf/05/05/IHT-25-802.PMC3886392.pdf
Available from: http://www.euro.who.int/__data/assets/pdf_file/0004/162535/ e96541.pdf.,OADS,/arxiv_data1/oa_pdf/05/05/IHT-25-802.PMC3886392.pdf
Availablefrom: http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report.pdf [Last accessed: 28 Oct 2013].,OADS,/arxiv_data1/oa_pdf/05/05/IHT-25-802.PMC3886392.pdf
"Searches were performed against the latest available FASTA format fullyannotated SwissProt human protein database (UniProtKB/ Swiss-Prot; release 2010 –12 [January 18, 2011 to February 7, 2011] downloaded from the website: http://www.uniprot.",OADS,/arxiv_data1/oa_pdf/cb/b6/jah3-2-e000138.PMC3886733.pdf
"Protein equivalency, transfer ef ﬁciency, membrane blocking, immunoblotting, detection, and densitometry analy- sis (Image J analysis software; http://rsbweb.nih.gov/ij/) were performed as previously described.",OADS,/arxiv_data1/oa_pdf/cb/b6/jah3-2-e000138.PMC3886733.pdf
"Total RNA was isolated using the PAXgene Blood RNA Kit (PreAnalytiX, A Qiagen/BD Company; http://www.preanalytix.com/).",Non-OADS,/arxiv_data1/oa_pdf/cb/b6/jah3-2-e000138.PMC3886733.pdf
"Control reactions without reverse transcriptase were also performed for each reac- tion.16 Oligonucleotide primers (Table 1) were designed using Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and were synthesized by Oligos ETC, Inc.",OADS,/arxiv_data1/oa_pdf/cb/b6/jah3-2-e000138.PMC3886733.pdf
"Accompanying Figures S1 and S2 and Tables S1 through S5 are available at http://jaha.ahajournals.org/content/2/6/e000542/suppl/DC1 Correspondence to: Sahir Kalim, Nephrology Division, Department of Medicine, MGH, 165 Cambridge Street, Suite 302, Boston, MA 02114.",Non-OADS,/arxiv_data1/oa_pdf/72/fa/jah3-2-e000542.PMC3886735.pdf
"More speci ﬁcally, we note that our platform monitors 24 metabolites (Table 5) previously described as potential uremic toxins (http://www.uremic-toxins.org).27By ttest, 5 of these metabolites had nominal associations with case status, with uridine ( P=0.01), sorbitol ( P=0.02), and creatine ( P=0.02) higher in cases than controls and indoxyl sulfate ( P=0.002) and niacinamide ( P=0.04) lower in cases than controls.",Non-OADS,/arxiv_data1/oa_pdf/72/fa/jah3-2-e000542.PMC3886735.pdf
We have used http://strimmerlab.org/notes/fdr.html for FDR analysis as recommended by a statistician.,Non-OADS,/arxiv_data1/oa_pdf/7f/41/jah3-2-e000246.PMC3886739.pdf
Available at: http://www.cdc.gov/dhdsp/ncvdss/index.Htm.,OADS,/arxiv_data1/oa_pdf/6c/b4/jah3-2-e000370.PMC3886741.pdf
Available at http://www.cms.gov/medicare-coverage-database.,Non-OADS,/arxiv_data1/oa_pdf/f8/1f/jah3-2-e000421.PMC3886742.pdf
Clinical Trial Registration- —URL: http://clinicaltrials.gov/ Unique identi ﬁer: NCT01072500.,Non-OADS,/arxiv_data1/oa_pdf/f8/52/jah3-2-e000257.PMC3886743.pdf
A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.,Non-OADS,/arxiv_data1/oa_pdf/26/0c/jah3-2-e000506.PMC3886748.pdf
Available at http://riskfactor.cancer.,Non-OADS,/arxiv_data1/oa_pdf/26/0c/jah3-2-e000506.PMC3886748.pdf
Clinical Trial Registration- —URL: clinicaltrials.gov (http://www.clinicaltrials.gov).,Non-OADS,/arxiv_data1/oa_pdf/d9/21/jah3-2-e000426.PMC3886751.pdf
Available from: http://pewinternet.org/ ∼/media//Files/Reports/ 2012/PIP_Just_In_Time_Info.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e5/92/jah3-2-e000568.PMC3886753.pdf
Available from: http://pewinternet.org/Reports/2013/Smartphone-Ownership-2013.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e5/92/jah3-2-e000568.PMC3886753.pdf
Available from: http://pewinternet.org/Reports/2012/Mobile-Health.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e5/92/jah3-2-e000568.PMC3886753.pdf
Available from: http://www.pewinternet.org/ ∼/media//Files/Reports/2012/PIP_Older_adults_and_ internet_use.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e5/92/jah3-2-e000568.PMC3886753.pdf
Accompanying Tables S1 through S3 are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/01/8a/jah3-2-e000565.PMC3886759.pdf
All calculations were performed using R statistical software (version 3.0.1; http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/01/8a/jah3-2-e000565.PMC3886759.pdf
"The identity and primary intra- or extracellular localization of these proteins according to Gene Ontology (http://www.geneontology.org/) analysis are listed in Table 3, which shows that 7 proteins localized in the cytoplasm, 6 in mitochondria, 1 in the nucleus, and 7 in the extramyocardial space.",OADS,/arxiv_data1/oa_pdf/01/8a/jah3-2-e000565.PMC3886759.pdf
http://depts.washington.edu/ uwruca/ruca-codes.php.,Non-OADS,/arxiv_data1/oa_pdf/be/cd/jah3-2-e000447.PMC3886761.pdf
(Archived by WebCite at http://www.webcitation.,Non-OADS,/arxiv_data1/oa_pdf/be/cd/jah3-2-e000447.PMC3886761.pdf
A full listing of WHI investigators can be found at: https://cleo.whi.org/researchers/Documents%20%20Write%20a%20Paper/ WHI%20Investigator%20Short%20List.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e3/e6/jah3-2-e000369.PMC3886762.pdf
The Top Ten Causes of Death 2008. http://www.who.int/mediacentre/ factsheets/fs310/en/index4.html.,Non-OADS,/arxiv_data1/oa_pdf/e3/e6/jah3-2-e000369.PMC3886762.pdf
Available at: http://www.heart.org/ HEARTORG/HealthcareResearch/MissionLifelineHomePage/Mission-Life- line-Home-Page_UCM_305495_SubHomePage.jsp.,Non-OADS,/arxiv_data1/oa_pdf/db/86/jah3-2-e000552.PMC3886764.pdf
Methods Study Sample The study design and methods of the Framingham Heart Studyhave been described in detail at http://www.framingham heartstudy.org.,Non-OADS,/arxiv_data1/oa_pdf/b0/a8/jah3-2-e000399.PMC3886765.pdf
"Methods Literature Search We performed a literature search through April 2013 on PubMed (http://www.ncbi.nlm.nih.gov/pubmed) and EM- BASE (http://www.embase.com/home) using the searchFrom the Departments of Epidemiology (G.-C.C., Q.-F.L.",OADS,/arxiv_data1/oa_pdf/c5/78/jah3-2-e000329.PMC3886767.pdf
Details regarding the VSGNE have previously been published 11and are available online at http://www.vsgne.com.,Non-OADS,/arxiv_data1/oa_pdf/d5/55/jah3-2-e000345.PMC3886769.pdf
"An accompanying Appendix S1 is available at http://jaha.ahajournals.org/ content/2/6/e000505/suppl/DC1 This work was presented at the 2012 American Heart Association Quality ofCare and Outcomes Research (QCOR) meeting in Atlanta, GA, and the 2012 Society for Medical Decision Making meeting in Phoenix, AZ.",Non-OADS,/arxiv_data1/oa_pdf/05/8a/jah3-2-e000505.PMC3886773.pdf
Available at http://www.who.int/whr/ 2002/en.,OADS,/arxiv_data1/oa_pdf/55/ae/jah3-2-e000344.PMC3886774.pdf
Details of the RCSN can be obtained from http://www.rcsn.org.,Non-OADS,/arxiv_data1/oa_pdf/ac/e7/jah3-2-e000372.PMC3886778.pdf
Available at: http://dx.doi.org/10.1016/S0140-6736(13)61050-8.,OADS,/arxiv_data1/oa_pdf/ac/e7/jah3-2-e000372.PMC3886778.pdf
Available at: http://www.strokebestprac- tices.ca.,Non-OADS,/arxiv_data1/oa_pdf/ac/e7/jah3-2-e000372.PMC3886778.pdf
Clinical Trials Registration Information- —URL: http://www.clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/d5/1b/jah3-2-e000152.PMC3886783.pdf
2011. http://www.who.int/childgrowth/software/en/ 4.,Non-OADS,/arxiv_data1/oa_pdf/71/0e/nihms539861.PMC3886916.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, providedthe original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/c4/dkt349.PMC3886928.pdf
"Geneva, 2012. http://apps.who.",Non-OADS,/arxiv_data1/oa_pdf/de/c4/dkt349.PMC3886928.pdf
"13ResIn—Research Investments in Global Health.http://www.researchinv estments.org/ (15 July 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/de/c4/dkt349.PMC3886928.pdf
"London, 2013. http://www.gov.uk/government/publications/chief-medical- ofﬁcer-annual-report-volume-2 (15 July 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/de/c4/dkt349.PMC3886928.pdf
"http://www.themedcalls.nihr.ac.uk/amr (19 August 2013, date last accessed).17Antibiotic Action - The Arms Race.",Non-OADS,/arxiv_data1/oa_pdf/de/c4/dkt349.PMC3886928.pdf
"http://antibiotic-action.com/ (15 July 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/de/c4/dkt349.PMC3886928.pdf
"London, 2012. http://www.gov.uk/government/publications/esbls-a-threat- to-human-and-animal-health (15 July 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/de/c4/dkt349.PMC3886928.pdf
"2012. http://www.gov.uk/government/news/funding-for-new-research- into-antibiotic-resistance-bacteria-announced (15 July 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/de/c4/dkt349.PMC3886928.pdf
"http://www.who.int/ neglected_diseases/diseases/en/ (15 July 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/de/c4/dkt349.PMC3886928.pdf
"Thisisan Open Access articledistributedunder the terms ofthe Creative Commons Attribution Non-Commercial License(http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/da/dkt370.PMC3886932.pdf
"2001. http://www2.mst.dk/Udgiv/publications/ 2001/87-7944-383-4/pdf/87-7944-384-2.pdf (1 August 2013, date lastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/f3/da/dkt370.PMC3886932.pdf
"2011. http://www.danmap.org/Downloads/~/media/Projekt%20sites/Danmap/ DANMAP%20reports/Danmap_2011.ashx (1 August 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/f3/da/dkt370.PMC3886932.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/9a/dkt381.PMC3886934.pdf
"www.landesbioscience.com Tissue Barriers  e23993-1 COMMENTARY COMMENTARY Tissue Barriers 1:2, e23993; April/May/June 2013; © 2013 Landes Bioscience Keywords:  Alzheimer disease, amyloid- beta peptide, blood brain barrier, tight  junction-associated protein, calcium,  RAGE Abbreviations:  Aβ, amyloid- β peptide;  AD, Alzheimer disease; BBB, blood  brain barrier; CAA, cerebral amyloid  angiopathy; CaN, calcineurin; CNS,  central nervous system; EM, electron  microscopy; FD-40, FITC-dextran  40,000 kDa; GLUT1, glucose  transporter type-1; LRP, low-density  lipoprotein receptor-related protein;  MMP, matrix metalloproteinase; RAGE,  receptor for advanced glycation end  products; SIM, structured illumination  microscopy; TJ, tight junction; ZO-1,  zonula occludens-1 Submitted: 12/24/12 Revised: 02/02/13 Accepted: 02/12/13 http://dx.doi.org/10.4161/tisb.23993 Citation: Kook S-Y, Hong HS, Moon M, Mook-Jung I.  Disruption of blood brain barrier in Alzheimer dis - ease pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Tissue Barriers 2013; 1: e23993;  http://dx.doi.org/10.4161/tisb.23993 *Correspondence to: Inhee Mook-Jung;   Email: inhee@snu.ac.krBlood-brain barrier (BBB) regulates  transport of various molecules and  maintains brain homeostasis.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
J  Neurosci 2012;32:8845-54; PMID:22745485;   http://dx.doi.org/10.1523/JNEUROSCI.6102-11.2012,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Alzheimer  Dis Assoc Disord 1998; 12:182-9; PMID:9772021;  http://dx.doi.org/10.1097/00002093-199809000- 00010.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Neurology  1996; 46:1592-6; PMID:8649554; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Acta Neuropathol 1996; 91:6- 14; PMID:8773140; http://dx.doi.org/10.1007/ s004010050386.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Nat Rev Neurosci 2006; 7:41-53; PMID:16371949;  http://dx.doi.org/10.1038/nrn1824.7.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Neurosci Lett 1991; 129:6-10; PMID:1922971;  http://dx.doi.org/10.1016/0304-3940(91)90708-2.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
J Biol Chem 1998; 273:29745- 53; PMID:9792688; http://dx.doi.org/10.1074/ jbc.273.45.29745.,OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Nature 1996;  382:685-91; PMID:8751438; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Neurochem Int 2008;  52:1226-33; PMID:18295934; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Exp Gerontol 2004; 39:407-13; PMID:15036400;  http://dx.doi.org/10.1016/j.exger.2003.12.006.,OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
J Immunol 2009;  182:5778-88; PMID:19380826; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
J Neurosci  2006; 26:10129-40; PMID:17021169; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
J Neurochem 2009; 109:1636-47;  PMID:19457117; http://dx.doi.org/10.1111/j.1471- 4159.2009.06096.x.17.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
J  Biol Chem 1996; 271:13636-41; PMID:8662885;  http://dx.doi.org/10.1074/jbc.271.23.13636.,OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
FASEB J 2009; 23:2639-49;  PMID:19332646; http://dx.doi.org/10.1096/fj.08- 126383.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
J Neurosci  2011; 31:12083-93; PMID:21865451; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
J  Biol Chem 2005; 280:37755-62; PMID:16150694;  http://dx.doi.org/10.1074/jbc.M507475200.10.,OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Nat Med 2003; 9:907- 13; PMID:12808450; http://dx.doi.org/10.1038/ nm890.,OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Ann Neurol 1999; 45:537-41;  PMID:10211483; http://dx.doi.org/10.1002/1531- 8249(199904)45:4<537::AID-ANA20>3.0.CO;2-2.,Non-OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Peptides 2002; 23:1311-5;  PMID:12128087; http://dx.doi.org/10.1016/S0196- 9781(02)00067-0.,OADS,/arxiv_data1/oa_pdf/85/1c/tisb-1-e23993.PMC3887048.pdf
Tissue Barriers 2013; 1:e24377; http://dx.doi.org/10.4161/tisb.24377The cellular prion protein was historically characterized owing  to its misfolding in prion disease.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Proc Natl Acad Sci U S A 1998; 95:13363-83; PMID:9811807; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Proc Natl Acad Sci U S A 1986; 83:7358- 62; PMID:3094007; http://dx.doi.org/10.1073/ pnas.83.19.7358.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Brain Res Rev 2009; 61:170-84;  PMID:19523487; http://dx.doi.org/10.1016/j.brain- resrev.2009.06.002.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Cold Spring Harb Perspect Biol 2011; 3:a006833; PMID:21421910;  http://dx.doi.org/10.1101/cshperspect.a006833.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Mol Biol  1999; 292:797-817; PMID:10525406; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Neurosci Res 2002; 67:211- 24; PMID:11782965; http://dx.doi.org/10.1002/ jnr.10118.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Prion 2007; 1:83-93; PMID:19164918; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Physiol Rev 2008; 88:673-728; PMID:18391177;  http://dx.doi.org/10.1152/physrev.00007.2007.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Nature 2009; 457:1128-32; PMID:19242475;  http://dx.doi.org/10.1038/nature07761.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
T rends Neurosci 2012; 35:92-103; PMID:22137337;  http://dx.doi.org/10.1016/j.tins.2011.10.002.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Cancer Lett 2010; 290:1-23;  PMID:19674833; http://dx.doi.org/10.1016/j.can- let.2009.07.009.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Int J Cancer 2005; 113:213- 20; PMID:15386405; http://dx.doi.org/10.1002/ ijc.20570.15.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Cancer Sci  2011; 102:400-6; PMID:21265952; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Gut 2012; 61:855- 64; PMID:21890811; http://dx.doi.org/10.1136/ gutjnl-2011-300511.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
FASEB J 2006; 20:1886-8;  PMID:16877520; http://dx.doi.org/10.1096/fj.06- 6138fje.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Int J Cancer 2009; 125:1523-31; PMID:19444918; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
PLoS Biol 2009; 7:e55;  PMID:19278297; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
FASEB J 2007; 21:2247-56; PMID:17409275;  http://dx.doi.org/10.1096/fj.06-7799com.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Brain Res Mol Brain Res 1995; 30:165-8;  PMID:7609638; http://dx.doi.org/10.1016/0169- 328X(95)00013-I.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Mol Cell Neurosci 2003; 22:227-33;  PMID:12676532; http://dx.doi.org/10.1016/S1044-7431(02)00014-3.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Nature 1997; 390:684-7; PMID:9414160; http://dx.doi.org/10.1038/37733.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J  Neurochem 2001; 76:69-76; PMID:11145979; http://dx.doi.org/10.1046/j.1471-4159.2001.00009.x.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Antioxid Redox Signal 2013; 18:400- 11; PMID:22861352; http://dx.doi.org/10.1089/ ars.2012.4637.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Science  2000; 289:1925-8; PMID:10988071; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Proc Natl Acad Sci U S A 2003; 100:13326- 31; PMID:14597699; http://dx.doi.org/10.1073/ pnas.2235648100.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
FEBS Lett 2000; 482:257-60;  PMID:11024471; http://dx.doi.org/10.1016/S0014-5793(00)02070-6.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Nat Med 1997; 3:1383-8; PMID:9396609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
EMBO J 2001; 20:5863-75; PMID:11689427;  http://dx.doi.org/10.1093/emboj/20.21.5863.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
EMBO J 2001; 20:5876- 86; PMID:11689428; http://dx.doi.org/10.1093/ emboj/20.21.5876.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Am J Pathol 2005; 167:1033-42; PMID:16192638;  http://dx.doi.org/10.1016/S0002-9440(10)61192-3.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Mol  Biol 2010; 402:293-300; PMID:20603132; http://dx.doi.org/10.1016/j.jmb.2010.06.055.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Cell Sci  2007; 120:1915-26; PMID:17504807; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Mol Biol 2001; 314:1209-25; PMID:11743735;  http://dx.doi.org/10.1006/jmbi.2000.5183.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
FEBS Lett 2002; 514:159-62; PMID:11943143;  http://dx.doi.org/10.1016/S0014-5793(02)02338-4.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Biochem Biophys  Res Commun 2008; 366:657-63; PMID:18068119;  http://dx.doi.org/10.1016/j.bbrc.2007.11.163.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Eur J Cell  Biol 2011; 90:414-9; PMID:21277044; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
EMBO J 2012; 31:2714- 36; PMID:22617422; http://dx.doi.org/10.1038/emboj.2012.150.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Neurosci Lett 2011; 496:121-4; PMID:21511010; http://dx.doi.org/10.1016/j.neu- let.2011.03.096.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Neurochem 2011; 116:467-75;  PMID:20804519; http://dx.doi.org/10.1111/j.1471- 4159.2010.06934.x.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Prion 2009; 3:129- 33; PMID:19786844; http://dx.doi.org/10.4161/ pri.3.3.9651.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Mol Biol Cell 2012; 23:1812-25; PMID:22438585; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Nat Struct Biol 2001; 8:770-4; PMID:11524679;  http://dx.doi.org/10.1038/nsb0901-770.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Cell Biol 2005; 169:341-54;  PMID:15851519; http://dx.doi.org/10.1083/ jcb.200409127.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Neurochem  2009; 110:194-207; PMID:19457127; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
FASEB  J 2012; 26:678-90; PMID:22038049; http://dx.doi.org/10.1096/fj.11-185579.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Eur J Cell Biol  2007; 86:525-32; PMID:17482313; http://dx.doi.org/10.1016/j.ejcb.2007.03.003.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
T rends Cell Biol 2010; 20:6-13; PMID:19896850;  http://dx.doi.org/10.1016/j.tcb.2009.10.003.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Neurochem 2011; 116:708-13;  PMID:21214550; http://dx.doi.org/10.1111/j.1471- 4159.2010.07007.x.55.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Mol Biol Cell 2007; 18:4565-78; PMID:17804817;  http://dx.doi.org/10.1091/mbc.E07-05-0426.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Am  J Physiol Gastrointest Liver Physiol 2010; 298:G774- 83; PMID:20224006; http://dx.doi.org/10.1152/ ajpgi.00239.2009.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Mol Biol  Cell 2012; 23:792-9; PMID:22238362; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
World  J Gastroenterol 2008; 14:401-7; PMID:18200662;  http://dx.doi.org/10.3748/wjg.14.401.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Science 1995; 270:1203- 7; PMID:7502046; http://dx.doi.org/10.1126/sci-ence.270.5239.1203.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Gastroenterology  2008; 135:173-84; PMID:18514073; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Gastroenterology 2009; 136:551-63; PMID:19027740;  http://dx.doi.org/10.1053/j.gastro.2008.10.081.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Clin Invest 2010; 120:1824- 35; PMID:20484816; http://dx.doi.org/10.1172/JCI41414.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Am J Pathol 2011; 179:2290-301; PMID:21924230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Stroke 2006; 37:1296-300;  PMID:16574930; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Am J Pathol 2008; 173:1029- 41; PMID:18815152; http://dx.doi.org/10.2353/ ajpath.2008.071062.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Biochim Biophys Acta  2009; 1788:761-7; PMID:19121284; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Nat Med 2001; 7:976-7; PMID:11533681;  http://dx.doi.org/10.1038/nm0901-976.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Am J Pathol 2003; 162:1103-11;  PMID:12651603; http://dx.doi.org/10.1016/S0002- 9440(10)63907-7.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Proc Natl Acad Sci U S A 2000; 97:5422- 7; PMID:10792029; http://dx.doi.org/10.1073/ pnas.080081197.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Virchows Arch  2000; 436:466-72; PMID:10881740; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Gastroenterology 2012; 143:122-32 e15;  PMID: 22446194; http://dx.doi.org/10.1053/j.gas- tro.2012.03.029.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Biol Chem 2004; 279:1499-505; PMID:14576159; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
T raffic 2002; 3:810-21; PMID:12383347; http://dx.doi.org/10.1034/j.1600-0854.2002.31106.x.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Cell Sci  2006; 119:4634-43; PMID:17062642; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Int Rev Cytol  2007; 264:65-163; PMID:17964922; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Mol Cell Biol 2008; 28:1657- 68; PMID:18160703; http://dx.doi.org/10.1128/ MCB.00695-07.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Cell Mol Life Sci  2012; 69:1105-24; PMID:21984610; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Cell Biol 2004; 166:743-53; PMID:15337781;  http://dx.doi.org/10.1083/jcb.200406078.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Biol Chem 2009; 284:23137- 45; PMID:19546217; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
Exp Cell Res 2011; 317:1422-36; PMID:21419117; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
J Neurosci  2011; 31:18013-25; PMID:22159115; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
FEBS Lett 2009; 583:389- 93; PMID:19116153; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/4f/tisb-1-e24377.PMC3887058.pdf
"OncoImmunology 2013; 2:e26619; http://dx.doi.org/10.4161/onci.26619Membrane-anchored chemokine fusion proteins A novel class of adjuvants for immunotherapy Peter J Nelson1,* and Niklas Muenchmeier2 1aG Klinische Biochemie; Medizinische Klinik und Poliklinik IV; u niversity of Munich; Munich, Germany;   2The s cripps r esearch Institute; Institute for Immunology and Microbial s cience; s an Diego, C a usa Keywords:  active immunotherapy, adoptive immunotherapy, cancer therapy, chemokine, endothelial anergy,   GPI anchor, leukocyte recruitment Abbreviations: ICAM, intercellular adhesion molecule; GPI, glycosylphosphatidylinositol;   VCAM1, vascular cell adhesion molecule 1 adoptive or active cancer immunotherapy can fail owing to the inefficient recruitment of effector leukocytes to  malignant lesions.",Non-OADS,/arxiv_data1/oa_pdf/a2/b4/onci-2-e26619.PMC3887060.pdf
"Int J Cancer 1999; 80:315- 9; PMID:9935216 ; http://dx.doi.org/10.1002/ (SICI)1097-0215(19990118)80:2<315::AID-IJC23>3.0.CO;2-L 4. von Hundelshausen P, Weber KS, Huo Y,  Proudfoot AE, Nelson PJ, Ley K, Weber C.  RANTES deposition by platelets triggers monocyte  arrest on inflamed and atherosclerotic endothelium.",Non-OADS,/arxiv_data1/oa_pdf/a2/b4/onci-2-e26619.PMC3887060.pdf
Circulation 2001; 103:1772-7;  PMID:11282909 ;  http://dx.doi.org/10.1161/01.CIR.103.13.17725.,Non-OADS,/arxiv_data1/oa_pdf/a2/b4/onci-2-e26619.PMC3887060.pdf
J Cell Biochem 2005; 96:897-905; PMID:16149080 ; http://dx.doi.org/10.1002/ jcb.20602 6.,Non-OADS,/arxiv_data1/oa_pdf/a2/b4/onci-2-e26619.PMC3887060.pdf
PLoS One 2013; 8:e72749;  PMID:24023642 ; http://dx.doi.org/10.1371/jour - nal.pone.0072749 7.,Non-OADS,/arxiv_data1/oa_pdf/a2/b4/onci-2-e26619.PMC3887060.pdf
J Biol Chem  2000; 275:3781-6;  PMID:10660527 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/b4/onci-2-e26619.PMC3887060.pdf
Cell 1997; 91:521-30; PMID:9390561 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/b4/onci-2-e26619.PMC3887060.pdf
Stem Cells 2013; PMID:23744498 ;  http://dx.doi.org/10.1002/stem.1439,Non-OADS,/arxiv_data1/oa_pdf/a2/b4/onci-2-e26619.PMC3887060.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/21/jmdh-7-025.PMC3887073.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 25–35Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  25Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S5507 7Job satisfaction among nurses working in the  private and public sectors: a qualitative study   in tertiary care hospitals in Pakistan saima Hamid1 asmat Ullah Malik2 irum Kamran3 Musarat ramzan4 1Health services academy, islamabad,   Pakistan; 2integrated Health services,   islamabad, Pakistan; 3giZ, islamabad,   Pakistan; 4Wah Medical college, Wah  cantt, University of Health sciences,   Wah, Pakistan correspondence: saima Hamid   Health services academy, Ministry  of Health services, regulations and  coordination, government of Pakistan,  near national institute of Health, Park  road, chak shehzad, islamabad, Pakistan   email saima_hamid@yahoo.co mBackground:  Many low and middle income countries lack the human resources needed to  deliver essential health interventions.",Non-OADS,/arxiv_data1/oa_pdf/ba/21/jmdh-7-025.PMC3887073.pdf
"Available from: http://www.unicef.org/protection/World_report_on_   disability_eng.pd f. Accessed November 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ba/21/jmdh-7-025.PMC3887073.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/ba/21/jmdh-7-025.PMC3887073.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ba/21/jmdh-7-025.PMC3887073.pdf
Tissue Barriers 2013; 1: e24565 http://dx.doi.org/10.4161/tisb.24565A limitation in the uptake of many drugs is the restricted  permeation through tissue barriers.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=172&showFR=1; 2013).,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Int J  Microcirc Clin Exp 1997; 17:223-30; PMID:9370122;  http://dx.doi.org/10.1159/000179234.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Cell Mol Neurobiol  2005; 25:5-23; PMID:15962506; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Skin  Pharmacol Physiol 2006; 19:71-7; PMID:16685145;  http://dx.doi.org/10.1159/000091973.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Biochim  Biophys Acta 2008; 1778:631-45; PMID:18036336;  http://dx.doi.org/10.1016/j.bbamem.2007.10.018.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Mol Biol Cell 2010; 21:1200-13; PMID:20164257; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Biochim Biophys Acta  2009; 1788:813-9; PMID:18706387; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Cold Spring Harb Perspect Biol  2010; 2:a002907; PMID:20182608; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Cell Biol  1993; 123:1777-88; PMID:8276896; http://dx.doi.org/10.1083/jcb.123.6.1777.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Biomed Biotechnol 2012; 2012:807356; PMID:22315516; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Antioxid  Redox Signal 2011; 15:1195-219; PMID:21235353;  http://dx.doi.org/10.1089/ars.2010.3542.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Cell Biol  2005; 171:939-45; PMID:16365161; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Eur J Cell Biol 2011; 90:787- 96; PMID:21868126; http://dx.doi.org/10.1016/j.ejcb.2011.06.005.15.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Cell Biol 1998; 141:1539- 50; PMID:9647647; http://dx.doi.org/10.1083/ jcb.141.7.1539.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
FEBS Lett 2011; 585:606-12;  PMID:21276448; http://dx.doi.org/10.1016/j.febs- let.2011.01.028.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Cell 2006; 126:741- 54; PMID:16923393; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
FASEB J 2008a; 22:146-58; PMID:17761522;  http://dx.doi.org/10.1096/fj.07-8319com.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Cell Mol Life Sci 2011; 68:3903-18;  PMID:21533891; http://dx.doi.org/10.1007/s00018- 011-0680-z.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Cell Sci 2012; 126:554-64; PMID:23203797;  http://dx.doi.org/10.1242/jcs.114306.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Int J Pharm  2011; 404:36-41; PMID:21056096; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Int J Pharm 1999; 191:15-24;  PMID:10556736; http://dx.doi.org/10.1016/S0378-5173(99)00213-6.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Biomaterials 2013; 34:275- 82; PMID:23069717; http://dx.doi.org/10.1016/j.bio- materials.2012.09.051.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Mol Pharm 2012; 9:2523-33; PMID:22827574; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Drug Deliv 2011; 18:415-23; PMID:21554106; http://dx.doi.org/10.3109/10717544.2011.570807.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Semin Cell Dev  Biol 2000; 11:301-8; PMID:10966864; http://dx.doi.org/10.1006/scdb.2000.0180.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Pharm Res 2008; 25:1377-86;  PMID:18163202; http://dx.doi.org/10.1007/s11095- 007-9527-6.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Pharm Res 1993; 10:857-64; PMID:8321854;  http://dx.doi.org/10.1023/A:1018909210879.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Life Sci 1998;  63:45-54; PMID:9667764; http://dx.doi.org/10.1016/ S0024-3205(98)00235-5.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Life Sci  2006; 79:401-10; PMID:16566947; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Pharmacol Exp Ther 2003; 305:440-50;  PMID:12606647; http://dx.doi.org/10.1124/jpet.102.047654.37.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Braz Dent J 2005;  16:3-8; PMID:16113926; http://dx.doi.org/10.1590/ S0103-64402005000100001.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Cancer 2003; 97:2806-13; PMID:12767094;  http://dx.doi.org/10.1002/cncr.11409.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Pharm Res 1997; 14:930-5; PMID:9244152; http://dx.doi.org/10.1023/A:1012112219578.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Expert Opin Drug Deliv  2006; 3:685-92; PMID:16948563; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Int J Pharm 2011; 404:148- 58; PMID:21094233; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Adv  Drug Deliv Rev 2009; 61:1427-49; PMID:19800376;  http://dx.doi.org/10.1016/j.addr.2009.09.006.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Drug Dev Ind Pharm 2012; PMID:23020091; http://dx.doi.org/10.3109/0363904 5.2012.723219.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
AAPS  PharmSciTech 2010; 11:372-82; PMID:20237966;  http://dx.doi.org/10.1208/s12249-010-9386-z.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Chromatogr B Analyt Technol Biomed Life  Sci 2012; 907:21-6; PMID:23010479; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Eur J Pharm Sci 2002; 17:131-8;  PMID:12393140; http://dx.doi.org/10.1016/S0928-0987(02)00162-8.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Drug Deliv 2010; 17:214-22; PMID:20233089; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Cell Biol 1999; 147:891- 903; PMID:10562289; http://dx.doi.org/10.1083/ jcb.147.4.891.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Cell Sci 2002; 115:4969- 76; PMID:12432083; http://dx.doi.org/10.1242/ jcs.00165.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Cell Biol  2003; 161:653-60; PMID:12743111; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Mol  Cell Biol 2004; 24:8408-17; PMID:15367662; http://dx.doi.org/10.1128/MCB.24.19.8408-8417.2004.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Cell Mol Life Sci 2010; 67:2131-40;  PMID:20333434; http://dx.doi.org/10.1007/s00018- 010-0332-8.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Ann N Y Acad Sci  2012a; 1257:45-53; PMID:22671588; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Cell Mol Life  Sci 2006; 63:505-14; PMID:16456617; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
NeuroRx 2005; 2:3-14;  PMID:15717053; http://dx.doi.org/10.1602/neu - rorx.2.1.3.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Pharm Pharmacol 2008; 60:543- 85; PMID:18416933; http://dx.doi.org/10.1211/ jpp.60.5.0002.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
ChemMedChem 2009; 4:421-6; PMID:19101970;  http://dx.doi.org/10.1002/cmdc.200800346.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Mol Biol Cell 2005; 16:1725-34;  PMID:15659655; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Cell Sci  2011; 124:548-55; PMID:21245199; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Clin Gastroenterol  2011; 45:526-30; PMID:21336140; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Arterioscler Thromb Vasc Biol 2013; 33:489-500; PMID:23288152; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Mol Biol Cell 2009; 20:3930-40; PMID:19605556;  http://dx.doi.org/10.1091/mbc.E09-04-0320.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Am J Physiol Cell Physiol 2005; 288:C1231- 41; PMID:15689410; http://dx.doi.org/10.1152/ajp- cell.00581.2004.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Biol Chem  2006; 281:36117-23; PMID:17018523; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Expert Rev Mol Med 2006; 8:1-11;  PMID:16887048; http://dx.doi.org/10.1017/ S1462399406000056.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Cancer  Res 2005; 65:9603-6; PMID:16266975; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Cancer Sci 2009; 100:1623- 30; PMID:19555390; http://dx.doi.org/10.1111/ j.1349-7006.2009.01239.x.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
"Gastroenterology 2010;  139:953-64, e1-4; PMID:20685314; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Mol Pharm  2012; 9:1785-94; PMID:22524793; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Biol Chem 2009; 284:18863- 72; PMID:19429681; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Toxins (Basel)  2010; 2:1336-56; PMID:22069641; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Biol Chem 2012b; 287:1698- 708; PMID:22128179; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Biochem Biophys Res Commun  2012; 423:229-33; PMID:22659740; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Biomaterials 2012; 33:317-24;  PMID:21983135; http://dx.doi.org/10.1016/j.bioma- terials.2011.09.048.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Biol Chem 2001; 276:19160- 5; PMID:11278543; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Effect of the six-mer synthetic peptide (AT1002) fragment of zonula  occludens toxin on the intestinal absorption of cyclospo- rin A. Int J Pharm 2008; 351:8-14; PMID:17954018;  http://dx.doi.org/10.1016/j.ijpharm.2007.09.011.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Arch Pharm Res 2012a; 35:937- 43; PMID:22644862; http://dx.doi.org/10.1007/ s12272-012-0520-1.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Arch Pharm Res 2012b; 35:359-66;  PMID:22370791; http://dx.doi.org/10.1007/s12272- 012-0217-5.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
J Pharm Pharmacol 2012c; 64:30-9; PMID:22150669;  http://dx.doi.org/10.1111/j.2042-7158.2011.01381.x.66.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Mol Biol Cell 2009; 20:3713-24;  PMID:19535456; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Ther  Deliv 2010; 1:75-82; PMID:22816121; http://dx.doi.org/10.4155/tde.10.5.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Eur  J Pharm Biopharm 2006; 62:52-8; PMID:16289777;  http://dx.doi.org/10.1016/j.ejpb.2005.07.008.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Klin Wochenschr 1985; 63:565- 71; PMID:2411995; http://dx.doi.org/10.1007/ BF01733202.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Exp Brain Res 2000; 135:417- 22; PMID:11146820; http://dx.doi.org/10.1007/ s002210000553.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Br J Pharmacol 2003b; 140:1201-10; PMID:14597599; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Cancer Chemother Pharmacol 2002; 50:299-304;  PMID:12357304; http://dx.doi.org/10.1007/s00280- 002-0497-4.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Br J Pharmacol  2003a; 139:685-94; PMID:12812991; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Mol Pharmacol 2006; 69:492-500; PMID:16288084; http://dx.doi.org/10.1124/mol.105.017251.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Biol Reprod 2001; 65:1340-51;  PMID:11673248; http://dx.doi.org/10.1095/biolre- prod65.5.1340.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
FASEB  J 2007; 21:438-48; PMID:17167075; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
Am J Pathol 2008; 172:905-15; PMID:18349130;  http://dx.doi.org/10.2353/ajpath.2008.070698.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/tisb-1-e24565.PMC3887097.pdf
"505 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Solitary fibrous tumors (SFTs) most commonly occur in the  pleura, but may also occur in the central nervous system (CNS).",Non-OADS,/arxiv_data1/oa_pdf/b7/57/kjpathol-47-505.PMC3887151.pdf
"Microscopically, there are 3 common elements that ap -The Korean Journal of Pathology  2013; 47: 505-506 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.505▒ LETTER TO THE EDITOR ▒ Corresponding Author Yang Seok Chae, M.D.",Non-OADS,/arxiv_data1/oa_pdf/b7/57/kjpathol-47-505.PMC3887151.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.505506 • Han H, et al.",OADS,/arxiv_data1/oa_pdf/b7/57/kjpathol-47-505.PMC3887151.pdf
"507 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920All types of cancer require a specialized microenvironment,  referred to the cancer stroma, for cancer initiation and progres - sion.1 Carcinoma-associated fibroblast (CAF) is a primary cell  type among heterogeneous stromal cell populations, although  the origin of CAF is still ambiguous.2 The chemoattractants se - creted by cancer guide migration of bone marrow-derived mes - enchymal stem cells (BM-MSCs) to cancer tissues.3 Evidence  indicates that recruited BM-MSCs contribute to carcinogenesis,  progression, and angiogenesis by acting as progenitors for stro - mal cells.4 Mesenchymal stem cells (MSCs) are not restricted to bone  marrow and are widely distributed in almost all tissues as tissue  resident MSCs.5 Because tissue-resident MSCs retain a homing  property to inflammatory or injured sites,6 they have a role in the development of cancer.",Non-OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
"Department of Pathology, Paik Institute for Clinical  Research, Inje University School of Medicine,   75 Bokji-ro, Busanjin-gu, Busan 614-735, Korea Tel: +82-51-890-6630 Fax: +82-51-894-6709 E-mail: pathyang@inje.ac.kr *Eun-Kyung Kim and Hye-Jung Kim contributed  equally to this work.The Korean Journal of Pathology  2013; 47: 507-518 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507508 • Kim E-K, et al.",OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507Role of Endogenous Gastric-Resident MSCs in Gastric Carcinoma • 509 EC differentiation potential, subcultured cells were seeded on  fibrin hydrogel and induced with 20 ng/mL vascular endotheli - al growth factor (VEGF; R&D Systems, Minneapolis, MN,  USA) or conditioned media.",Non-OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507510 • Kim E-K, et al.",OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507Role of Endogenous Gastric-Resident MSCs in Gastric Carcinoma • 511 Fig.,Non-OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507512 • Kim E-K, et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507Role of Endogenous Gastric-Resident MSCs in Gastric Carcinoma • 513Fig.,Non-OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507514 • Kim E-K, et al.",OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507Role of Endogenous Gastric-Resident MSCs in Gastric Carcinoma • 515 Fig.,Non-OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507516 • Kim E-K, et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507Role of Endogenous Gastric-Resident MSCs in Gastric Carcinoma • 517 sults demonstrated that tumors with admixed GS-MSCs  showed hMt-Ag positive stromal cells that coexpressed with  CD105, CD140b, SMA, and CD34, indicating that GS-MSCs  can give rise to a set of stromal cell populations, including  CAFs and ECs.",Non-OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.507518 • Kim E-K, et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/1f/kjpathol-47-507.PMC3887152.pdf
"519 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Cholecystectomy specimens are one of the frequently encoun - tered specimens in daily, routine work in the pathology depart - ment.",Non-OADS,/arxiv_data1/oa_pdf/85/0a/kjpathol-47-519.PMC3887153.pdf
"Department of Pathology, Izmir Bozyaka Training  and Research Hospital, Izmir 35100, Turkey Tel: +90-2322505050 Fax: +90-2322502997 E-mail: asumanargon@gmail.comThe Korean Journal of Pathology  2013; 47: 519-525 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.519▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/85/0a/kjpathol-47-519.PMC3887153.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.519520 • Argon A, et al.",OADS,/arxiv_data1/oa_pdf/85/0a/kjpathol-47-519.PMC3887153.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.519Macroscopic Sampling of Cholecystectomy Specimens • 521 All of the glass slides of each specimen were evaluated by pa - thology specialists according to the length of sample taken, the  percentage of observable mucosa, the presence of intramucosal  acute and chronic inflammatory cells, cholesterolosis, papillary  hyperplasia, metaplasia (pyloric and intestinal type), dysplasia,  and invasive carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/85/0a/kjpathol-47-519.PMC3887153.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.519522 • Argon A, et al.",OADS,/arxiv_data1/oa_pdf/85/0a/kjpathol-47-519.PMC3887153.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.519Macroscopic Sampling of Cholecystectomy Specimens • 523 to autolysis, mucosal denudation, or curling.",Non-OADS,/arxiv_data1/oa_pdf/85/0a/kjpathol-47-519.PMC3887153.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.519524 • Argon A, et al.",OADS,/arxiv_data1/oa_pdf/85/0a/kjpathol-47-519.PMC3887153.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.519Macroscopic Sampling of Cholecystectomy Specimens • 525 Incidence, management, and outcome of incidental gallbladder  carcinoma: analysis of the database of the Swiss association of lapa - roscopic and thoracoscopic surgery.",Non-OADS,/arxiv_data1/oa_pdf/85/0a/kjpathol-47-519.PMC3887153.pdf
"526 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Absolute lymphocyte count (ALC) in peripheral blood may  reflect the body’s immune surveillance potential against cancer  cells.",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
"Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine,   88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736,  Korea Tel: +82-2-3010-4553 Fax: +82-2-472-7898 E-mail: jrhuh@amc.seoul.krThe Korean Journal of Pathology  2013; 47: 526-533 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.526▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.526Absolute Lymphocyte Count/Absolute Monocyte Count Ratio and Survival in Multiple Myeloma • 527 has recently been shown to be a reliable prognostic marker in  DLBCL,16 FL,17 and HL.18 The utility of AMC and its relationship with ALC have not  been investigated in MM.",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
"(R Development Core Team, Vienna, Austria;  http://www.R-project.org), was used to identify the optimal cut-off points for ALC, AMC and the ALC/AMC ratio.21,22 Correla - tions between ALC, AMC, and the ALC/AMC ratio with cate - gorical variables were analyzed using Pearson’s chi-square test or  Fisher’s exact test, and the Mann-Whitney U test was used to  evaluate associations with continuous variables.",OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.526528 • Shin S-J, et al.Table 1.",OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.526Absolute Lymphocyte Count/Absolute Monocyte Count Ratio and Survival in Multiple Myeloma • 529 Fig.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.526530 • Shin S-J, et al.",OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.526Absolute Lymphocyte Count/Absolute Monocyte Count Ratio and Survival in Multiple Myeloma • 531 tients subdivided for factors that can affect prognosis and treat - ment selection (such as ASCT vs no ASCT, age, sex, and ISS) to  determine whether they could predict OS.",OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.526532 • Shin S-J, et al.",OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.526Absolute Lymphocyte Count/Absolute Monocyte Count Ratio and Survival in Multiple Myeloma • 533 21.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
http://dx.doi.org/10.3109 /10428194.2013.813504.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/kjpathol-47-526.PMC3887154.pdf
"534 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Breast cancer is one of the most common malignancies and is  the leading cause of cancer death among women.1 The heteroge - neous nature of its histology, phenotype and clinical behavior  leads to the need for targeted therapeutic agents.",Non-OADS,/arxiv_data1/oa_pdf/ad/cb/kjpathol-47-534.PMC3887155.pdf
"Department of Hospital Pathology, St. Vincent  Hospital, The Catholic University of Korea College   of Medicine, 93 Jungbu-daero, Paldal-gu, Suwon  442-723, Korea Tel: +82-31-249-7592 Fax: +82-31-244-6786 E-mail: chj0103@catholic.ac.krThe Korean Journal of Pathology  2013; 47: 534-540 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.534▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/ad/cb/kjpathol-47-534.PMC3887155.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.534Tau, α-Tubulin, and βIII-Tubulin in Breast Cancer • 535 eosin (H&E)-stained slides for each patient were reviewed.",Non-OADS,/arxiv_data1/oa_pdf/ad/cb/kjpathol-47-534.PMC3887155.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.534536 • Im S, et al.",OADS,/arxiv_data1/oa_pdf/ad/cb/kjpathol-47-534.PMC3887155.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.534Tau, α-Tubulin, and βIII-Tubulin in Breast Cancer • 537 Of the 142 patients who were treated by adjuvant chemo - therapy, 45 (31.7%) received a taxane-containing regimen and  97 (68.3%) received a non-taxane-containing regimen.",Non-OADS,/arxiv_data1/oa_pdf/ad/cb/kjpathol-47-534.PMC3887155.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.534538 • Im S, et al.",OADS,/arxiv_data1/oa_pdf/ad/cb/kjpathol-47-534.PMC3887155.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.534Tau, α-Tubulin, and βIII-Tubulin in Breast Cancer • 539 DISCUSSION MAPs are a family of proteins that bind to and stabilize mi - crotubules.",Non-OADS,/arxiv_data1/oa_pdf/ad/cb/kjpathol-47-534.PMC3887155.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.534540 • Im S, et al.",OADS,/arxiv_data1/oa_pdf/ad/cb/kjpathol-47-534.PMC3887155.pdf
"541 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Glioblastomas (World Health Organization [WHO ] grade  IV) are the most common type of brain tumor and also the  most malignant.",Non-OADS,/arxiv_data1/oa_pdf/9f/fa/kjpathol-47-541.PMC3887156.pdf
"Department of Pathology, Seoul National University  Bundang Hospital, Seoul National University College  of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 463-707, Korea  Tel: +82-31-787-7711 Fax: +82-31-787-4012 E-mail: gychoe@snu.ac.krThe Korean Journal of Pathology  2013; 47: 541-548 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.541▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/9f/fa/kjpathol-47-541.PMC3887156.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.541542 • Lee KS, et al.",OADS,/arxiv_data1/oa_pdf/9f/fa/kjpathol-47-541.PMC3887156.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.541Immunohistochemical Classification of Glioblastomas • 543 compare the immunohistochemical classification of glioblasto - mas with clinically primary and secondary glioblastomas and to  determine the best combination of antibodies for their immu - nohistochemical classification.,Non-OADS,/arxiv_data1/oa_pdf/9f/fa/kjpathol-47-541.PMC3887156.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.541544 • Lee KS, et al.",OADS,/arxiv_data1/oa_pdf/9f/fa/kjpathol-47-541.PMC3887156.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.541Immunohistochemical Classification of Glioblastomas • 545 cases with an immunohistochemical profile typical of secondary  glioblastomas, IDH-1(+)/EGFR( –)/p53(+), and one case of  IDH-1(+)/EGFR( –)/p53(–).",Non-OADS,/arxiv_data1/oa_pdf/9f/fa/kjpathol-47-541.PMC3887156.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.541546 • Lee KS, et al.",OADS,/arxiv_data1/oa_pdf/9f/fa/kjpathol-47-541.PMC3887156.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.541Immunohistochemical Classification of Glioblastomas • 547 mutually exclusive in the evolution of primary and secondary  glioblastomas.7 Our study revealed an inverse correlation be - tween EGFR and p53 that was statistically significant (p <  0.001); however, 30% of glioblastomas exhibited ambiguous  immunoprofiles in our study.",Non-OADS,/arxiv_data1/oa_pdf/9f/fa/kjpathol-47-541.PMC3887156.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.541548 • Lee KS, et al.",OADS,/arxiv_data1/oa_pdf/9f/fa/kjpathol-47-541.PMC3887156.pdf
"549 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Squamous cell carcinoma (SCC) involving the upper genital  tract, including the endometrium, fallopian tubes, and ovarian  surface, is extremely rare, with most patients described in single  case reports.1-5 Its possible pathogenic mechanisms include 1) de  novo carcinogenesis; 2) extensive squamous metaplasia (ichthyo - sis uteri) in the mucosa of the upper genital tract with subse - quent malignant transformation; 3) endometrioid adenocarcino - ma with predominantly squamous differentiation; and 4) muco - sal spread from cervical SCC.6 Differentiating primary SCC aris - ing in the upper genital tract from primary cervical SCC ex - tending to the upper genital tract is clinically important for tu - mor staging and patient management, especially since the lo - coregional recurrence rate is higher and the disease-free survival  rate is lower in cervical SCC patients with endometrial involve - ment than it is in patients without endometrial involvement.7 The diagnostic criteria for primary SCC of the endometrium  include the absence of 1) coexisting endometrial adenocarcino -ma; 2) a connection between endometrial SCC and the squa - mous epithelium of the cervix; and 3) a primary squamous le - sion in the cervix, either in situ  SCC or invasive carcinoma.8 We  have found it difficult, however, to determine the primary sites  of SCCs detected in a fallopian tube or ovary in patients who  have undergone prior hysterectomy with insufficient histologi - cal examination of the uterine cervix at the time of surgery.",Non-OADS,/arxiv_data1/oa_pdf/20/ed/kjpathol-47-549.PMC3887157.pdf
"Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine,   88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736,  Korea Tel: +82-2-3010-4514 Fax: +82-2-472-7898 E-mail: krkim@amc.seoul.krThe Korean Journal of Pathology  2013; 47: 549-556 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.549▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/20/ed/kjpathol-47-549.PMC3887157.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.549550 • Yoo SH, et al.",OADS,/arxiv_data1/oa_pdf/20/ed/kjpathol-47-549.PMC3887157.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.549Squamous Cell Carcinoma of the Upper Genital Tract • 551 ing control, an ACTB  gene sequence from the HEK293 cell  line was amplified.",Non-OADS,/arxiv_data1/oa_pdf/20/ed/kjpathol-47-549.PMC3887157.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.549552 • Yoo SH, et al.",OADS,/arxiv_data1/oa_pdf/20/ed/kjpathol-47-549.PMC3887157.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.549Squamous Cell Carcinoma of the Upper Genital Tract • 553 gesting their pagetoid spread (Fig.,Non-OADS,/arxiv_data1/oa_pdf/20/ed/kjpathol-47-549.PMC3887157.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.549554 • Yoo SH, et al.",OADS,/arxiv_data1/oa_pdf/20/ed/kjpathol-47-549.PMC3887157.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.549Squamous Cell Carcinoma of the Upper Genital Tract • 555 mous metaplasia may be a preneoplastic or neoplastic lesion.,Non-OADS,/arxiv_data1/oa_pdf/20/ed/kjpathol-47-549.PMC3887157.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.549556 • Yoo SH, et al.",OADS,/arxiv_data1/oa_pdf/20/ed/kjpathol-47-549.PMC3887157.pdf
"557 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920In the histologic evaluation of nephrectomy specimens con - taining renal cell carcinoma (RCC), pathologists describe tumor  size, extent, and histology, including grade, tumor cell type,  nuclear grade, and the presence and proportion of necrosis or  sarcomatoid changes.",Non-OADS,/arxiv_data1/oa_pdf/c0/6c/kjpathol-47-557.PMC3887158.pdf
"Department of Pathology, Yonsei University College  of Medicine, 50 Yonsei-ro, Seodaemun-gu,   Seoul 120-752, Korea Tel: +82-2-2228-1766 Fax: +82-2-362-0860 E-mail: jeong10@yuhs.acThe Korean Journal of Pathology  2013; 47: 557-562 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.557▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/c0/6c/kjpathol-47-557.PMC3887158.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.557558 • Koh MJ, et al.",OADS,/arxiv_data1/oa_pdf/c0/6c/kjpathol-47-557.PMC3887158.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.557Renal Histology and Postoperative Renal Function • 559 cases.,Non-OADS,/arxiv_data1/oa_pdf/c0/6c/kjpathol-47-557.PMC3887158.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.557560 • Koh MJ, et al.",OADS,/arxiv_data1/oa_pdf/c0/6c/kjpathol-47-557.PMC3887158.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.557Renal Histology and Postoperative Renal Function • 561 tients with >20% glomerulosclerosis had eGFR values <60  mL/min/1.73 m2 at one year after surgery.,Non-OADS,/arxiv_data1/oa_pdf/c0/6c/kjpathol-47-557.PMC3887158.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.557562 • Koh MJ, et al.",OADS,/arxiv_data1/oa_pdf/c0/6c/kjpathol-47-557.PMC3887158.pdf
Available	 from:	http://www.cap.org/apps/ docs/committees/cancer/cancer_protocols/2009/Kidney_09protocol.,Non-OADS,/arxiv_data1/oa_pdf/c0/6c/kjpathol-47-557.PMC3887158.pdf
Available  from:	http://ncc.re.kr/manage/manage03_033_list.jsp.,OADS,/arxiv_data1/oa_pdf/c0/6c/kjpathol-47-557.PMC3887158.pdf
"563 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Since the first evidence of malignancy in cerebrospinal fluid  (CSF) was reported in 1904, CSF examination has been used to  diagnose numerous neoplastic diseases of the central nervous  system (CNS).1 In patients with CNS metastasis, diagnostic  confirmation is provided mostly through CSF cytology and  serves to verify the presence of malignancy.2,3 As most secondary  CNS tumors spread along the leptomeningeal space and com - municate with the ventricles or subarachnoid space, it is gener - ally not difficult to detect malignant cells in the CSF.",Non-OADS,/arxiv_data1/oa_pdf/24/14/kjpathol-47-563.PMC3887159.pdf
"Department of Pathology, Yonsei University College  of Medicine, 50 Yonsei-ro, Seodaemun-gu,   Seoul 120-752, Korea Tel: +82-2-2228-1769 Fax: +82-2-362-0860 E-mail: paxco@yuhs.acThe Korean Journal of Pathology  2013; 47: 563-568 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.563▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/24/14/kjpathol-47-563.PMC3887159.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.563564 • Bae YS, et al.",OADS,/arxiv_data1/oa_pdf/24/14/kjpathol-47-563.PMC3887159.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.563Metastatic Tumor in Cerebrospinal Fluid Cytology • 565 ing method.,Non-OADS,/arxiv_data1/oa_pdf/24/14/kjpathol-47-563.PMC3887159.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.563566 • Bae YS, et al.",OADS,/arxiv_data1/oa_pdf/24/14/kjpathol-47-563.PMC3887159.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.563Metastatic Tumor in Cerebrospinal Fluid Cytology • 567 each patient.,Non-OADS,/arxiv_data1/oa_pdf/24/14/kjpathol-47-563.PMC3887159.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.563568 • Bae YS, et al.",OADS,/arxiv_data1/oa_pdf/24/14/kjpathol-47-563.PMC3887159.pdf
"569 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Nevus sebaceus of Jadassohn (NS) or organoid nevus is a com - plex cutaneous hamartoma involving not only the pilosebaceus  follicle but also the epidermis and often other adnexal struc - tures.1 It may present at birth or develop in early childhood.",Non-OADS,/arxiv_data1/oa_pdf/9b/db/kjpathol-47-569.PMC3887160.pdf
1477) Fax: +90-312-3230632  E-mail: hulyayikilkan@hotmail.comThe Korean Journal of Pathology  2013; 47: 569-574 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.569▒ CASE STUDY ▒,Non-OADS,/arxiv_data1/oa_pdf/9b/db/kjpathol-47-569.PMC3887160.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.569570 • Gozel S, et al.",OADS,/arxiv_data1/oa_pdf/9b/db/kjpathol-47-569.PMC3887160.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.569Sebaceus Nevus of Jadassohn • 571 lymphocytes and large numbers of plasma cells (Fig.,Non-OADS,/arxiv_data1/oa_pdf/9b/db/kjpathol-47-569.PMC3887160.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.569572 • Gozel S, et al.",OADS,/arxiv_data1/oa_pdf/9b/db/kjpathol-47-569.PMC3887160.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.569Sebaceus Nevus of Jadassohn • 573 dermis.,Non-OADS,/arxiv_data1/oa_pdf/9b/db/kjpathol-47-569.PMC3887160.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.569574 • Gozel S, et al.",OADS,/arxiv_data1/oa_pdf/9b/db/kjpathol-47-569.PMC3887160.pdf
"575 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920The Prototheca  species is classified as achlorophyllic algae that  does not possess chloroplast or pyrenoids and behaves as sapro - phytes.",Non-OADS,/arxiv_data1/oa_pdf/22/03/kjpathol-47-575.PMC3887161.pdf
"Department of Pathology, Kwandong University  College of Medicine, 1 Gangwondaehak-gil,  Chuncheon 200-701, Korea Tel: +82-33-649-7442 Fax: +82-33-641-1074 E-mail: jssong@kd.ac.krThe Korean Journal of Pathology  2013; 47: 575-578 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.575▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/22/03/kjpathol-47-575.PMC3887161.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.575576 • Seok JY, et al.",OADS,/arxiv_data1/oa_pdf/22/03/kjpathol-47-575.PMC3887161.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.575Human Cutaneous Protothecosis • 577 DISCUSSION Prototheca  is ubiquitously isolated from tap water, freshwater  streams, swimming pools, soil, stables, and foodstuffs, such as  shrimp, cow’s milk, butter, potato peel, and bananas.2 A trau - matic inoculation plays a role in protothecal infections.2 The  major sites of involvement are the exposed areas, including the  upper and lower extremities.",Non-OADS,/arxiv_data1/oa_pdf/22/03/kjpathol-47-575.PMC3887161.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.575578 • Seok JY, et al.",OADS,/arxiv_data1/oa_pdf/22/03/kjpathol-47-575.PMC3887161.pdf
"579 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Warthin’s tumor (WT) is a benign neoplasm with a prolifera - tive epithelial component of the salivary gland epithelium and  the lymphoid stroma.1 It is commonly found in the lower pole  of the parotid gland, and an estimated 12-20% are multicentric  and 5-14% are bilateral.2-4 Approximately 1% of WT undergo  malignant transformation, which can be seen in both the epi - thelial and lymphoid components.5 While some studies indi - cate a higher frequency of malignant transformation in the  lymphoid components, others indicate that non-Hodgkin’s  lymphoma diagnosed in WT excision materials is almost rare.1,4  Furthermore, literature indicates that some malignant lympho - ma cases are a component of disseminated disease in WT exci - sion.6 This paper presents a diffuse large B-cell lymphoma  (DLBCL) in WT, found in superficial parotidectomy material.",Non-OADS,/arxiv_data1/oa_pdf/f0/34/kjpathol-47-579.PMC3887162.pdf
"59  Bozyaka, İzmir, Turkey Tel: +90-232-2505050 Fax: +90-232-2614444 E-mail: fundadr@gmail.comThe Korean Journal of Pathology  2013; 47: 579-582 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.579▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/f0/34/kjpathol-47-579.PMC3887162.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.579580 • Özkök G, et al.",OADS,/arxiv_data1/oa_pdf/f0/34/kjpathol-47-579.PMC3887162.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.579Lymphoma Arising in Warthin’s Tumor • 581 with no lymphoma involvement.,Non-OADS,/arxiv_data1/oa_pdf/f0/34/kjpathol-47-579.PMC3887162.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.579582 • Özkök G, et al.",OADS,/arxiv_data1/oa_pdf/f0/34/kjpathol-47-579.PMC3887162.pdf
"583 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Ectopic breasts mostly occur in the axilla.",Non-OADS,/arxiv_data1/oa_pdf/21/bd/kjpathol-47-583.PMC3887163.pdf
"Department of Pathology, Dankook University  College of Medicine, 119 Dandae-ro, Dongnam-gu,  Cheonan 330-997, Korea Tel: +82-41-550-6972 Fax: +82-41-561-9127 E-mail: cyjy555@hanmail.netThe Korean Journal of Pathology  2013; 47: 583-586 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.583▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/21/bd/kjpathol-47-583.PMC3887163.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.583584 • Go JH  Fig.,Non-OADS,/arxiv_data1/oa_pdf/21/bd/kjpathol-47-583.PMC3887163.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.583Cystic Phyllodes Tumor of Inguinal Region • 585 DISCUSSION Ectopic breast tissue occurs along the milk lines, which ex - tend bilaterally from the mid-axillae through the normal breasts  and then inferiorly to the medial groins.",Non-OADS,/arxiv_data1/oa_pdf/21/bd/kjpathol-47-583.PMC3887163.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.583586 • Go JH  tant in these tumors of the breast.,Non-OADS,/arxiv_data1/oa_pdf/21/bd/kjpathol-47-583.PMC3887163.pdf
"587 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Gliomatosis peritonei (GP) was first described in 1905 as a  condition of mature glial nodular implants on the peritoneum  and omentum associated with ovarian teratoma.1 To date, ap - proximately 100 cases have been described in the literature.",Non-OADS,/arxiv_data1/oa_pdf/f3/00/kjpathol-47-587.PMC3887164.pdf
"Department of Pathology, Gachon University Gil  Medical Center, 21 Namdong-daero 774beon-gil,  Namdong-gu, Incheon 405-760, Korea Tel: +82-32-460-3865 Fax: +82-32-460-3073 E-mail: hicho@gilhospital.comThe Korean Journal of Pathology  2013; 47: 587-591 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.587▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/f3/00/kjpathol-47-587.PMC3887164.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.587588 • Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/f3/00/kjpathol-47-587.PMC3887164.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.587Peritoneal and Nodal Gliomatosis with Endometriosis • 589 patient had an uneventful course.,Non-OADS,/arxiv_data1/oa_pdf/f3/00/kjpathol-47-587.PMC3887164.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.587590 • Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/f3/00/kjpathol-47-587.PMC3887164.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.587Peritoneal and Nodal Gliomatosis with Endometriosis • 591 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/00/kjpathol-47-587.PMC3887164.pdf
"592 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Low-grade cribriform cystadenocarcinoma (LGCCC) is a rare  tumor defined as “a primary salivary duct tumor with clinically  indolent behavior” in the 2005 World Health Organization  (WHO) classification.1 This tumor was initially described as a  “low grade salivary duct carcinoma” by Delgado et al.2 The  characteristic histologic findings of this tumor were detailed in  previously reported cases by several authors, and these findings  included the absence of encapsulation, but a well-circum - scribed, cystic, and cribriform pattern, resembling “low grade  ductal carcinoma in situ  or atypical ductal hyperplasia (ADH)  pattern of breast”.1-8 Clinically, salivary gland tumors are pri - marily aspirated, not excised.",Non-OADS,/arxiv_data1/oa_pdf/ca/07/kjpathol-47-592.PMC3887165.pdf
"Department of Pathology, Yonsei University College  of Medicine, 50 Yonsei-ro, Seodaemun-gu,   Seoul 120-752, Korea Tel: +82-2-2228-1772 Fax: +82-2-362-0860 E-mail: kjs1976@yuhs.acThe Korean Journal of Pathology  2013; 47: 592-595 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.592▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/ca/07/kjpathol-47-592.PMC3887165.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.592Cytology of Low-Grade Cribriform Cystadenocarcinoma • 593 and partly cystic (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ca/07/kjpathol-47-592.PMC3887165.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.592594 • Ko YS, et al.",OADS,/arxiv_data1/oa_pdf/ca/07/kjpathol-47-592.PMC3887165.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.592Cytology of Low-Grade Cribriform Cystadenocarcinoma • 595 the cytoplasm of the tumor cells; 3) the smear in our case  showed more benign-looking cytomorphology, with almost all  tumor cells presenting inconspicuous cytologic atypia, resem - bling instead benign, ductal proliferating cells.",Non-OADS,/arxiv_data1/oa_pdf/ca/07/kjpathol-47-592.PMC3887165.pdf
"596 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Thymolipoma is a rare anterior mediastinal tumor composed  of mature adipose tissue and benign thymic tissue, and is a be - nign neoplasm for which complete surgical excision is curative.1  Literature has reported that the thymic parenchyma of thymoli - poma exceptionally contain myoid cells that are immunoreac - tive for desmin, muscle-specific actin and myoglobin.2,3 Herein,  we describe a very rare case of thymolipoma with myoid cells.",Non-OADS,/arxiv_data1/oa_pdf/c3/ee/kjpathol-47-596.PMC3887166.pdf
"Smooth muscle actin is a ubiqui -The Korean Journal of Pathology  2013; 47: 596-598 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.596▒ BRIEF CASE REPORT ▒ Corresponding Author Chang Hun Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/c3/ee/kjpathol-47-596.PMC3887166.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.596Mediastinal Thymolipoma with Myoid Cells  • 597 tous contractile protein responsible for muscle cell motility.,Non-OADS,/arxiv_data1/oa_pdf/c3/ee/kjpathol-47-596.PMC3887166.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.596598 • Kim YK, et al.",OADS,/arxiv_data1/oa_pdf/c3/ee/kjpathol-47-596.PMC3887166.pdf
"599 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Inflammatory pseudotumor (IPT)-like follicular dendritic  cell tumor (FDCT) has been recently designated1 and character - ized by proliferation of Epstein-Barr virus (EBV)-positive fol - licular dendritic cell (FDC) and commonly occurs in the liver  and spleen.2-9 Histologically, it is characterized by spindle cell  proliferation admixed with abundant inflammatory cells, main - ly lymphocytes and plasma cells.",Non-OADS,/arxiv_data1/oa_pdf/8a/29/kjpathol-47-599.PMC3887167.pdf
"The tumor size ranged from 3.5 Inflammatory Pseudotumor-like Follicular Dendritic Cell Tumor of   the Spleen with Extensive Histiocytic Granulomas and Necrosis:   A Case Report and Literature Review Hyun-Jung Kim ·Ji Eun Kim1·Gu-Hyun Kang ·Jung Yeon Kim ·Kyeongmee Park Department of Pathology, Inje University Sanggye Paik Hospital, Inje University College of Medicine, 1Department of Pathology, SMG-SNU Boramae Medical Center,   Seoul National University College of Medicine, Seoul, KoreaThe Korean Journal of Pathology  2013; 47: 599-602 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.599▒ BRIEF CASE REPORT ▒ Corresponding Author Hyun-Jung Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/8a/29/kjpathol-47-599.PMC3887167.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.599600 • Kim H-J, et al.",OADS,/arxiv_data1/oa_pdf/8a/29/kjpathol-47-599.PMC3887167.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.599IPT-like FDCT with Histiocytic Granulomas • 601 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/8a/29/kjpathol-47-599.PMC3887167.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.599602 • Kim H-J, et al.",OADS,/arxiv_data1/oa_pdf/8a/29/kjpathol-47-599.PMC3887167.pdf
"603 © 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920In 2011, the International Association for the Study of Lung  Cancer/American Thoracic Society/European Respiratory Society  (IASLC/ATS/ERS) classification added micropapillary predomi - nant adenocarcinoma of the lung as a new histologic subtype  and reclassified the former mucinous bronchioloalveolar carcino - ma (BAC) as a variant of invasive mucinous adenocarcinoma.1 Recent studies regarding epidermal growth factor receptor  (EGFR ) and K-ras mutations in lung cancer demonstrated that  BAC with a lepidic or hobnail growth pattern is more typically  associated with EGFR  mutation, while mucinous differentiation  is more common in cases with K-ras mutation.2-4 However,  these studies were based on the 2004 World Health Organiza - tion (WHO) classification, and there had been a few reports on  the micropapillary pattern of this disease and its correlation with  EGFR  and K-ras mutations.4,5 According to the report of the  IASLC,1 micropapillary predominant adenocarcinoma is known  to be related to K-ras (33%), EGFR  (20%), and BRAF  (20%)  mutations.",Non-OADS,/arxiv_data1/oa_pdf/a8/3e/kjpathol-47-603.PMC3887168.pdf
"No complications were noted in the two-month follow-up  period after discharge.The Korean Journal of Pathology  2013; 47: 603-605 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.603▒ BRIEF CASE REPORT ▒ Corresponding Author Joungho Han, M.D.",Non-OADS,/arxiv_data1/oa_pdf/a8/3e/kjpathol-47-603.PMC3887168.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.603604 • Choi IH et al.,OADS,/arxiv_data1/oa_pdf/a8/3e/kjpathol-47-603.PMC3887168.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.603Micropapillary Mucinous Adenocarcinoma of the Lung  • 605 K-ras, and BRAF  mutation tests, and both K-ras and EGFR   mutations could occur in mucin-producing tumors.",Non-OADS,/arxiv_data1/oa_pdf/a8/3e/kjpathol-47-603.PMC3887168.pdf
"606 pISSN 1738-1843 eISSN 2092-8920© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Malignant melanomas display a wide variety of morphologic  patterns.1 Melanomas with rhabdoid appearance are rare and  appear mostly as a recurrent or metastatic form, and only atypi - cally arise as a primary lesion.",Non-OADS,/arxiv_data1/oa_pdf/9f/8b/kjpathol-47-606.PMC3887169.pdf
"They were negative for human melanoma black-45 anti - gen (HMB-45 antigen, prediluted, Dako), Melan-A (predilut - ed, A103, Dako), CD117 (prediluted, c-kit, Dako), CD34  (prediluted, QBEnd10, Dako), calretinin (1:100, calret 1, Dako),  pancytokeratin (prediluted, AE1/AE3, Dako), epithelial mem - brane antigen (prediluted, E29, Dako), myoD-1 (1:50, 5.8A,  Dako), myogenin (1:50, MyG007, Biocare Medical, Concord,  CA, USA), smooth muscle actin (prediluted, IA4, Dako), des - min (prediluted, D33, Dako), synaptophysin (prediluted, The Korean Journal of Pathology  2013; 47: 606-609 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.606▒ BRIEF CASE REPORT ▒ Corresponding Author Dong Hae Chung, M.D.",Non-OADS,/arxiv_data1/oa_pdf/9f/8b/kjpathol-47-606.PMC3887169.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.606Primary Gastric Melanoma with Rhabdoid Features • 607 SY38, Dako), chromogranin (prediluted, DAK-A3, Dako),  CD56 (1:100, 123C2, Dako), CD68 (1:50, PG-M1, Dako),  leukocyte common antigen (prediluted, Dako), CD79a (1:50,  JCB117, Dako), CD138 (prediluted, MI/5, Dako), and CD99  (prediluted, 12E7, Dako).",Non-OADS,/arxiv_data1/oa_pdf/9f/8b/kjpathol-47-606.PMC3887169.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.606608 • Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/9f/8b/kjpathol-47-606.PMC3887169.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.606Primary Gastric Melanoma with Rhabdoid Features • 609 anoma-markers in rhabdoid melanoma may be ascribed to the  clonal selection of a subpopulation in the progression of a tu - mor, or to the dedifferentiation of neoplastic tissue by tumor  growth and/or chemotherapy regimens.10 In particular, the loss  of S-100 protein in rhabdoid melanoma defines the most dedif - ferentiated form.",Non-OADS,/arxiv_data1/oa_pdf/9f/8b/kjpathol-47-606.PMC3887169.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs3 69/en/index.,OADS,/arxiv_data1/oa_pdf/b2/8e/IJPS-8-113.PMC3887227.pdf
2001;  Retrieved from http://www.nwrel.org.,OADS,/arxiv_data1/oa_pdf/6c/f2/IJPS-8-118.PMC3887228.pdf
http://etd.uovs.ac.za/ETD - db/theses/available/etd-09292005-154532/unrestricted/GREEFFP; 2004.,OADS,/arxiv_data1/oa_pdf/6c/f2/IJPS-8-118.PMC3887228.pdf
http://geospatial.intergraph.,Non-OADS,/arxiv_data1/oa_pdf/44/ad/10661_2013_Article_3435.PMC3887259.pdf
http://srtm.die.unifi.it/Atticonvegno/doc/RP16.pdf .,Non-OADS,/arxiv_data1/oa_pdf/44/ad/10661_2013_Article_3435.PMC3887259.pdf
http://www.ametsoc.org/ policy/2012climatechange.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d9/2b/484_2013_Article_696.PMC3887260.pdf
"Cambridge University Press, Cambridge, UK, pp 899 –932 IPCC (2013) Fifth Assessment Report (AR5) Authors and Review Editors: As of 12 March 2013. http://www.ipcc.ch/pdf/ar5/ar5_ authors_review_editors_updated.pdf .",Non-OADS,/arxiv_data1/oa_pdf/d9/2b/484_2013_Article_696.PMC3887260.pdf
A description of each level III ecoregion included in the study is available at http://www.epa.gov/wed/pages/ ecoregions/level_iii_iv.htm (accessed 2 Nov 2012).,OADS,/arxiv_data1/oa_pdf/d8/04/10661_2013_Article_3426.PMC3887264.pdf
http://water.epa.gov/type/oceb/upload/ 2008_02_06_riverssurvey_flowingwatersurvey0809.pdf .,OADS,/arxiv_data1/oa_pdf/d8/04/10661_2013_Article_3426.PMC3887264.pdf
ISBN 3-900051-07-0. http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/d8/04/10661_2013_Article_3426.PMC3887264.pdf
http://water.epa.gov/ type/watersheds/monitoring/upload/nars-progress.pdf .,OADS,/arxiv_data1/oa_pdf/d8/04/10661_2013_Article_3426.PMC3887264.pdf
http://water.epa.gov/ type/watersheds/monitoring/aquaticsurvey_index.cfm .,OADS,/arxiv_data1/oa_pdf/d8/04/10661_2013_Article_3426.PMC3887264.pdf
http://water.epa.gov/ type/rsl/monitoring/ri verssurvey /index.cfm .,OADS,/arxiv_data1/oa_pdf/d8/04/10661_2013_Article_3426.PMC3887264.pdf
"http://dx.doi.org/10.1016/j.redox.2013.12.007Abbreviations: ARA, 20:4 ω-6, arachidonic acid; CNS, central nervous system; dn, deuterium-labeled; δT3, delta-tocotrienol; DHA, 22:6 ω-3, docosahexaenoic acid; hpf, hours post-fertilization; HETEs, hydroxy-eicosatetraenoic acids; HDHA, hydroxy-DHA; LTA4, leukotriene A4 ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/e6/66/main.PMC3887274.pdf
"http://dx.doi.org/10.1016/j.redox.2013.12.005Abbreviations: hIAPP, human islet amyloid polypeptide; rIAPP, rat islet amyloid polypeptide; ROS, reactive oxygen species; RAGE, receptor for advanced glycation end-products; AGE, advanced glycation end products; DPI, diphenyleneiodonium;MDA, malonyldialdehyde; CAT, catalase; GPx, glutathione peroxidase; SOD, super-oxide dismutase; ATZ, 3-amino-1,2,4-triazole; MS, mercaptosuccinic acid ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/fb/a2/main.PMC3887275.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Targeting sialophorin in breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.526 155,Non-OADS,/arxiv_data1/oa_pdf/3a/53/bjc2013526a.PMC3887278.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Canadian nuclear workers reanalysis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.592 223,Non-OADS,/arxiv_data1/oa_pdf/b5/e9/bjc2013592a.PMC3887280.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Smoking, alcohol intake, and risk of glioma 248 www.bjcancer.com | DOI:10.1038/bjc.2013.611",Non-OADS,/arxiv_data1/oa_pdf/0f/7f/bjc2013611a.PMC3887282.pdf
Department of Health and NHS Health and Social Care Information Centre (2005) Practical guide to ethnic monitoring in the NHS and social carehttp://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4116839.,Non-OADS,/arxiv_data1/oa_pdf/dc/ab/bjc2013632a.PMC3887283.pdf
http://www.ncin.org.uk (accessed June 2013).,Non-OADS,/arxiv_data1/oa_pdf/dc/ab/bjc2013632a.PMC3887283.pdf
Office for National Statistics (2010) 2001 Census of England and Wales: Country of Birth by Ethnic Groups by Sex and Age Group (PreviouslyCommissioned Table C1151) http://www.ons.gov.uk/ons/guide-method/census/census-2001/data-and-products/data-and-product-catalogue/ commissioned-output/commissioned-tables/index.html.,OADS,/arxiv_data1/oa_pdf/dc/ab/bjc2013632a.PMC3887283.pdf
"Office for National Statistics (2012a) Breast Cancer: Incidence, Mortality and Survival, 2010. http://www.ons.gov.uk/ons/rel/cancer-unit/breast-cancer-in-england/2010/sum-1.html (accessed June 2013).",Non-OADS,/arxiv_data1/oa_pdf/dc/ab/bjc2013632a.PMC3887283.pdf
http://www.ons.gov.uk (accessedJune 2013).,Non-OADS,/arxiv_data1/oa_pdf/dc/ab/bjc2013632a.PMC3887283.pdf
"PATIENTS AND METHODS POSH is a multicentre prospective observational cohort study ofyoung women diagnosed with breast cancer in the United Kingdom between 2000 and 2008, (http://www.southampton.",Non-OADS,/arxiv_data1/oa_pdf/df/0b/bjc2013650a.PMC3887284.pdf
"Ethnicity was self-reported, and patients were subsequently categorised into ethnic and racial categories according to National Institute of Health reporting guidelines, (NIH policy on reporting race and ethnicity data: subjects in clinical research 8-2001 http://grants1.nih.gov/grants/ guide/notice-files/NOT-OD-01-053.html).",Non-OADS,/arxiv_data1/oa_pdf/df/0b/bjc2013650a.PMC3887284.pdf
(http://www.ncrn.org.uk/Portfolio/index.htm).,Non-OADS,/arxiv_data1/oa_pdf/df/0b/bjc2013650a.PMC3887284.pdf
http://www.southampton.ac.uk/ medicine/ research/posh.page CONFLICT OF INTEREST EC has received honoraria from Roche and RIC has receivedhonoraria from GSK and Pfizer.,Non-OADS,/arxiv_data1/oa_pdf/df/0b/bjc2013650a.PMC3887284.pdf
Second all breast cancer report (2011) http://www.ncin.org.uk/publications/reports/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/df/0b/bjc2013650a.PMC3887284.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc) APPENDIX POSH Steering group: Professor Diana Eccles, Dr Peter Simmonds, Professor Douglas G Altman, Dr Paul Pharoah, Professor LouiseJones, Professor Ros Eeles, Professor Gareth Evans, Professor Alistair Thompson, Professor Shirley Hodgson, Mr Hisham Hammad, Professor Tim Bishop, Dr Ruth Warren, Professor Fiona Gilbert, Professor Sunil Lakhani, Professor Andrew Hanby.Ethnicity and young breast cancer; POSH BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.650 241",Non-OADS,/arxiv_data1/oa_pdf/df/0b/bjc2013650a.PMC3887284.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)G-CSFR signalling in ovarian cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.673 145,Non-OADS,/arxiv_data1/oa_pdf/79/bd/bjc2013673a.PMC3887286.pdf
miRNA targets were predicted by the algorithms of the miRWalk online prediction software program (http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/).,OADS,/arxiv_data1/oa_pdf/c3/0a/bjc2013676a.PMC3887287.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Lactate dehydrogenase inhibitors in combination with gemcitabine in pancreas cancer 182 www.bjcancer.com | DOI:10.1038/bjc.2013.681,Non-OADS,/arxiv_data1/oa_pdf/51/65/bjc2013681a.PMC3887288.pdf
Retrieved 21 March 2013 from http://www.cancerresearchuk.org/cancer-info/spotcancerearly/ICBP.CR-UK (2012a) Spotting The Signs of Cancer for Men.,Non-OADS,/arxiv_data1/oa_pdf/72/a6/bjc2013684a.PMC3887291.pdf
Retrieved 21 March 2013 from http://publications.cancerresearchuk.org/downloads/product/HM_AP_SCE_Male_July_2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/a6/bjc2013684a.PMC3887291.pdf
Retrieved 21 March 2013 from http://publications.cancerresearchuk.org/downloads/product/HM_AP_SCE_Female_July_2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/a6/bjc2013684a.PMC3887291.pdf
Retrieved 21 March 2013 from http://www.nisra.gov.uk/archive/census/2001/theme/theme_tables.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/a6/bjc2013684a.PMC3887291.pdf
Retrieved 21 March 2013 from http://www.ons.gov.uk/ons/rel/census-2001-national-report-for-england-and-wales/national-report-for-england-and-wales-part-1/index.html?format=hi-vis.,OADS,/arxiv_data1/oa_pdf/72/a6/bjc2013684a.PMC3887291.pdf
Retrieved 21 March 2013 from http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-50846.,Non-OADS,/arxiv_data1/oa_pdf/72/a6/bjc2013684a.PMC3887291.pdf
Retrieved 21 March 2013 from http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-231847.,Non-OADS,/arxiv_data1/oa_pdf/72/a6/bjc2013684a.PMC3887291.pdf
"Tandem mass spectra were searched against the UniProt human protein database (downloaded on 25/10/2012, 68 109 sequences) from the European Bioinformatics Institute (http://www.ebi.ac.u/integr8/) using the Mascot Daemon (Matrix Science Inc., Boston, MA, USA).",OADS,/arxiv_data1/oa_pdf/67/1f/bjc2013687a.PMC3887292.pdf
"CuratedOvarianData, a manually curated data collection by Ganzfried et al (2013), were downloaded on 23 April 2013 from the web site (http://bcb.dfci.harvard.edu/ovariancancer) using the statistical computing language ‘R’ with the Bioconductor package.",OADS,/arxiv_data1/oa_pdf/67/1f/bjc2013687a.PMC3887292.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Secretome proteomics of cisplatin-resistant ovarian cancer 132 www.bjcancer.com | DOI:10.1038/bjc.2013.687,Non-OADS,/arxiv_data1/oa_pdf/67/1f/bjc2013687a.PMC3887292.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Transcriptionally regulated oncolytic HSV-1 106 www.bjcancer.com | DOI:10.1038/bjc.2013.692,Non-OADS,/arxiv_data1/oa_pdf/47/62/bjc2013692a.PMC3887293.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Gemcitabine to enhance reovirus oncotherapy efficacy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.695 93,Non-OADS,/arxiv_data1/oa_pdf/1e/a0/bjc2013695a.PMC3887295.pdf
"This result was validated with the Cancer Cell Line Encyclopedia (CCLE, http://www.broadinstitute.org/ccle/home), which is a recently compiled public resource that contains gene expression and chromosomal copy-number data from nearly 1000 cancer cell lines(Barretina et al , 2012).",OADS,/arxiv_data1/oa_pdf/f2/7c/bjc2013698a.PMC3887297.pdf
"Functional annotation analyses were performed using David Bioinformatics Resources 6.7, which is a web-based bioinformatics application (http://david.abcc.",OADS,/arxiv_data1/oa_pdf/f2/7c/bjc2013698a.PMC3887297.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)PVT-1 in colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.698 171,Non-OADS,/arxiv_data1/oa_pdf/f2/7c/bjc2013698a.PMC3887297.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Fucosylated TGF- breceptor induces EMT in CRC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.699 163,Non-OADS,/arxiv_data1/oa_pdf/b3/a4/bjc2013699a.PMC3887298.pdf
"The intensity of each band was quantified by densitometry using ImageJ (developed by NIH, http://rsbweb.nih.gov/ij/), normalised against the density of the loading control, and is shown as a histogram in the Supplementary Online Material.",OADS,/arxiv_data1/oa_pdf/c7/64/bjc2013710a.PMC3887302.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Inhibition of HSP90 by cysteine-reactive sulphoxythiocarbamates 82 www.bjcancer.com | DOI:10.1038/bjc.2013.710,Non-OADS,/arxiv_data1/oa_pdf/c7/64/bjc2013710a.PMC3887302.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prognostic models for OS in patients with advanced stage ovarian cancer 48 www.bjcancer.com | DOI:10.1038/bjc.2013.717,Non-OADS,/arxiv_data1/oa_pdf/93/bf/bjc2013717a.PMC3887305.pdf
"All analyses were performed using SPSS version 19.0 (SPSS, Chicago, IL, USA) and R version 3.0.0 (http://cran.r-project.org/mirrors.html).",OADS,/arxiv_data1/oa_pdf/d0/a2/bjc2013718a.PMC3887306.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Nomogram for nodal metastasis in cervical cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.718 41,Non-OADS,/arxiv_data1/oa_pdf/d0/a2/bjc2013718a.PMC3887306.pdf
"The analyses were carried out using the SAS (SAS Institute Inc., version 9.2) and R 2.15.2 software (http://www.r-project.org/, last access September 30th, 2013).",OADS,/arxiv_data1/oa_pdf/76/75/bjc2013719a.PMC3887307.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Pazopanib biomarkers in urothelial cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.719 33,Non-OADS,/arxiv_data1/oa_pdf/76/75/bjc2013719a.PMC3887307.pdf
Radiation Therapy Oncology Group (2008) Radiation Therapy Oncology Group Protocol 0225 http://www.rtog.org/members/protocols/0225/0225.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/04/bjc2013720a.PMC3887308.pdf
Available athttp://www.ema.europa.eu/.,Non-OADS,/arxiv_data1/oa_pdf/dd/1c/bjc2013721a.PMC3887309.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER First-line gefitinib: Caucasian EGFR mutation-positive NSCLC 62 www.bjcancer.com | DOI:10.1038/bjc.2013.721,Non-OADS,/arxiv_data1/oa_pdf/dd/1c/bjc2013721a.PMC3887309.pdf
"The hemispheres as well as the areas of reduced Tl þ staining intensity and the lesioned areas in Nissl- and PI-stained sectionswere outlined on adjacent sections at six different stereotactic levels (at 2.80 mm, 2.10 mm, 0.5 mm rostral, /C00.10 mm, /C01.70 mm, and /C03.8 mm caudal from bregma) for each animal using the ImageJ v.1.45 software(available at the internet http://www.rsb.info.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/bf/cd/jcbfm2013177a.PMC3887354.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Thallium autometallography in cerebral ischemia F Stober et al 152 Journal of Cerebral Blood Flow & Metabolism (2014), 144 – 152 &2014 ISCBFM",Non-OADS,/arxiv_data1/oa_pdf/bf/cd/jcbfm2013177a.PMC3887354.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3635 | DOI: 10.1038/srep03635 6",Non-OADS,/arxiv_data1/oa_pdf/bc/12/srep03635.PMC3887372.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f7/35/srep03643.PMC3887373.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3643 | DOI: 10.1038/srep03643 10",Non-OADS,/arxiv_data1/oa_pdf/f7/35/srep03643.PMC3887373.pdf
in the use of the fiber-optical nonlinear endoscope.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0b/48/srep03627.PMC3887375.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3627 | DOI: 10.1038/srep03627 6",Non-OADS,/arxiv_data1/oa_pdf/0b/48/srep03627.PMC3887375.pdf
URL: http://news.sina.com.cn/c/2008-07-21/ 170415971186.shtml.,Non-OADS,/arxiv_data1/oa_pdf/0c/d6/srep03624.PMC3887376.pdf
URL: http://www.theage.,Non-OADS,/arxiv_data1/oa_pdf/0c/d6/srep03624.PMC3887376.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0c/d6/srep03624.PMC3887376.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3624 | DOI: 10.1038/srep03624 7",Non-OADS,/arxiv_data1/oa_pdf/0c/d6/srep03624.PMC3887376.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d5/68/srep03622.PMC3887378.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3622 | DOI: 10.1038/srep03622 7",Non-OADS,/arxiv_data1/oa_pdf/d5/68/srep03622.PMC3887378.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/23/33/srep03625.PMC3887379.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3625 | DOI: 10.1038/srep03625 7",Non-OADS,/arxiv_data1/oa_pdf/23/33/srep03625.PMC3887379.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3634 | DOI: 10.1038/srep03634 6",Non-OADS,/arxiv_data1/oa_pdf/44/22/srep03634.PMC3887380.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3628 | DOI: 10.1038/srep03628 7",Non-OADS,/arxiv_data1/oa_pdf/6f/bf/srep03628.PMC3887381.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4c/07/srep03633.PMC3887382.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3633 | DOI: 10.1038/srep03633 6",Non-OADS,/arxiv_data1/oa_pdf/4c/07/srep03633.PMC3887382.pdf
DNA band intensity in the Surveyor assay was estimated by the ImageJ software (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/30/0f/srep03632.PMC3887383.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/30/0f/srep03632.PMC3887383.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3632 | DOI: 10.1038/srep03632 7",Non-OADS,/arxiv_data1/oa_pdf/30/0f/srep03632.PMC3887383.pdf
"URL http://www.faqs.org/patents/ app/20110170697, Date Accessed Nov. 18, 2013.",OADS,/arxiv_data1/oa_pdf/93/1a/srep03629.PMC3887384.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 Figure 5 |Performance plot for the Santa Fe laser prediction task for random and optimal masks.",Non-OADS,/arxiv_data1/oa_pdf/93/1a/srep03629.PMC3887384.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3642 | DOI: 10.1038/srep03642 6",Non-OADS,/arxiv_data1/oa_pdf/b0/61/srep03642.PMC3887385.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/63/b9/srep03636.PMC3887386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3636 | DOI: 10.1038/srep03636 7",Non-OADS,/arxiv_data1/oa_pdf/63/b9/srep03636.PMC3887386.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f4/38/srep03626.PMC3887387.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3626 | DOI: 10.1038/srep03626 6",Non-OADS,/arxiv_data1/oa_pdf/f4/38/srep03626.PMC3887387.pdf
http://www.nf-kb.org (accessed December 30 2009).,Non-OADS,/arxiv_data1/oa_pdf/6e/81/srep03631.PMC3887388.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6e/81/srep03631.PMC3887388.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3631 | DOI: 10.1038/srep03631 11",Non-OADS,/arxiv_data1/oa_pdf/6e/81/srep03631.PMC3887388.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/39/7c/srep03630.PMC3887389.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3630 | DOI: 10.1038/srep03630 11",Non-OADS,/arxiv_data1/oa_pdf/39/7c/srep03630.PMC3887389.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The corresponding author is responsible for submitting a competing financial interests statement on behalf of all authors of the paper.,Non-OADS,/arxiv_data1/oa_pdf/e0/8b/srep03644.PMC3887390.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3644 | DOI: 10.1038/srep03644 7",Non-OADS,/arxiv_data1/oa_pdf/e0/8b/srep03644.PMC3887390.pdf
Published by Elsevier B.V.  http://dx.doi.org/10.1016/j.prevetmed.2013.11.004Open access under CC BY-NC-ND license .,OADS,/arxiv_data1/oa_pdf/a9/82/main.PMC3887397.pdf
"National  Academies  Press,  Washington,  D.C.,  U.S.A, http://www.nap.edu/catalog/11996.html Mariner,  J.C.,  2009.",Non-OADS,/arxiv_data1/oa_pdf/a9/82/main.PMC3887397.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Letters to the Editor 212 Leukemia (2014) 179 – 238 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d0/53/leu2013216a.PMC3887407.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Multifaceted roles of GSK-3 and Wnt JA McCubrey et al 33 &2014 Macmillan Publishers Limited Leukemia (2014) 15 – 33",Non-OADS,/arxiv_data1/oa_pdf/ac/7d/leu2013184a.PMC3887408.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/3/e4/v4n3e4ht.pdf doi: 10.5037/jomr.2013.4304 http://www.ejomr.org/JOMR/archives/2013/3/e4/v4n3e4ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/3d/jomr-04-e4.PMC3887571.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e4/v4n3e4ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/3d/jomr-04-e4.PMC3887571.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e4/v4n3e4ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/3d/jomr-04-e4.PMC3887571.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e4/v4n3e4ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/3d/jomr-04-e4.PMC3887571.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e4/v4n3e4ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/3d/jomr-04-e4.PMC3887571.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e4/v4n3e4ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/3d/jomr-04-e4.PMC3887571.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e4/v4n3e4ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/3d/jomr-04-e4.PMC3887571.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e4/v4n3e4ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/a6/3d/jomr-04-e4.PMC3887571.pdf
"J Oral Maxillofac Res 2013;4(3):e4 URL: http://www.ejomr.org/JOMR/archives/2013/3/e4/v4n3e4ht.pdf doi: 10.5037/jomr.2013.4304 Copyright ©  Satomi T, Tanaka T, Kobayashi T, Iino M. Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 1 October 2013.",Non-OADS,/arxiv_data1/oa_pdf/a6/3d/jomr-04-e4.PMC3887571.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.15.",Non-OADS,/arxiv_data1/oa_pdf/a6/3d/jomr-04-e4.PMC3887571.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/3/e5/v4n3e5ht.pdf doi: 10.5037/jomr.2013.4305 http://www.ejomr.org/JOMR/archives/2013/3/e5/v4n3e5ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/af/jomr-04-e5.PMC3887572.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e5/v4n3e5ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/af/jomr-04-e5.PMC3887572.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e5/v4n3e5ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/af/jomr-04-e5.PMC3887572.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e5/v4n3e5ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/af/jomr-04-e5.PMC3887572.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e5/v4n3e5ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/af/jomr-04-e5.PMC3887572.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e5/v4n3e5ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/74/af/jomr-04-e5.PMC3887572.pdf
"J Oral Maxillofac Res 2013;4(3):e5 URL: http://www.ejomr.org/JOMR/archives/2013/3/e5/v4n3e5ht.pdf doi: 10.5037/jomr.2013.4305 Copyright ©  Malkoç MA, Demir N, Ileri Z, Apiliogullari S. Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 1 October 2013.",Non-OADS,/arxiv_data1/oa_pdf/74/af/jomr-04-e5.PMC3887572.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/74/af/jomr-04-e5.PMC3887572.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/3/e2/v4n3e2ht.pdf doi: 10.5037/jomr.2013.4302 http://www.ejomr.org/JOMR/archives/2013/3/e2/v4n3e2ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e2/v4n3e2ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e2/v4n3e2ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e2/v4n3e2ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e2/v4n3e2ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e2/v4n3e2ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/1/e5/e5ht.pdf 16.,OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
"Bethesda, MD, USA, 2003: European Commission on radiation protection (RP 91) URL: http://ec.europa.eu/energy/ nuclear/radiation_protection/doc/publication/091_en.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
European Commission on radiation protection RP (162) URL: http://ec.europa.eu/energy/nuclear/radiation_protection/ consultations/doc/rp_91_update_2009_draft_for_consultation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
URL: http://www.stralsakerhetsmyndigheten.se/In-English/About-the-Swedish- Radiation-Safety-Authority1 .,Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
[Medline: 9446976 ] http://www.ejomr.org/JOMR/archives/2013/3/e2/v4n3e2ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
"J Oral Maxillofac Res 2013;4(3):e2 URL: http://www.ejomr.org/JOMR/archives/2013/3/e2/v4n3e2ht.pdf doi: 10.5037/jomr.2013.4302 Copyright ©  Hellén-Halme K, Nilsson M. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH  (http://www.ejomr.org ), 1 October 2013.",Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/f7/7a/jomr-04-e2.PMC3887573.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.pdf doi: 10.5037/jomr.2013.4303 http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
"J Oral Maxillofac Res 2013;4(3):e3 URL: http://www.ejomr.org/JOMR/archives/2013/3/e3/v4n3e3ht.pdf doi: 10.5037/jomr.2013.4303 Copyright ©  Pappalardo S, Guarnieri R. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http:// www.ejomr.org ), 1 October 2013.",Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.57.",Non-OADS,/arxiv_data1/oa_pdf/c1/a6/jomr-04-e3.PMC3887574.pdf
URL: http://www.ejomr.org/JOMR/archives/2013/3/e1/v4n3e1ht.pdf doi: 10.5037/jomr.2013.4301 http://www.ejomr.org/JOMR/archives/2013/3/e1/v4n3e1ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e1/v4n3e1ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e1/v4n3e1ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e1/v4n3e1ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e1/v4n3e1ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e1/v4n3e1ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e1/v4n3e1ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
URL: http://www.upf.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
http://www.ejomr.org/JOMR/archives/2013/3/e1/v4n3e1ht.htm J Oral Maxillofac Res 2013 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
"J Oral Maxillofac Res 2013;4(3):e1 URL: http://www.ejomr.org/JOMR/archives/2013/3/e1/v4n3e1ht.pdf doi: 10.5037/jomr.2013.4301 Copyright ©  Scherbaum Eidt JM, De Conto F, De Bortoli MM, Engelmann JM, Rocha FD.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
"Published in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 1 October 2013.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/jomr-04-e1.PMC3887575.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2014; 109:76–84;  doi: 10.1038/ajg.2013.406; published online 24 December 2013                1   Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Division of Surgery and Cancer, Imperial  College London ,  London ,  UK   ;          2   Hepatology and Gastroenterology Section, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial C ollege London ,  London ,   UK   ;         3   The Rotunda Hospital ,  Dublin ,  Ireland   ;         4   Harris Birthright Research Centre for Fetal Medicine, King ’ s College Hospital ,  London ,  UK   ;         5   Department of  Gastroenterology, Hepatology and Infectious Diseases, University of D ü sseldorf ,  D ü sseldorf ,  Germany   ;         6   Department of Medicine II, Saarland University Medical  Centre ,  Homburg ,  Germany   ;         7   Division of Women ’ s Health, King ’ s College London ,  London ,  UK   ;         8   Department of Gastroenterology, Singleton Hospital, Abertawe  Bro Morgannwg University Health Board ,  Swansea ,  UK   ;         9   Sahlgrenska Academy, Institute of Medicine, Department of Molecular and Clinical Medicine, University  of Gothenburg ,  Gothenburg ,  Sweden   ;         10   Antenatal Care, Gothenburg, Prim ä rv å rdskansliet ,  Hisings Backa ,  Sweden     ;         11   London School of Hygiene and Tropical  Medicine,   University of London ,  London ,  UK   ;         12   Quantitative Sciences, GlaxoSmithKline ,  Stevenage ,  UK   ;         13  Present address: Division of Women ’ s Health, King ’ s  College London,  London ,  UK   .",Non-OADS,/arxiv_data1/oa_pdf/27/03/ajg2013406a.PMC3887577.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2014; 109:36–45;  doi: 10.1038/ajg.2013.384; published online 3 December 2013                1   Institute of Oncologic Pathology, The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shan tou University Medical College ,   Shantou, Guangdong ,  China   ;         2   Department of Clinical Laboratory, the Cancer Hospital of Shantou University Medical College ,  Shantou, Guangdong ,  China   ;         3   Department  of Biochemistry and Molecular Biology, The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area,  Shantou University Medical College ,   Shantou, Guangdong ,  China   ;         4   Department of Oncology Surgery, Shantou Central Hospital, Afﬁ  liated Shantou Hospital of Sun Yat-sen University ,  Shantou, Guangdong ,   China   ;         5   Department of Pathology, Shantou Central Hospital, Afﬁ  liated Shantou Hospital of Sun Yat-sen University ,  Shantou, Guangdong ,  China   ;         6   Department of Head  and Neck Surgery, the Cancer Hospital of Shantou University Medical College ,  Shantou, Guangdong ,  China   .",Non-OADS,/arxiv_data1/oa_pdf/c4/b8/ajg2013384a.PMC3887578.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/c4/b8/ajg2013384a.PMC3887578.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/78/sfs174.PMC3888094.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/9c/bbs053.PMC3888109.pdf
The OBO Foundry principles (accepted and pro- posed principles can be found on http://obofoundry.org/crit.shtml) form some of the most widely usedcriteria for ontology development in biology.,Non-OADS,/arxiv_data1/oa_pdf/ae/9c/bbs053.PMC3888109.pdf
"Manchester, UK: University of Manchester, 2007. http://www.cs.man.ac.uk/ /C24horrocks/obo/.",Non-OADS,/arxiv_data1/oa_pdf/ae/9c/bbs053.PMC3888109.pdf
"Lawrence Berkeley National Laboratory, 2011. http://berkeleybop.org/ /C24cjm/obo2 owl/obo-syntax.html.710 Hoehndorf et al.",OADS,/arxiv_data1/oa_pdf/ae/9c/bbs053.PMC3888109.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/73/cia-9-095.PMC3888266.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 95–103Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  95OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5592 5self-care telephone talks as a health-promotion  intervention in urban home-living persons   75+ years of age: a randomized controlled study Kari sundsli1,2 Ulrika söderhamn2 geir Arild espnes3 Olle söderhamn2 1Department of social Work and  health science, Faculty of social  sciences and T echnology Management,   norwegian University of science  and T echnology, Trondheim, norway;   2Centre for Caring research –  southern norway, University of Agder,   grimstad, norway; 3research Centre  for health Promotion and resources,   Department of social Work and  health science, Faculty of social  sciences and T echnology Management,   norwegian University of science and  T echnology, Trondheim, norway Correspondence: Kari sundsli   Centre for Caring research – southern   norway, Faculty of health and sport   sciences, University of Agder,   PO Box 509, grimstad nO-4898,   norway   Tel +47 3723 3784   email kari.sundsli@uia.n oAim:  The aim of this study was to evaluate the effects of a telephone-based self-care  intervention  among urban living individuals 75 + years of age by comparing self-reported perceived health,  mental health, sense of coherence, self-care ability, and self-care agency before and after the  intervention.",Non-OADS,/arxiv_data1/oa_pdf/fc/73/cia-9-095.PMC3888266.pdf
Available from: http://apps.who.int/iris/bitstream/10665/70230/1/ WHO_WKC_WHD_2010.1_eng.pdf .,OADS,/arxiv_data1/oa_pdf/fc/73/cia-9-095.PMC3888266.pdf
Available from: http://www.who.int/healthpromotion/ conferences/ previous/ottawa/en/index1.html .,Non-OADS,/arxiv_data1/oa_pdf/fc/73/cia-9-095.PMC3888266.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/fc/73/cia-9-095.PMC3888266.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/73/cia-9-095.PMC3888266.pdf
Available from: http://www.wma.net/ en/30publications/10policies/b3/index.html .,Non-OADS,/arxiv_data1/oa_pdf/fc/73/cia-9-095.PMC3888266.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/5e/ijn-9-273.PMC3888267.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 273–287International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  273OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5511 8superparamagnetic iron oxide nanoparticles   conjugated with epidermal growth factor   (sPION–egF) for targeting brain tumors Maxim a shevtsov1,2 Boris P Nikolaev3 ludmila Y Yakovleva3 Yaroslav Y Marchenko3 anatolii V Dobrodumov4 anastasiya l Mikhrina5 Marina g Martynova1 Olga a Bystrova1 Igor V Yakovenko2 alexander M Ischenko3 1Institute of cytology of the  russian academy of sciences (ras),   2al Polenov russian scientific  research Institute of Neurosurgery,   3research Institute of highly Pure  Biopreparations, 4Institute of  Macromolecular compounds of the  russian academy of sciences (ras),   5IM sechenov Institute of evolutionary  Physiology and Biochemistry of the  russian academy of sciences (ras),    st Petersburg, russia correspondence: Maxim a shevtsov   Institute of cytology of the russian   academy of sciences (ras), 194064   Tikhoretsky ave 4, st Petersburg, russia   Tel +7 812 297 7450   Fax +7 812 297 0341   email shevtsov-max@mail.r uAbstract:  Superparamagnetic iron oxide nanoparticles (SPIONs) conjugated with recombinant  human epidermal growth factor (SPION–EGF) were studied as a potential agent for magnetic  resonance imaging contrast enhancement of malignant brain tumors.",Non-OADS,/arxiv_data1/oa_pdf/b3/5e/ijn-9-273.PMC3888267.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b3/5e/ijn-9-273.PMC3888267.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/5e/ijn-9-273.PMC3888267.pdf
of fetal-loss reportsRate (fetal-loss reports/million population) Alabama 4.803 1 0.208 Alaska 0.721 1 1.387 Arizona 6.413 2 0.312 Arkansas 2.926 2 0.684 California 37.342 20 0.536 Colorado 4.939 5 1.012 District of Columbia0.602 5 8.306 Florida 18.901 7 0.370 Georgia 9.727 5 0.514 Hawaii 1.367 1 0.732 Illinois 12.864 6 0.466 Indiana 6.501 6 0.923 Iowa 3.054 2 0.655 Kansas 2.864 4 1.397 Kentucky 4.351 2 0.460 Maine 1.333 2 1.500 Maryland 5.790 6 1.036 Massachusetts 6.560 13 1.982 Michigan 9.912 8 0.807 Minnesota 5.315 2 0.376 Mississippi 2.978 1 0.336 Missouri 6.011 5 0.832 Montana 0.994 3 3.018 Nebraska 1.832 2 1.092 Nevada 2.709 3 0.738 New Jersey 8.807 1 0.114 New York 19.421 3 0.154 North Carolina9.566 8 0.836 Ohio 11.568 5 0.432 Oregon 3.849 2 0.520 Pennsylvania 12.735 6 0.471 Puerto Rico 3.989 1 0.251 Rhode Island 1.055 1 0.948 South Carolina4.646 1 0.215 South Dakota 0.820 1 1.220 Tennessee 6.375 2 0.314 Texas 25.268 5 0.198 Utah 2.771 1 0.361 Vermont 0.630 2 3.175 Virginia 8.038 6 0.746 Washington 6.753 5 0.740 West Virginia 1.860 1 0.538 Wisconsin 5.698 6 1.053 ahttp://www.worldatlas.com/aatlas/populations/usapoptable.htm for the States; DC and Puerto Rico from www.cia.gov.,Non-OADS,/arxiv_data1/oa_pdf/77/27/10.1177_0960327112455067.PMC3888271.pdf
"National Vital Statistics Reports (NVSS) 2009; 58(4), http://www.cdc.gov/nchs/data/ nvsr/nvsr58/nvsr58_04.pdf (2009, accessed 11 Novem- ber 2011).",OADS,/arxiv_data1/oa_pdf/77/27/10.1177_0960327112455067.PMC3888271.pdf
"Influenza vaccination coverage levels for the 2006-07, 2007-08, and 2008-09 influenza seasons, among population groups: N ational Health Interview Survey (NHIS), United States 2007–2009, and National Immunization Survey (NIS), 2006–2008, http://www.cdc.gov/flu/profe ssionals/acip/coveragelevels.",Non-OADS,/arxiv_data1/oa_pdf/77/27/10.1177_0960327112455067.PMC3888271.pdf
Avail- able at: http://www.babycenter.com/average-fetal-- length-weight-chart (accessed on 16 July 2012).,Non-OADS,/arxiv_data1/oa_pdf/77/27/10.1177_0960327112455067.PMC3888271.pdf
Available at: http://www.epa.,OADS,/arxiv_data1/oa_pdf/77/27/10.1177_0960327112455067.PMC3888271.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/d0/gft349.PMC3888309.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/26/ppa-8-043.PMC3888346.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 43–51Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  43Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5393 0Clinical applications of somatostatin analogs   for growth hormone-secreting pituitary adenomas Ji-wen wang1,2 Ying Li3 Zhi-gang Mao1,2 Bin Hu1,2 Xiao-bing Jiang1,2 Bing-bing Song4 Xin wang4 Y ong-hong Zhu4 Hai-jun wang1,2 1Department of Neurosurgery  and Pituitary Tumor Center, The  First Affiliated Hospital, Sun Yat- sen University, 2Key Laboratory of  Pituitary Adenoma in Guangdong  Province, 3State Key Laboratory  of Ophthalmology, Zhongshan  Ophthalmic Center, Sun Yat-sen  University, 4Department of Histology  and embryology, Zhongshan School  of Medicine, Sun Yat-sen University,   Guangzhou, People’s Republic of  China Correspondence: Hai-jun wang;   Department of Neurosurgery and  Pituitary Tumor Center, The First  Affiliated Hospital, Sun Yat-sen  University, No 58, Zhongshan Road 2,  Guangzhou 510080, People’s Republic  of China   email wzwxr_1995@aliyun.co m    Y ong-hong Zhu   Department of Histology and  embryology, Zhongshan School of  Medicine, Sun Yat-sen University,  No.",Non-OADS,/arxiv_data1/oa_pdf/62/26/ppa-8-043.PMC3888346.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/62/26/ppa-8-043.PMC3888346.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/26/ppa-8-043.PMC3888346.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/c4/ndt-10-063.PMC3888347.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 63–69Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  63OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5496 4acute stimulation effect of the ventral capsule/ ventral striatum in patients with refractory  obsessive–compulsive disorder –   a double-blinded trial hsin-chi Tsai1,2 chun-hung chang3,4 Jiann-i Pan5 hung-Jen hsieh6 sheng-Tzung Tsai7 hsiang-Yi hung7 shin-Yuan chen1,7 1institute of Medical science, Tzu- chi University, hualien city, Taiwan;   2Department of Psychiatry, Tzu-chi  general hospital, hualien city,   Taiwan; 3Department of Psychiatry,   china Medical University and  hospital, Taichung, Taiwan; 4china  Medical University, Taichung, Taiwan;   5Department of Medical informatics,   Tzu-chi University, hualien, Taiwan;   6Nuclear Medicine, Tzu chi general  hospital, hualien city, Taiwan;   7Department of Neurosurgery,    Tzu-chi general hospital,    hualien city, Taiwan correspondence: shin-Yuan chen   institute of Medical science, Tzu-chi  University, Department of Neurosurgery,  Tzu-chi general hospital, No 707,   sec 3, chung Yang rd,   hualien 970, Taiwan   Tel +886 03 8561825   Fax +886 03 8574049   email b89401068@ntu.edu.t wObjective:  Deep-brain stimulation (DBS) for treating refractory obsessive–compulsive disorder  (OCD) has shown positive results in small clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/eb/c4/ndt-10-063.PMC3888347.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/eb/c4/ndt-10-063.PMC3888347.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/c4/ndt-10-063.PMC3888347.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/49/opth-8-169.PMC3888348.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 169–176Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  169Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5465 8effectiveness and tolerability of dietary   supplementation with a combination of omega-3   polyunsaturated fatty acids and antioxidants   in the treatment of dry eye symptoms: results   of a prospective study andrea Oleñik On behalf of the Dry  eye Clinical study group  (DeCsg) Ophthalmology Department,   Fundación Jiménez Díaz, Madrid, spain Correspondence: Jaume Borrás   riera sant Miquel 3, 2 ° 4ª,   e-08006 Barcelona, spain   Tel +34 93 217 0366   Fax +34 93 217 7841   email 20513 jbf@comb.ca tBackground:  We assessed the effectiveness and tolerability of a dietary supplement based on the  combination of omega-3 essential fatty acids and antioxidants on dry eye-related symptoms.",Non-OADS,/arxiv_data1/oa_pdf/31/49/opth-8-169.PMC3888348.pdf
Statistical  analyses were performed with the R Project for Statistical  Computing (R 3.0) program ( http://www.r-project.org /).,OADS,/arxiv_data1/oa_pdf/31/49/opth-8-169.PMC3888348.pdf
Available from http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=OJ:L:2012:136:0001:0040:en:PDF.,Non-OADS,/arxiv_data1/oa_pdf/31/49/opth-8-169.PMC3888348.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/31/49/opth-8-169.PMC3888348.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/49/opth-8-169.PMC3888348.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/de/vhrm-10-025.PMC3888349.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 25–32Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  25ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S5415 9Risk of stroke associated with nonsteroidal   anti-inflammatory drugs Ki Park Anthony A Bavry Division of Cardiovascular   Medicine, University of Florida,    Gainesville, FL, USA Correspondence: Anthony A Bavry   Division of Cardiovascular   Medicine, University of Florida,   1600 SW Archer Road, Box 100277,   Gainesville, FL 32610, USA   email bavryaa@medicine.ufl.ed uAbstract:  Nonsteroidal anti-inflammatory drugs (NSAIDs), both cyclooxygenase (COX)- 2-selective and nonselective agents, have been associated with the increased risk of adverse  cardiovascular events.",Non-OADS,/arxiv_data1/oa_pdf/67/de/vhrm-10-025.PMC3888349.pdf
Or use: http://dvpr.es/1c1r1V T,Non-OADS,/arxiv_data1/oa_pdf/67/de/vhrm-10-025.PMC3888349.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/67/de/vhrm-10-025.PMC3888349.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/de/vhrm-10-025.PMC3888349.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/a0/ijn-9-327.PMC3888350.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 327–336International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  327OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5496 7evaluating the potential of cubosomal nanoparticles   for oral delivery of amphotericin B  in treating fungal infection Zhiwen Yang1,3 Meiwan chen2 Muhua Yang1 Jian chen1 Weijun Fang1 Ping Xu1 1Department of Pharmacy, songjiang  hospital affiliated The First People’s  hospital, shanghai Jiao T ong University,   shanghai, 2state Key laboratory of  Quality research in chinese Medicine,   Institute of chinese Medical sciences,   University of Macau, Macau, 3shanghai  songjiang hospital affiliated Nanjing  Medical University, Nanjing, People’s  republic of china correspondence: Ping Xu   Songjiang Hospital Affiliated the   First People’s hospital, shanghai Jiao   Tong University, shanghai, 201600,   People’s republic of china   Tel +86 21 6772 0472   email luozonghua2012@126.co mAbstract:  The oral administration of amphotericin B (AmB) has a major drawback of poor  bioavailability.",Non-OADS,/arxiv_data1/oa_pdf/de/a0/ijn-9-327.PMC3888350.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/de/a0/ijn-9-327.PMC3888350.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/a0/ijn-9-327.PMC3888350.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/75/ott-7-091.PMC3888351.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 91–100OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  91Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5271 0comparison of concurrent chemoradiotherapy  followed by radical surgery and high-dose-rate  intracavitary brachytherapy: a retrospective   study of 240 patients with FigO stage iiB   cervical carcinoma ning Wang1 Wei-Wei li1 Jian-Ping li1 Juan-Yue liu1 Y ong-chun Zhou1 Ying Zhang1 Jing hu1 Yan-hong huang2 Yan chen3 li-chun Wei1,* Mei shi1,* 1Department of radiation Oncology,   2Department of gynecology and  Obstetrics, 3Department of Oncology,   Xijing hospital, Fourth Military  Medical University, Xi’an, People’s  republic of china *These authors both contributed  equally correspondence: li-chun Wei; Mei shi   Department of radiation Oncology,  Xijing hospital, Fourth Military Medical  University, 169 changle West road,  Xi’an 710032, People’s republic of china   Tel +86 29 8477 5432   email weilichun@fmmu.edu.c n;   mshi82@fmmu.edu.c nBackground:  The aim of this study was to compare the long-term survival outcome and late  toxicity in patients with FIGO (International Federation of Gynecology and Obstetrics) stage IIB  cervical carcinoma after two treatment modalities, ie, concurrent chemoradiotherapy followed  by radical surgery and concurrent chemoradiotherapy followed by high-dose-rate intracavitary  brachytherapy.",Non-OADS,/arxiv_data1/oa_pdf/23/75/ott-7-091.PMC3888351.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/23/75/ott-7-091.PMC3888351.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/75/ott-7-091.PMC3888351.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/03/ijn-9-311.PMC3888352.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 311–326International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  311OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5125 8local sustained delivery of acetylsalicylic acid  via hybrid stent with biodegradable nanofibers  reduces adhesion of blood cells and promotes  reendothelialization of the denuded artery cheng-hung lee1,2 Yu-huang lin3 shang-hung chang1 chun-Der Tai3 shih-Jung liu2 Yen chu4 chao-Jan Wang5 Ming-Yi hsu5 hung chang6 gwo-Jyh chang7 Kuo-chun hung1 Ming-Jer hsieh1 Fen-chiung lin1 I-chang hsieh1 Ming-shien Wen1 Yenlin huang8 1Division of cardiology, Department of  Internal Medicine, chang gung Memorial  hospital, chang gung University college  of Medicine, linkou, 2Department of  Mechanical engineering, 3graduate Institute  of Medical Mechatronics, chang gung  University, 4laboratory of cardiovascular  Physiology, Division of Thoracic and  cardiovascular surgery, 5Department  of Medical Imaging and Intervention,  6hematology-Oncology Division,  Department of Internal Medicine, chang  gung Memorial hospital, linkou, 7graduate  Institute of clinical Medicinal sciences,  chang gung University college of Medicine,  linkou, 8Department of anatomical  Pathology, chang gung Memorial hospital,  linkou, Tao-Yuan, Taiwan correspondence: shih-Jung liu   Biomaterials lab, Mechanical engineering,   chang gung University, 259 Wen-hwa   1st road, wei-shan, Tao-Yuan 333, Taiwan   Tel +886 3211 8166   Fax +886 3211 8558   email shihjung@mail.cgu.edu.t wAbstract:  Incomplete endothelialization, blood cell adhesion to vascular stents, and   inflammation of arteries can result in acute stent thromboses.",Non-OADS,/arxiv_data1/oa_pdf/8e/03/ijn-9-311.PMC3888352.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8e/03/ijn-9-311.PMC3888352.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/03/ijn-9-311.PMC3888352.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/2d/bhs311.PMC3888365.pdf
Calculation and visualization of thefODF was done using the spherical deconvolution methodimplemented in the MRTrix package ( http://www.brain.org.,OADS,/arxiv_data1/oa_pdf/d4/2d/bhs311.PMC3888365.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/da/bhs326.PMC3888369.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/30/bhs327.PMC3888370.pdf
"2011 ), available fromhttp://www.ini.uzh.ch/projects/cx3d/ , and with MATLAB (Mathworks Inc.).",Non-OADS,/arxiv_data1/oa_pdf/b2/30/bhs327.PMC3888370.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.oxford journals.org/ Funding This work was supported by European Union Project grant FP7-216593 “SECO.,Non-OADS,/arxiv_data1/oa_pdf/b2/30/bhs327.PMC3888370.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/bhs333.PMC3888372.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/8c/bhs334.PMC3888373.pdf
"Measure- ments from the deconvolved and thresholded images were made using Measurement Pro running under Imaris x64 (Bitplane, Zurich, Switzerland), ImageJ v1.36 –1.43 ( http://rsb.info.nih.gov/ij ), and Fiji (http:// ﬁji.sc/wiki/index.php/Fiji ).",OADS,/arxiv_data1/oa_pdf/a5/8c/bhs334.PMC3888373.pdf
The FWHMs of each PSF were measured in Fiji usingthe MetroloJ plugin ( http://imagejdocu.tudor.lu/doku.php?id=plugin: analysis:metroloj:start ).,OADS,/arxiv_data1/oa_pdf/a5/8c/bhs334.PMC3888373.pdf
"The relationships between the area of the postsynaptic density and the area of the contact zone from our EM measurements; spine volume and varicosity volume from our confocal images; and age and the size of the varicosity, spine, or contact zone were modeled under the gener- alized linear model framework using the “stat” package in R (R Project for Statistical Computing; http://www.r-project.org ), as described pre- viously ( Cheetham et al.",OADS,/arxiv_data1/oa_pdf/a5/8c/bhs334.PMC3888373.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.oxford- journals.org/ Funding This work was supported by the King ’s Medical Research Trust (C.E.J.C.,Non-OADS,/arxiv_data1/oa_pdf/a5/8c/bhs334.PMC3888373.pdf
10. http://optn.transplant.hrsa.gov/latestData/rptStrat.asp.,OADS,/arxiv_data1/oa_pdf/6a/57/tp-96-1073.PMC3888463.pdf
"log 10 of mean GI50 values for the NCI-60 cell lines over seven experiments at a concentration of 10–6mol/l for the drug of interest (gemcitabine, NSC613327) was queried and downloaded from the NCI DTP website http://dtp.nci.nih.gov .",OADS,/arxiv_data1/oa_pdf/56/04/fpc-24-81.PMC3888473.pdf
We chose two methods to analyze these SNP data sets: FET and Probabilistic Network Analysis (PNA) using the software BayesiaLab 5.0.6 http://www.bayesia.com/en/ products/bayesialab.php .,OADS,/arxiv_data1/oa_pdf/56/04/fpc-24-81.PMC3888473.pdf
"The structural coefficient analysis, the final network obtained from PNA, and the cross-validation results are shown in Supplementary File S2 (Supple- mental digital content 2, http://links.lww.com/FPC/A661 ).",OADS,/arxiv_data1/oa_pdf/56/04/fpc-24-81.PMC3888473.pdf
"Pathway analysis was performed using IPA (Ingenuity Systems Inc., Redwood City, California, USA; http://www.ingenuity.com ) and Ariadne’s Pathway Studio (Rockville, Maryland, USA).",OADS,/arxiv_data1/oa_pdf/56/04/fpc-24-81.PMC3888473.pdf
"Detailed results of the SNP comparative analysis using PNA and FET can be found in Supplementary File S3 (Supplemental digital content 3, http://links.lww.com/FPC/ A662 ) and Supplementary File S4 (Supplemental digital content 4, http://links.lww.com/FPC/A663 ), respectively.",OADS,/arxiv_data1/oa_pdf/56/04/fpc-24-81.PMC3888473.pdf
"Haploblock analysis The haplotype block estimation (Supplementary File S5, Supplemental digital content 5, http://links.lww.com/FPC/A664 ) revealed that SNP rs4148943 in the CHST3 gene, which was a top hit in the NCI-60 analysis, is found in the same haplotype block as rs4148946, which was previously reported as a top hit in an analysis of long-term survival in stage III myeloma patients (Table 2) [21].",Non-OADS,/arxiv_data1/oa_pdf/56/04/fpc-24-81.PMC3888473.pdf
"Supplementary File S6 (Supplemental digital content 6, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/56/04/fpc-24-81.PMC3888473.pdf
Available at: http://www.fda.gov/regulatoryscience.,Non-OADS,/arxiv_data1/oa_pdf/56/04/fpc-24-81.PMC3888473.pdf
Available at: http://www.hindawi.com/ journals/ppar/si/987203/.,Non-OADS,/arxiv_data1/oa_pdf/56/04/fpc-24-81.PMC3888473.pdf
Available at: http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm (Accessed 4 March 2013).Pharmacogenomics of gemcitabine response Harris et al.9 3 Copyright © Lippincott Williams & Wilkins.,Non-OADS,/arxiv_data1/oa_pdf/56/04/fpc-24-81.PMC3888473.pdf
"In response to these changes, a jointly awarded modular qual-iﬁcation, the Edinburgh Surgical Sciences Qualiﬁcation (ESSQ—http://www.essq.rcsed.ac.uk ), was launched in 2007 by the Univer- sity of Edinburgh and the Royal College of Surgeons of Edinburgh(RCSEd).",Non-OADS,/arxiv_data1/oa_pdf/e2/a8/ansu-258-838.PMC3888474.pdf
"Annals of Surgery rVolume 258, Number 5, November 2013 Distance Learning and Surgical Training expected to lead debate and facilitate interaction with others and bring original material to support their arguments ( http://demo.essq.ed.ac.",Non-OADS,/arxiv_data1/oa_pdf/e2/a8/ansu-258-838.PMC3888474.pdf
"developed in-house (eeSURG, http://learning.essq.ed.ac.uk ) allows students to navigate resources easily, follow the programme curricu-lum, access course material, and interact with course tutors and otherstudents.",Non-OADS,/arxiv_data1/oa_pdf/e2/a8/ansu-258-838.PMC3888474.pdf
"Central to course design, Blanchard and Frasson 11empha- size the importance of roleplay to enhance constructivist learning.The activity model within the eeSURG platform is provided byLabyrinth ( http://labyrinth.mvm.ed.ac.uk ), a tool for authoring and delivering case narratives.",Non-OADS,/arxiv_data1/oa_pdf/e2/a8/ansu-258-838.PMC3888474.pdf
Available at http://www.itdl.org/Journal/Jan 05/index.,Non-OADS,/arxiv_data1/oa_pdf/e2/a8/ansu-258-838.PMC3888474.pdf
Avail- able at http://jolt.merlot.org/V ol2 No2 TylerSmith.htm .,Non-OADS,/arxiv_data1/oa_pdf/e2/a8/ansu-258-838.PMC3888474.pdf
Available at http://www.westga.edu/ ∼ distance/ojdla/summer122/patterson112.html .,Non-OADS,/arxiv_data1/oa_pdf/e2/a8/ansu-258-838.PMC3888474.pdf
"Our previous  studies and other reports showed that HGF and KGF activate Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> Received 11 March 2013 | Accepted 2 January 2014 | Published 6 January 2014© 2014 Molecular Vision 24Differential effects of hepatocyte growth factor and keratinocyte  growth factor on corneal epithelial cell cycle protein expression,  cell survival, and growth Gudiseva Chandrasekher,1,2 Swetha Pothula,1 Glenn Maharaj,1 Haydee.E.P.",Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
"Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  25signal mediators phosphatidylinositol 3-kinase (PI-3K)/Akt,  p70S6K, and Erk [ 17-23].",Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  26MRC 5 color camera fitted to the microscope.,Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  27The distribution of apoptotic and normal cells under various  conditions is presented in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  28 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  29presence of HGF did not have a significant effect on blocking  PARP degradation.,Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  30 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
"Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  31the G1/S cell cycle phase progression restricting protein and  promotes cell cycle progression following mitogenic stimula - tion [ 37], can also be degraded in response to death stimuli  [38,39].",Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
"Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  32with the corneal epithelium in certain chemical injuries,  UVB radiation, and infections [ 42-45].",Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  33p53 and p27kip level is also evident in the apoptosis environ - ment.,Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  34phase progression gatekeeper protein Rb in the presence of  KGF.,Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  35studies are needed to evaluate such possibilities.,Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  366.,Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
Molecular Vision  2014; 20:24-37 <http://www.molvis.org/molvis/v 20/24> © 2014 Molecular Vision  37apoptosis by platelet-activating factor.,Non-OADS,/arxiv_data1/oa_pdf/77/dc/mv-v20-24.PMC3888494.pdf
"Higdon and colleagues  recently demonstrated that RPE-specific gene expression  could be detected in purified pigment cells from whole  zebrafish embryos, using density gradient centrifugation Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> Received 27 August 2013 | Accepted 2 January 2014 | Published 6 January 2014© 2014 Molecular Vision 56Expression profiling of the RPE in zebrafish smarca4  mutant  revealed altered signals that potentially affect RPE and retinal  differentiation Liyun Zhang,1 Ping Ma,2 Ross Collery,3 Sara Trowbridge,4 Mingzhi Zhang,5 Wenxuan Zhong,2 Yuk Fai  Leung1,6 1Department of Biological Sciences, Purdue University, West Lafayette, IN; 2Department of Statistics, University of Georgia,  Athens, GA; 3Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI;  4Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA; 5Joint Shantou International Eye Center,  Shantou University and the Chinese University of Hong Kong, Shantou, China; 6Department of Biochemistry and Molecular  Biology, Indiana University School of Medicine Lafayette, West Lafayette, IN Purpose:  The purpose of this study was to develop a framework for analyzing retinal pigment epithelium (RPE) expres - sion profiles from zebrafish eye mutants.",Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  57and fluorescence-activated cell sorting (FACS) based on the  pigment granule density of the cells [ 12].,OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
"Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  58collected and reported in [ 8], smarca4/yng  retinas (YR52)  were originally collected and reported in [ 23], and smarca4   RPE-attached retinas (YRR52) were collected in this study.",Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  59by the center of the RPE nuclei and their number counted.,OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  60 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
"Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  61RESULTS Differentiation of smarca4  RPE is abnormal: One distinctive  feature of smarca4  mutant was the lower level of pigmenta - tion in pigment cells, including the RPE.",Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  62The differentiation defects of the smarca4  RPE were  further analyzed with TEM at 52 hpf.,OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
"Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  63structures that are not bound by a lipid bilayer membrane  including the cytoskeleton, suggesting that the cytoskeletal  dynamics of the smarca4  RPE were impaired.",Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  64Table  2. m orphome Tric analyses  of melanosomes  in WT and smarca 4 rpe .,Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  65functional annotation groups that were enriched (Appendix  8; Benjamini-adjusted p value <0.05; see the table for the gene  count and percentage of total annotated genes).,Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  66as secreted ligands or the intracellular signal transducers.,Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
"Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  67tissue-level expression, and thus may complement cell-level  approaches, including expression profiling of FACS-purified  cells from the RPE-specific reporter lines.",Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
"Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  68Furthermore, ppp1r12a  (also known as MYPT1 (Entrez Gene  ID: 4659)) is a myosin phosphatase.",Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  69APPENDIX 1.,Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  70Pigmented Epithelium Reveals Indicators of Biological Func - tion and Developmental Origin.,Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v 20/56> © 2014 Molecular Vision  7139.,Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
Molecular Vision  2014; 20:56-72 <http://www.molvis.org/molvis/v20/56> © 2014 Molecular Vision  7264.,Non-OADS,/arxiv_data1/oa_pdf/16/da/mv-v20-56.PMC3888495.pdf
"Genome-wide scans localized the disease gene to Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> Received 9 December 2012 | Accepted 2 January 2014 | Published 6 January 2014© 2014 Molecular Vision 1AIPL1  implicated in the pathogenesis of two cases of autosomal  recessive retinal degeneration David Li,1 Chongfei Jin,1,2 Xiaodong Jiao,1 Lin Li,1 Tahmina Bushra,3 Muhammad Asif Naeem,3 Nadeem H.  Butt,4 Tayyab Husnain,3 Paul A. Sieving,1 Sheikh Riazuddin,3,4 S. Amer Riazuddin,3, 5 J.",Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
"Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  2chromosome 17p with two-point lod scores of 3.82 and 2.45  at θ=0, respectively.",Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  3System 9700 (Applied Biosystems).,Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  4analyzed as a fully penetrant trait with an affected allele  frequency of 0.001.,Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  5individuals from both families have no recollection of having  vision or carrying out common early visual activities.,Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  6of family 61032.,Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  7Table  3.,Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  8at θ=0 (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
"Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  9AIPL1 c.773G>C and c.465G>T mutations in families 61032  and 61277, respectively.",Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
"Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  10the PolyPhen-2, SIFT, and MutationAssessor programs.",Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
"Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  11DISCUSSION Here, we report linkage of autosomal recessive retinal  degeneration in two consanguineous Pakistani families to  markers on chromosome 17p13.2.",Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  12has been shown to bind NUB1 and inhibit NUB1-mediated  degradation of FAT10 conjugated proteins [ 46].,Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  13Pakistani Family Maps to Chromosome 2p.,Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
Molecular Vision  2014; 20:1-14 <http://www.molvis.org/molvis/v 20/1> © 2014 Molecular Vision  14remaining.,Non-OADS,/arxiv_data1/oa_pdf/99/7b/mv-v20-1.PMC3888496.pdf
"For patients with CFEOM1, the atrophic  levator palpebrae superioris and other EOMs as well as the  hypoplastic oculomotor nerves can be detected with MRI.Molecular Vision  2014; 20:15-23 <http://www.molvis.org/molvis/v 20/15> Received 27 July 2013 | Accepted 2 January 2014 | Published 6 January 2014© 2014 Molecular Vision 15Maternal germline mosaicism of kinesin family member 21A  (KIF21A)  mutation causes complex phenotypes in a Chinese family  with congenital fibrosis of the extraocular muscles Gang Liu,1 Xue Chen,2, 3 Xiantao Sun,4 Hu Liu,2 Kanxing Zhao,5 Qinglin Chang,6 Xinyuan Pan,2 Xiuying  Wang,2 Songtao Yuan,2 Qinghuai Liu,2 Chen Zhao2 (The first three authors contributed equally to this article.)",Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
"Molecular Vision  2014; 20:15-23 <http://www.molvis.org/molvis/v 20/15> © 2014 Molecular Vision  16To date, five loci have been associated with CFEOM,  including the FEOM1  locus [ 5], the paired-like homeobox  2a (PHOX2A ) locus [ 6], the FEOM3  locus [ 7], the FEOM4   locus [ 8], and the Tukel syndrome gene ( TUKLS)  locus [ 9].",Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
Molecular Vision  2014; 20:15-23 <http://www.molvis.org/molvis/v 20/15> © 2014 Molecular Vision  17forced duction testing demonstrated marked restrictions  in passive elevation of the globes in all three patients.,Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
"Molecular Vision  2014; 20:15-23 <http://www.molvis.org/molvis/v 20/15> © 2014 Molecular Vision  18hypoplastic medial rectus (MR) muscles, and inferior rectus  (IR) muscles were observed in continuous sections in both  examined patients at the primary position.",Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
Molecular Vision  2014; 20:15-23 <http://www.molvis.org/molvis/v 20/15> © 2014 Molecular Vision  19 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
"Molecular Vision  2014; 20:15-23 <http://www.molvis.org/molvis/v 20/15> © 2014 Molecular Vision  20spliced regions, and seven WD repeats in the tail.",Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
"Molecular Vision  2014; 20:15-23 <http://www.molvis.org/molvis/v 20/15> © 2014 Molecular Vision  21sex determining region Y-box 2 (SOX2)-related eye disor - ders [ 25], and ankyloblepharon-ectodermal defects-cleft lip/ palate (AEC) syndrome [ 26].",Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
Molecular Vision  2014; 20:15-23 <http://www.molvis.org/molvis/v 20/15> © 2014 Molecular Vision  225.,Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
GeneReviews 1993; http://www.ncbi.nlm.nih.gov/books/ NBK1480/ .,Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
GeneReviews  1993; http://www.ncbi.nlm.nih.gov/books/NBK1472/ .,Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
GeneReviews  1993; http://www.ncbi.nlm.nih.gov/books/NBK1300/ .,Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
Molecular Vision  2014; 20:15-23 <http://www.molvis.org/molvis/v 20/15> © 2014 Molecular Vision  23implications for recurrence risk and prenatal diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/f2/e0/mv-v20-15.PMC3888497.pdf
"This of course is wholly understandable as these early Molecular Vision  2014; 20:46-55 <http://www.molvis.org/molvis/v 20/46> Received 3 May 2013 | Accepted 2 January 2014 | Published 6 January 2014© 2014 Molecular Vision 46Age-related macular degeneration: Beyond anti-angiogenesis David L. Kent1,2 1The Vision Clinic, Circular Road, Kilkenny, Ireland; 2Institute of Ageing and Chronic Disease, Faculty of Health & Life Sciences,  University of Liverpool, UK Recently, anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration have been  developed.",Non-OADS,/arxiv_data1/oa_pdf/3d/e4/mv-v20-46.PMC3888498.pdf
Molecular Vision  2014; 20:46-55 <http://www.molvis.org/molvis/v 20/46> © 2014 Molecular Vision  47retinal pioneers strove admirably to deal with these visually  devastating conditions as the race began to halt sight loss and  refine this vascular-only therapeutic approach.,Non-OADS,/arxiv_data1/oa_pdf/3d/e4/mv-v20-46.PMC3888498.pdf
Molecular Vision  2014; 20:46-55 <http://www.molvis.org/molvis/v 20/46> © 2014 Molecular Vision  48aberrant since loss of central vision ensues.,Non-OADS,/arxiv_data1/oa_pdf/3d/e4/mv-v20-46.PMC3888498.pdf
"Molecular Vision  2014; 20:46-55 <http://www.molvis.org/molvis/v 20/46> © 2014 Molecular Vision  49blood supply, it seems reasonable to suggest that this prob - ably requires the preservation of the neovessels (CNV).",Non-OADS,/arxiv_data1/oa_pdf/3d/e4/mv-v20-46.PMC3888498.pdf
Molecular Vision  2014; 20:46-55 <http://www.molvis.org/molvis/v 20/46> © 2014 Molecular Vision  50of the overlying NSR.,Non-OADS,/arxiv_data1/oa_pdf/3d/e4/mv-v20-46.PMC3888498.pdf
"Molecular Vision  2014; 20:46-55 <http://www.molvis.org/molvis/v 20/46> © 2014 Molecular Vision  51mature vessels can often be visualized clinically and can  demonstrate vascular maturation and competence angio - graphically and histologically [ 49,94].",Non-OADS,/arxiv_data1/oa_pdf/3d/e4/mv-v20-46.PMC3888498.pdf
Molecular Vision  2014; 20:46-55 <http://www.molvis.org/molvis/v 20/46> © 2014 Molecular Vision  52Group.,Non-OADS,/arxiv_data1/oa_pdf/3d/e4/mv-v20-46.PMC3888498.pdf
Molecular Vision  2014; 20:46-55 <http://www.molvis.org/molvis/v 20/46> © 2014 Molecular Vision  53of age-related macular degeneration.,Non-OADS,/arxiv_data1/oa_pdf/3d/e4/mv-v20-46.PMC3888498.pdf
Molecular Vision  2014; 20:46-55 <http://www.molvis.org/molvis/v 20/46> © 2014 Molecular Vision  5462.,Non-OADS,/arxiv_data1/oa_pdf/3d/e4/mv-v20-46.PMC3888498.pdf
Molecular Vision  2014; 20:46-55 <http://www.molvis.org/molvis/v 20/46> © 2014 Molecular Vision  55neovascularization in a murine model.,Non-OADS,/arxiv_data1/oa_pdf/3d/e4/mv-v20-46.PMC3888498.pdf
"Mannose-binding lectin (MBL), a pattern recognition  receptor of the lectin pathway of complement, is a circu - lating oligomeric protein that is produced primarily by the Molecular Vision  2014; 20:38-45 <http://www.molvis.org/molvis/v 20/38> Received 6 November 2013 | Accepted 2 January 2014 | Published 6 January 2014© 2014 Molecular Vision 38Activation of the lectin pathway of complement in experimental  human keratitis with Pseudomonas aeruginosa Michael Osthoff,1,2 Karl D. Brown,3 David C.M.",Non-OADS,/arxiv_data1/oa_pdf/88/77/mv-v20-38.PMC3888499.pdf
Molecular Vision  2014; 20:38-45 <http://www.molvis.org/molvis/v 20/38> © 2014 Molecular Vision  39liver with minor transcription in the intestine and testis  [16].,Non-OADS,/arxiv_data1/oa_pdf/88/77/mv-v20-38.PMC3888499.pdf
Molecular Vision  2014; 20:38-45 <http://www.molvis.org/molvis/v 20/38> © 2014 Molecular Vision  40Table  1.,Non-OADS,/arxiv_data1/oa_pdf/88/77/mv-v20-38.PMC3888499.pdf
Molecular Vision  2014; 20:38-45 <http://www.molvis.org/molvis/v 20/38> © 2014 Molecular Vision  41and adherent bacteria.,Non-OADS,/arxiv_data1/oa_pdf/88/77/mv-v20-38.PMC3888499.pdf
"Molecular Vision  2014; 20:38-45 <http://www.molvis.org/molvis/v 20/38> © 2014 Molecular Vision  42[SD] 17.99 [0.65] at 1 h, 17.57 [0.21] at 3 h, 17.09 [0.79] at  5 h, 15.37 [1.26] at 18 h; p<0.05 for the comparison of 1 h  versus 18 h; one-way ANOVA with Bonferroni’s multiple  comparison test).",Non-OADS,/arxiv_data1/oa_pdf/88/77/mv-v20-38.PMC3888499.pdf
Molecular Vision  2014; 20:38-45 <http://www.molvis.org/molvis/v 20/38> © 2014 Molecular Vision  43in the human intestine and testis [ 16].,Non-OADS,/arxiv_data1/oa_pdf/88/77/mv-v20-38.PMC3888499.pdf
Molecular Vision  2014; 20:38-45 <http://www.molvis.org/molvis/v 20/38> © 2014 Molecular Vision  44The limited number of cadaveric corneal samples is  the main limitation of our study.,Non-OADS,/arxiv_data1/oa_pdf/88/77/mv-v20-38.PMC3888499.pdf
Molecular Vision  2014; 20:38-45 <http://www.molvis.org/molvis/v 20/38> © 2014 Molecular Vision  4521.,Non-OADS,/arxiv_data1/oa_pdf/88/77/mv-v20-38.PMC3888499.pdf
"Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> Received 21 March 2013 | Accepted 3 January 2014 | Published 7 January 2014© 2014 Molecular Vision 73L-2-oxothiazolidine-4-carboxylic acid attenuates oxidative stress  and inflammation in retinal pigment epithelium Wanwisa Promsote,1 Rajalakshmi Veeranan-Karmegam,1 Sudha Ananth,1 Defen Shen,2 Chi-Chao Chan,2  Nevin A. Lambert,3 Vadivel Ganapathy,1,5 Pamela M. Martin1,4,5 1Department of Biochemistry and Molecular Biology, Georgia Regents University, Augusta, GA; 2Laboratory of Immunology,  National Eye Institute, National Institutes of Health, Bethesda, MD; 3Department of Pharmacology and Toxicology, Georgia  Regents University, Augusta, GA; 4Department of Ophthalmology, and the Georgia Regents University, Augusta, GA; 5James and  Jean Culver Vision Discovery Institute, Georgia Regents University, Augusta, GA Purpose:  Oxidant- and inflammation-induced damage to retinal pigment epithelial (RPE) cells is central to the patho - genesis of age-related macular degeneration (AMD).",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  74The beneficial effects of OTC in terms of augmenting levels  of this major cellular antioxidant have been documented in  several cell and tissue types and confirmed by studies in  animals and humans [ 6-13].,Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  75mRPE cells were used for all experiments.,Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  76the presence of increasing concentrations of OTC (1 h treat - ment).,Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
"Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  77RESULTS In vitro suppression of inflammatory molecules by treatment  with OTC:  In keeping with the role as a key regulator of  retinal immunity and inflammation, RPE cells express and  secrete several cytokines, both pro- and anti-inflammatory in  nature, in response to various stimuli [ 18,20].",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
"Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  78owing to the presence of the rd8 mutation within the strain,  may not be ideal for use in studies of morphological features  characteristic of human AMD and the ability of agents to  prevent or slow down the progression thereof.",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
"Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  79with NLRP3 inflammasome activation in RPE cells, a  phenomenon highly relevant to geographic atrophy (dry) and  neovascular (wet) AMD in human patients [ 16,42].",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  80 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
"Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  81with ELISA (Figure 4A,B, respectively).",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  82 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
"Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  83in BRET activity was significantly inhibited by PTX, indi - cating that the BRET signal observed in the presence of OTC  was due specifically to its activation of a Gi-linked receptor.",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  84 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  85systems.,Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
"Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  86This study represents, to our knowledge, the first  report of the suppressive effects of OTC on inflammation in  cultured RPE cells, and on inflammation and oxidative stress  in the retina in vivo.",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  8715.,Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
Molecular Vision  2014; 20:73-88 <http://www.molvis.org/molvis/v 20/73> © 2014 Molecular Vision  8840.,Non-OADS,/arxiv_data1/oa_pdf/a4/ae/mv-v20-73.PMC3888500.pdf
"Microarrays were validated by SYBR Green qRT- PCR (a list of the primers used is shown in SupplementaryTable 3, available on the Arthritis & Rheumatism web site at http://onlinelibrary.wiley.com/doi/10.1002/art.38035/abstract),using the comparative C tmethod.",OADS,/arxiv_data1/oa_pdf/4b/af/art0065-2334.PMC3888512.pdf
"Thisrevealed rhythmic PER2::luc activity from the cartilagi-nous tissue (Figure 1B) (see also Supplementary Video,available on the Arthritis & Rheumatism web site at http://onlinelibrary.wiley.com/doi/10.1002/art.38035/abstract).",Non-OADS,/arxiv_data1/oa_pdf/4b/af/art0065-2334.PMC3888512.pdf
"Thus, we identified615 genes with rhythmic expression and a circadianperiod of /H1101124 hours (3.9% of expressed genes, repre- sented by 704 probes) (Figure 3A and SupplementaryTable 1, available on the Arthritis & Rheumatism web site at http://onlinelibrary.wiley.com/doi/10.1002/art.38035/abstract).",OADS,/arxiv_data1/oa_pdf/4b/af/art0065-2334.PMC3888512.pdf
"We compared our gene list to published sequen- tial chromatin immunoprecipitation assay data on theexpression of circadian clock transcription factor Bmal1 in the liver (30), and we found that 132 of our rhythmicgenes had previously determined Bmal1 binding sites (see Supplementary Table 1, available on the Arthritis & Rheumatism web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.38035/abstract).",Non-OADS,/arxiv_data1/oa_pdf/4b/af/art0065-2334.PMC3888512.pdf
2012. arXiv: 1206.5162 [cs.LG].URL: http://arxiv.org/abs/1206.5162.,Non-OADS,/arxiv_data1/oa_pdf/4b/af/art0065-2334.PMC3888512.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Jonsson A, Segesten K, Mattsson B. Post-traumatic stress among Swedish ambulance personnel.",Non-OADS,/arxiv_data1/oa_pdf/84/ee/emermed-2011-200511.PMC3888584.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2013-203860).,Non-OADS,/arxiv_data1/oa_pdf/1f/16/annrheumdis-2013-203860.PMC3888585.pdf
"Correspondence to Dr Monika M Schoels, 2nd Department of Medicine, Centre for Rheumatic Diseases,Hietzing Hospital, Wolkersbergenstrasse 1, Vienna 1130, Austria;monika.schoels@live.com Accepted 15 May 2013 Published Online First 5 June 2013 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-203419 To cite: Schoels MM, Braun J, Dougados M, et al .",Non-OADS,/arxiv_data1/oa_pdf/1f/16/annrheumdis-2013-203860.PMC3888585.pdf
"An international expert panel has been convened to develop‘treat-to-target ’recommendations, based on published evidence and expert opinion.Objective To review evidence on targeted treatment for axial and peripheral SpA, as well as for psoriatic skindisease.Methods We performed a systematic literature search covering Medline, Embase and Cochrane, conferenceabstracts and studies in http://www.clinicaltrials.gov.Results Randomised comparisons of targeted versus routine treatment are lacking.",Non-OADS,/arxiv_data1/oa_pdf/1f/16/annrheumdis-2013-203860.PMC3888585.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Braun J, van den Berg R, Baraliakos X, et al .",Non-OADS,/arxiv_data1/oa_pdf/1f/16/annrheumdis-2013-203860.PMC3888585.pdf
"7 http://www.abstracts2view.com/eular/[Online] 8 http://www.rheumatology.org/publications/acr_arhp_annual_meeting.asp [Online]9 http://www.clinicaltrials.gov [Online] 10 Schoels M, Knevel R, Aletaha D, et al .",Non-OADS,/arxiv_data1/oa_pdf/1f/16/annrheumdis-2013-203860.PMC3888585.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2012-202634).,OADS,/arxiv_data1/oa_pdf/6c/ca/annrheumdis-2012-202634.PMC3888586.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/REFERENCES 1 Croft P, Blyth FM, van der Windt D. The global occurrence of chronic pain: an introduction.",Non-OADS,/arxiv_data1/oa_pdf/6c/ca/annrheumdis-2012-202634.PMC3888586.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ thoraxjnl-2012-202878).,Non-OADS,/arxiv_data1/oa_pdf/7e/49/thoraxjnl-2012-202878.PMC3888587.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Mannino DM, Homa DM, Akinbami LJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/49/thoraxjnl-2012-202878.PMC3888587.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ jclinpath-2013-201691).,OADS,/arxiv_data1/oa_pdf/10/bf/jclinpath-2013-201691.PMC3888588.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Swerdlow SH, Campo E, et al, eds.",Non-OADS,/arxiv_data1/oa_pdf/10/bf/jclinpath-2013-201691.PMC3888588.pdf
"http://myeloma.org/ArticlePage.action?tabId=0&menuId=0&articleId=3069&aTab=-1&gParentType=nugget&gParentId=18&parentIndexPageId=284 22 Munshi NC, Anderson KC, Bergsagel PL, et al.",OADS,/arxiv_data1/oa_pdf/10/bf/jclinpath-2013-201691.PMC3888588.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/gutjnl-2012-303715).,Non-OADS,/arxiv_data1/oa_pdf/fa/3c/gutjnl-2012-303715.PMC3888589.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Gangadhar T, Schilsky RL.",Non-OADS,/arxiv_data1/oa_pdf/fa/3c/gutjnl-2012-303715.PMC3888589.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1 Acute Medicine T askforce.,Non-OADS,/arxiv_data1/oa_pdf/2f/4e/bmjqs-2012-001404.PMC3888590.pdf
http://www.ncepod.org.uk/ 2005aap.htm (accessed 8 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/2f/4e/bmjqs-2012-001404.PMC3888590.pdf
http://www.ncepod.org.uk/ 2012report1/downloads/CAP_fullreport.pdf (accessed 20 May2013).,Non-OADS,/arxiv_data1/oa_pdf/2f/4e/bmjqs-2012-001404.PMC3888590.pdf
http://www.resus.org.uk/pages/ncaa.htm (accessed 8Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/2f/4e/bmjqs-2012-001404.PMC3888590.pdf
http://www.sicsag.scot.nhs.uk/Levels_of_Care_Intensive_Care_Society_2009.pdf (accessed 20 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2f/4e/bmjqs-2012-001404.PMC3888590.pdf
http://www.rcplondon.ac.uk/resources/national-early-warning-score-news (accessed 20 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2f/4e/bmjqs-2012-001404.PMC3888590.pdf
http://www.ihi.org/knowledge/Pages/T ools/SBART echniqueforCommunicationASituationalBriefingModel.aspx (accessed 24 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/2f/4e/bmjqs-2012-001404.PMC3888590.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2013-203697).,Non-OADS,/arxiv_data1/oa_pdf/2c/29/annrheumdis-2013-203697.PMC3888591.pdf
"1Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands 2University of Texas SW Medical Center, Dallas, Texas, USA 3Schoen Klinik, Hamburg, Germany 4Division of Arthritis/Rheumatic Diseases (OPO9), Oregon Health & Science University, Portland, Oregon, USA 5UCB Pharma, Brussels, Belgium 6UCB Pharma, Monheim am Rhein, Germany 7UCB Pharma, Raleigh, North Carolina, USA 8Swedish Medical Center and University of Washington,Seattle, Washington, USA Correspondence to Professor Désirée van der Heijde, Department ofRheumatology, LeidenUniversity Medical Center, PO Box 9600, Leiden 2300 RC,The Netherlands;Email: mail@dvanderheijde.nl Received 27 March 2013 Revised 12 June 2013 Accepted 26 June 2013Published Online First13 August 2013 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-203696▸http://dx.doi.org/10.1136/ annrheumdis-2013-204231 To cite: van der Heijde D, Fleischmann R, Wollenhaupt J, et al.Ann Rheum Dis 2014; 73: 233 –237.ABSTRACT Objectives To report the effect of different imputation methodologies on the assessment of radiographicprogression in clinical trials.Methods The 216-week RAPID-psoriatic arthritis (PsA) (NCT01087788) trial of certolizumab pegol (CZP) in patients with active PsA was double-blind and placebo- controlled until week 24.",Non-OADS,/arxiv_data1/oa_pdf/2c/29/annrheumdis-2013-203697.PMC3888591.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Van Der Heijde D. Use of imaging as an outcome measure in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/2c/29/annrheumdis-2013-203697.PMC3888591.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ archdischild-2013-304699).,Non-OADS,/arxiv_data1/oa_pdf/6a/79/archdischild-2013-304699.PMC3888592.pdf
"1MRC Centre of Epidemiology for Child Health/Centre forPaediatric Epidemiology &Biostatistics, UCL Institute of Child Health, London, UK 2Division of Population Health Sciences and Education, StGeorge ’s, University of London, London, UK Correspondence to Dr L Li, MRC Centre ofEpidemiology for Child Health, UCL Institute of Child Health, 30 Guilford Street,London WC1N 1EH, UK;leah.li@ucl.ac.uk Received 21 June 2013 Revised 13 September 2013 Accepted 15 September 2013Published Online First13 November 2013 ▸http://dx.doi.org/10.1136/ archdischild-2013-305252 To cite: Peters H, Whincup PH, Cook DG, et al.Arch Dis Child 2014; 99:10–14.ABSTRACT Objective Little is known about whether levels of physical ﬁtness, which is related to adiposity and physical activity (PA), have changed in children,particularly the progressive increase in childhood obesitylevels.",Non-OADS,/arxiv_data1/oa_pdf/6a/79/archdischild-2013-304699.PMC3888592.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Armstrong N. Young people ’s physical activity patterns as assessed by heart rate monitoring.,Non-OADS,/arxiv_data1/oa_pdf/6a/79/archdischild-2013-304699.PMC3888592.pdf
2002. http://www.archive2.,Non-OADS,/arxiv_data1/oa_pdf/6a/79/archdischild-2013-304699.PMC3888592.pdf
2008. http://www.esds.ac.,Non-OADS,/arxiv_data1/oa_pdf/6a/79/archdischild-2013-304699.PMC3888592.pdf
"Competing interests Both authors have completed the unified competing interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) anddeclare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previousViewpoint Goldberg SE, et al.BMJ Qual Saf 2013; 22:977 –980.",Non-OADS,/arxiv_data1/oa_pdf/5c/27/bmjqs-2013-001961.PMC3888593.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Legido-Quigley H, McKee M, Nolte E, et al.Assuring the quality of healthcare in the European Union.",Non-OADS,/arxiv_data1/oa_pdf/5c/27/bmjqs-2013-001961.PMC3888593.pdf
See: http://creativecommons.org/licenses/ by-nc/3.0/ To cite Rudling M. Gut2014; 63:205 –206.,Non-OADS,/arxiv_data1/oa_pdf/26/78/gutjnl-2013-305227.PMC3888594.pdf
Received 5 May 2013 Revised 7 May 2013 Accepted 8 May 2013 Published Online First 8 June 2013 ▸http://dx.doi.org/10.1136/gutjnl-2012-302945 ▸http://dx.doi.org/10.1136/gutjnl-2013-305251 Gut2014; 63:205 –206.,Non-OADS,/arxiv_data1/oa_pdf/26/78/gutjnl-2013-305227.PMC3888594.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Shand L, Lunt M, Nihtyanova S, et al.",Non-OADS,/arxiv_data1/oa_pdf/7a/8f/annrheumdis-2013-203674.PMC3888595.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Watson DJ, Rhodes T, Guess HA.",Non-OADS,/arxiv_data1/oa_pdf/b4/b9/annrheumdis-2012-202089.PMC3888596.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Blunt I, Bardsley M, Dixon J. T rends in emergency admissions in England 2004 –2009 .",Non-OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
"London: The Nuffield T rust, 2010. http://www.nuffieldtrust.org.uk/publications/trends-emergency-admissions-england-2004-2009 (accessed 1 Feb 2013).",Non-OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
"Sheffield: Medical Care Research Unit, 2009. http://www.shef.ac.uk/content/1/c6/05/91/04/finalreport.pdf(accessed 31 Jan 2013).",Non-OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
http://www.dh.gov.uk/en/ Publicationsandstatistics/Statistics/HospitalEpisodeStatistics/index.htm (accessed 31 Jan 2013).,OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
http://www.ons.gov.uk/ons/index.,Non-OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
https://www.gov.uk/government/publications/english-indices-of-deprivation-2010 (accessed 29 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-250425 (accessed 29 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
https://indicators.ic.nhs.uk/webview/ (accessed 29 Jan 2013).,OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
http://www.ons.gov.uk/ ons/guide-method/geography/products/area-classifications/rural-urban-definition-and-la/rural-urban-local-authority —la— classification —england-/index.html (accessed 29 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
https://indicators.ic.nhs.uk/webview/ (accessed 29 Jan 2013).,OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
http://www.dh.,Non-OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
http://www.lho.org.uk/viewResource.aspx?id=9319 (accessed 1 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
http://www.ic.nhs.uk/article/ 2021/W ebsite-Search?productid=173&q=Emergency+calls+resolved+through+telephone+advice+only%2c+by +ambulance+service+2009-10&sort=Relevance&size=10&page=1&area=both#top (accessed 1 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/77/6c/bmjqs-2013-002003.PMC3888597.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2013-204231).,OADS,/arxiv_data1/oa_pdf/33/88/annrheumdis-2013-204231.PMC3888598.pdf
"Correspondence to Professor Robert Landewé, Department of Clinical Immunology andRheumatology, AcademicMedical Center, University of Amsterdam & Atrium Medical Center, Meibergdreef 9,Amsterdam 1105AZ,The Netherlands; landewe@rlandewe.nl Received 4 July 2013 Revised 19 August 2013Accepted 20 August 2013 Published Online First 6 September 2013 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-203696 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-203697 To cite: Landewé R, Braun J, Deodhar A, et al.",Non-OADS,/arxiv_data1/oa_pdf/33/88/annrheumdis-2013-204231.PMC3888598.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Sieper J, Rudwaleit M, Baraliakos X, et al.",Non-OADS,/arxiv_data1/oa_pdf/33/88/annrheumdis-2013-204231.PMC3888598.pdf
The contents of the compendium canbe accessed freely at https://sites.google.com/site/compendiumofphysicalactivities/.,Non-OADS,/arxiv_data1/oa_pdf/cc/82/postgradmedj-2012-131366.PMC3888599.pdf
RESOURCES FOR FURTHER INFORMATION ON PHYSICAL ACTIVITY IN OLDER ADULTS http://www.exerciseismedicine.org this website provides further background information on the value of exercises and has freelyavailable resources physicians can use in their practice.,Non-OADS,/arxiv_data1/oa_pdf/cc/82/postgradmedj-2012-131366.PMC3888599.pdf
http://www.cdc.gov/physicalactivity/growingstronger/index.,OADS,/arxiv_data1/oa_pdf/cc/82/postgradmedj-2012-131366.PMC3888599.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/cc/82/postgradmedj-2012-131366.PMC3888599.pdf
"2013. http://www.who.int/dietphysicalactivity/factsheet_inactivity/en/index.html 2 Bauman A, Craig C. The place of physical activity in the WHO Global Strategy on Diet and physical activity.",Non-OADS,/arxiv_data1/oa_pdf/cc/82/postgradmedj-2012-131366.PMC3888599.pdf
"2013. http://www.cdc.gov/ncbddd/disabilityandhealth/data.html 54 Tak E, Kuiper R, Chorus A, et al.",OADS,/arxiv_data1/oa_pdf/cc/82/postgradmedj-2012-131366.PMC3888599.pdf
"1Parkland Center for Clinical Innovation, Dallas, Texas, USA 2Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA 3Department of Cardiovascular Disease and Transplantation, Mayo Clinic, Jacksonville, Florida, USA 4Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA 5Department of Pharmacy, Parkland Health and Hospital System, Dallas, Texas, USA 6Department of Nutrition Services, Parkland Health and Hospital System, Dallas, Texas, USA Correspondence to Dr Ruben Amarasingham, Parkland Center for ClinicalInnovation, 6300 Harry Hines Blvd, Dallas, TX 75235, USA; ruben.amarasingham@phhs.org Received 10 February 2013 Revised 12 June 2013 Accepted 30 June 2013 Published Online First1 August 2013 ▸http://dx.doi.org/10.1136/ bmjqs-2013-002407 To cite: Amarasingham R, Patel PC, Toto K, et al.BMJ Qual Saf 2013; 22:998–1005.ABSTRACT Objective To test a multidisciplinary approach to reduce heart failure (HF) readmissions that tailors the intensity of care transition intervention to the risk of the patient using a suite of electronicmedical record (EMR)-enabled programmes.",Non-OADS,/arxiv_data1/oa_pdf/61/6b/bmjqs-2013-001901.PMC3888600.pdf
http://www.cms.gov/medicare-coverage- database/staticpages/icd9-code-range.aspx?DocT ype=LCD&DocID=28695&ver=32&Group=1&RangeStart=428.0&RangeEnd=428.9 (accessed 24 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/6b/bmjqs-2013-001901.PMC3888600.pdf
http://www.cms.gov/ medicare-coverage-database/staticpages/icd9-code-range.aspx?,Non-OADS,/arxiv_data1/oa_pdf/61/6b/bmjqs-2013-001901.PMC3888600.pdf
http://www.hospitalmedicine.org/AM/T emplate.cfm?Section=Home&TEMPLATE=/CM/HTMLDisplay.cfm&CONTENTID=27659 (accessed 20 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/61/6b/bmjqs-2013-001901.PMC3888600.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/oemed-2013-101452).,Non-OADS,/arxiv_data1/oa_pdf/40/36/oemed-2013-101452.PMC3888602.pdf
"1Department of Pharmaceutical Sciences, Universidade Estadual de Londrina (UEL), Londrina, Paraná, Brazil 2Postgraduate Program in Public Health, Universidade Estadual de Londrina (UEL), Londrina, Paraná, Brazil 3Department of Public Health, Universidade Estadual de Londrina (UEL), Londrina, Paraná, Brazil Correspondence to Professor Edmarlon Girotto,Department of Pharmaceutical Sciences, Universidade Estadual de Londrina, Robert KochAvenue, 60, Londrina,Paraná 86038-350, Brazil; eddieuel@yahoo.com.br Received 15 February 2013 Revised 29 July 2013Accepted 6 August 2013 Published Online First 21 October 2013 ▸http://dx.doi.org/10.1136/ oemed-2013-101791 To cite: Girotto E, Mesas AE, de Andrade SM, et al.Occup Environ Med 2014; 71:71–76.ABSTRACT The aim of this study was to summarise the scienti ﬁc evidence on the prevalence of psychoactive substanceuse and on the factors associated with their intakeamong truck drivers.",Non-OADS,/arxiv_data1/oa_pdf/40/36/oemed-2013-101452.PMC3888602.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Toyoshima S, Ferreira MJ.",Non-OADS,/arxiv_data1/oa_pdf/40/36/oemed-2013-101452.PMC3888602.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2012-202760).,OADS,/arxiv_data1/oa_pdf/ca/ba/annrheumdis-2012-202760.PMC3888603.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1D ’Cruz DP, Khamashta MA, Hughes GR.",Non-OADS,/arxiv_data1/oa_pdf/ca/ba/annrheumdis-2012-202760.PMC3888603.pdf
http://us.gsk.com/ products/assets/us_benlysta.pdf (accessed Jan 2013).,OADS,/arxiv_data1/oa_pdf/ca/ba/annrheumdis-2012-202760.PMC3888603.pdf
http://www.ema.europa.eu/ docs/en_GB/document_libr ary/EPAR_-_Product_Information/human/002015/ WC500110150.pdf (accessed Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/ca/ba/annrheumdis-2012-202760.PMC3888603.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Virta R. Worldwide Asbestos Supply and Consumption Trends from 1900 through 2003.,Non-OADS,/arxiv_data1/oa_pdf/c2/b9/oemed-2013-101555.PMC3888604.pdf
2006. http://pubs.usgs.gov/circ/2006/ 1298/c1298.pdf2 Ban Asbestos Secretariat.,OADS,/arxiv_data1/oa_pdf/c2/b9/oemed-2013-101555.PMC3888604.pdf
http://ibasecretariat.org 3 Kamp DW.,Non-OADS,/arxiv_data1/oa_pdf/c2/b9/oemed-2013-101555.PMC3888604.pdf
"http://www.who.int/mediacentre/ factsheets/fs343/en/index.html 5 Diandini R, Takahashi K, Park EK, et al.",OADS,/arxiv_data1/oa_pdf/c2/b9/oemed-2013-101555.PMC3888604.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Tam LS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis.",Non-OADS,/arxiv_data1/oa_pdf/d9/fc/annrheumdis-2013-203559.PMC3888605.pdf
"To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2012-203201) 1Medical Department I, Rheumatology, Charité CampusBenjamin Franklin, Berlin, Germany 2Department of Rheumatology, REUMA Instituut, Hasselt,Belgium 3Klinik für Rheumatologie und klinische Immunologie, Schön-Klinik, Hamburg, Germany 4St.",Non-OADS,/arxiv_data1/oa_pdf/ba/b2/annrheumdis-2012-203201.PMC3888606.pdf
"sieper@charite.de Accepted 14 April 2013 Published Online First21 May 2013 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-203460 To cite: Sieper J, Lenaerts J, Wollenhaupt J, et al.Ann Rheum Dis 2014; 73: 101 –107.ABSTRACT Objectives To assess whether combination therapy with in ﬂiximab (IFX) plus nonsteroidal anti-in ﬂammatory drugs (NSAIDs) is superior to NSAID monotherapy forreaching Assessment of SpondyloArthritis internationalSociety (ASAS) partial remission in patients with early,active axial spondyloarthritis (SpA) who were naïve toNSAIDs or received a submaximal dose of NSAIDs.Methods Patients were randomised (2 : 1 ratio) to receive naproxen (NPX) 1000 mg daily plus either IFX5 mg/kg or placebo (PBO) at weeks 0, 2, 6, 12, 18and 24.",Non-OADS,/arxiv_data1/oa_pdf/ba/b2/annrheumdis-2012-203201.PMC3888606.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 van der Linden S, Valkenburg HA, Cats A.",Non-OADS,/arxiv_data1/oa_pdf/ba/b2/annrheumdis-2012-203201.PMC3888606.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Holgate S, Casale T, Wenzel S, et al.",Non-OADS,/arxiv_data1/oa_pdf/21/03/thoraxjnl-2013-203738.PMC3888607.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-203460).,OADS,/arxiv_data1/oa_pdf/79/d7/annrheumdis-2013-203460.PMC3888608.pdf
"sieper@charite.de Accepted 14 April 2013 Published Online First 5 June 2013 ▸http://dx.doi.org/10.1136/ annrheumdis-2012-203201 To cite: Sieper J, Lenaerts J, Wollenhaupt J, et al.Ann Rheum Dis 2014; 73: 108–113.ABSTRACT Objective To investigate whether biologic-free remission can be achieved in patients with early, activeaxial spondyloarthritis (SpA) who were in partialremission after 28 weeks of in ﬂiximab (IFX)+naproxen (NPX) or placebo (PBO)+NPX treatment and whethertreatment with NPX was superior to no treatment tomaintain disease control.Method Inﬂiximab as First-Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial (INFAST)Part 1 was a double-blind, randomised, controlled trialin biologic-naïve patients with early, active, moderate-to-severe axial SpA treated with either IFX 5 mg/kg+NPX1000 mg/d or PBO+NPX 1000 mg/d for 28 weeks.Patients achieving Assessment of SpondyloArthritisinternational Society (ASAS) partial remission at week 28continued to Part 2 and were randomised (1:1) to NPXor no treatment until week 52.",Non-OADS,/arxiv_data1/oa_pdf/79/d7/annrheumdis-2013-203460.PMC3888608.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 van der Heijde D, Sieper J, Maksymowych WP, et al.",Non-OADS,/arxiv_data1/oa_pdf/79/d7/annrheumdis-2013-203460.PMC3888608.pdf
"To viewplease visit the journal online (http://dx.doi.org/10.1136/bmjqs- 2013-002039) 1Department of Health Administration, University of Montreal, Montréal, Québec, Canada 2Department of Health Sciences, St Lawrence College, Kingston, Ontario, Canada 3Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada 4Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto,Ontario, Canada 5School of Nursing, Dalhousie University, Halifax, Nova Scotia, Canada 6Winnipeg Regional Health Authority, Winnipeg, Manitoba, Canada 7Institut de recherche en santé publique, University of Montreal, Montréal, Quebec, Canada Correspondence to Dr Régis Blais, Department of Health Administration, University of Montreal, PO Box 6128,Station Centre-ville, Montréal, QC, Canada H3C 3J7; regis.blais@umontreal.ca Received 27 March 2013 Revised 10 June 2013Accepted 11 June 2013 Published Online First 4 July 2013 ▸http://dx.doi.org/10.1136/ bmjqs-2013-002339 To cite: Blais R, Sears NA, Doran D, et al.BMJ Qual Saf 2013; 22:989–997.ABSTRACT Objectives The objectives of this study were to document the incidence rate and types of adverse events (AEs) among home care (HC)clients in Canada; identify factors contributing to these AEs; and determine to what extent evidence of completion of incident reports weredocumented in charts where AEs were found.",Non-OADS,/arxiv_data1/oa_pdf/8a/e3/bmjqs-2013-002039.PMC3888609.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Baker GR, Norton PG, Flintoft V ,et al.",Non-OADS,/arxiv_data1/oa_pdf/8a/e3/bmjqs-2013-002039.PMC3888609.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/bjsports-2012-091912).,Non-OADS,/arxiv_data1/oa_pdf/8b/7b/bjsports-2012-091912.PMC3888610.pdf
13Deﬁnitions of common features can be found at: http://www.snowboard-coach.com/freestyle-snowboarding-features.html and in appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/8b/7b/bjsports-2012-091912.PMC3888610.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Emery CA, Meeuwisse WH, McAllister JR. Survey of sport participation and sport injury in Calgary and area high schools.",Non-OADS,/arxiv_data1/oa_pdf/8b/7b/bjsports-2012-091912.PMC3888610.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2012-202481).,Non-OADS,/arxiv_data1/oa_pdf/9c/56/annrheumdis-2012-202481.PMC3888611.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Alamanos Y, Voulgari PV, Drosos AA.",Non-OADS,/arxiv_data1/oa_pdf/9c/56/annrheumdis-2012-202481.PMC3888611.pdf
"♥For infants, Z score for internal coronary artery diameter >7 based on Montreal normative data: http://parameterz.blogspot.co.uk/2010/11/montreal-coronary-artery-z-scores .html.",Non-OADS,/arxiv_data1/oa_pdf/80/12/archdischild-2012-302841.PMC3888612.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Harnden A, Alves B, Sheikh A.",Non-OADS,/arxiv_data1/oa_pdf/80/12/archdischild-2012-302841.PMC3888612.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ jmedgenet-2013-101938).,OADS,/arxiv_data1/oa_pdf/e4/84/jmedgenet-2013-101938.PMC3888613.pdf
"W e next used our in-houseinternal allele count data, removing variants detected more than10 times across a database of 500 exomes available from theUK10K_RARE cohort (http://www.uk10k.org/studies/rarediseases.html), because PCD-causing mutations would notbe predicted as likely to appear in multiple well-phenotypednon-PCD patients.",Non-OADS,/arxiv_data1/oa_pdf/e4/84/jmedgenet-2013-101938.PMC3888613.pdf
"This contrasts with the study of Hjeij et al 7which predicts 10 ARM motifs and one HEAT repeat in ARMC4, as is annotated in the Swissprot data-base (http://www.ncbi.nlm.nih.gov/protein/74744660).",OADS,/arxiv_data1/oa_pdf/e4/84/jmedgenet-2013-101938.PMC3888613.pdf
"motility which includes RSP8, RSP14 and PF16.17 19 25The exact nature of the essential role of ARMC4 in targeting theouter dynein arms to cilia remains to be fully characterised,however, these results further expand our understanding of themolecular genetic basis of PCD, and facilitate the rapidlygrowing application of genetics in PCD diagnostics.WEB RESOURCES 1000 Genomes Project, http://www.1000genomes.org OMIM, http://www.omim.orgPolyphen-2, http://genetics.bwh.harvard.edu/pph2/index.shtmlUMCG Groningen Gene Network, http://genenetwork.nl:8080/ GeneNetwork/ Figure 2 ARMC4 mutations result in outer dynein arms defects.",Non-OADS,/arxiv_data1/oa_pdf/e4/84/jmedgenet-2013-101938.PMC3888613.pdf
"BLAST , http://blast.ncbi.nlm.nih.gov/Blast.cgi SMART , http://smart.embl-heidelberg.de/I-TASSER, http://zhanglab.ccmb.med.umich.edu/I-TASSER/STRING, http://string-db.org/SWISSPROT , http://www.uniprot.org/ Author af ﬁliations 1Molecular Medicine Unit, Birth Defects Research Centre, Institute of Child Health, University College London, London, UK 2Department of Paediatric Respiratory Medicine, Royal Brompton and Hare ﬁeld NHS Trust, London, UK 3Molecular Immunology Unit, Institute of Child Health, University College London, London, UK 4Centre for Translational Genomics-GOSgene, Institute of Child Health, University College London, London, UK 5Clinical Genetics Unit, Great Ormond Street Hospital, London, UK 6Department of Pediatrics, Atrium Medical Center, Heerlen, The Netherlands 7UCL Institute of Ophthalmology, Moor ﬁelds Eye Hospital, London, UK 8School of Veterinary Medicine and Science, University of Nottingham, Nottingham, Leicestershire, UK 9Advanced Data Analysis Centre, University of Nottingham, Sutton Bonington Campus, Nottingham, Leicestershire, UK 10Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands 11General and Adolescent Paediatric Unit, Institute of Child Health, University College London, London, UK 12http://www.uk10k.org/ Acknowledgements We would like to thank the PCD families for their participation in the study, and the PCD Family Support Group.",Non-OADS,/arxiv_data1/oa_pdf/e4/84/jmedgenet-2013-101938.PMC3888613.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bush A, Chodhari R, Collins N, Copeland F, Hall P, Harcourt J, Hariri M, Hogg C, Lucas J, Mitchison HM, O ’Callaghan C, Phillips G. Primary ciliary dyskinesia: current state of the art.",Non-OADS,/arxiv_data1/oa_pdf/e4/84/jmedgenet-2013-101938.PMC3888613.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2013-203523).,OADS,/arxiv_data1/oa_pdf/27/08/annrheumdis-2013-203523.PMC3888614.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Scott DL.,Non-OADS,/arxiv_data1/oa_pdf/27/08/annrheumdis-2013-203523.PMC3888614.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2012-202726).,OADS,/arxiv_data1/oa_pdf/9a/2d/annrheumdis-2012-202726.PMC3888615.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Wegner N, Lundberg K, Kinloch A, et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/2d/annrheumdis-2012-202726.PMC3888615.pdf
"Correspondence to Professor Josef S Smolen, Division of Rheumatology,Department of Medicine 3,Medical University of Vienna, Waehringer Guertel 18-20, Vienna A-1090, Austria; josef.smolen@meduniwien.ac.at;josef.smolen@wienkav.at Accepted 15 May 2013 Published Online First 8 June 2013 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-203860 To cite: Smolen JS, Braun J, Dougados M, et al.Ann Rheum Dis 2014; 73:6–16.ABSTRACT Background Therapeutic targets have been de ﬁned for diseases like diabetes, hypertension or rheumatoidarthritis and adhering to them has improved outcomes.Such targets are just emerging for spondyloarthritis(SpA).Objective To de ﬁne the treatment target for SpA including ankylosing spondylitis and psoriatic arthritis(PsA) and develop recommendations for achieving thetarget, including a treat-to-target management strategy.Methods Based on results of a systematic literature review and expert opinion, a task force of expertphysicians and patients developed recommendationswhich were broadly discussed and voted upon in a Delphi-like process.",Non-OADS,/arxiv_data1/oa_pdf/2f/b2/annrheumdis-2013-203419.PMC3888616.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Rudwaleit M, van der Heijde D, Landewe R, et al.",Non-OADS,/arxiv_data1/oa_pdf/2f/b2/annrheumdis-2013-203419.PMC3888616.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Knevel R, Schoels M, Huizinga TW, et al.",Non-OADS,/arxiv_data1/oa_pdf/60/a6/annrheumdis-2013-203843.PMC3888617.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Lam CS, Edwards M, Millodot M, et al.",OADS,/arxiv_data1/oa_pdf/b3/b8/bjophthalmol-2013-303914.PMC3888618.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 New MI.,Non-OADS,/arxiv_data1/oa_pdf/1c/93/archdischild-2012-303070.PMC3888619.pdf
"The NHS Healthand Social Care Information Centre, 2008. http://www.hscic.gov.uk/catalogue/PUB02314 (accessed 5 May 2013).",Non-OADS,/arxiv_data1/oa_pdf/1c/93/archdischild-2012-303070.PMC3888619.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2012-202794).,OADS,/arxiv_data1/oa_pdf/55/2b/annrheumdis-2012-202794.PMC3888620.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Mastaglia FL, Garlepp MJ, Phillips BA, et al.I nﬂammatory myopathies: clinical, diagnostic and therapeutic aspects.",Non-OADS,/arxiv_data1/oa_pdf/55/2b/annrheumdis-2012-202794.PMC3888620.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/REFERENCES 1 Lara JF, Catroppo JF, Kim DU, et al .",Non-OADS,/arxiv_data1/oa_pdf/4e/d2/thoraxjnl-2012-203024.PMC3888621.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2013-203696).,Non-OADS,/arxiv_data1/oa_pdf/3c/38/annrheumdis-2013-203696.PMC3888622.pdf
"Correspondence to Professor Philip J Mease,Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle,WA, 98122, USA;pmease@philipmease.com Received 27 March 2013 Revised 12 June 2013Accepted 26 June 2013Published Online First 13 August 2013 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-203697 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-204231 To cite: Mease PJ, Fleischmann R, Deodhar AA, et al.Ann Rheum Dis 2014; 73:48–55.ABSTRACT Objectives To evaluate the ef ﬁcacy and safety of certolizumab pegol (CZP) after 24 weeks in RAPID-PsA(NCT01087788), an ongoing Phase 3 trial in patientswith psoriatic arthritis (PsA).Methods Patients were randomised 1:1:1 to placebo, 200 mg CZP every 2 weeks (Q2W) or 400 mg CZP every4 weeks (Q4W).",Non-OADS,/arxiv_data1/oa_pdf/3c/38/annrheumdis-2013-203696.PMC3888622.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ 54 Mease PJ, et al.Ann Rheum Dis 2014; 73:48–55.",Non-OADS,/arxiv_data1/oa_pdf/3c/38/annrheumdis-2013-203696.PMC3888622.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2013-204223).,Non-OADS,/arxiv_data1/oa_pdf/60/82/annrheumdis-2013-204223.PMC3888623.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Shourt CA, Crowson CS, Gabriel SE, et al.",Non-OADS,/arxiv_data1/oa_pdf/60/82/annrheumdis-2013-204223.PMC3888623.pdf
"25 http://www.HAS.org26 http://www.rhumatismes.net 27 Grundy SM, Pasternak R, Greenland P, et al.",Non-OADS,/arxiv_data1/oa_pdf/60/82/annrheumdis-2013-204223.PMC3888623.pdf
"28 http://www.AFSSAPS 29 Naranjo A, Sokka T, Descalzo MA, et al.",Non-OADS,/arxiv_data1/oa_pdf/60/82/annrheumdis-2013-204223.PMC3888623.pdf
"31 http://www.reynoldsriskscore.org32 Boechat Nde O, Ogusku MM, Boechat AL, et al.",Non-OADS,/arxiv_data1/oa_pdf/60/82/annrheumdis-2013-204223.PMC3888623.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Kessler RC, Chiu WT, Demler O, et al.",Non-OADS,/arxiv_data1/oa_pdf/a7/88/jech-2013-202838.PMC3888625.pdf
"The information collected includes parentalbackground (eg, maternal age, father/partner ’s age), measures of growth/development and health behaviour(height, weight, maternal smoking status, exposure to passivesmoking, type of infant feeding at birth, hospital discharge,ﬁrst visit and the 6 –8 week review) (details on ISD website — http://www.isdscotland.org/Health-Topics/Child-Health/Child-Health-Programme/Child-Health-Systems-Programme-Pre-School.asp).",Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Brookes EL, Rosman DL, Holman CDJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
( web publication ) http://www.scotland.gov.uk/Topics/Statistics/datalinkageframework (accessed Dec 2012).,OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
2011 http://scotland.gov.uk/Publications/2011/01/13095228/0 (accessed Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
http://www.scotpho.org.uk/comparative-health/scotland-and- european-hfa-database (accessed Dec 2012: provides comparative information forScotland/Europe for breastfeeding rates at 3 months and 6 months until 2004).,Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
http://www.isdscotland.org/ Health-Topics/Child-Health/Infant-Feeding (accessed Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
"Millennium cohort study: exploration of some distinctive results for Scotland (edited by Shirley Dex, Centre for Longitudinal Studies, Instituteof Education, University of London) http://www.scotland.gov.uk/Publications/2007/ 12/18133613/0 (accessed Nov 2012).",Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
https://catalogue.ic.nhs.uk/publications/public-health/surveys/infant-feed-surv- 2010/ifs-uk-2010-chap2-inc-prev-dur.pdf (accessed Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
2008. http://www.scotland.gov.uk/Publications/2008/03/12101843/5 (accessed Aug 2009).,Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
NHS Health Scotland and Scottish Public Health Observatory Publication2010 (web publication) http://www.scotpho.org.uk/publications/reports-and-papers/480-what-is-known-about-maternal-and-infant-nutrition-in-scotland —(accessed Jan 2011).,Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
http://www.nhsnss.org/pages/corporate/ privacy_advisory_committee.php (accessed Aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
CASA working paper 2007:116. http://www.bartlett.ucl.ac.uk/casa/publications/working-paper-116 (accessed Aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
http://progress.babyfriendly.org.uk/htables/all_hospitals_ acc_status.asp (accessed Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
2008. http://www.gcph.co.uk/communitypro ﬁles (accessed Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/3a/54/jech-2013-202718.PMC3888626.pdf
See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Bernhardt M. Ueber isoliert im Geblete des N. cutaneus femoris externus vorkommende paraesthesien.,Non-OADS,/arxiv_data1/oa_pdf/d2/66/acupmed-2013-010395.PMC3888628.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 T russell J.,Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jfprhc-2013-100636.PMC3888629.pdf
2011. http://www.cks.nhs.uk/contraception_ius_iud/management/scenario_intrauterine_system/starting_a_levonorgestrel_releasing_ius/uk_medical_eligibility_criteria [accessed 26 November 2012].,Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jfprhc-2013-100636.PMC3888629.pdf
2011. http://www.cks.nhs.uk/contraception_ius_iud/management/scenario_intrauterine_device/starting_an_iud/uk_medical_eligibility_criteria [accessed26 November 2012].,Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jfprhc-2013-100636.PMC3888629.pdf
2010. http://www.who.int/ reproductivehealth/publications/family_planning/9789241563888/en/ [accessed 26 November 2012].,Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jfprhc-2013-100636.PMC3888629.pdf
2010. http://www.cdc.gov/mmwr/pdf/rr/rr59e0528.pdf[accessed 26 November 2012].,OADS,/arxiv_data1/oa_pdf/e9/cd/jfprhc-2013-100636.PMC3888629.pdf
2007. http://www.fsrh.org/pdfs/ CEUGuidanceIntrauterineContraceptionNov07.pdf [accessed 14 March 2013].,Non-OADS,/arxiv_data1/oa_pdf/e9/cd/jfprhc-2013-100636.PMC3888629.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 van Laerhoven H, deHaan TR, Offringa M, et al.",Non-OADS,/arxiv_data1/oa_pdf/4d/78/fetalneonatal-2013-303710.PMC3888630.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/83/5e/tobaccocontrol-2012-050765.PMC3888631.pdf
"Available: http://www.parliament.uk/ brieﬁng-papers/SN05537 (accessed 21 Apr 2012).8 Paynter J, Edwards R, Schluter PJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/83/5e/tobaccocontrol-2012-050765.PMC3888631.pdf
13 National Youth Tobacco Survey 2009. http://www.cdc.gov/tobacco/data_statistics/ surveys/nyts/index.htm (accessed 30 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/83/5e/tobaccocontrol-2012-050765.PMC3888631.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Shaffer ER, Brenner JE, Houston TP.",Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://www.tobaccofreekids.,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
20 August 2012. http://ash.org/hidden-hand-of-big-tobacco-leads-to-wto-challenge/ (accessed 15 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.turanga.,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
23 May 2012. http://www.reuters.com/article/2012/05/23/us-trade-tobacco- idUSBRE84M0IO20120523 (accessed 10 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Canberra Times 28 June 2011. http://www.canberratimes.com.au/news/opinion/editorial/ general/gillard-must-repel-big-tobaccos-latest-attack/2209168.aspx (accessed 15 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
23 March 2012. http://www2.wsls.com/news/2012/mar/23/companies-push-keep-tobacco-trade- agreement-ar-1789898/ (accessed 14 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://www.unescap.org/tid/ artnet/mtg/2-2Ann%20Capling.pdf (accessed 15 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
106. http://www.eclac.org/comercio/publicaciones/xml/6/42966/Transpaci ﬁc_strategic_economic_ partnership_Latin_American_serie_106.pdf (accessed 15 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2005. http://www.mfat.govt.nz/downloads/trade-agreement/ transpaci ﬁc/main-agreement.pdf (accessed 15 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Asia-Paci ﬁc trade talks entering delicate phase: U.S. 12 September 2012. http://www.reuters.com/article/2012/09/12/us-usa-asia-trade-idUSBRE88B1G320120912 (accessed 14 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://www.dfat.gov.au/fta/tpp/index.html (accessed 9 Oct 2012).,OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://www.converge.org.nz/watchdog/29/08.htm (accessed 9 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
8 May 2012 http://tpplegal.wordpress.com/open-letter/(accessed 9 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Submission to the Department of Foreign Affairs and Trade 2010.http://www.dfat.gov.au/fta/tpp/subs/tpp_sub_tienhaara_100519.pdf (accessed11 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
27 August 2012. http://www.guardian.co.uk/commentisfree/2012/aug/27/paciﬁc-free-trade-deal#start-of-comments (accessed 15 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
11 September 2012. http://www.smh.com.au/business/world-business/big-tobacco- warning-at-freetrade-talks-20120911-25qam.html (accessed 15 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
20 August 2012. http://www.smh.com.au/opinion/political-news/ hidden-hand-of-big-tobacco-leads-to-wto-challenge-20120819-24gjo.html (accessed 10 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
The Nation 2012. http://www.thenation.com/article/ 168627/nafta-steroids# (accessed 15 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.nftc.org/default/Press% 20Release/2012/090412%20Statement%20of%20Asia-Paci ﬁc%20Business% 20Leaders.pdf(accessed 27 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2010. http://www.regulations.gov/search/Regs/home.html#documentDetail?R=0900006480a81299 (accessed 17 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
"2011. http://keionline.org/sites/default/ ﬁles/tpp-10feb2011- us-text-ipr-chapter.pdf (accessed 26 Oct 2012).37 Smith KE, Fooks G, Collin J, et al.",OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://www.citizenstrade.org/ctc/wp-content/uploads/2011/10/ TransPaci ﬁc_RegCoherenceMemo.pdf (accessed 22 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.ustr.gov/webfm_send/3323 (accessed 27 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2000. http://www.jisc.go.jp/eng/apec-asem/pdf/grp_info.pdf (accessed 10 Oct 2012.,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2011. http://www.health.gov.au/internet/yourhealth/ publishing.nsf/Content/british-american-tobacco-australia#.UIBe2vUlqSo(accessed 18 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.oecd.org/ daf/inv/internationalinvestmentagreements/50291642.pdf (accessed 12 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Dispute settlement: investor-state UNCTAD issues in international investment agreements 2003.http://unctad.org/en/docs/iteiit30_en.pdf (accessed 27 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
University of New South Wales Faculty of Law Research Series 2012.http://law.bepress.com/cgi/viewcontent.cgi?article=1378&context=unswwps- ﬂrps12 (accessed 8 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Faculty of Law Research Series 2012; Working Paper 6. http://law.bepress.com/cgi/viewcontent.cgi?article=1338&context= unswwps- ﬂrps12 (accessed 10 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2010. http://www.pc.gov.au/__data/assets/pdf_ ﬁle/0005/102488/subdr067-attachment2.,OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://www.ag.gov.au/Internationalrelations/InternationalLaw/Documents/Philip%20Morris% 20Asia%20Limited%20Notice%20of%20Claim%2027%20June%202011.pdf (accessed 6 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://docsonline.wto.org/imrd/directdoc.asp?DDFDocuments/t/WT/DS/27ARB.DOC 74 United States —Continued Dumping and Subsidy Offset Act of 2000 (Original Complaint by Brazil) —recourse to arbitration by the United States under Article 22.6 of the DSU.,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://docsonline.wto.org/imrd/directdoc.asp?DDFDocuments/t/WT/DS/217ARBBRA.doc 75 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://www.who.int/fctc/1-1-1-Summary_Workshop_Content_EN.pdf accessed 19 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
The Sydney Morning Herald .3 September 2012. http://www.smh.com.au/national/health/australia-challenges- ukraine-on-tobacco-20120902-258hv.html (accessed 10 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
general functions of the Secretariat 2006; Regulation 22.https://icsid.worldbank.org/ICSID/StaticFiles/basicdoc/partC-chap04.htm#r22 (accessed 12 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
UNCTAD series on international investment policies for development 2010. http://unctad.org/en/docs/ diaeia200911_en.pdf (accessed 23 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
4. http://www.unctad.,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
June 2009. http://www.smoke-free.ca/plain-packaging/documents/2009/ packagingphoneyipclaims-june2009-a4.pdf (accessed 19 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.bat.com/group/sites/uk__3mnfen.nsf/vwPagesWebLive/DO8WZC5E/$FILE/medMD8WZC6J.pdf?openelement (accessed 22 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.pmi.com/eng/tobacco_regulation/submissions/documents/submission%20and% 20all%20annexes%20%28combined%29.pdf (accessed 22 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.pmi.com/eng/tobacco_regulation/submissions/documents/ philip_morris_new_zealand_limited_submission_on_plain_packaging_ ﬁnal.pdf (accessed 22 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2009. http://www.imperial-tobacco.com/ ﬁles/misc/submission_on_proposals.pdf (accessed 22 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2011. http://www.health.gov.au/internet/yourhealth/publishing.nsf/Content/ british-american-tobacco-australia#.UIVtL_KwWk4 (accessed 22 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Press Release 20 April 2012. http://www.scoop.co.nz/stories/HL1204/S00134/jane-kelsey-tobacco-industry-will-use-offshore-courts.htm (accessed 22 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://dx.doi.org/10.2139/ssrn.2144269 117 Brazil —measures affecting imports of retreaded tyres —AB-2007-4 —report of the appellate body.,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://www.wto.org/english/tratop_e/dispu_e/cases_e/ds332_e.htm (accessed 19 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2011. http://infojustice.org/download/tpp/tpp-texts/TransPaci ﬁcIP1.pdf (accessed 19 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.tobaccofreekids.org/content/what_we_do/ federal_issues/trade/20120507_ngo_letter.pdf (accessed 15 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
10 September 2012. http://ash.org/tobacco-a-big-issue-among-tpp-negotiators/(accessed 15 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.tobaccofreekids.org/content/what_we_do/federal_issues/trade/TPP.pdf (accessed 14 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
21 August 2012. http://ash.org/14th-round-of-tpp-negotiations/(accessed 15 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
6 July 2012. http://ash.org/ united-states-does-not-table-its-tobacco-exception-at-the-transpaci ﬁc-partnership- negotiations/ (accessed 15 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
"Washington, DC: US GAO, 2003. http://www.gao.gov/products/GAO-03-618(accessed 20 Oct 2012).",Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
May 2012. http://www.ustr.gov/about-us/press-of ﬁce/fact-sheets/2012/ may/tpp-tobacco-proposal (accessed 6 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.ustr.gov/about-us/press-of ﬁce/factsheets/2012/may/tpp-tobacco- proposal (accessed 18 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
S389/2011) .http://www.austlii.edu.au/au/cases/ cth/HCA/2012/43.html#fnB420 (accessed 15 Jan 2013).133 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://www.wto.org/english/docs_e/ legal_e/legal_e.htm (accessed 27 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2012. http://www.unctad-docs.org/UNCTAD-WIR2012-Full-en.pdf (accessed3 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
http://www.oecd.org/daf/inv/internationalinvestmentagreements/31784519.pdf (accessed 8 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Dispute Settlement 28 September 2012. http://www.wto.org/ english/tratop_e/dispu_e/cases_e/ds434_e.htm (accessed 10 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Request for Consultations by the Dominican Republic 2012. http://www.wto.org/english/news_e/news12_e/ds441rfc_18jul12_e.htm 140 World Trade Organization.,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Request for Consultations by Honduras 2012.http://www.wto.org/english/tratop_e/dispu_e/cases_e/ds435_e.htm (accessed17 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Request for Consultations by Ukraine 2012.http://www.wto.org/english/news_e/news12_e/ds434rfc_13mar12_e.htm (accessed 17 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
Arbitration under theRules of the International Centre for Settlement of Investment Disputes 2010. http://www.arbitration.fr/resources/ICSID-ARB-10-7-Notice-of-arbitration.pdf (accessed 17 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
2011. http://www.iisd.org/ itn/2011/07/12/philip-morris-v-uruguay-will-investor-state-arbitration-send- restrictions-on-tobacco-marketing-up-in-smoke/ (accessed 17 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/e6/tobaccocontrol-2012-050869.PMC3888632.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ jnnp-2013-305420).,OADS,/arxiv_data1/oa_pdf/dd/15/jnnp-2013-305420.PMC3888633.pdf
14The BRAIN test can be accessed at http://www.predictpd.com/braintest and applications to use this can be directed to AJN viathe same web link.,Non-OADS,/arxiv_data1/oa_pdf/dd/15/jnnp-2013-305420.PMC3888633.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Driver JA, Logroscino G, Gaziano JM, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/15/jnnp-2013-305420.PMC3888633.pdf
http://www.nominettrust.org.uk/ (accessed 23 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/dd/15/jnnp-2013-305420.PMC3888633.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bell ML, Davis D, Cifuentes L, et al.",Non-OADS,/arxiv_data1/oa_pdf/71/71/jech-2013-202722.PMC3888634.pdf
See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Jia JP .,Non-OADS,/arxiv_data1/oa_pdf/86/41/acupmed-2013-010363.PMC3888636.pdf
http://www.cochrane-handbook.org(accessed 20 Jan 2013).,OADS,/arxiv_data1/oa_pdf/86/41/acupmed-2013-010363.PMC3888636.pdf
"http://www.consort-statement.orgOriginal paper 374 Cao H, et al.Acupunct Med 2013; 31:368–374.",Non-OADS,/arxiv_data1/oa_pdf/86/41/acupmed-2013-010363.PMC3888636.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Wright CM, Williams AF, Elliman D, et al.",Non-OADS,/arxiv_data1/oa_pdf/a0/cc/fetalneonatal-2012-303536.PMC3888637.pdf
6 http://www.growthcharts.rcpch.ac.uk/ (accessed 6 Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/a0/cc/fetalneonatal-2012-303536.PMC3888637.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ References ALMEIDA, F .",Non-OADS,/arxiv_data1/oa_pdf/cd/43/vetrec-2013-101700.PMC3888638.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jnnp-2013-305450).,Non-OADS,/arxiv_data1/oa_pdf/19/9a/jnnp-2013-305450.PMC3888639.pdf
"3–6T o address this need, work on compiling an online national MSregister began in 2011 (http://www.ukmsregister.org).A dedicated Scottish National MS Register for inci-dent MS cases was established in 2010.",Non-OADS,/arxiv_data1/oa_pdf/19/9a/jnnp-2013-305450.PMC3888639.pdf
"Competing interests All authors have completed the Uni ﬁed Competing Interests form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) the authors have no support from any company for the submitted work; (2) JOR has been involved as principal investigatorin clinical trials, a consultant on advisory boards and invited guest speaker forBiogen Idec, Merc Serono, Bayer Schering, Teva Pharmaceuticals and Novartis; TM has been a consultant on advisory boards for Novartis in the area of multiple sclerosis and has other potential competing interests but not in this therapeuticarea; IM holds research grants from Novartis and Menarini in different therapeuticareas; GB and SM have no speci ﬁed relationships with companies that might have an interest in the submitted work in the previous 3 years; (3) the authors ’spouses, partners or children have no ﬁnancial relationships that may be relevant to the submitted work; (4) GB was a trustee of MSNTC from June 2008 to June 2012 andnow acts as a consultant for MSNTC (both positions were unpaid).",Non-OADS,/arxiv_data1/oa_pdf/19/9a/jnnp-2013-305450.PMC3888639.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1 McCrone P, Heslin M, Knapp M, et al.",Non-OADS,/arxiv_data1/oa_pdf/19/9a/jnnp-2013-305450.PMC3888639.pdf
http://www.isdscotland.org/ Health-Topics/Quality-Improvement/The-MS-Register (accessed 29 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/19/9a/jnnp-2013-305450.PMC3888639.pdf
http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk — england-and-wales —scotland-and-northern-ireland/population-estimates- timeseries-1971-to-current-year/index.html (accessed 27 Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/19/9a/jnnp-2013-305450.PMC3888639.pdf
"Death registrations summary tables, England and Wales, 2010. http://www.ons.gov.uk/ons/publications/re-reference-tables.html?",Non-OADS,/arxiv_data1/oa_pdf/19/9a/jnnp-2013-305450.PMC3888639.pdf
"June 2009. http://www.mssociety.org.uk/ ms-resources/ms-society-brie ﬁng-uk-prevalence-study 14 Alonso A, Hernán MA.",Non-OADS,/arxiv_data1/oa_pdf/19/9a/jnnp-2013-305450.PMC3888639.pdf
"Several clinical studies have shown that pharmacologic and  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 491-492  http://dx.doi.org/10.4097/kjae.2013.65.6.491 Editorial",Non-OADS,/arxiv_data1/oa_pdf/62/d8/kjae-65-491.PMC3888839.pdf
"However, sugammadex is not an omnipotent drug, and one  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 493-494  http://dx.doi.org/10.4097/kjae.2013.65.6.493 Editorial",Non-OADS,/arxiv_data1/oa_pdf/06/9f/kjae-65-493.PMC3888840.pdf
Available from http://custom.kims.co.kr/DrugSearch/PopDrugGenMonoPrint.aspx?KIMSCode=  EMSDSIJC5U3.,Non-OADS,/arxiv_data1/oa_pdf/06/9f/kjae-65-493.PMC3888840.pdf
"Tel: 33-383-15-39-42, Fax: 33-383-15-43-42, E-mail: t.fuchs-buder@chu-nancy.fr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 495-500  http://dx.doi.org/10.4097/kjae.2013.65.6.495  Introduction Residual effects of neuromuscular block are now well  identified.",Non-OADS,/arxiv_data1/oa_pdf/e0/02/kjae-65-495.PMC3888841.pdf
Avaliable from http://www.omicsonline.org/2155-6148/2155-6148-2-140.pdf 28.,Non-OADS,/arxiv_data1/oa_pdf/e0/02/kjae-65-495.PMC3888841.pdf
"Tel: 1-732-594-5427, Fax: 1-732-594-5770, E-mail: tiffany.woo@merck.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 501-507  http://dx.doi.org/10.4097/kjae.2013.65.6.501",Non-OADS,/arxiv_data1/oa_pdf/d8/bf/kjae-65-501.PMC3888842.pdf
"Tel: 82-42-611-3655, Fax : 82-42-482-9036, E-mail: woonoh@eulji.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 508-518  http://dx.doi.org/10.4097/kjae.2013.65.6.508",Non-OADS,/arxiv_data1/oa_pdf/7e/18/kjae-65-508.PMC3888843.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 519-524  http://dx.doi.org/10.4097/kjae.2013.65.6.519",Non-OADS,/arxiv_data1/oa_pdf/18/a6/kjae-65-519.PMC3888844.pdf
"Tel: 82-2-3410-0369, Fax: 82-2-3410-0361,  E-mail: duckhwan.choi@samsung.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 525-530  http://dx.doi.org/10.4097/kjae.2013.65.6.525",Non-OADS,/arxiv_data1/oa_pdf/49/74/kjae-65-525.PMC3888845.pdf
"Tel: 82-62-220-6893, Fax: 82-62-232-6294, E-mail: kyyoo@jnu.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 531-538  http://dx.doi.org/10.4097/kjae.2013.65.6.531",Non-OADS,/arxiv_data1/oa_pdf/a8/c9/kjae-65-531.PMC3888846.pdf
"Tel: 82-2-2290-8680, Fax: 82-2-2299-0742, E-mail: kimks@hanyang.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 539-543  http://dx.doi.org/10.4097/kjae.2013.65.6.539  Introduction Postoperative nausea and vomiting (PONV) is unpleasant  and is a frequent adverse event associated with anesthesia and  surgery.",Non-OADS,/arxiv_data1/oa_pdf/c8/50/kjae-65-539.PMC3888847.pdf
"Tel: 82-31-219-5572, Fax: 82-31-219-5579, E-mail: anesmin@nate.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 544-551  http://dx.doi.org/10.4097/kjae.2013.65.6.544",Non-OADS,/arxiv_data1/oa_pdf/39/85/kjae-65-544.PMC3888848.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CCKorean J Anesthesiol 2013 December 65(6): 552-558  http://dx.doi.org/10.4097/kjae.2013.65.6.552",Non-OADS,/arxiv_data1/oa_pdf/51/dc/kjae-65-552.PMC3888849.pdf
"The chest x-ray confirmed the proper placement of the catheter,  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 559-561  http://dx.doi.org/10.4097/kjae.2013.65.6.559 Case Report",Non-OADS,/arxiv_data1/oa_pdf/4c/6b/kjae-65-559.PMC3888850.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 562-564  http://dx.doi.org/10.4097/kjae.2013.65.6.562 Case Report",Non-OADS,/arxiv_data1/oa_pdf/a4/17/kjae-65-562.PMC3888851.pdf
"Since the clinical features  and strategy for surgical correction of cortriatriatum are closely  related to the characteristics of the LA diaphragm and resultant  intracardiac blood flow pattern, a thorough understanding of the  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 565-568  http://dx.doi.org/10.4097/kjae.2013.65.6.565 Case Report",Non-OADS,/arxiv_data1/oa_pdf/4d/17/kjae-65-565.PMC3888852.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 569-573  http://dx.doi.org/10.4097/kjae.2013.65.6.569 Case Report",Non-OADS,/arxiv_data1/oa_pdf/5c/d7/kjae-65-569.PMC3888853.pdf
"Sometimes, extra-adrenal paraganglioma can  be discovered only after apparent during or after procedures or  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 574-577  http://dx.doi.org/10.4097/kjae.2013.65.6.574 Case Report",Non-OADS,/arxiv_data1/oa_pdf/97/38/kjae-65-574.PMC3888854.pdf
"Case Reports Case 1 A 40-year-old woman, 169 cm, 57 kg, underwent laparo - scopic right adrenalectomy due to an adrenal pheochromocy - Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 578-582  http://dx.doi.org/10.4097/kjae.2013.65.6.578 Case Report",Non-OADS,/arxiv_data1/oa_pdf/b3/b9/kjae-65-578.PMC3888855.pdf
"The patient  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 583-584  http://dx.doi.org/10.4097/kjae.2013.65.6.583 Letter to the Editor Fig.",Non-OADS,/arxiv_data1/oa_pdf/1f/97/kjae-65-583.PMC3888856.pdf
"It was found that a longitudinal bulla stretched across the entire  length, which was a dissection of the plastic film along the inner  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 585-586  http://dx.doi.org/10.4097/kjae.2013.65.6.585 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/a0/2b/kjae-65-585.PMC3888857.pdf
"Second, as  citrate phosphate dextrose adenine (CPDA-1) is broadly used,  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 587-588  http://dx.doi.org/10.4097/kjae.2013.65.6.587 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/f9/8d/kjae-65-587.PMC3888858.pdf
"Chest tube  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 589-590  http://dx.doi.org/10.4097/kjae.2013.65.6.589 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/b8/50/kjae-65-589.PMC3888859.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 December 65(6): 591-592  http://dx.doi.org/10.4097/kjae.2013.65.6.591 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/5e/80/kjae-65-591.PMC3888860.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 183-192 http://dx.doi.org/10.5534/wjmh.2013.31.3.183 Review Articl e Received: Oct 2, 2013; Revised: Oct 12, 2013; Accepted: Oct 28,  2013 Correspondence to: Wayne John G. Hellstrom Department of Urology, Tulane University School of Medicine, 14 30 Tulane Ave. Suite SL-42, New Orleans, LA 70112, USA.",Non-OADS,/arxiv_data1/oa_pdf/c5/92/wjmh-31-183.PMC3888887.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 193-207 http://dx.doi.org/10.5534/wjmh.2013.31.3.193 Review Articl e Received: Oct 10, 2013; Revised: Oct 24, 2013; Accepted: Nov 7,  2013 Correspondence to: Seung Wook Lee D e p a r t m e n t  o f  U r o l o g y ,  H a n y a n g  U n i v e r s i t y  G u r i  H o s p i t a l ,  1 5 3  G y eongchun-ro, Guri 471-701, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4e/e7/wjmh-31-193.PMC3888888.pdf
Available from: http://www.theprostate.org.,Non-OADS,/arxiv_data1/oa_pdf/4e/e7/wjmh-31-193.PMC3888888.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 208-214 http://dx.doi.org/10.5534/wjmh.2013.31.3.208 Review Articl e Received: Sep 2, 2013; Revised: Sep 15, 2013; Accepted: Oct 2, 2013 Correspondence to: Zhongcheng Xin  Andrology Center, Peking University First Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/55/87/wjmh-31-208.PMC3888889.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 215-219 http://dx.doi.org/10.5534/wjmh.2013.31.3.215 Original Articl e Received: May 16, 2013; Revised: (1st) Jun 11, 2013, (2nd) Jul 1, 2013; Accepted: Jul 2, 2013 Correspondence to: Halil Ciftci Department of Urology, Harran University Faculty of Medicine, T R-63100, Sanliurfa, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/8e/39/wjmh-31-215.PMC3888890.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 220-225 http://dx.doi.org/10.5534/wjmh.2013.31.3.220 Original Articl e Received: Sep 5, 2013; Revised: Oct 30, 2013; Accepted: Nov 4, 2013 Correspondence to: Henry H. Woo Sydney Advent i st  Hospi t al  Cl i ni cal  School ,  Uni ver si t y of  Sydney ,  Sui t e 406,  SAN Cl i ni c,  185 Fox Val l ey Road,  Wahroonga, Sydney, New South Wales 2076, Australia.",Non-OADS,/arxiv_data1/oa_pdf/5e/59/wjmh-31-220.PMC3888891.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 226-231 http://dx.doi.org/10.5534/wjmh.2013.31.3.226 Original Articl e Received: Oct 5, 2013; Revised: (1st) Nov 4, 2013, (2nd) Nov 12 , 2013; Accepted: Nov 13, 2013 Correspondence to: Sung Won Lee Department of Urology, Samsung Medical Center, 81 Ilwon-ro, Gan gnam-gu, Seoul 135-710, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d4/18/wjmh-31-226.PMC3888892.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 232-238 http://dx.doi.org/10.5534/wjmh.2013.31.3.232 Original Articl e Received: Jul 11, 2013; Revised: (1st) Aug 1, 2013, (2nd) Aug 6 , 2013; Accepted: Aug 7, 2013 Correspondence to: Jun Ho Lee Department of Urology, National Police Hospital, 123 Songi-ro, Songpa-gu, Seoul 138-708, Korea.",Non-OADS,/arxiv_data1/oa_pdf/89/f7/wjmh-31-232.PMC3888893.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 239-246 http://dx.doi.org/10.5534/wjmh.2013.31.3.239 Original Articl e Received: Sep 24, 2013; Revised: (1st) Oct 23, 2013, (2nd) Oct 25, 2013; Accepted: Oct 28, 2013 Correspondence to: Sae Woong Kim Department of Urology, The Catholic University of Korea, Seoul St. Mary ’s Hospital, 222 Banpo-daero, Seocho-gu, Seou l 137-701, Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/16/wjmh-31-239.PMC3888894.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 247-253 http://dx.doi.org/10.5534/wjmh.2013.31.3.247 Original Articl e Received: February 22, 2013; Revised: (1st) July 17, 2013, (2nd ) October 11, 2013; Accepted: October 17, 2013 Correspondence to: Seung Wook Lee D e p a r t m e n t  o f  U r o l o g y ,  H a n y a n g  U n i v e r s i t y  G u r i  H o s p i t a l ,  1 5 3  G y eongchun-ro, Guri 471-701, Korea.",Non-OADS,/arxiv_data1/oa_pdf/dd/17/wjmh-31-247.PMC3888895.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 254-261 http://dx.doi.org/10.5534/wjmh.2013.31.3.254 Original Articl e Received: Jul 1, 2013; Revised: Nov 24, 2013; Accepted: Nov 27,  2013 Correspondence to: Sae Woong Kim Department of Urology, The Catholic University of Korea, Seoul St .",Non-OADS,/arxiv_data1/oa_pdf/1d/0a/wjmh-31-254.PMC3888896.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 262-264 http://dx.doi.org/10.5534/wjmh.2013.31.3.262 Case Repor t Received: Jul 29, 2013; Revised: Sep 16, 2013; Accepted: Oct 1,  2013 Correspondence to: Jyotsna Naresh Bharti  D e p a r t m e n t  o f  P a t h o l o g y ,  M a u l a n a  A z a d  M e d i c a l  C o l l e g e ,  B a h a d u r  Shah Zafar Marg, New Delhi 110002, India.",Non-OADS,/arxiv_data1/oa_pdf/64/71/wjmh-31-262.PMC3888897.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December 31(3): 265-267 http://dx.doi.org/10.5534/wjmh.2013.31.3.265 Case Repor t Received: Jun 19, 2013; Revised: Jul 10, 2013; Accepted: Jul 18 , 2013 Correspondence to: Gilho Lee Department of Urology, Dankook University Medical College, 119 Dandae-ro, Dongnam-gu, Cheonan 330-714, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b0/8f/wjmh-31-265.PMC3888898.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2013 December  31(3): 268-271 http://dx.doi.org/10.5534/wjmh.2013.31.3.268 Case Repor t Received: May 12, 2013; Revised: Jun 28, 2013; Accepted: Jul 15 , 2013 Correspondence to: Bum Soo Kim D e p a r t m e n t  o f  U r o l o g y ,  K y u n g p o o k  N a t i o n a l  U n i v e r s i t y  H o s p i t a l ,  130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c1/df/wjmh-31-268.PMC3888899.pdf
" Journal of Geriatric Cardiology (201 3) 10: 310316   ©2013 JGC All rights reserved ; www.jgc301.com      http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology   Research Article     Open Access     Impact of admission blood glucose levels on prognosis of elderly patients with  ST elevation myocardial infarction treated by primary percutaneous c oronary  intervention     Ahmet Ekmekci1, Mahmut Uluganyan2, Fatif Tufan3, Huseyin Uyarel4, Gurkan Karaca1, Seref Kul4,   Barış Gungor1, Gokhan Ertas1, Betul Erer1, Nurten Sayar1, Mehmet Gul5, Mehmet Eren1  1Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center Training and Research Hospital, T ıbbiye Caddesi, 34000  Istanbul,  Turkey   2Department of Cardiology, Kadirli State Hospital, Toki Caddesi, 8075  Osmaniye, Turkey   3Department of Geriatric, Istanbul University Medical Hospital, Vatan Cadddessi, 34000  Istanbul, Turkey   4Department of Cardiology, Bezmialem Vakif University Medical Hospital, Vatan C addesi, 34000  Istanbul, Turkey   5 Department of Cardiology, Mehmet Akif Ersoy Cardiovascular and Thoracic Surgery Training and Research Hospital, Istasyon mah,  Istanbul 34000, Turkey     Abstract   Objective   Admission hyperglycemia in acute myocardial infarc tion (MI) is related with increased in -hospital and long term mortality  and major cardiac adverse events.",Non-OADS,/arxiv_data1/oa_pdf/75/33/jgc-10-04-310.PMC3888911.pdf
Admission hyperglycemia predicts in -hospital and long term mortality in elderly  patients     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  compared by the Chi -square test or Fisher’s exact test.,Non-OADS,/arxiv_data1/oa_pdf/75/33/jgc-10-04-310.PMC3888911.pdf
Admission hyperglycemia predicts in -hospital and long term mortality in elderly  patients     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  The receive -operating characteristic (ROC) curve with  regard to MACE is shown in Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/75/33/jgc-10-04-310.PMC3888911.pdf
"Admission hyperglycemia predicts in -hospital and long term mortality in elderly  patients     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  14  Rasoul S, Ottervanger JP, Bilo HJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/75/33/jgc-10-04-310.PMC3888911.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4b/79/srep03654.PMC3888966.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3654 | DOI: 10.1038/srep03654 8",Non-OADS,/arxiv_data1/oa_pdf/4b/79/srep03654.PMC3888966.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ea/7c/srep03651.PMC3888967.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3651 | DOI: 10.1038/srep03651 5",Non-OADS,/arxiv_data1/oa_pdf/ea/7c/srep03651.PMC3888967.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9b/17/srep03649.PMC3888968.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3649 | DOI: 10.1038/srep03649 7",Non-OADS,/arxiv_data1/oa_pdf/9b/17/srep03649.PMC3888968.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ac/8d/srep03652.PMC3888969.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3652 | DOI: 10.1038/srep03652 9",Non-OADS,/arxiv_data1/oa_pdf/ac/8d/srep03652.PMC3888969.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3659 | DOI: 10.1038/srep03659 5",Non-OADS,/arxiv_data1/oa_pdf/c5/5e/srep03659.PMC3888970.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3661 | DOI: 10.1038/srep03661 7",Non-OADS,/arxiv_data1/oa_pdf/f0/67/srep03661.PMC3888972.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/63/srep03667.PMC3888973.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3667 | DOI: 10.1038/srep03667 5",Non-OADS,/arxiv_data1/oa_pdf/6a/63/srep03667.PMC3888973.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e2/df/srep03658.PMC3888974.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3658 | DOI: 10.1038/srep03658 7",Non-OADS,/arxiv_data1/oa_pdf/e2/df/srep03658.PMC3888974.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d4/f0/srep03660.PMC3888975.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3660 | DOI: 10.1038/srep03660 7",Non-OADS,/arxiv_data1/oa_pdf/d4/f0/srep03660.PMC3888975.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3645 | DOI: 10.1038/srep03645 9",Non-OADS,/arxiv_data1/oa_pdf/9e/c1/srep03645.PMC3888976.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Ritenberg, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/e5/6b/srep03666.PMC3888977.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3666 | DOI: 10.1038/srep03666 6",Non-OADS,/arxiv_data1/oa_pdf/e5/6b/srep03666.PMC3888977.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/26/e4/srep03656.PMC3888978.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3656 | DOI: 10.1038/srep03656 9",Non-OADS,/arxiv_data1/oa_pdf/26/e4/srep03656.PMC3888978.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3b/e1/srep03662.PMC3888979.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3662 | DOI: 10.1038/srep03662 6",Non-OADS,/arxiv_data1/oa_pdf/3b/e1/srep03662.PMC3888979.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3657 | DOI: 10.1038/srep03657 6",Non-OADS,/arxiv_data1/oa_pdf/1c/e9/srep03657.PMC3888981.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/16/d1/srep03669.PMC3888982.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3669 | DOI: 10.1038/srep03669 8",Non-OADS,/arxiv_data1/oa_pdf/16/d1/srep03669.PMC3888982.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e6/0a/srep03655.PMC3888986.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3655 | DOI: 10.1038/srep03655 7",Non-OADS,/arxiv_data1/oa_pdf/e6/0a/srep03655.PMC3888986.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/5e/ed/JSTCR-5-1.PMC3888996.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/5e/ed/JSTCR-5-1.PMC3888996.pdf
A vailable from: http://whoindia.org/en/Section3/Section123.htm[Last  accessed on 2012  Dec].,Non-OADS,/arxiv_data1/oa_pdf/8e/dc/JSTCR-5-32.PMC3889001.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/33/e1/JSTCR-5-35.PMC3889002.pdf
Available from: http://archive.ispub.com/journal/ the-internet -journal -of-gynecology -and-obstetrics/volume -11-number - 2/ vesical -calculus -resulting -from -forgotten -intrauterine -contraceptive -device.,Non-OADS,/arxiv_data1/oa_pdf/5f/2a/JSTCR-5-48.PMC3889006.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/5f/2a/JSTCR-5-48.PMC3889006.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/e3/ef/JSTCR-5-51.PMC3889007.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/ef/ab/JSTCR-5-8.PMC3889013.pdf
Available from: http://apps.who.int/hpvcentre/statistics/ dynamic/ico/country_pdf/IND.pdf.,OADS,/arxiv_data1/oa_pdf/a1/55/SAJC-2-187.PMC3889021.pdf
Available from: http://www.fda.gov/ohrms/dockets/ac/06/ briefing/2006-4222B3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a1/55/SAJC-2-187.PMC3889021.pdf
Available from:  http://www.cdc.gov./vaccinesafety/Vaccines/HPV/Index.,Non-OADS,/arxiv_data1/oa_pdf/a1/55/SAJC-2-187.PMC3889021.pdf
Available from:  http://www.WHO.int/nuvi/hpv/VaccRate_Infosheet_Poster.,Non-OADS,/arxiv_data1/oa_pdf/a1/55/SAJC-2-187.PMC3889021.pdf
Available from: http://www.cdc.gov/vaccinesafety/vaers/ gardasil.htm.,Non-OADS,/arxiv_data1/oa_pdf/a1/55/SAJC-2-187.PMC3889021.pdf
Available from: http://www.mhra.gov.,Non-OADS,/arxiv_data1/oa_pdf/a1/55/SAJC-2-187.PMC3889021.pdf
Available from: http://dx.doi.org/10.41 72/2167 -7689.,Non-OADS,/arxiv_data1/oa_pdf/a1/55/SAJC-2-187.PMC3889021.pdf
Available from: http://www.atsdr.cdc.,Non-OADS,/arxiv_data1/oa_pdf/e7/df/SAJC-2-192c.PMC3889024.pdf
Available from: http://monographs.iarc.fr/ENG/ Monographs/suppl7/Suppl7-83.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e7/df/SAJC-2-192c.PMC3889024.pdf
Available from : http://www.york.ac.uk/inst/ crd/CRD_Reports/crdreport18.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e7/df/SAJC-2-192c.PMC3889024.pdf
Available from: http://www.cancer.gov/ cancertopics/factsheet/Risk/fluoridated-water.,Non-OADS,/arxiv_data1/oa_pdf/e7/df/SAJC-2-192c.PMC3889024.pdf
Available from: http://www.nap.edu/catalog.php?record_id=2204.,Non-OADS,/arxiv_data1/oa_pdf/e7/df/SAJC-2-192c.PMC3889024.pdf
Available from: http://www.health.gov/environment/ ReviewofFluoride/default.htm.,OADS,/arxiv_data1/oa_pdf/e7/df/SAJC-2-192c.PMC3889024.pdf
Available from: http://www.fda.gov/ohrms/dockets/ac/06/ briefing/2006-4222B3.pdf [Last accessed on 2013 Apr 27].,Non-OADS,/arxiv_data1/oa_pdf/db/00/SAJC-2-193.PMC3889025.pdf
Available from: http://www.dh.gov.uk/prod_consum_dh/groups/ dh_Digital ssets/@dh/@ab/documents/digitalasset/dh_11001 7 .,OADS,/arxiv_data1/oa_pdf/db/00/SAJC-2-193.PMC3889025.pdf
Available from: http://www.lareb.nl/ documents/kwb_2010_2_cerva.pdf  [Last accessed on 2011  Jul 24].,OADS,/arxiv_data1/oa_pdf/db/00/SAJC-2-193.PMC3889025.pdf
Available from:  http://www.imb.ie/images/uploaded/documents/IMB_Gardasil_ WebUpdate_09Feb2011.pdf [Last accessed on 2011 Jul 1 7].,Non-OADS,/arxiv_data1/oa_pdf/db/00/SAJC-2-193.PMC3889025.pdf
Available from: http://globocan.iarc.fr/factsheet.,Non-OADS,/arxiv_data1/oa_pdf/26/65/SAJC-2-198.PMC3889028.pdf
Available from: http://www.Censusindia.gov.in/vital_statistics/srs/ chapter- 2-2010 [last accessed on 2013 Aug 1 7].,OADS,/arxiv_data1/oa_pdf/c1/99/SAJC-2-200.PMC3889031.pdf
Available from:  http://www.ncrpindia.,Non-OADS,/arxiv_data1/oa_pdf/c1/99/SAJC-2-200.PMC3889031.pdf
Available from: http://pib.nic.in/archieve/ flagship/bkg_mdm1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/d4/SAJC-2-201.PMC3889032.pdf
Available from: http://www.jknrhm.com/PDF/JSR.,Non-OADS,/arxiv_data1/oa_pdf/2c/d4/SAJC-2-201.PMC3889032.pdf
Available from:  http://www.chicago2013.asco.org/vinegar- screening -  could -slash -cervical -cancer- mortality- one-third -low- resource -  countries.,Non-OADS,/arxiv_data1/oa_pdf/05/8d/SAJC-2-242.PMC3889051.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/33/ed/SAJC-2-243.PMC3889052.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.News,Non-OADS,/arxiv_data1/oa_pdf/33/ed/SAJC-2-243.PMC3889052.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/2f/9f/SAJC-2-245.PMC3889053.pdf
Available from: http://www.ban.searo.who.,Non-OADS,/arxiv_data1/oa_pdf/3b/00/SAJC-2-279.PMC3889062.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/44/main.PMC3889076.pdf
http://dx.doi.org/10.1016/j.shaw.2013.07.006Safety and Health at Work 4 (2013) 177 e186,Non-OADS,/arxiv_data1/oa_pdf/ab/44/main.PMC3889076.pdf
"ncbi.nlm.nih.gov/pubmed/ ), Google Scholar ( http://scholar.google.",OADS,/arxiv_data1/oa_pdf/ab/44/main.PMC3889076.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/74/main.PMC3889077.pdf
http://dx.doi.org/10.1016/j.shaw.2013.09.001Safety and Health at Work 4 (2013) 197 e200,Non-OADS,/arxiv_data1/oa_pdf/56/74/main.PMC3889077.pdf
Available from: http://knhanes.cdc.go.kr .,Non-OADS,/arxiv_data1/oa_pdf/56/74/main.PMC3889077.pdf
Available from: http://www.moel.go.kr/english/topic/laborlaw_view.jsp?idx ¼254&tab ¼ Standards .,Non-OADS,/arxiv_data1/oa_pdf/56/74/main.PMC3889077.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC3889078.pdf
http://dx.doi.org/10.1016/j.shaw.2013.09.002Safety and Health at Work 4 (2013) 216 e220,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC3889078.pdf
Available from: http://www.cdc.gov/niosh/docs/2003-154/ .,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC3889078.pdf
Available from: http://www.oehha.org/prop65/CRNR_ notices/safe_use/sudsilica.html .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC3889078.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/99/main.PMC3889079.pdf
http://dx.doi.org/10.1016/j.shaw.2013.10.002Safety and Health at Work 4 (2013) 201 e209,Non-OADS,/arxiv_data1/oa_pdf/1b/99/main.PMC3889079.pdf
Available from: http://ecos.bok.or.kr/ [2] Korea Occupational Safety and Health Agency (KOSHA).,Non-OADS,/arxiv_data1/oa_pdf/1b/99/main.PMC3889079.pdf
Available from: http://www.kosha.or.kr/board.do?menuId ¼553.,Non-OADS,/arxiv_data1/oa_pdf/1b/99/main.PMC3889079.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/6e/main.PMC3889080.pdf
http://dx.doi.org/10.1016/j.shaw.2013.10.003Safety and Health at Work 4 (2013) 210 e215,Non-OADS,/arxiv_data1/oa_pdf/b6/6e/main.PMC3889080.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/68/main.PMC3889081.pdf
http://dx.doi.org/10.1016/j.shaw.2013.10.001Safety and Health at Work 4 (2013) 187 e196,Non-OADS,/arxiv_data1/oa_pdf/58/68/main.PMC3889081.pdf
Available from: http://oxforddictionaries.com/de ﬁnition/english/ value?q ¼value .,Non-OADS,/arxiv_data1/oa_pdf/58/68/main.PMC3889081.pdf
Available from: http://www.bqf.org.uk/efqm-excellence- model/glossary-terms .,Non-OADS,/arxiv_data1/oa_pdf/58/68/main.PMC3889081.pdf
Available from: http://dictionary.cambridge.org/dictionary/ british/core_1?q ¼coreþvalue#core_1__3 .,OADS,/arxiv_data1/oa_pdf/58/68/main.PMC3889081.pdf
Available from: http://www.dguv.de/iag/en/veranstaltungen_en/strategie2011/index.jsp .,Non-OADS,/arxiv_data1/oa_pdf/58/68/main.PMC3889081.pdf
from: http://www.ilo.org/empent/areas/business-helpdesk/WCMS_DOC_ ENT_HLP_OSH_FAQ_EN/lang –en/index.htm#F12 .,Non-OADS,/arxiv_data1/oa_pdf/58/68/main.PMC3889081.pdf
"Van der Bruggen, PS, Vigneron, N and Van den Eynde, B. Peptide database at <http://www.cancerimmunity.org/peptidedatabase/Tcellepitopes.htm> 46.",OADS,/arxiv_data1/oa_pdf/39/1c/mtna201354a.PMC3889186.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/39/1c/mtna201354a.PMC3889186.pdf
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy <http://clinicaltrials.gov/ct/show/NCT00788307>.,Non-OADS,/arxiv_data1/oa_pdf/b2/b3/mtna201358a.PMC3889187.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/b2/b3/mtna201358a.PMC3889187.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/a2/de/mtna201359a.PMC3889188.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/6e/b2/mtna201362a.PMC3889189.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/4d/5a/mtna201363a.PMC3889190.pdf
"Positive clinical trial results using these LNPs have been reported for the treatment of  cardiovascular disease, certain forms of amyloidosis, and  other disorders (http://www.alnylam.com/Programs-and-Pipeline/Alnylam-5x15/index.php).",Non-OADS,/arxiv_data1/oa_pdf/1d/b7/mtna201365a.PMC3889191.pdf
"Clinical studies suggest that the immunostimulatory effects of LNP-siRNA injections are infrequent and readily managed, see http://www.alnylam.com/capella/wp-content/uploads/2012/07/ Alnylam-ALN-TTR02-PhaseI-Results-120716.pdf.",Non-OADS,/arxiv_data1/oa_pdf/1d/b7/mtna201365a.PMC3889191.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/1d/b7/mtna201365a.PMC3889191.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/ca/82/SAJC-2-160.PMC3889193.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/18580212.,Non-OADS,/arxiv_data1/oa_pdf/ca/82/SAJC-2-160.PMC3889193.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/21 761104.,Non-OADS,/arxiv_data1/oa_pdf/ca/82/SAJC-2-160.PMC3889193.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ca/82/SAJC-2-160.PMC3889193.pdf
The marmoset monkey study was ap- proved by the IACUC under permit number DEC#674.BPRC ’s policy on the welfare of experimental animals can be found at http://www.bprc.nl/en/animal-welfare/ .,Non-OADS,/arxiv_data1/oa_pdf/3d/41/11481_2013_Article_9487.PMC3889224.pdf
"Author Note We thank C. Cortelyou and C. Howard for technical assistance, and N. Apple and J. M. King of the Hyperscan Development Team at the Virginia Tech Carilion Research Institute for Network Exper- iment Management Object (NEMO) software implementation ( http://research.vtc.vt.edu/ hnl/nemo/index.html ).",Non-OADS,/arxiv_data1/oa_pdf/e9/65/13415_2013_Article_191.PMC3889258.pdf
http://www.acr.org/~/media/2A0EB28EB59041E2825179A FB72EF624.pdf .A c c e s s e d2 3A u g2 0 1 2 8.,Non-OADS,/arxiv_data1/oa_pdf/b6/de/330_2013_Article_2989.PMC3889280.pdf
http://www.mibb.ch/Documents/consensus_mri_ deu- %281 %29.aspx.,OADS,/arxiv_data1/oa_pdf/b6/de/330_2013_Article_2989.PMC3889280.pdf
"Tulsa, OK: StatSoft; 2012. http://www.statsoft.com/textbook/stathome.html .",Non-OADS,/arxiv_data1/oa_pdf/89/73/535_2013_Article_752.PMC3889282.pdf
Available at http://www.medscape.,Non-OADS,/arxiv_data1/oa_pdf/ff/37/13555_2013_Article_33.PMC3889301.pdf
Available at: http://www.medicalnewstoday.,Non-OADS,/arxiv_data1/oa_pdf/ff/37/13555_2013_Article_33.PMC3889301.pdf
Available at http://emedicine.medscape.com/article/ 1271380-overview .,Non-OADS,/arxiv_data1/oa_pdf/ff/37/13555_2013_Article_33.PMC3889301.pdf
http://www.bnf.org/bnf/ index.htm .,Non-OADS,/arxiv_data1/oa_pdf/4c/47/13555_2013_Article_38.PMC3889302.pdf
http://www.portalfarma.com/ .,Non-OADS,/arxiv_data1/oa_pdf/4f/19/13555_2013_Article_30.PMC3889303.pdf
http://www.juntadeandalucia.es/boja/boletines/2005/210/ .,Non-OADS,/arxiv_data1/oa_pdf/4f/19/13555_2013_Article_30.PMC3889303.pdf
Available at: http://epp.eurostat.ec.,Non-OADS,/arxiv_data1/oa_pdf/4f/19/13555_2013_Article_30.PMC3889303.pdf
Available at:http://www.aucorsa.es/ .,Non-OADS,/arxiv_data1/oa_pdf/4f/19/13555_2013_Article_30.PMC3889303.pdf
http://www.r-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/4f/19/13555_2013_Article_30.PMC3889303.pdf
http://www.abw-verlag.com/db_picture.,Non-OADS,/arxiv_data1/oa_pdf/da/03/13555_2013_Article_31.PMC3889305.pdf
http://www.sign.ac.uk/ guidelines/fulltext/121/contents.html .,Non-OADS,/arxiv_data1/oa_pdf/da/03/13555_2013_Article_31.PMC3889305.pdf
http://www.dh.gov.uk/health/2011/07/mental-health-strategy .,Non-OADS,/arxiv_data1/oa_pdf/da/03/13555_2013_Article_31.PMC3889305.pdf
"CONSORT: http://www.consort-statement.org (Last accessed November 14, 2013).",Non-OADS,/arxiv_data1/oa_pdf/24/fb/13555_2013_Article_39.PMC3889306.pdf
"Statistical analysis was performed using SPSS software package (IBMSPSS software, USA http://www-01.ibm.com/ software/analytics/spss/ ).",OADS,/arxiv_data1/oa_pdf/96/f0/13555_2013_Article_36.PMC3889307.pdf
"Ltd. ( http://www.knowledgeisotopes.com ) for the writing support, Wockhardt Ltd funded this support.",Non-OADS,/arxiv_data1/oa_pdf/96/f0/13555_2013_Article_36.PMC3889307.pdf
https://investor.lilly.,Non-OADS,/arxiv_data1/oa_pdf/db/fa/13300_2013_Article_37.PMC3889314.pdf
Available at:https://www.idf.org/guidelines .,Non-OADS,/arxiv_data1/oa_pdf/ef/cc/13300_2013_Article_42.PMC3889318.pdf
Available at: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/ef/cc/13300_2013_Article_42.PMC3889318.pdf
Availableat: http://www.invokanahcp.com/prescribing- information.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ef/cc/13300_2013_Article_42.PMC3889318.pdf
Availableat:http://www.fda.gov/downloads/AdvisoryComm ittees/CommitteesMeetingMaterials/drugs/Endocri nologicandMetabolicDru gsAdvisoryCommittee/ ucm262994.pdf .,OADS,/arxiv_data1/oa_pdf/ef/cc/13300_2013_Article_42.PMC3889318.pdf
Available at: http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolic DrugsAdvisoryCommittee/UCM334551.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ef/cc/13300_2013_Article_42.PMC3889318.pdf
"Brussels, Belgium; 2011, updated 14 November 2012. http://www.idf.org/diabetesatlas/5e .A c c e s s e d 23 September 2013.",Non-OADS,/arxiv_data1/oa_pdf/24/4b/13300_2013_Article_41.PMC3889319.pdf
2012. http://www.medscape.,Non-OADS,/arxiv_data1/oa_pdf/ce/0c/13300_2013_Article_39.PMC3889320.pdf
2013. http://wwwmedscape.com/ viewarticle/778235_print .,Non-OADS,/arxiv_data1/oa_pdf/ce/0c/13300_2013_Article_39.PMC3889320.pdf
"Study of Sitagliptin in Older Type 2 Diabetics (Clincal trial identiﬁer NCT00305604), 2013. http://clinicaltrials.gov/show/NCT00305604 .",Non-OADS,/arxiv_data1/oa_pdf/ce/0c/13300_2013_Article_39.PMC3889320.pdf
"Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin(GENERATION) (Clincal trial identiﬁerNCT01006603), 2013. http://clinicaltrials.gov/ show/NCT01006603 .",Non-OADS,/arxiv_data1/oa_pdf/ce/0c/13300_2013_Article_39.PMC3889320.pdf
2012. http://www.ema.europaeu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000771/WC500020327.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ce/0c/13300_2013_Article_39.PMC3889320.pdf
http://www.nih.gov/ news/health/oct2012/niddk-19.htm (Accessed 9 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2b/8e/13300_2013_Article_40.PMC3889321.pdf
http://www.accessdata.fda.gov/drug satfda_docs/label/2009/021773s9s11s18s22s25lbl.pdf(Accessed 9 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2b/8e/13300_2013_Article_40.PMC3889321.pdf
"http://www.novonordisk.co.jp (last accessed November 15, 2013).",OADS,/arxiv_data1/oa_pdf/7a/31/13300_2013_Article_48.PMC3889322.pdf
2011.http://www.idf.org/sites/default/ﬁles/postmeal%20 glucose%20guidelines.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7f/73/13300_2013_Article_32.PMC3889323.pdf
Available fromhttp://www.un.org/esa/population/publications/worldageing19502050/ .,Non-OADS,/arxiv_data1/oa_pdf/e7/ab/13300_2013_Article_49.PMC3889325.pdf
Available from http://www.mhlw.go.jp/stf/houdou/2r9852000002q1st-att/2r9852000002q1wo.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e7/ab/13300_2013_Article_49.PMC3889325.pdf
Available from http://www-bm.mhlw.go.,Non-OADS,/arxiv_data1/oa_pdf/e7/ab/13300_2013_Article_49.PMC3889325.pdf
"National Diabetes Fact Sheet: National estimatesand general information on diabetes andprediabetes in the United States, 2011; 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.",OADS,/arxiv_data1/oa_pdf/a8/d3/13300_2013_Article_46.PMC3889326.pdf
"Diabetes in the UK 2012: key statistics on diabetes; 2012. http://www.diabetes.org.uk/ Documents/Reports/Diabetes-in-the-UK-2012.pdf(Accessed Dec 13, 2012).3.",Non-OADS,/arxiv_data1/oa_pdf/a8/d3/13300_2013_Article_46.PMC3889326.pdf
"Kanavos P, van den Aardweg S, Schurer W. Diabetes expenditure, burden of disease and management in 5 EU countries; 2012. http://www2.lse.ac.uk/ LSEHealthAndSocialCare/research/LSEHealth/MTRG/LSEDiabetesReport26Jan2012.pdf (Accessed Dec 13, 2012).",Non-OADS,/arxiv_data1/oa_pdf/a8/d3/13300_2013_Article_46.PMC3889326.pdf
"http://www.nice.org.uk/guidance/QS6 (Accessed 30 Aug, 2013).35.",Non-OADS,/arxiv_data1/oa_pdf/a8/d3/13300_2013_Article_46.PMC3889326.pdf
http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/a8/d3/13300_2013_Article_46.PMC3889326.pdf
http://www.pewforum.org/2011/01/27/the- future-of-the-global-muslim-population/#europe .,Non-OADS,/arxiv_data1/oa_pdf/c6/5f/13300_2013_Article_38.PMC3889327.pdf
"For conversion to measurements with the DCCT/NGSP method, the following conversion formula may be used: HbA1c (NGSP)(%)=0.956 9HbA1c (Mono S) (%) ?1.182 (see e.g., http://www.hba1c.nu/ ).",OADS,/arxiv_data1/oa_pdf/69/af/13300_2013_Article_35.PMC3889328.pdf
London School of Economics; 2012. http://www.lse.ac.uk/ lsehealthandsocialcare/r esearch/lsehealth/mtrg/ lsediabetesreport26jan2012.pdf (Accessed 29 July 2013).,Non-OADS,/arxiv_data1/oa_pdf/69/af/13300_2013_Article_35.PMC3889328.pdf
Swedish National Board of Health and Welfare; 2012.http://www.socialstyrelsen.se/nationellariktlinjer fordiabetesvarden (Accessed 29 July 2013).Diabetes Ther (2013) 4:363–374 373 123,Non-OADS,/arxiv_data1/oa_pdf/69/af/13300_2013_Article_35.PMC3889328.pdf
Region Skane; 2012. http://www.skane.se/sv/ (Accessed 29 July 2013).,OADS,/arxiv_data1/oa_pdf/69/af/13300_2013_Article_35.PMC3889328.pdf
"IDF Diabetes Atlas, 5th edition Brussels, Belgium: International Diabetes Federation, 2011. http://www.idf.org/dia betesatlas/5e/diabetes .",Non-OADS,/arxiv_data1/oa_pdf/cb/8f/13300_2013_Article_27.PMC3889331.pdf
‘‘Diabetes Statistics.’’ http://www.diabetes.org/diabetes-basics/ diabetes-statistics/ .,Non-OADS,/arxiv_data1/oa_pdf/e8/70/13300_2013_Article_36.PMC3889332.pdf
"Ministerio de Sanidad, Politica Social e Igualdad, Grupos Relacionados de Diagno ´astico (GRD), 2008 http://www.msps.es/estadEstudios/estadisticas/docs/ PESOS_ESPANOLES_AP_GRD_V23_2008.pdf .",Non-OADS,/arxiv_data1/oa_pdf/3b/d7/13300_2013_Article_44.PMC3889333.pdf
Available at: http://www.familypractice news.com/news/diabetes-e ndocrinology-metabolism/ single-article/fda-withholds- insulin-degludec-approval- wants-safety-data/db819817d382fd2744a59c04cad79c62.html .,Non-OADS,/arxiv_data1/oa_pdf/9b/71/13300_2013_Article_47.PMC3889334.pdf
Right-hand chorea increases when walking.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/89/37/tre-04-213-4821-1.PMC3889335.pdf
"Lancet Neurol 2010;9:776–785, doi: http://dx.doi.org/10.1016/ S1474-4422(10)70137-X.",OADS,/arxiv_data1/oa_pdf/89/37/tre-04-213-4821-1.PMC3889335.pdf
"Ann Neurol 2011;69:892–900, doi: http://dx.doi.org/10.1002/ana.22307.",Non-OADS,/arxiv_data1/oa_pdf/89/37/tre-04-213-4821-1.PMC3889335.pdf
"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody.Neurology 2004;62:1177–1182, doi: http://dx.doi.org/10.1212/01.WNL.",Non-OADS,/arxiv_data1/oa_pdf/89/37/tre-04-213-4821-1.PMC3889335.pdf
"Neurology 2009;72:99; author reply 99–100, doi: http://dx.doi.org/10.1212/01.wnl.0000339405.94708.8d 6.Tan KM, Lennon VA, Klein CJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/89/37/tre-04-213-4821-1.PMC3889335.pdf
"Neurology 2012; 79:195–196, doi: http://dx.doi.org/10.1212/WNL.0b013e31825f0522.",Non-OADS,/arxiv_data1/oa_pdf/89/37/tre-04-213-4821-1.PMC3889335.pdf
"Brain 2010;133:2734–2748, doi: http://dx.doi.org/ 10.1093/brain/awq213.",OADS,/arxiv_data1/oa_pdf/89/37/tre-04-213-4821-1.PMC3889335.pdf
"Nat Med 2009;15:1208– 1214, doi: http://dx.doi.org/10.1038/nm.2019.",Non-OADS,/arxiv_data1/oa_pdf/89/37/tre-04-213-4821-1.PMC3889335.pdf
"There is no chorea at rest orwhen walking.Ramdhani RA, Frucht SJ LGI1-Induced Reversible Chorea Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/89/37/tre-04-213-4821-1.PMC3889335.pdf
His past medical history was unremarkable except for a mild left ulnar nerve compression neuropathy that was evident on electromyography(EMG) approximately 1 year prior to his presentation at our movementFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/21/2e/tre-04-194-4738-1.PMC3889336.pdf
Unilateral Isometric Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/21/2e/tre-04-194-4738-1.PMC3889336.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/21/2e/tre-04-194-4738-1.PMC3889336.pdf
"J Psychiatr Res 1975;12:189–198, doi: http://dx.doi.org/10.1016/0022-3956(75)90026-6.",Non-OADS,/arxiv_data1/oa_pdf/21/2e/tre-04-194-4738-1.PMC3889336.pdf
"Mov Disord 1998;13:2–23, doi: http://dx.doi.org/ 10.1002/mds.870131303.",OADS,/arxiv_data1/oa_pdf/21/2e/tre-04-194-4738-1.PMC3889336.pdf
Unilateral Isometric Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/21/2e/tre-04-194-4738-1.PMC3889336.pdf
Presented at the annual meeting of Pop-ulation Approach Group of Australia and New Zealand (PAGANZ).Available at: http://www.paganz.org/abstracts/identification-of- continuous-covariate-relationships 23.,OADS,/arxiv_data1/oa_pdf/e3/b4/228_2013_Article_1584.PMC3889505.pdf
Available at: http://wfn.sourceforge.net 28.,Non-OADS,/arxiv_data1/oa_pdf/e3/b4/228_2013_Article_1584.PMC3889505.pdf
"Primers were designed based on sequences derived from NCBI ( http://www.ncbi.nlm.nih.gov/ ), control region accession number: AB202062.1, and for RAG1 gene: EU349904.1 using Primer 3 software (Rozen and Skaletsky 2000 ).",OADS,/arxiv_data1/oa_pdf/cb/4d/13364_2013_Article_144.PMC3889517.pdf
BLAST (http://blast.ncbi.nlm.nih.gov/ ) was used for verification and confirmation if the sequences obtained belong to appropri- ate species and for elimination of the suspicion of contamination.,OADS,/arxiv_data1/oa_pdf/cb/4d/13364_2013_Article_144.PMC3889517.pdf
"Available from http://www.lifetechnologies.com/ForensicNews Casas-Marce M, Revilla E, Godoy JA (2010) Searching for DNA in museum specimens: a comparison of sources in a mammal species.M o lE c o lR e s o u r1 0 : 5 0 2 –507 Eilert KD, Foran DR (2009) Polymerase resistance to polymerase chain reaction inhibitors in bone.",OADS,/arxiv_data1/oa_pdf/cb/4d/13364_2013_Article_144.PMC3889517.pdf
"R Foundation for Statistical Computing, Vienna, http://www.R-project.org/ .",Non-OADS,/arxiv_data1/oa_pdf/cb/4d/13364_2013_Article_144.PMC3889517.pdf
"Humana, Totowa, pp 365 –386, Source code available at http://fokker.wi.mit.edu/primer3/ Satoh M, Kuroiwa T (1991) Organization of multiple nucleids and DNA molecules in mitochondria of a human cell.",OADS,/arxiv_data1/oa_pdf/cb/4d/13364_2013_Article_144.PMC3889517.pdf
Accessed September 2013 at: http://www.fda.gov/ downloads/Drugs/GuidanceComp lianceRegulatoryInformation/ Guidances/ucm292362.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b3/64/228_2013_Article_1592.PMC3889518.pdf
"The NIMH PDSP(http://pdsp.med.unc.edu/ ) is directed by Bryan L. Roth MD, PhD at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscol at NIMH, Bethesda MD, USA.",Non-OADS,/arxiv_data1/oa_pdf/53/f5/213_2013_Article_3234.PMC3889519.pdf
http://www.fda.gov/ downloads/Drugs/GuidanceComp lianceRegulatoryInformation/ Guidances/UCM204959.pdf .,Non-OADS,/arxiv_data1/oa_pdf/16/31/228_2013_Article_1590.PMC3889630.pdf
February 2008. http://www.fda.gov/ downloads/Drugs/GuidanceComp lianceRegulatoryInformation/ Guidances/UCM079266.pdf Accessed 27 May 2013.,Non-OADS,/arxiv_data1/oa_pdf/16/31/228_2013_Article_1590.PMC3889630.pdf
"One thousand five hundred twenty-four patients with BCR-ABL-positive chronic phase CML were divided into four age groups: (1) 16 –29 years, n=120; (2) 30 –44 years, n=383; Data presented in part at the ELN Frontiers Meeting, November 9 –11, 2012, Istanbul, Turkey The study is registered at NIH, ClinicalTrials.gov identifier: NCT00055874 ( http://clinicaltrials.gov ) Electronic supplementary material The online version of this article (doi:10.1007/s00277-013-1937-4) contains supplementary material, which is available to authorized users.",Non-OADS,/arxiv_data1/oa_pdf/d4/76/277_2013_Article_1937.PMC3889634.pdf
"Bethesda, MD 2006. http://seer.cancer.gov/publications/aya/ .",Non-OADS,/arxiv_data1/oa_pdf/d4/76/277_2013_Article_1937.PMC3889634.pdf
"Retrieved May 18, 2012. http://www.ema.europa.eu/docs/en_GB/document_library/ EPAR_-_Summary_for_t he_public/human/000435/ WC500046724.pdf Orphanet Report Series, Rare Diseases collection , November 2012, Number 1: Listed in alphabetical order of disease orgroup of diseases, http://www.orpha.net/orphacom/cahiers/ docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, NP-C Guidelines Working Group (2012) Recommen-dations for the diagnosis and management of Niemann-Pick dis-ease type C: an update.",Non-OADS,/arxiv_data1/oa_pdf/b6/48/10545_2013_Article_9626.PMC3889645.pdf
"Available at http://cran.r-project.org/web/packages/nlme/ Price JJ, Earnshaw SM, Webster MS (2006) Montezuma oropendolas modify a component of song constrained by body size during vocalcontests.",Non-OADS,/arxiv_data1/oa_pdf/0c/b7/265_2013_Article_1616.PMC3889651.pdf
Available from: http://manual.jointcommission.org/ releases/TJC2011A/PerinatalCare.html .,Non-OADS,/arxiv_data1/oa_pdf/16/ae/10995_2013_Article_1229.PMC3889674.pdf
Xarelto/C210(rivaroxaban) Summary of Product Characteristics; 2013. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000944/WC500057108.pdf (Accessed 23 Jul 2013).,OADS,/arxiv_data1/oa_pdf/34/e8/40262_2013_Article_100.PMC3889701.pdf
Janssen Pharmaceuticals Inc. Xarelto /C210(rivaroxaban) Prescribing Information; 2013. http://www.accessdata.fda.gov/drugsatfda_ docs/label/2013/022406s004lbl.pdf (Accessed 23 Jul 2013).,OADS,/arxiv_data1/oa_pdf/34/e8/40262_2013_Article_100.PMC3889701.pdf
Guidance for industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosageforms based on a biopharmaceutics classiﬁcation system; 2000. http://www.fda.gov/downloads/D rugs/GuidanceCompliance RegulatoryInformation/Guidances/ucm070246.pdf (Accessed 23 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/34/e8/40262_2013_Article_100.PMC3889701.pdf
ICH E14 The clini- cal evaluation of QT/QTc interval prolongation and proarrhyth- mic potential for non-antiarrhythmic drugs (CHMP/ICH/2/04); 2005. http://www.ich.org/ﬁleadmin/Pub lic_Web_Site/ICH_Products/ Guidelines/Efﬁcacy/E14/E14_Guideline.pdf (Accessed 23 Jul 2013).,OADS,/arxiv_data1/oa_pdf/34/e8/40262_2013_Article_100.PMC3889701.pdf
FDA Advisory Committee Brieﬁng Document; 2009. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/34/e8/40262_2013_Article_100.PMC3889701.pdf
CHMP assessment report for Xarelto; 2008. http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Public_assessment_report/human/000944/WC500057122.pdf (Accessed 23 Jul 2013).41.,OADS,/arxiv_data1/oa_pdf/34/e8/40262_2013_Article_100.PMC3889701.pdf
Guideline on the evaluation of the pharmacokinetics of medicinal products in patients with impairedhepatic function; 2005. http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2009/09/WC500003122.pdf (Accessed 24 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/34/e8/40262_2013_Article_100.PMC3889701.pdf
Eliquis /C210(apixaban) Summary of Product Characteristics; 2013. http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Product_Information/human/002148/WC500107728.pdf (Accessed 3 Jul 2013).,OADS,/arxiv_data1/oa_pdf/34/e8/40262_2013_Article_100.PMC3889701.pdf
U.S. Department of Health and HumanServices; 2012. http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ucm292362.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/5b/40262_2013_Article_97.PMC3889821.pdf
http://www.msct.eu/CT_Quality_Criteria.htm .,Non-OADS,/arxiv_data1/oa_pdf/4c/f1/40261_2013_Article_149.PMC3889825.pdf
Xarelto /C210(rivaroxaban) summary of product characteristics; 2013. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000944/WC500057108.pdf (Accessed 22 May 2013).,OADS,/arxiv_data1/oa_pdf/a2/ba/40262_2013_Article_90.PMC3889826.pdf
US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER).General considerations for pediatric pharmacokinetic studiesfor drugs and biological products; 1998. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm072114.pdf (Accessed 19 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/a2/ba/40262_2013_Article_90.PMC3889826.pdf
Version 3.2012. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7b/45/10549_2013_Article_2778.PMC3889833.pdf
http://www.clinicaltrials.gov/ct2/show/ NCT00253422?term=sofea&rank=1 .,Non-OADS,/arxiv_data1/oa_pdf/7b/45/10549_2013_Article_2778.PMC3889833.pdf
Last updated April 2012. http://www.nicedsu.org.uk .,Non-OADS,/arxiv_data1/oa_pdf/7b/45/10549_2013_Article_2778.PMC3889833.pdf
"Kazanjian A, Howett C, Chan V , Smillie K (2009a) Knowledge exchange decision-support toolkit for supportive cancer care, finalreport 2009. http://spph.ubc.ca/sites/healthcare/files/2009/KE-DS_ Toolkit_October2009.pdf Accessed on 6 Dec 2012 13.",Non-OADS,/arxiv_data1/oa_pdf/fd/cc/520_2013_Article_1982.PMC3889872.pdf
"Kazanjian A, Howett C, Smillie K (2009b) Supportive cancer care programs: further applic ation of the knowledge exchange-decision sup- port toolkit final report, 2009. http://spph.ubc.ca/sites/healthcare/files/ 2009/KEDS_Report_Cancer _Transitions_OCT09.pdf Accessed on 6 Dec 2012 14.",Non-OADS,/arxiv_data1/oa_pdf/fd/cc/520_2013_Article_1982.PMC3889872.pdf
"Vancouver, Canadahttp://www.bccancer.bc.ca/NR/rdonlyres/FBBD2D27-7E88-4340-AE76-5552E2B57C5C/14927/prin t_Final_Navigation1.pdf .",Non-OADS,/arxiv_data1/oa_pdf/fd/cc/520_2013_Article_1982.PMC3889872.pdf
"Data generated were the average of three independent experiments, with each experiment performed in tripli cate and analyzed using the Rela- tive Expression Software Tool ( http://REST.gene-quantiﬁcation.",OADS,/arxiv_data1/oa_pdf/62/0b/10549_2013_Article_2812.PMC3889873.pdf
"Detection of biotin- dUTP was performed according to a standard procedure (http://www.cambio.co.uk ) with Star*FISH ©biotin detec- tion kit containing avidin-FITC (Cambio, UK).",Non-OADS,/arxiv_data1/oa_pdf/19/8a/11357_2013_Article_9541.PMC3889908.pdf
"To analyze nucleolar 5- mdC content, ImageJ software ( http://rsbweb.nih.gov/ij/ ) was used.",OADS,/arxiv_data1/oa_pdf/19/8a/11357_2013_Article_9541.PMC3889908.pdf
The OD1 and L1 were estimated usingImageJ software ( http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/19/8a/11357_2013_Article_9541.PMC3889908.pdf
The mean size of pericentromeric heterochro- matin blocks were estimated by morphometric methodwith ImageJ software ( http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/19/8a/11357_2013_Article_9541.PMC3889908.pdf
"Mascot search result processing used MScan, a pro- prietary software tool implemented in the Java pro- gramming language ( http://proteom.ibb.waw.pl/ ).",OADS,/arxiv_data1/oa_pdf/7d/33/11357_2013_Article_9562.PMC3889913.pdf
"All statistical analyses used proprietary soft- ware running in the MATLAB (MathWorks) environ- ment (MStat, available at http://proteom.ibb.waw.pl/ ).",OADS,/arxiv_data1/oa_pdf/7d/33/11357_2013_Article_9562.PMC3889913.pdf
fda.gov/Drugs/DrugSafety/ucm237081.htm ;o n d a n s e t r o n : http://www.fda.gov/Drugs/DrugSafety/ucm271913.htm ).,Non-OADS,/arxiv_data1/oa_pdf/63/7f/520_2013_Article_1999.PMC3889920.pdf
"Notably, QTc prolongation with ondansetron appears to bedose dependent, which led to the removal of the 32-mg IV single daily dose from the ondansetron label ( http://www.fda.",Non-OADS,/arxiv_data1/oa_pdf/63/7f/520_2013_Article_1999.PMC3889920.pdf
The surveillance and outcomes unit population oncology (2010) BC Cancer Agency Survival Statistics 2007. http://www.bccan cer.bc.ca/NR/rdonlyres/D8291ED8-FAEE-4692-A256-5320928187F2/44155/Survival_Statistics_2007_Rerun.pdf .,Non-OADS,/arxiv_data1/oa_pdf/36/78/10549_2013_Article_2795.PMC3889923.pdf
311 http://www.who.int/mediacentre/factsheets/fs311/en/ (2011) 3.,Non-OADS,/arxiv_data1/oa_pdf/fa/eb/11695_2013_Article_1037.PMC3889984.pdf
"Passive measures includ- ed a removable sound-insulating foam insert (Ultra BarrierHD Composite; American Micro Industries, Chambersburg, PA, USA,) rated to reduce noise levels on the order of 20 dB (http://www.soundprooffoam.com/pdf/Ultra-Barrier.pdf )a n d electrodynamic headphones (MR Confon, Magdeburg, Ger- many) with embedded MiniMuff ear pads (Natus Medical Inc., San Carlos, CA, USA) ( http://www.natus.com )p r o v i d e d a further 45 dB reduction ( http://www.mr-confon.de/en/ products/headphones.html )( F i g .",Non-OADS,/arxiv_data1/oa_pdf/9a/3d/247_2013_Article_2752.PMC3889986.pdf
[http://www.heartfoundation.org.,Non-OADS,/arxiv_data1/oa_pdf/4b/e7/12471_2013_Article_482.PMC3890007.pdf
Surveil- lance of invasive bacterial diseases in Europe (2007); 2012. http://www.ecdc.europa.eu/en/publications/Publications/101011_SUR_Surveillance_of_invasive_bacterial_diseases_in_Europe_2007.pdf (Accessed 14 Aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/c9/59/40265_2013_Article_155.PMC3890039.pdf
"Active bacterial core surveillance report, emerging infections program network, Neis- seria meningitidis ; 2008. http://www.cdc.gov/abcs/reports- ﬁndings/survreports/mening08.html (Accessed 14 Aug 2012).",OADS,/arxiv_data1/oa_pdf/c9/59/40265_2013_Article_155.PMC3890039.pdf
"www.landesbioscience.com Human Vaccines & Immunotherapeutics 1425Human Vaccines & Immunotherapeutics 9:7, 1425–1429; July 2013; © 2013 Landes Bioscience SHort report SHort report *Correspondence to: Himal Lal; Email: Himal.x.Lal@GSK.com Submitted: 01/02/13; Revised: 03/05/13; Accepted: 03/12/13http://dx.doi.org/10.4161/hv.24269Introduction Herpes zoster (HZ), or shingles, occurs as a result of the reactiva - tion of latent varicella-zoster virus (VZV) in the dorsal or cranial  root ganglia, typically many years after primary VZV infection is acquired during childhood as chickenpox.",Non-OADS,/arxiv_data1/oa_pdf/a6/b5/hvi-9-1425.PMC3890214.pdf
Available at: http://www.herpesvirusworkshop.,Non-OADS,/arxiv_data1/oa_pdf/a6/b5/hvi-9-1425.PMC3890214.pdf
*Correspondence to: James E. Galen; Email: jgalen@medicine.umaryland.edu Submitted: 12/04/12; Accepted: 12/12/12http://dx.doi.org/10.4161/hv.23248Bacterial live vector vaccines represent a vaccine development strategy that offers exceptional flexibility.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Proc Natl Acad Sci USA 1995; 92:2904- 8; PMID:7708746; http://dx.doi.org/10.1073/ pnas.92.7.2904.,OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Infect Immun  2001; 69:4734-41; PMID:11447145; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
J Bacteriol  2008; 190:2450-7; PMID:18203835; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Proc Natl Acad Sci USA 2000; 97:6640- 5; PMID:10829079; http://dx.doi.org/10.1073/ pnas.120163297.,OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
J Infect Dis  2009; 199:326-35; PMID:19099487; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
T rends Microbiol 2002; 10:39-45;  PMID:11755084; http://dx.doi.org/10.1016/S0966- 842X(01)02259-4.,OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
FEMS Immunol Med Microbiol 2003; 37:99-104; PMID:12832112; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Can J Microbiol 1998; 44:351-5; PMID:9674107;  http://dx.doi.org/10.1139/w98-020.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Vaccine 2009; 27:3780- 7; PMID:19464562; http://dx.doi.org/10.1016/j.vac- cine.2009.03.053.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
J Infect Dis 1994; 169:927-31; PMID:8133113; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
T rends Microbiol 2001;  9:372-6; PMID:11514219; http://dx.doi.org/10.1016/ S0966-842X(01)02096-0.,OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Infect Immun  2010; 78:337-47; PMID:19884333; http://dx.doi.org/10.1128/IAI.00916-09.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
J Mol Microbiol Biotechnol  2004; 7:197-203; PMID:15383717; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Bio/Technology 1988;  6:693-7; http://dx.doi.org/10.1038/nbt0688-693.,OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Infect Immun 2010;  78:4828-38; PMID:20732994; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
FEMS Microbiol Lett 1995; 126:97-101; PMID:7896085; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Microbiology 2009; 155:873- 81; PMID:19246758; http://dx.doi.org/10.1099/ mic.0.023754-0.,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Res Microbiol 2009; 160:800-8; PMID:19835951; http://dx.doi.org/10.1016/j.res-mic.2009.09.016.,OADS,/arxiv_data1/oa_pdf/f3/d2/hvi-9-1558.PMC3890216.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/77/7a/213.PMC3890342.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/48/52/222.PMC3890343.pdf
"On the basis of a morphological analysis of the 4718 haploid nones - sential gene deletion mutants, we created a morphological data - base named the Saccharomyces cerevisiae  Morphological Database  (SCMD; http://yeast.gi.k.u-tokyo.ac.jp; Saito et al., 2004).",OADS,/arxiv_data1/oa_pdf/48/52/222.PMC3890343.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1d/b8/234.PMC3890344.pdf
"For RNAi knockdown, we designed pairs of single-stranded  DNA oligonucleotides (one encoding target pre-miRNA and  the other corresponding its complement) for 10 potential target  sequences by using RNAi Designer (Invitrogen, Carlsbad, CA;  https://rnaidesigner.invitrogen.com/rnaiexpress/).",OADS,/arxiv_data1/oa_pdf/1d/b8/234.PMC3890344.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/69/8a/245.PMC3890345.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d6/4b/257.PMC3890346.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/aa/b7/267.PMC3890347.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b2/38/276.PMC3890348.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/38/21/290.PMC3890349.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/99/51/302.PMC3890350.pdf
"OncoImmunology 2014; 3:e26967;  http://dx.doi.org/10.4161/onci.26967Myeloid-derived suppressor cells Cellular missiles to target tumors Dinesh Chandra* and Claudia Gravekamp albert e instein College of Medicine; Department of Microbiology and Immunology; Bronx, N y US a Keywords:  MDSC, listeria, cancer vaccine, tumor microenvironment, targeted therapy While conventional anticancer therapies, including surgical  resection, radiotherapy, and/or chemotherapy, are relatively  efficient at eliminating primary tumors, these treatment  modalities are largely ineffective against metastases.",Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
Nat Rev Immunol 2009; 9:162-74; PMID:19197294 ;  http://dx.doi.org/10.1038/nri2506 2.,Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
J Immunol  2009 ; 182:4499 -506; PMID:19342621 ;  http://dx.doi.org/10.4049/jimmunol.0802740 3.,Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
Blood  2007 ; 109:4336 -42; PMID:17244679 ;  http://dx.doi.org/10.1182/blood-2006-09-046201 4.,Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
Br  J Cancer 2013 ; 108:2281 -90; PMID:23640395 ;  http://dx.doi.org/10.1038/bjc.2013.206 5.,Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
Cancer Biol Ther  2010 ; 9:257-265 ; PMID:20038820 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
J Cell Biol 2002 ; 158:409- 14; PMID:12163465 ; http://dx.doi.org/10.1083/ jcb.200205009 9.,OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
Proc Natl Acad Sci U S A 2013 ;  110:8325 -6; PMID :23667150 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
J Skin Cancer 2013 ;  2013 :828329 ; PMID:23365757 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
Cancer Res 2013 ; 73:5003 -15; PMID:23536556 ;  http://dx.doi.org/10.1158/0008-5472.CAN-12-1597 13.,Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
Nat Biotechnol  2004 ; 22:313-20;  PMID:14990953 ; http://dx.doi.org/10.1038/nbt937 14.,Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
J Biomed Sci  2010 ; 17:21; PMID:20331869 ;  http://dx.doi.org/10.1186/1423-0127-17-21 15.,OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
Cancer Cell  2008 ; 14:299- 311; PMID:18835032 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
J Natl Cancer Inst  2004 ; 96:1593 -603; PMID:15523088 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/a5/onci-2-e26967.PMC3890360.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/32/copd-9-057.PMC3890400.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 57–63International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  57OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5241 6Comparison of clinical features between non-   smokers with COPD and smokers with COPD:   a retrospective observational study Jing Zhang* Xin-feng lin* Chun-xue Bai Department of Pulmonary Medicine,   Zhongshan hospital, shanghai Medical  College, Fudan University, shanghai,   People’s republic of China *These authors contributed equally   to this paper Correspondence: Chun-xue Bai   180 Fenglin road, Department   of Pulmonary Medicine, Zhongshan   hospital, shanghai, 200032,   People’s republic of China   email bai.chunxue@zs-hospital.sh.c nBackground:  Smoking is a major risk factor for chronic obstructive pulmonary disease  (COPD); however, the similarities and differences in clinical presentation between smokers and  nonsmokers are not fully described in patients with COPD.",Non-OADS,/arxiv_data1/oa_pdf/c7/32/copd-9-057.PMC3890400.pdf
"International Journal of COPD 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 58Zhang et al T able  1 Definition and severity grading of COPD according to  airflow obstruction Grade Post-bronchodilator  spirometry grade 1 (Mild COPD) FeV1/FVC ,70%; FeV1 %pred $80% grade 2 (Moderate COPD) FeV1/FVC ,70%; 50% #FeV1 %pred  ,80% grade 3 (severe COPD) FeV1/FVC ,70%; 30% #FeV1 %pred  ,50% grade 4 (Very severe COPD) FeV1/FVC ,70%; FeV1 %pred ,30%  or FeV1 %pred ,50% plus chronic  respiratory failure Notes:  adapted by the author from the “global strategy for Diagnosis, Management  and Prevention of COPD, 2013” global initiative for Chronic Obstructive lung  Disease (gOlD), available from http://www.goldcopd.org .1 Abbreviations:  COPD, chronic obstructive pulmonary disease; FeV1, forced  expiratory volume in one second; FVC, forced vital capacity; %pred, percentage  of predicted.social burden.1 It is characterized by chronic inflammation  and irreversible airflow obstruction, involving structural  changes in the lung.2 Tobacco smoking is the most important  risk factor for the development of COPD;1 however, not all  patents with COPD have a history of smoking.",Non-OADS,/arxiv_data1/oa_pdf/c7/32/copd-9-057.PMC3890400.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c7/32/copd-9-057.PMC3890400.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/32/copd-9-057.PMC3890400.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/81/copd-9-065.PMC3890403.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 65–73International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  65OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5441 7COPD management costs according   to the frequency of COPD exacerbations   in UK primary care Y ogesh suresh Punekar1 amit shukla2 hana Müllerova3 1global health Outcomes,   glaxo smithKline r&D, Uxbridge,   UK; 2Worldwide epidemiology,   glaxosmithKline r&D, Upper  Providence, P a, Usa; 3Worldwide  epidemiology, glaxo smithKline r&D,   Uxbridge, UK Correspondence: Yogesh suresh Punekar   global health Outcomes,  glaxosmithKline, stockley Park,   Uxbridge UB11 1BT, UK   Tel +44 020 8990 4786   Fax +44 020 8990 3505   email yogesh.q.punekar@gsk.co mBackground:  The economic burden of chronic obstructive pulmonary disease (COPD) exacer - bations is significant, but the impact of other sources on the overall cost of COPD management  is largely unknown.",Non-OADS,/arxiv_data1/oa_pdf/29/81/copd-9-065.PMC3890403.pdf
Available from: http://www.cprd.,Non-OADS,/arxiv_data1/oa_pdf/29/81/copd-9-065.PMC3890403.pdf
"Available from:  https://www.gov.uk/government/publications/2010-11-reference-costs- publicatio n. Accessed October 4, 2012.",Non-OADS,/arxiv_data1/oa_pdf/29/81/copd-9-065.PMC3890403.pdf
Available from: http://www.goldcopd.org/uploads/users/files/ GOLDReport_April112011 .pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/81/copd-9-065.PMC3890403.pdf
"Available from: http://www.pssru.ac.uk/project-pages/   unit-costs/2011/index.ph p. Accessed October 4, 2012.",Non-OADS,/arxiv_data1/oa_pdf/29/81/copd-9-065.PMC3890403.pdf
"Available from: http://bnf.org/ bnf/index.ht m. Accessed October 4, 2012.",Non-OADS,/arxiv_data1/oa_pdf/29/81/copd-9-065.PMC3890403.pdf
"Available from: http://www.nice.org.uk/   usingguidance /commissioningguides/ pulmonaryrehabilitationservicefor   patientswithcopd /mrc_dyspnoea_scale.js p. Accessed June 20, 2011.",Non-OADS,/arxiv_data1/oa_pdf/29/81/copd-9-065.PMC3890403.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/29/81/copd-9-065.PMC3890403.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/81/copd-9-065.PMC3890403.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/33/cmar-6-015.PMC3890404.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 15–25Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  15Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S5392 8MicroRNA function and dysregulation in bone  tumors: the evidence to date Mary Nugent Department of Orthopaedic Surgery,   Cappagh National Orthopaedic  Hospital, Finglas, Dublin, ireland Correspondence: Mary Nugent   Department of Orthopaedic Surgery,  Cappagh National Orthopaedic   Hospital, Cappagh Road, Finglas west,   Dublin 11, ireland   email nugentmary@gmail.co mAbstract:  Micro ribonucleic acids (miRNAs) are small non-coding RNA segments that have  a role in the regulation of normal cellular development and proliferation including normal  osteogenesis.",Non-OADS,/arxiv_data1/oa_pdf/9b/33/cmar-6-015.PMC3890404.pdf
Available from: http://www.mirbase.org/index.,OADS,/arxiv_data1/oa_pdf/9b/33/cmar-6-015.PMC3890404.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/9b/33/cmar-6-015.PMC3890404.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/33/cmar-6-015.PMC3890404.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/97/cia-9-121.PMC3890406.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 121–127Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  121OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5410 7Menatetrenone versus alfacalcidol in the treatment of  Chinese postmenopausal women with osteoporosis:  a multicenter, randomized, double-blinded, double- dummy, positive drug-controlled clinical trial Yan Jiang1,* Zhen-lin Zhang2,* Zhong-lan Zhang3 han-Min Zhu4 Yi-Y ong Wu5 Qun Cheng4 Feng-li Wu5 Xiao-Ping Xing1 Jian-li liu3 Wei Yu6 Xun-Wu Meng1 1Department of endocrinology, Key laboratory  of endocrinology, Peking Union Medical College  hospital, Chinese Academy of Medical sciences,   Beijing, 2Metabolic Bone Disease and genetic  research Unit, Department of Osteoporosis  and Bone Disease, shanghai Jiao Tong University  Affiliated sixth People’s hospital, shanghai,   3Department of gynecology and Obstetrics,   general hospital of the People’s liberation Army,   Beijing, 4Department of geriatrics, shanghai  huadong hospital, shanghai, 5Department of  gynecology and Obstetrics, Beijing hospital,   Ministry of Public health, Beijing, 6Department of  radiology, Peking Union Medical College hospital,   Chinese Academy of Medical sciences, Beijing,   People’s republic of China *These authors contributed equally to this work Correspondence: Xiao-Ping Xing   Department of endocrinology, Key laboratory  of endocrinology, Ministry of health, Peking  Union Medical College hospital, Chinese  Academy of Medical sciences, Beijing 100730,  People’s republic of China   T el +86 10 6915 5084   Fax +86 10 6915 1552   email xingxp2006@126.co m Jian-li liu   Department of gynecology and Obstetrics,  general hospital of the People’s liberation  Army, Beijing 100853, People’s republic   of China   email 1316167397@qq.co mObjective:  To evaluate whether the efficacy and safety of menatetrenone for the treatment of  osteoporosis is noninferior to alfacalcidol in Chinese postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/79/97/cia-9-121.PMC3890406.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/79/97/cia-9-121.PMC3890406.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/97/cia-9-121.PMC3890406.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/c7/cia-9-111.PMC3890407.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 111–119Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  111OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S5364 5The Walking Trail-Making T est is an early   detection tool for mild cognitive impairment Anaick Perrochon gilles Kemoun laboratoire Mobilité, Vieillissement,   exercice (MOVe), eA 6314, Faculté  des sciences du sport, Université  de Poitiers, 8 Allée Jean Monnet,   86000 Poitiers, France; I sIs, research  Institute on handicap and Aging, Paris,   France Correspondence: Anaick Perrochon   laboratoire Mobilité, Vieillissement,  exercice (MOVe), eA 6314, Faculté des  sciences du sport, Université de Poitiers,  8 Allée Jean Monnet, 86000 Poitiers,  France   Tel +33 6797 23648   email anaick.perrochon@hotmail.f rBackground:  Executive function impairment (in particular, mental flexibility) in the elderly,  and in patients with mild cognitive impairment (MCI), is strongly correlated with difficulties  in performing complex walking tasks.",Non-OADS,/arxiv_data1/oa_pdf/6c/c7/cia-9-111.PMC3890407.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6c/c7/cia-9-111.PMC3890407.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/c7/cia-9-111.PMC3890407.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/ae/cmar-6-027.PMC3890408.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 27–38Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  27Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S3774 5Developments in Burkitt’s lymphoma: novel  cooperations in oncogenic MYC signaling Lindsay C Spender Gareth J inman Division of Cancer Research, Medical  Research institute, Jacqui wood  Cancer Centre, University of Dundee,   Ninewells Hospital and Medical  School, Dundee, UK Correspondence: Lindsay C Spender,  Gareth J inman   Division of Cancer Research, Medical  Research institute, Jacqui wood Cancer  Centre, University of Dundee, James  Arrott Drive, Ninewells Hospital and  Medical School, Dundee, DD1 9SY, UK   Tel +44 013 823 833 66   Fax +44 013 823 864 19   email l.spender@dundee.ac.u k,  g.j.inman@dundee.ac.u kAbstract:  Burkitt’ s lymphoma (BL) is an aggressive disorder associated with extremely high  rates of cell proliferation tempered by high levels of apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/22/ae/cmar-6-027.PMC3890408.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/22/ae/cmar-6-027.PMC3890408.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/ae/cmar-6-027.PMC3890408.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/4d/ijn-9-379.PMC3890422.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 379–388International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  379OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5354 6rapid green synthesis of silver nanoparticles   from Chrysanthemum indicum  l and its antibacterial  and cytotoxic effects: an in vitro study selvaraj arokiyaraj1 Mariadhas Valan arasu2 savariar Vincent3 Nyayirukannaian Udaya  Prakash4 seong ho choi5 Y oung-Kyoon Oh1 Ki choon choi2 Kyoung hoon Kim1,6 1Department of animal Nutrition  and Physiology, National Institute of  animal science, rural Development  administration, suwon, republic  of Korea; 2grassland and Forage  Division, National Institute of  animal science, rural Development  administration, seonghwan-eup,   cheonan-si, chungnam, republic of  Korea; 3center for environmental  research and Development, loyola  college, chennai, India; 4research  and Development, Vel Tech Dr rr and  Dr sr T echnical University, chennai,   India; 5Department of animal science,   chungbuk National University,   chungbuk, republic of Korea;   6Department of animal science,    seoul National University,   Pyeongchang, republic of Korea correspondence: Kyoung hoon Kim   Department of animal Nutrition and  Physiology, National Institute   of animal science, rural Development  administration, 126 suin-ro  gwonseon-gu suwon-si gyeonggi-do  441-707, republic of Korea   Tel +82 102 315 0434   email kh665@korea.k rAbstract:  The present work reports a simple, cost-effective, and ecofriendly method for the  synthesis of silver nanoparticles (AgNPs) using Chrysanthemum indicum  and its antibacterial  and cytotoxic effects.",Non-OADS,/arxiv_data1/oa_pdf/1f/4d/ijn-9-379.PMC3890422.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1f/4d/ijn-9-379.PMC3890422.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/4d/ijn-9-379.PMC3890422.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/95/ijn-9-389.PMC3890423.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 389–402International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  389OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5422 6Preparation and efficacy of Newcastle disease  virus DNa vaccine encapsulated in chitosan  nanoparticles Kai Zhao1,2,* Yang Zhang1,2,* Xiaoyan Zhang1,* Wei li1 ci shi1,2 chen guo1 chunxiao Dai3 Qian chen1 Zheng Jin3 Yan Zhao2 Hongyu Cui2 Yunfeng Wang2 1college of life science,   Heilongjiang University, 2Division  of avian Infectious Diseases, state  Key Laboratory of Veterinary  Biotechnology, Harbin Veterinary  research Institute, 3Key Laboratory  of chemical engineering Process  and Technology for High-Efficiency  Conversion, Heilongjiang University,   Harbin, People’s Republic of China *These authors contributed equally to  this work correspondence: Kai Zhao   Laboratory of Microbiology, College of  Life Science, Heilongjiang University,   74 Xuefu road, Nangang District,   Harbin 150080, People’s Republic of China   Tel +86 451 8660 9046   Fax +86 451 8660 9016   email zybin395@126.co m    Yunfeng Wang   Division of avian Infectious Diseases,  State Key Laboratory of Veterinary  Biotechnology, Harbin Veterinary  Research Institute, 427 Maduan street,  Nangang District, Harbin 150001,  People’s Republic of China   Tel +86 451 5199 7167   Fax +86 451 5199 7167   email yfwang@hvri.ac.c nAbstract:  Optimal preparation conditions of Newcastle disease virus (NDV) F gene  deoxyribonucleic acid (DNA) vaccine encapsulated in chitosan nanoparticles (pFNDV -CS-NPs)  were determined.",Non-OADS,/arxiv_data1/oa_pdf/eb/95/ijn-9-389.PMC3890423.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/eb/95/ijn-9-389.PMC3890423.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/95/ijn-9-389.PMC3890423.pdf
1 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHEditorial Vaccination should be the most economical and sustainable way of combating with  infectious diseases.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/cevr-3-1.PMC3890443.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:1-4 http://dx.doi.org/10.7774/cevr.2014.3.1.1 pISSN 2287-3651 • eISSN 2287-366X  Joon Haeng Rhee  Department of Microbiology and Clinical Vaccine  R&D Center, Chonnam National University  Medical School, Gwangju, Korea Received: November 10, 2013 Revised: November 20, 2013 Accepted: November 25, 2013 Corresponding author: Joon Haeng Rhee, MD, PhD Department of Microbiology and Clinical Vaccine  R&D Center, Chonnam National University   Medical School, 160 Baekseo-ro, Dong-gu,  Gwangju 501-746, Korea Tel: +82-61-379-8479, Fax: +82-61-379-8455 E-mail: jhrhee@chonnam.ac.kr No potential conflict of interest relevant to this  article was reported.Towards Vaccine 3.0: new era  opened in vaccine research and  industry",Non-OADS,/arxiv_data1/oa_pdf/07/4f/cevr-3-1.PMC3890443.pdf
"Joon Haeng Rhee • Towards Vaccine 3.0 2 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.1industry, vaccines have long been regarded as a non­for ­ profit sector.",Non-OADS,/arxiv_data1/oa_pdf/07/4f/cevr-3-1.PMC3890443.pdf
"” Among  top 15 vaccines marketed in 2012, the number of commercial  market vaccines exceeded non­commercial market vaccines  (http://www.genengnews.com/insight ­and­intelligence ­ and153/top­15­ vaccines ­of­2012/).",Non-OADS,/arxiv_data1/oa_pdf/07/4f/cevr-3-1.PMC3890443.pdf
Joon Haeng Rhee • Towards Vaccine 3.0 3 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.1protected vaccine industry seemed open ajar to the follower  companies during later 2000s.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/cevr-3-1.PMC3890443.pdf
Joon Haeng Rhee • Towards Vaccine 3.0 4 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.1should be incorporated into existing vaccine formulations.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/cevr-3-1.PMC3890443.pdf
"100 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Foot-and-mouth disease virus (FMDV) is an important animal pathogen that infects  cloven-hoofed animals, and economically devastating disease of livestock worldwide  [1].",Non-OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:100-109 http://dx.doi.org/10.7774/cevr.2014.3.1.100 pISSN 2287-3651 • eISSN 2287-366X  Subbiah Jeeva, Jung-Ah Lee,  Seung-Yong Park, Chang-Seon Song,  In-Soo Choi, Joong-Bok Lee College of Veterinary Medicine and Veterinary  Science Research institute, Konkuk University,  Seoul, Korea Received: October 20, 2013 Revised: November 10, 2013 Accepted: November 14, 2013 Corresponding author: Joong-Bok Lee, PhD College of Veterinary Medicine and Veterinary  Science Research Institute, Konkuk University,  120 Neungdong-ro, Gwangjin-gu, Seoul 143-729,  Korea Tel: +82-2-450-3714, Fax: +82-2-3437-1960.",Non-OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
 Subbiah Jeeva et al • FMDV gene expression by PRRSV replicon vector 101 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.100nome is translated as a single ORF into a precursor polyprot - ein and the precursor protein is cleaved by viral coded prote - ases into both the intermediate and mature structural and  nonstructural (NS) viral proteins.,OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
"Subbiah Jeeva et al • FMDV gene expression by PRRSV replicon vector 102 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.100primers 12AF and 12AR (Table 1) were synthesized by Mac - rogen (Seoul, Korea).",OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
 Subbiah Jeeva et al • FMDV gene expression by PRRSV replicon vector 103 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.100DMSO in a 60 mm cell culture plate for virus recovery and in  a separate plate for immunofluorescence staining; incubated  at 37°C under 5% CO 2.,OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
"Subbiah Jeeva et al • FMDV gene expression by PRRSV replicon vector 104 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.100was used for this complete study, and the schematic repre - sentation of the PRRSV replicon containing P12A3C con - struction was mentioned in Fig.",OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
 Subbiah Jeeva et al • FMDV gene expression by PRRSV replicon vector 105 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.100Fig.,OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
Subbiah Jeeva et al • FMDV gene expression by PRRSV replicon vector 106 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.100reverse transcription polymerase chain reaction using specif - ic primers for N gene and VP1 gene (data not shown).,OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
" Subbiah Jeeva et al • FMDV gene expression by PRRSV replicon vector 107 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.1005 has the ability to carry about 5-8 kb of foreign genes, which  facilitate the production of complete FMDV structural pro - teins [34].",OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
Subbiah Jeeva et al • FMDV gene expression by PRRSV replicon vector 108 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.100biol 1968;22:201-44.,OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
 Subbiah Jeeva et al • FMDV gene expression by PRRSV replicon vector 109 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.10031.,OADS,/arxiv_data1/oa_pdf/42/41/cevr-3-100.PMC3890444.pdf
"110 http://www.ecevr.org/Recommended immunization  schedule for adults in Korea, by  the Korean Society of Infectious  Diseases, 2012CLINICAL    EXPERIMENTAL  VACCINE   RESEARCHGuideline This guideline contains the recommended immunization schedule for adults in Korea.",Non-OADS,/arxiv_data1/oa_pdf/13/3d/cevr-3-110.PMC3890445.pdf
Available from: http://www.ksid.or.kr/  file/vaccine_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/13/3d/cevr-3-110.PMC3890445.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:110-112 http://dx.doi.org/10.7774/cevr.2014.3.1.110 pISSN 2287-3651 • eISSN 2287-366X  Received: August 16, 2013 Revised: September 15, 2013 Accepted: September 25, 2013 No potential conflict of interest relevant to this  article was reported.This guideline contains the recommended immunization schedule for adults in Korea, updated  in 2012.",Non-OADS,/arxiv_data1/oa_pdf/13/3d/cevr-3-110.PMC3890445.pdf
"Guideline: Immunization schedule for adults in Korea 111 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.110                          Age group Vaccine19-29 30-39 40-49 50-64 ≥65 Te tanus-diphtheria-   pertussis1-time dose of Tdap for Td booster;   then boost with Td every 10 yr (strength I)  First dose with Tdap, Td at 1-, and 6-mo; then Td booster   every 10 yr (strength I) (Tdap only for age of 65 or less) Influenza 1 dose annually (strength III) 1 dose annually (strength I) Hepatitis A 2 doses (at 0 and   6 mo) (strength II)For seronegative, 2 doses   (at 0 and 6 mo) (strength II)For high-risk groupa), seronegative,   2 doses (at 0 and 6 mo) (strength II) Hepatitis B When 3 doses of immunization uncertain,   check HBsAb and vaccinate seronegatives (strength III)For high-risk groupb) with uncertain immunization  history, check HBsAb and vaccinate seronegative  (strength III) Measles-mumps-rubella For high-risk groupc), at least 1 dose;   check rubella IgG for women who is   planning pregnancy (strength III) Varicella For high-risk groupd), check serology;   2 doses for seronegatives (strength II) Human papillomavirus Female (strength II) Meningococcal For high-risk groupe), 1 or 2 doses Pneumococcal For high-risk groupf), 1 dose (strength I) 1 dose (strength I) Zoster 1 dose (strength U) 1 dose (strength III) Strength of recommendation   I.",Non-OADS,/arxiv_data1/oa_pdf/13/3d/cevr-3-110.PMC3890445.pdf
 Guideline: Immunization schedule for adults in Korea112 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.110 Vaccinations indicated based on medical and other conditions Contraindicated No recommendation a) Hepatitis A vaccination is indicated for adult patients for liver transplantation.,Non-OADS,/arxiv_data1/oa_pdf/13/3d/cevr-3-110.PMC3890445.pdf
12 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHSpecial article Introduction Vaccination is a deliberate attempt to protect humans against disease.,Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:12-28 http://dx.doi.org/10.7774/cevr.2014.3.1.12 pISSN 2287-3651 • eISSN 2287-366X  Young-Tae Lee1, Ki-Hye Kim1,   Eun-Ju Ko1, Yu-Na Lee1,   Min-Chul Kim2, Young-Man Kwon1,  Yinghua Tang1, Min-Kyoung Cho1,  Youn-Jeong Lee2, Sang-Moo Kang1 1Center for Inflammation, Immunity & Infection,  and Department of Biology, Georgia State  University, Atlanta, GA, USA; 2Animal and Plant  Quarantine Agency, Anyang, Korea Received: November 3, 2013 Revised: November 15, 2013 Accepted: November 20, 2013 Corresponding author: Sang-Moo Kang, PhD Center for Inflammation, Immunity & Infection,  and Department of Biology, Georgia State   University, Atlanta, GA 30303, USA Tel: +1-404-413-3588, Fax: +1-404-413-3580 E-mail: skang24@gsu.edu No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
" Young-Tae Lee et al • New influenza vaccine approaches 13 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12as the development of influenza vaccines [1,2].",OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
Young-Tae Lee et al • New influenza vaccine approaches 14 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12ently used as master donor strains in the production of sea - sonal LAIV vaccines.,Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
 Young-Tae Lee et al • New influenza vaccine approaches 15 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12fluenza A viruses.,OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
Young-Tae Lee et al • New influenza vaccine approaches 16 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12was incorporated into VLPs at low levels similar to those in  influenza viruses [69].,Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
 Young-Tae Lee et al • New influenza vaccine approaches 17 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12Another M2e-carrier vaccine using Mycobacterium tubercu - losis  heat shock protein 70 (M2e-HSP70 359-610 ) was shown to  provide protection via alveolar macrophages and Fc receptor- dependent elimination of influenza A virus-infected cells [73].,Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
"Young-Tae Lee et al • New influenza vaccine approaches 18 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12confer partial survival protection against heterosubtypic chal - lenge viruses (A/PR8 H1N1, A/Vietnam/04 H5N1 virus) and  the homologous virus H3 subtype.",Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
 Young-Tae Lee et al • New influenza vaccine approaches 19 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12CTLs than inactivated influenza vaccine [100].,OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
"Young-Tae Lee et al • New influenza vaccine approaches 20 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12phages prominently express toll-like receptors (TLRs) which  recognize pathogen, vaccine antigen, or adjuvant components.",OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
" Young-Tae Lee et al • New influenza vaccine approaches 21 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12ing intermediates, MyD88, Toll-interleukin (IL)-1 receptor- associated-protein (also known as MAL), TRIF , Toll receptor- associated molecule, IL-1 receptor associated kinase, and tu - mor necrosis factor receptor-associated factor 6.",Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
Young-Tae Lee et al • New influenza vaccine approaches 22 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12adjuvant effects [135].,Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
 Young-Tae Lee et al • New influenza vaccine approaches 23 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.126.,Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
Young-Tae Lee et al • New influenza vaccine approaches 24 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12enza A H5N1 virus related to a highly pathogenic avian  influenza virus.,Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
 Young-Tae Lee et al • New influenza vaccine approaches 25 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12tide as recombinant virus like particle or conjugate vac - cines in mice and monkeys.,OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
Available from: http://www.vaxinnate.com/pages/press - releases/20081026_001.html.,Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
Young-Tae Lee et al • New influenza vaccine approaches 26 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12Nature 1980;283:454-7.,Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
 Young-Tae Lee et al • New influenza vaccine approaches 27 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12mediated immunity against influenza A virus infection  following influenza virus-like particle vaccination.,OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
Young-Tae Lee et al • New influenza vaccine approaches 28 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.12135.,Non-OADS,/arxiv_data1/oa_pdf/13/ed/cevr-3-12.PMC3890446.pdf
"29 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHReview article Introduction Hepatitis E virus (HEV), originally recognized as non-A and non-B hepatitis inducing  agent, was recently classified into the genus Hepevirus  and family Hepeviridae  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/82/2b/cevr-3-29.PMC3890447.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:29-36 http://dx.doi.org/10.7774/cevr.2014.3.1.29 pISSN 2287-3651 • eISSN 2287-366X  Young-Jo Song1, Woo-Jung Park1,  Byung-Joo Park1, Joong-Bok Lee1,  Seung-Yong Park1,  Chang-Seon Song1,  Nak-Hyung Lee1, Kun-Ho Seo2,  Young-Sun Kang3, In-Soo Choi1,4 Departments of 1Infectious Diseases and 2Public  Health, College of Veterinary Medicine, Konkuk  University; 3Department of Biomedical Science  and Technology, SMART Institute of Advanced  Biomedical Science, Konkuk University;   4Veterinary Science Research Institute, College  of Veterinary Medicine, Konkuk University, Seoul,  Korea  Received: August 16, 2013 Revised: September 20, 2013 Accepted: September 30, 2013 Corresponding author: In-Soo Choi, PhD Department of Infectious Diseases, College of  Veterinary Medicine, Konkuk University, 263  Achasan-ro, Gwangjin-gu, Seoul 143-701, Korea Tel: +82-2-2049-6055, Fax: +82-2-3436-5880 E-mail: ischoi@konkuk.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/82/2b/cevr-3-29.PMC3890447.pdf
Young-Jo Song et al • Hepatitis E virus in humans and animals30 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.29 ruses.,OADS,/arxiv_data1/oa_pdf/82/2b/cevr-3-29.PMC3890447.pdf
 Young-Jo Song et al • Hepatitis E virus in humans and animals31 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.29strong evidence that genotypes 3 and 4 of swine HEV could  be the primary sources for human infections.,Non-OADS,/arxiv_data1/oa_pdf/82/2b/cevr-3-29.PMC3890447.pdf
Young-Jo Song et al • Hepatitis E virus in humans and animals32 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.29 deer and patients who contracted HEV after eating raw deer  meat [80].,Non-OADS,/arxiv_data1/oa_pdf/82/2b/cevr-3-29.PMC3890447.pdf
 Young-Jo Song et al • Hepatitis E virus in humans and animals33 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.29tion.,Non-OADS,/arxiv_data1/oa_pdf/82/2b/cevr-3-29.PMC3890447.pdf
Young-Jo Song et al • Hepatitis E virus in humans and animals34 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.29 41.,Non-OADS,/arxiv_data1/oa_pdf/82/2b/cevr-3-29.PMC3890447.pdf
 Young-Jo Song et al • Hepatitis E virus in humans and animals35 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.29of hepatitis E virus isolated in the United States.,Non-OADS,/arxiv_data1/oa_pdf/82/2b/cevr-3-29.PMC3890447.pdf
Young-Jo Song et al • Hepatitis E virus in humans and animals36 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.29 gene gun in the cynomolgus macaque model of infection.,Non-OADS,/arxiv_data1/oa_pdf/82/2b/cevr-3-29.PMC3890447.pdf
37 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHReview article Introduction Vaccines have been developed for many infectious diseases since the early twentieth  century and they have provided numerous benefits to human society.,Non-OADS,/arxiv_data1/oa_pdf/83/28/cevr-3-37.PMC3890448.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:37-41 http://dx.doi.org/10.7774/cevr.2014.3.1.37 pISSN 2287-3651 • eISSN 2287-366X  Ha-Na Na1, Hun Kim2,  Jae-Hwan Nam3 1Department of Infection and Obesity, Pennington  Biomedical Research Center, Baton Rouge, LA,  USA; 2SK Chemicals, Seongnam; 3Department of  Biotechnology, The Catholic University of Korea,  Bucheon, Korea Received: August 27, 2013 Revised: October 7, 2013 Accepted: October 25, 2013 Corresponding author: Jae-Hwan Nam, PhD Department of Biotechnology, The Catholic  University of Korea, 43 Jibong-ro, Wonmi-gu,  Bucheon 420-743, Korea Tel: +82-2-2164-4852, Fax: +82-2-2164-4865 E-mail: jhnam@catholic.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/83/28/cevr-3-37.PMC3890448.pdf
"Ha-Na Na et al • Obesity vaccine38 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.37  Obesity causes many problems in humans, but the treat - ment options for obesity are very limited.",Non-OADS,/arxiv_data1/oa_pdf/83/28/cevr-3-37.PMC3890448.pdf
 Ha-Na Na et al • Obesity vaccine39 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.37triggers islet cell apoptosis and is a primary agonist in the loss  of beta cell mass in type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/83/28/cevr-3-37.PMC3890448.pdf
"Ha-Na Na et al • Obesity vaccine40 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.37 Live Ad36 increased the size of the epididymal fat pad at 4  days post-inoculation, whereas UV-inactivated Ad36 did not  cause an increase [45].",Non-OADS,/arxiv_data1/oa_pdf/83/28/cevr-3-37.PMC3890448.pdf
Available from: http://www.who.int/whr/   2002/index.html.,OADS,/arxiv_data1/oa_pdf/83/28/cevr-3-37.PMC3890448.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/83/28/cevr-3-37.PMC3890448.pdf
 Ha-Na Na et al • Obesity vaccine41 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.37Y signaling via the Y1 receptor partially dissociates feed - ing behavior from lipoprotein metabolism in lean rats.,Non-OADS,/arxiv_data1/oa_pdf/83/28/cevr-3-37.PMC3890448.pdf
Available from: http://www.nhs.uk/news/2012/07July/ Pages/obesity-vaccine-fat-jab-hope.aspx.,Non-OADS,/arxiv_data1/oa_pdf/83/28/cevr-3-37.PMC3890448.pdf
"42 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction  By definition, vaccines are pharmacological formulations that incorporate the disease- causing antigen which could innocuously induce an immune response when admin - istered into a healthy human being, without causing the disease itself [1].",Non-OADS,/arxiv_data1/oa_pdf/69/5d/cevr-3-42.PMC3890449.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:42-49 http://dx.doi.org/10.7774/cevr.2014.3.1.42 pISSN 2287-3651 • eISSN 2287-366X  Hyemee Suh, Juhyung Shin,   Yeu-Chun Kim Department of Chemical and Biomolecular  Engineering, Korea Advanced Institute of Science  and Technology (KAIST), Daejeon, Korea Received: September 18, 2013 Revised: September 30, 2013 Accepted: October 10, 2013 Corresponding author: Yeu-Chun Kim, PhD Department of Chemical and Biomolecular   Engineering, Korea Advanced Institute of Science  and Technology (KAIST), 291 Daehak-ro, Yuseong- gu, Daejeon 305-701, Korea Tel: +82-42-350-3939, Fax: +82-42-350-3910 E-mail: dohnanyi@kaist.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/69/5d/cevr-3-42.PMC3890449.pdf
 Hyemee Suh et al • Microneedle patches for vaccine delivery 43 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.42 It has been noted in numerous studies that the measured  efficacy of vaccines is highly affected by the route of adminis - tration.,Non-OADS,/arxiv_data1/oa_pdf/69/5d/cevr-3-42.PMC3890449.pdf
"Hyemee Suh et al • Microneedle patches for vaccine delivery 44 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.42of a live attenuated Japanese encephalitis vaccine Chime - riVax in nonhuman primates provided evidence in support of  the superior immunogenicity, in terms of higher neutralizing  antibody titers and increased viremia duration, of cutaneous  delivery by skin microabrasion and microneedle penetration  than subcutaneous injection [4].",Non-OADS,/arxiv_data1/oa_pdf/69/5d/cevr-3-42.PMC3890449.pdf
" Hyemee Suh et al • Microneedle patches for vaccine delivery 45 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.42ly packed array of microneedle projections, Nanopatch, was  devised to generate greater immune responses by directly  contacting thousands of APCs.",OADS,/arxiv_data1/oa_pdf/69/5d/cevr-3-42.PMC3890449.pdf
"Hyemee Suh et al • Microneedle patches for vaccine delivery 46 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.42tered by microneedles to provide immunity against bacterial  disease is expansive, including anthrax [34-36], diphtheria  [37-39], tetanus [40], tuberculosis [41], botulism, plague [42],  and staphylococcal toxic shock [43].",Non-OADS,/arxiv_data1/oa_pdf/69/5d/cevr-3-42.PMC3890449.pdf
" Hyemee Suh et al • Microneedle patches for vaccine delivery 47 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.42duced comparable responses to intramuscular administra - tion, but a specific mucosal immunity and more balanc ed  type 1 and 2 helper T cell responses.",Non-OADS,/arxiv_data1/oa_pdf/69/5d/cevr-3-42.PMC3890449.pdf
Hyemee Suh et al • Microneedle patches for vaccine delivery 48 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.42nation using a microneedle patch.,Non-OADS,/arxiv_data1/oa_pdf/69/5d/cevr-3-42.PMC3890449.pdf
 Hyemee Suh et al • Microneedle patches for vaccine delivery 49 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.42wstra JA.,Non-OADS,/arxiv_data1/oa_pdf/69/5d/cevr-3-42.PMC3890449.pdf
"5 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHSpecial article Introduction Influenza A virus, a negative-stranded RNA virus that belongs to the Orthomyxoviridae   family, is responsible for annual epidemics that cause severe morbidity or death in ap - proximately 5 million people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0c/a6/cevr-3-5.PMC3890450.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:5-11 http://dx.doi.org/10.7774/cevr.2014.3.1.5 pISSN 2287-3651 • eISSN 2287-366X  Tatsuya Yamazaki, Takeshi Ichinohe Division of Viral Infection, Department of  Infectious Disease Control, International Research  Center for Infectious Diseases, Institute of  Medical Science, The University of Tokyo, Tokyo,  Japan Received: October 3, 2013 Revised: October 29, 2013 Accepted: November 13, 2013 Corresponding author: Takeshi Ichinohe, PhD Division of Viral Infection, Department of   Infectious Disease Control, International Research  Center for Infectious Diseases, Institute of   Medical Science, The University of Tokyo,   Minato-ku, Tokyo 108-8639, Japan Tel: +81-3-6409-2125, Fax: +81-3-6409-2134 E-mail: ichinohe@ims.u-tokyo.ac.jp No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/0c/a6/cevr-3-5.PMC3890450.pdf
Tatsuya Yamazaki et al • Inflammasomes in antiviral immunity 6 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.5fection that bridges the innate and adaptive immune respons - es.,OADS,/arxiv_data1/oa_pdf/0c/a6/cevr-3-5.PMC3890450.pdf
 Tatsuya Yamazaki et al • : Inflammasomes in antiviral immunity 7 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.5The AIM2 inflammasome is activated by intracellular double- stranded DNA (dsDNA) derived from DNA viruses [19-22].,OADS,/arxiv_data1/oa_pdf/0c/a6/cevr-3-5.PMC3890450.pdf
"Tatsuya Yamazaki et al • Inflammasomes in antiviral immunity 8 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.5bers of the NLRP family, such as NLRP6 and NLRP12, form  an ASC-dependent caspase-1 activating complex [39,40].",OADS,/arxiv_data1/oa_pdf/0c/a6/cevr-3-5.PMC3890450.pdf
 Tatsuya Yamazaki et al • : Inflammasomes in antiviral immunity 9 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.5sponses to influenza virus infection when compared with  water-fed mice [63].,OADS,/arxiv_data1/oa_pdf/0c/a6/cevr-3-5.PMC3890450.pdf
Tatsuya Yamazaki et al • Inflammasomes in antiviral immunity 10 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.5Immunol 2010;11:63-9.,OADS,/arxiv_data1/oa_pdf/0c/a6/cevr-3-5.PMC3890450.pdf
 Tatsuya Yamazaki et al • : Inflammasomes in antiviral immunity 11 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.51:127-31.,OADS,/arxiv_data1/oa_pdf/0c/a6/cevr-3-5.PMC3890450.pdf
"50 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHReview article Introduction Similar to other drugs, vaccines have the potential to cause allergic reactions [1-3].",Non-OADS,/arxiv_data1/oa_pdf/ce/db/cevr-3-50.PMC3890451.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:50-57 http://dx.doi.org/10.7774/cevr.2014.3.1.50 pISSN 2287-3651 • eISSN 2287-366X  Eun Hee Chung Department of Pediatrics, National Medical  Center, Seoul, Korea Received: September 21, 2013 Revised: October 10, 2013 Accepted: October 30, 2013 Corresponding author: Eun Hee Chung, MD, PhD Department of Pediatrics, National Medical   Center, 245 Euljiro, Jung-gu, Seoul 100-799, Korea  Tel: +82-2-2260-7301, Fax: +82-2-2260-7306 E-mail: ehchung@nmc.or.kr No potential conflict of interest relevant to this  article was reported.Currently, the increasing numbers of vaccine administrations are associated with increased  reports of adverse vaccine reactions.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/cevr-3-50.PMC3890451.pdf
 Eun Hee Chung • Vaccine allergies51 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.50Mechanisms of Allergic Responses to   Vaccines The immune-mediated reactions caused by individual com - ponents of the vaccines are outlined in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ce/db/cevr-3-50.PMC3890451.pdf
"Eun Hee Chung • Vaccine allergies52 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.50 thralgia, arthritis, joint swelling, serum sickness, and Henoch- Schönlein purpura may occur, in conjunction with a variety  of other hematologic, renal and gastrointestinal manifesta - tions.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/cevr-3-50.PMC3890451.pdf
 Eun Hee Chung • Vaccine allergies53 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.50Table 4.,Non-OADS,/arxiv_data1/oa_pdf/ce/db/cevr-3-50.PMC3890451.pdf
Eun Hee Chung • Vaccine allergies54 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.50 Allergic Reactions to Egg Protein MMR vaccines MMR vaccines are created by cell cultures using a chicken  embryo fibroblast.,Non-OADS,/arxiv_data1/oa_pdf/ce/db/cevr-3-50.PMC3890451.pdf
" Eun Hee Chung • Vaccine allergies55 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.50From 2004 to 2006, 9 different influenza vaccines were dis - tributed in Korea by either domestic and/or foreign compa - nies.",Non-OADS,/arxiv_data1/oa_pdf/ce/db/cevr-3-50.PMC3890451.pdf
Eun Hee Chung • Vaccine allergies56 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.50 ministered safely without causing an allergic reaction.,Non-OADS,/arxiv_data1/oa_pdf/ce/db/cevr-3-50.PMC3890451.pdf
 Eun Hee Chung • Vaccine allergies57 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.50shock attributed to latex allergy during gastric cancer sur - gery.,Non-OADS,/arxiv_data1/oa_pdf/ce/db/cevr-3-50.PMC3890451.pdf
58 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction “Zoonosis” is defined as a disease or infection that is naturally transmitted from verte - brate animals to humans [1].,Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:58-77 http://dx.doi.org/10.7774/cevr.2014.3.1.58 pISSN 2287-3651 • eISSN 2287-366X  Yun Young Go1,   Udeni B. R. Balasuriya2,3,   Chong-kyo Lee1 1Virus Research and Testing Group, Division  of Drug Discovery Research, Korea Research  Institute of Chemical Technology, Daejeon, Korea;  2Maxwell H. Gluck Equine Research Center,  Department of Veterinary Science, College of  Agriculture, Food and Environment; 3Department  of Microbiology, Immunology and Molecular  Genetics, College of Medicine, University of  Kentucky, Lexington, KY , USA Received: September 30, 2013 Revised: October 3, 2013 Accepted: October 20, 2013 Corresponding author: Yun Young Go, MVD, PhD Virus Research and Testing Group, Division  of Drug Discovery Research, Korea Research  Institute of Chemical Technology, 141 Gajeong-ro,  Yuseong-gu, Daejeon 305-343, Korea  Tel: +82-42-860-7401, Fax: +82-42-860-7400 E-mail: yygo@krict.re.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
" Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 59 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58Alphavirus ), Rhabdoviridae  (genus Vesiculovirus ), Ortho - myxoviridae  (genus Thogotovirus ), and Reoviridae  (genus  Orbivirus  and Coltivirus ) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 60 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58gence/reemergence of arboviral disease outbreaks in new re - gions in the world.,OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
 Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 61 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58EEEV is a zoonotic virus transmitted by mosquitoes and orig - inating in birds [27].,Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
"Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 62 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58Thus, the rapid detection of EEEV in equine specimens is crit - ical for control of disease outbreaks in humans, horses, and  other animal species.",Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
 Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 63 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58ica (sporadic cases of WEE).,Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
"Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 64 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.5844,79].",OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
" Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 65 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58fected during an epizootic [26,33].",Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 66 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58Table 2.,Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
" Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 67 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58encephalitis) in Australia, 5) Murray Valley encephalitis  virus (MVEV; Murray Valley encephalitis) in Australia and  New Guinea, 6) Rocio virus (Rocio encephalitis) in South  America, and 7) Usutu virus in Africa and Europe.",Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
"Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 68 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58wan, and Vietnam since 1967.",Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
 Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 69 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58prepared in mouse brains or primary hamster kidney cells  with protection efficacy of 76% to 95% [140].,Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 70 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58mal Health/Merck) and has been commercially available  since 2006 in the US [142].,Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
 Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 71 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58and reinitiate urban transmission cycles that infect humans  and domestic animals.,Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 72 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58sequence of the genomic RNA of Sindbis virus.,OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
 Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 73 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.5846.,OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 74 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.5871.,OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
 Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 75 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.5896.,OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 76 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.582003;21:3854-62.,OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
Available from: http://www.who.int/media - centre/factsheets/fs117/en/.,Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
 Yun Young Go et al • Zoonotic encephalitides caused by arboviruses 77 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.58clinical features of an emerging epidemic in the United  States.,Non-OADS,/arxiv_data1/oa_pdf/f5/67/cevr-3-58.PMC3890452.pdf
78 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Rabies is an important zoonosis in the public health and veterinary arenas.,Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:78-90 http://dx.doi.org/10.7774/cevr.2014.3.1.78 pISSN 2287-3651 • eISSN 2287-366X  Yeotaek Cheong1*, Bongjun Kim2*,  Ki Joong Lee3, Donghwa Park3,  Sooyeon Kim4, Hyeoncheol Kim5,  Eunyeon Park1, Hyeongchan Lee4,  Chaewun Bae6, Changin Oh1,   Seung-Yong Park1, Chang-Seon Song1,  Sang-Won Lee1, In-Soo Choi1,  Joong-Bok Lee1 1Department of Infectious Diseases, College of  Veterinary Medicine, Konkuk University, Seoul;  2Seoul High Prosecutors’ Office, Seoul; 3Animal  Health Division, Ministry of Agriculture Food  and Rural Affairs, Sejong; 4Chungbuk National  University Law School, Cheongju; 5Sungkyunkwan  University Law School, Seoul; 6Pukyung Pig  Farmers Agriculture Cooperative, Gimhae, Korea *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
" Yeotaek Cheong et al • Strategic model of national rabies control in Korea 79 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78An injection vaccine can be used as management for live - stock or pets, which may be the case.",Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
Yeotaek Cheong et al • Strategic model of national rabies control in Korea 80 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78Table 2.,Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
" Yeotaek Cheong et al • Strategic model of national rabies control in Korea 81 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78around rivers, which were areas where contact possibility with  wild animals was high.",Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
Yeotaek Cheong et al • Strategic model of national rabies control in Korea 82 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78Rabies Prevention Overseas Depopulation of carrier animals Transmission of rabies is influenced by the population densi - ty of susceptible animals in the area [11].,Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
 Yeotaek Cheong et al • Strategic model of national rabies control in Korea 83 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78a public information plan.,OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
"Yeotaek Cheong et al • Strategic model of national rabies control in Korea 84 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78sity of raccoon dogs and a higher proportion of mountain ter - rainas compared with Gyeonggi-do, but the determination of  the bait vaccine quantity did not consider these points.",Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
" Yeotaek Cheong et al • Strategic model of national rabies control in Korea 85 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78In hunting dogs, most large-scale breeders of hunting dogs  focus on rabies vaccination, but small-scale breeders are not  concerned about rabies vaccination for various reasons.",Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
Yeotaek Cheong et al • Strategic model of national rabies control in Korea 86 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78Vaccination of all rabies-susceptible animals within rabies   outbreak areas It is possible that rabies antibody-negative wild raccoon dogs  that infiltrate urban areas act as transmitters.,Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
" Yeotaek Cheong et al • Strategic model of national rabies control in Korea 87 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78Systematic introduction of population reduction (PR), TVR, and  oral rabies vaccination (OVR) complex programs There should be PR of target animals such as the wild rac - coon dog in Korea by slaughtering or other methods.",Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
Yeotaek Cheong et al • Strategic model of national rabies control in Korea 88 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78not researched.,OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
 Yeotaek Cheong et al • Strategic model of national rabies control in Korea 89 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78ucated about the raccoon dog and that wild animal bites can  induce rabies infection.,Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
Yeotaek Cheong et al • Strategic model of national rabies control in Korea 90 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.78antine Agency; 2009.,Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
Available  from: http://www.odh.ohio.gov/odhprograms/dis/zoo - noses/rabies/orv/orv1.aspx.,Non-OADS,/arxiv_data1/oa_pdf/a8/20/cevr-3-78.PMC3890453.pdf
"91 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Measles, mumps, rubella and varicella are four common and potentially serious infec - tious diseases in children worldwide [1-3].",Non-OADS,/arxiv_data1/oa_pdf/ea/70/cevr-3-91.PMC3890454.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:91-99 http://dx.doi.org/10.7774/cevr.2014.3.1.91 pISSN 2287-3651 • eISSN 2287-366X  Sung-Ho Cha1, Seon-Hee Shin2,  Taek-jin Lee3, Chang Hwi Kim4,  Michael Povey5, Hwang Min Kim6,  Ouzama Nicholson7 1Department of Pediatrics, Kyung Hee University  Hospital, Kung Hee University School of Medicine,  Seoul; 2Department of Pediatrics, Hangang Sacred  Heart Hospital, Hallym University Medical Center,  Hallym University College of Medicine, Seoul;  3Department of Pediatrics, CHA Bundang Medical  Center, CHA University, Seongnam; 4Department  of Pediatrics, Soonchunhyang University Bucheon  Hospital, Soonchunhyang University College  of Medicine, Bucheon, Korea; 5Department of  Statistics, GlaxoSmithKline Biologicals, Wavre,  Belgium; 6Department of Pediatrics, Yonsei  University Wonju College of Medicine, Wonju,  Korea; 7Clinical Development, MMR/V Vaccines,  Global Vaccines Development, GlaxoSmithKline  Biologicals-Philadelphia, King of Prussia, PA, USA Received: August 25, 2013 Revised: September 20, 2013 Accepted: September 30, 2013 Corresponding author: Sung-Ho Cha, MD, PhD Department of Pediatrics, Kyung Hee University  Hospital, 26 Kyungheedae-ro, Dongdaemun-gu,  Seoul 130-701, Korea Tel: +82-2-958-8303, Fax: +82-2-958-8304 E-mail: sunghocha@khu.ac.kr  No potential conflict of interest relevant to this  article was reported.Purpose:  This study (NCT00751348) evaluated the immunogenicity and safety of a combined  measles-mumps-rubella-varicella (MMRV) vaccine compared to co-administration of mea- sles-mumps-rubella and varicella (MMR + V) vaccines in Korean children during their second  year of life.",Non-OADS,/arxiv_data1/oa_pdf/ea/70/cevr-3-91.PMC3890454.pdf
"Sung-Ho Cha et al • Immunogenicity and safety of the MMRV vaccine in Korea92 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.91 Infants born to women infected with rubella in their first tri - mester of pregnancy are at high risk of congenital rubella  syndrome, which may result in death [3,4].",Non-OADS,/arxiv_data1/oa_pdf/ea/70/cevr-3-91.PMC3890454.pdf
 Sung-Ho Cha et al • Immunogenicity and safety of the MMRV vaccine in Korea93 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.91constituted with the diluent (provided in a pre-filled syringe)  as a 0.5 mL dose at the time of injection.,Non-OADS,/arxiv_data1/oa_pdf/ea/70/cevr-3-91.PMC3890454.pdf
Sung-Ho Cha et al • Immunogenicity and safety of the MMRV vaccine in Korea94 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.91 were seronegative before vaccination.,Non-OADS,/arxiv_data1/oa_pdf/ea/70/cevr-3-91.PMC3890454.pdf
 Sung-Ho Cha et al • Immunogenicity and safety of the MMRV vaccine in Korea95 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.91rubella and anti-varicella antibodies as the lower limit of the  95% CI for the group difference between MMRV and MMR + V  groups in terms of seroconversion rates 43 days post-vaccina - tion was greater than the pre-specified cut-off (‒10%) (Table  2).,Non-OADS,/arxiv_data1/oa_pdf/ea/70/cevr-3-91.PMC3890454.pdf
Sung-Ho Cha et al • Immunogenicity and safety of the MMRV vaccine in Korea96 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.91 Table 4.,Non-OADS,/arxiv_data1/oa_pdf/ea/70/cevr-3-91.PMC3890454.pdf
" Sung-Ho Cha et al • Immunogenicity and safety of the MMRV vaccine in Korea97 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.91the MMRV group developed a fever four days post-vaccina - tion and was hospitalized for three days, with a highest re - ported temperature of 38.8°C.",Non-OADS,/arxiv_data1/oa_pdf/ea/70/cevr-3-91.PMC3890454.pdf
"Sung-Ho Cha et al • Immunogenicity and safety of the MMRV vaccine in Korea98 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.91 significantly higher rates of elevated temperatures than sub - jects co-administered with MMR + V vaccines, M-M-R II and  Varivax (both are manufactured by Merck and Co. Inc.) [22].",Non-OADS,/arxiv_data1/oa_pdf/ea/70/cevr-3-91.PMC3890454.pdf
" Sung-Ho Cha et al • Immunogenicity and safety of the MMRV vaccine in Korea99 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.1.91creasing coverage and efficiency of measles, mumps, and  rubella vaccine and introducing universal varicella vacci - nation in Europe: a role for the combined vaccine.",Non-OADS,/arxiv_data1/oa_pdf/ea/70/cevr-3-91.PMC3890454.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/3a/88/mtna201355a.PMC3890457.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Launching a New Section for the Journal of Korean Medical  Science : Focusing on Editing, Writing, and Publishing Issues Sung-Tae Hong Editor-in-Chief, Journal of Korean Medical Science, Seoul, Korea (http://orcid.org/0000-0002-0300-1944)http://dx.doi.org/10.3346/jkms.2014.29.1.1  • J Korean Med Sci 2014; 29: 1EDITORIAL Editing, Writing, & Publishing  The Journal of Korean Medical Science  (JKMS ) is the leading pe ­ riodical for science communication in Korea, covering all areas  of medicine (http://jkms.org).",Non-OADS,/arxiv_data1/oa_pdf/f0/14/jkms-29-1.PMC3890458.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Correlation between Positive Rate and Number of Biopsy  Samples on Urease Test in Childhood Helicobacter pylori   Infection To identify the correlation between the number of gastric biopsy samples and the positive  rate, we compared the results of urease test using one and three biopsy samples from each  255 children who underwent gastroduodenoscopy at Gyeongsang National University  Hospital.",Non-OADS,/arxiv_data1/oa_pdf/ea/83/jkms-29-106.PMC3890459.pdf
"Keywords:  Urease Test; Helicobacter pylori  Infection; Age; Histopathology Ji-Hyun Seo,1 Ji Sook Park,1   Jung Sook Yeom,1 Jae-Young Lim,1   Chan-Hoo Park,1 Hyang-Ok Woo,1  Seung-Chul Baik,2 Woo-Kon Lee,2  Myung-Je Cho,2 Kwang-Ho Rhee,2   and Hee-Shang Youn1 Departments of 1Pediatrics and 2Microbiology,  Gyeongsang National University School of Medicine,  Gyeongsang Institute of Health Sciences, Jinju,  Korea  Received: 20 August 2013 Accepted: 1 November 2013 Address for Correspondence: Hee-Shang Youn, MD Department of Pediatrics, School of Medicine, Gyeongsang  National University, 79 Gangnam-ro, Jinju 660-702, Korea Tel: +82.55-750-8158, Fax: +82.55-752-9339 E-mail: hsyoun@gnu.ac.kr This study was supported by a grant from the National R&D  Program for Cancer Control of the Ministry of Health & Welfare  of the Republic of Korea (0820050).http://dx.doi.org/10.3346/jkms.2014.29.1.106  • J Korean Med Sci 2014; 29: 106-109 INTRODUCTION Most cases of Helicobacter pylori  infection occur in children (1).",Non-OADS,/arxiv_data1/oa_pdf/ea/83/jkms-29-106.PMC3890459.pdf
"• Urease Test and Number of Gastric Biopsy Samples http://jkms.org   107 http://dx.doi.org/10.3346/jkms.2014.29.1.106based on the time to positive reaction, the children were classi ­ fied into three grades: Grade 0 (no color change), 1 (6­24 hr), 2  (1­6 hr) and 3 ( < 1 hr).",Non-OADS,/arxiv_data1/oa_pdf/ea/83/jkms-29-106.PMC3890459.pdf
• Urease Test and Number of Gastric Biopsy Samples 108  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.106tive reaction was significantly different from in the Group I ( P=  0.001) and II ( P< 0.001) to in the Group III ( P= 0.029) (Fig.,OADS,/arxiv_data1/oa_pdf/ea/83/jkms-29-106.PMC3890459.pdf
• Urease Test and Number of Gastric Biopsy Samples http://jkms.org   109 http://dx.doi.org/10.3346/jkms.2014.29.1.106made on H&E­ stained histopathologic samples.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jkms-29-106.PMC3890459.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Optimal Time to Start Peripheral Blood Stem Cell Collection in  Children with High-Risk Solid Tumors In order to clarify the optimal timing for peripheral blood stem cell (PBSC) collection, PBSC  collection records of 323 children who were scheduled to undergo autologous stem cell  transplantation from two study periods differing in the timing of PBSC collection were  analyzed.",Non-OADS,/arxiv_data1/oa_pdf/ec/cc/jkms-29-110.PMC3890460.pdf
"Received: 6 July 2013 Accepted: 6 November 2013 Address for Correspondence: Dae Won Kim, MD Department of Laboratory Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-2701, Fax: +82.2-3410-2719 E-mail: dwsmc.kim@samsung.comhttp://dx.doi.org/10.3346/jkms.2014.29.1.110  • J Korean Med Sci 2014; 29: 110-116 INTRODUCTION In children with high-risk or recurrent solid tumors, a treatment  strategy involving high-dose chemotherapy and autologous  stem cell transplantation (HDCT/autoSCT) has shown the po - tential to improve outcomes (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/ec/cc/jkms-29-110.PMC3890460.pdf
"• Optimal Time to Start PBSC Collection http://jkms.org   111 http://dx.doi.org/10.3346/jkms.2014.29.1.110geous (18, 21).",Non-OADS,/arxiv_data1/oa_pdf/ec/cc/jkms-29-110.PMC3890460.pdf
• Optimal Time to Start PBSC Collection 112  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.110treated in this period were analyzed to test preliminary conclu - sions derived from the early study period.,OADS,/arxiv_data1/oa_pdf/ec/cc/jkms-29-110.PMC3890460.pdf
• Optimal Time to Start PBSC Collection http://jkms.org   113 http://dx.doi.org/10.3346/jkms.2014.29.1.110let recovery in the first HDCT/autoSCT were faster in the late  study period than in the early study period (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/ec/cc/jkms-29-110.PMC3890460.pdf
"• Optimal Time to Start PBSC Collection 114  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.110For this procedure, the number of CD34+ cells collected is of  particular concern because the number of cells transplanted  during each session may be lower than the number transplant - ed when only a single HDCT/autoSCT is performed.",Non-OADS,/arxiv_data1/oa_pdf/ec/cc/jkms-29-110.PMC3890460.pdf
• Optimal Time to Start PBSC Collection http://jkms.org   115 http://dx.doi.org/10.3346/jkms.2014.29.1.110lection were independently associated with a lower CD34+ cell  yield.,Non-OADS,/arxiv_data1/oa_pdf/ec/cc/jkms-29-110.PMC3890460.pdf
• Optimal Time to Start PBSC Collection 116  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.110ing induction chemotherapy and granulocyte-macrophage colony-stim - ulating factor for autologous transplantation in advanced breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/ec/cc/jkms-29-110.PMC3890460.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Chlorogenic Acid Supplementation Improves Multifocal  Electroretinography in Patients with Retinitis Pigmentosa  To evaluate the effect of chlorogenic acid supplementation in patients with retinitis  pigmentosa, we evaluated objective change in visual function with multifocal  electroretinography, along with visual acuity, visual field, standard electroretinography,  and contrast sensitivity.",Non-OADS,/arxiv_data1/oa_pdf/e0/18/jkms-29-117.PMC3890461.pdf
"Keywords:  Retinitis Pigmentosa; Chlorogenic Acid; Oxidative Stress; Antioxidants; Retinal  DegenerationJoo Young Shin1 and Hyeong Gon Yu1,2 1Department of Ophthalmology, Seoul National  University Hospital, 2Sensory Organs Institute,  Medical Research Center, Seoul National University,  Seoul, Korea Received: 21 August 2013 Accepted: 22 October 2013 Address for Correspondence: Hyeong Gon Yu, MD Department of Ophthalmology, Seoul National University  College of Medicine, 101 Daehak-ro, Jongro-gu, Seoul 110-744,  Korea Tel: +82.2-2072-2438, Fax: +82.2-741-3187  E-mail: hgonyu@snu.ac.kr This study was supported by a research grant from the company  THEye Korea, Seoul, Korea (2010).http://dx.doi.org/10.3346/jkms.2014.29.1.117  • J Korean Med Sci 2014; 29: 117-121 INTRODUCTION Retinitis pigmentosa (RP) is known to be caused by various ge ­ netic changes in the components of the phototransduction pa­ thway.",Non-OADS,/arxiv_data1/oa_pdf/e0/18/jkms-29-117.PMC3890461.pdf
"• Chlorogenic Acid in Retinitis Pigmentosa 118  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.117 In order to evaluate the effect of CGA supplementation in pa­ tients with RP , we utilized mERG to objectively evaluate changes  in visual function, along with visual acuity, visual field, standard  electroretinography (ERG) results, and contrast sensitivity.",OADS,/arxiv_data1/oa_pdf/e0/18/jkms-29-117.PMC3890461.pdf
• Chlorogenic Acid in Retinitis Pigmentosa http://jkms.org   119 http://dx.doi.org/10.3346/jkms.2014.29.1.117Fig.,Non-OADS,/arxiv_data1/oa_pdf/e0/18/jkms-29-117.PMC3890461.pdf
"• Chlorogenic Acid in Retinitis Pigmentosa 120  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.117fatty acid, was found to have an additional benefit in patients  naïve to vitamin A supplementation in the initial 2 yr (8).",Non-OADS,/arxiv_data1/oa_pdf/e0/18/jkms-29-117.PMC3890461.pdf
• Chlorogenic Acid in Retinitis Pigmentosa http://jkms.org   121 http://dx.doi.org/10.3346/jkms.2014.29.1.117mentosa receiving vitamin A treatment: subgroup analyses.,Non-OADS,/arxiv_data1/oa_pdf/e0/18/jkms-29-117.PMC3890461.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Evidence-Based, Non-Pharmacological Treatment Guideline for  Depression in Korea Although pharmacological treatment constitutes the main therapeutic approach for  depression, non-pharmacological treatments (self-care or psychotherapeutic approach) are  usually regarded as more essential therapeutic approaches in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
"Keywords:  Depression; Non-Pharmacological Treatment; Self-Care; Psychotherapy;  Guideline; KoreaSeon-Cheol Park,1,2 Hong Seok Oh,1  Dong-Hoon Oh,2,3 Seung Ah Jung,4  Kyoung-Sae Na,5 Hwa-Young Lee,6   Ree-Hun Kang,7 Yun-Kyeung Choi,8   Min-Soo Lee,9 and Yong Chon Park10,11 1Department of Psychiatry, Yong-In Mental Hospital,  Yongin; 2Institute of Mental Health, Hanyang  University, Seoul; 3Department of Psychiatry,  Hanyang University Seoul Hospital, Seoul;  4Department of Counseling Psychology, Chosun  University, Gwangju; 5Department of Psychiatry,  Soonchunhyang University Bucheon Hospital,  Bucheon; 6Department of Psychiatry, College of  Medicine, Soonchunhyang University, Asan; 7RH  Depression Clinic, Seoul; 8Department of Psychology,  College of Humanities, Keimyung University, Daegu;  9Department of Psychiatry, College of Medicine,  Korea University, Seoul; 10Department of Psychiatry,  College of Medicine, Hanyang University, Seoul;  11Department of Psychiatry, Hanyang University Guri  Hospital, Guri, Korea Received: 2 August 2013 Accepted: 16 September 2013 Address for Correspondence: Yong Chon Park, MD Department of Psychiatry, Hanyang University Guri Hospital,  153 Gyeongchun-ro, Guri 471-701, Korea Tel: +82.31-560-2273, Fax: +82.31-554-2599 E-mail: hypyc@hanyang.ac.kr This research was supported by a grant from the Korea Health  21 R&D, Ministry of Health and Welfare, Republic of Korea  (A102065).http://dx.doi.org/10.3346/jkms.2014.29.1.12  • J Korean Med Sci 2014; 29: 12-22 INTRODUCTION Depression is a highly prevalent psychiatric disorder that tends  to be recurrent and chronic (1).",Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
• Guideline for Non-Pharmacological Treatment of Depression http://jkms.org   13 http://dx.doi.org/10.3346/jkms.2014.29.1.12dence-based treatment guideline for depression.,Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
• Guideline for Non-Pharmacological Treatment of Depression 14  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.12unique and clear psychotherapeutic principle that distinguish - es it from other forms of psychotherapy.,Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
"• Guideline for Non-Pharmacological Treatment of Depression http://jkms.org   15 http://dx.doi.org/10.3346/jkms.2014.29.1.12evidence; un-randomized clinical research and observational  research as mid level evidence; and, expert opinion and case  reports were allocated as low level evidence.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
"• Guideline for Non-Pharmacological Treatment of Depression 16  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.12cal description; third, if the literature search was comprehen - sive enough to discover all the appropriate findings; and fourth,  if all the research findings were homogeneous enough to be  combined together.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
• Guideline for Non-Pharmacological Treatment of Depression http://jkms.org   17 http://dx.doi.org/10.3346/jkms.2014.29.1.12the review result was considered for during the revision process  after a subsequent internal discussion.,Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
• Guideline for Non-Pharmacological Treatment of Depression 18  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.12sion (Recommendation Grade: B).,Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
• Guideline for Non-Pharmacological Treatment of Depression http://jkms.org   19 http://dx.doi.org/10.3346/jkms.2014.29.1.12Table 6.,Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
• Guideline for Non-Pharmacological Treatment of Depression 20  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.12tinuation of psychiatric treatment.,Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
• Guideline for Non-Pharmacological Treatment of Depression http://jkms.org   21 http://dx.doi.org/10.3346/jkms.2014.29.1.12tocol for IPT has recently been translated and introduced in  Korea.,Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
• Guideline for Non-Pharmacological Treatment of Depression 22  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.1229.,Non-OADS,/arxiv_data1/oa_pdf/4d/63/jkms-29-12.PMC3890462.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Scientific Framework for Research on Disaster and Mass Casualty  Incident in Korea: Building Consensus Using Delphi Method We aimed to determine the scientific framework for research on disaster and mass casualty  incident (MCI) in Korea, especially Korean terminology, feasible definition, and  epidemiologic indices.",Non-OADS,/arxiv_data1/oa_pdf/b6/45/jkms-29-122.PMC3890463.pdf
2009E00689001).http://dx.doi.org/10.3346/jkms.2014.29.1.122  • J Korean Med Sci 2014; 29: 122-128 INTRODUCTION Disaster is generally defined as an event that demands more  resources than the community can provide in natural or man- made incidents (1).,Non-OADS,/arxiv_data1/oa_pdf/b6/45/jkms-29-122.PMC3890463.pdf
• Scientific Research Framework on Disaster and Mass Casualty Incident in Korea http://jkms.org   123 http://dx.doi.org/10.3346/jkms.2014.29.1.122just each single case.,Non-OADS,/arxiv_data1/oa_pdf/b6/45/jkms-29-122.PMC3890463.pdf
• Scientific Research Framework on Disaster and Mass Casualty Incident in Korea 124  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.122Fig.,Non-OADS,/arxiv_data1/oa_pdf/b6/45/jkms-29-122.PMC3890463.pdf
• Scientific Research Framework on Disaster and Mass Casualty Incident in Korea http://jkms.org   125 http://dx.doi.org/10.3346/jkms.2014.29.1.122Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b6/45/jkms-29-122.PMC3890463.pdf
"• Scientific Research Framework on Disaster and Mass Casualty Incident in Korea 126  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.122suggested if the minimum number casualties including death  and injured is over 6, the event can be defined as MCI.",Non-OADS,/arxiv_data1/oa_pdf/b6/45/jkms-29-122.PMC3890463.pdf
• Scientific Research Framework on Disaster and Mass Casualty Incident in Korea http://jkms.org   127 http://dx.doi.org/10.3346/jkms.2014.29.1.122Table 5.,Non-OADS,/arxiv_data1/oa_pdf/b6/45/jkms-29-122.PMC3890463.pdf
• Scientific Research Framework on Disaster and Mass Casualty Incident in Korea 128  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.122explain an event and outcome of health properly.,Non-OADS,/arxiv_data1/oa_pdf/b6/45/jkms-29-122.PMC3890463.pdf
"Available at http://elaw.klri.re.kr/kor_service/ lawPopupView.do?hseq=21330,21330 [accessed on 1 March 2013].",OADS,/arxiv_data1/oa_pdf/b6/45/jkms-29-122.PMC3890463.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Computed Tomography Guided Percutaneous Injection of a  Mixture of Lipiodol and Methylene Blue in Rabbit Lungs:  Evaluation of Localization Ability for Video-Assisted  Thoracoscopic Surgery Preoperative localization is necessary prior to video assisted thoracoscopic surgery for the  detection of small or deeply located lung nodules.",Non-OADS,/arxiv_data1/oa_pdf/34/25/jkms-29-129.PMC3890464.pdf
"Keywords:  Lung; Ethiodized Oil; Methylene Blue; Tomography, X-Ray Computed;  Radiology, InterventionalKwang Nam Jin,1 Kyung Won Lee,2   Tae Jung Kim,2 Yong Sub Song,3   and Dong Il Kim4 1Department of Radiology, Seoul Metropolitan  Government-Seoul National University Boramae  Medical Center, Seoul; 2Department of Radiology,  Seoul National University Bundang Hospital,  Seongnam; 3Department of Radiology, Seoul  National University Hospital, Seoul; 4Department of  Pathology, Green Cross Laboratories, Yongin, Korea Received: 13 May 2013 Accepted: 22 October 2013 Address for Correspondence: Kyung Won Lee, MD Department of Radiology, Seoul National University Bundang  Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam  463-707, Korea Tel: +82.31-787-7604, Fax: +82.31-787-4011 E-mail: lkwrad@radiol.snu.ac.kr This study was supported by grant from the Seoul National  University College of Medicine Research Fund 2012 (800- 20120036).http://dx.doi.org/10.3346/jkms.2014.29.1.129  • J Korean Med Sci 2014; 29: 129-136 INTRODUCTION Preoperative localization is necessary for video-assisted thora - coscopic surgery (VATS) when pulmonary nodules are too small  or distant from the visceral pleura to be detected (1-3).",Non-OADS,/arxiv_data1/oa_pdf/34/25/jkms-29-129.PMC3890464.pdf
• Mixture of Lipiodol and Methylene Blue for Pulmonary Localization 130  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.129MATERIALS AND METHODS Animal preparation  This study was performed after approval by the Institutional  Animal Care and Use Committee (IACUC) in Seoul National  University Hospital biomedical research institute (IACUC ap - proval No.,Non-OADS,/arxiv_data1/oa_pdf/34/25/jkms-29-129.PMC3890464.pdf
• Mixture of Lipiodol and Methylene Blue for Pulmonary Localization http://jkms.org   131 http://dx.doi.org/10.3346/jkms.2014.29.1.129 A B C Fig.,Non-OADS,/arxiv_data1/oa_pdf/34/25/jkms-29-129.PMC3890464.pdf
• Mixture of Lipiodol and Methylene Blue for Pulmonary Localization 132  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.129normal lung was defined as diffuse.,Non-OADS,/arxiv_data1/oa_pdf/34/25/jkms-29-129.PMC3890464.pdf
• Mixture of Lipiodol and Methylene Blue for Pulmonary Localization http://jkms.org   133 http://dx.doi.org/10.3346/jkms.2014.29.1.129Table 1.,Non-OADS,/arxiv_data1/oa_pdf/34/25/jkms-29-129.PMC3890464.pdf
"• Mixture of Lipiodol and Methylene Blue for Pulmonary Localization 134  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.129tures, the number of specimen that showed diffuse extent was  more in Group B than Group A for both MLM and methylene  blue.",Non-OADS,/arxiv_data1/oa_pdf/34/25/jkms-29-129.PMC3890464.pdf
• Mixture of Lipiodol and Methylene Blue for Pulmonary Localization http://jkms.org   135 http://dx.doi.org/10.3346/jkms.2014.29.1.129scopic examinations.,Non-OADS,/arxiv_data1/oa_pdf/34/25/jkms-29-129.PMC3890464.pdf
• Mixture of Lipiodol and Methylene Blue for Pulmonary Localization 136  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.129pulmonary nodules.,Non-OADS,/arxiv_data1/oa_pdf/34/25/jkms-29-129.PMC3890464.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Successful Implantation of Continuous-Flow Left Ventricular  Assist Device as a Destination Therapy in Korea:  Echocardiographic Assessment Left ventricular assist device (LVAD) is a good treatment option for the patients ineligible  for cardiac transplantation.",Non-OADS,/arxiv_data1/oa_pdf/85/e0/jkms-29-137.PMC3890465.pdf
"Received: 21 February 2013 Accepted: 4 July 2013 Address for Correspondence: Young Tak Lee, MD Department of Thoracic and Cardiovascular Surgery, Cardiac and  Vascular Center, Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu,   Seoul 135-710, Korea Tel: +82.2-3410-3480, Fax: +82.2-3410-0089 E-mail: ytlee55@yahoo.comhttp://dx.doi.org/10.3346/jkms.2014.29.1.137  • J Korean Med Sci 2014; 29: 137-140 INTRODUCTION Cardiac transplantation is a good treatment option for the pa - tients with end-stage heart failure.",Non-OADS,/arxiv_data1/oa_pdf/85/e0/jkms-29-137.PMC3890465.pdf
"• Successful Continuous-Flow LVAD Implantation in Korea 138  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.137 On preoperative evaluation, he had insignificant stenosis in  the coronary arteries in coronary angiography.",Non-OADS,/arxiv_data1/oa_pdf/85/e0/jkms-29-137.PMC3890465.pdf
• Successful Continuous-Flow LVAD Implantation in Korea http://jkms.org   139 http://dx.doi.org/10.3346/jkms.2014.29.1.137Fig.,Non-OADS,/arxiv_data1/oa_pdf/85/e0/jkms-29-137.PMC3890465.pdf
• Successful Continuous-Flow LVAD Implantation in Korea 140  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.137intraoperative transesophageal echocardiography.,Non-OADS,/arxiv_data1/oa_pdf/85/e0/jkms-29-137.PMC3890465.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Pyeloduodenal Fistula Successfully Treated By Endoscopic  Ligation without Surgical Nephrectomy: Case Report  A 74-yr-old woman presented with fever and abdominal discomfort.",Non-OADS,/arxiv_data1/oa_pdf/e2/74/jkms-29-141.PMC3890466.pdf
"Keywords:  Duodenal Diseases; Intestinal Fistula; Kidney Diseases; Urinary Fistula;  EndoscopyKyung Nam Lee,1,2 In Hye Hwang,1,2   Min Ji Shin,1,3 Soo Bong Lee,1,2   Il Young Kim,1,2 Dong Won Lee,1,2   Harin Rhee,1,3 Byeong Yun Yang,1,3   Eun Young Seong,1,3   and Ihm Soo Kwak1,3 1Department of Internal Medicine, Pusan National  University School of Medicine, Yangsan; 2Research  Institute for Convergence of Biomedical Science  and Technology, Pusan National University Yangsan  Hospital, Yangsan; 3Medical Research Institute,  Pusan National University Hospital, Busan, Korea Received: 13 May 2013 Accepted: 8 July 2013 Address for Correspondence: Soo Bong Lee, MD Division of Nephrology, Department of Internal Medicine,   Pusan National University Yangsan Hospital, 20 Geumo-ro,  Mulgeum-eup, Yangsan 626-770, Korea Tel: +82.55-360-2371, Fax: +82.55-360-1605 E-mail: sbleemd@pusan.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.1.141  • J Korean Med Sci 2014; 29: 141-144 INTRODUCTION  Fistula development between the kidney and gastrointestinal  tract is a rare clinical event (1-3).",Non-OADS,/arxiv_data1/oa_pdf/e2/74/jkms-29-141.PMC3890466.pdf
• Pyeloduodenal Fistula Treated By Endoscopic Ligation 142  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.141Pyelography revealed a fistula to the descending part of the du - odenum (Fig.,Non-OADS,/arxiv_data1/oa_pdf/e2/74/jkms-29-141.PMC3890466.pdf
• Pyeloduodenal Fistula Treated By Endoscopic Ligation http://jkms.org   143 http://dx.doi.org/10.3346/jkms.2014.29.1.141sociated with fistula formation.,Non-OADS,/arxiv_data1/oa_pdf/e2/74/jkms-29-141.PMC3890466.pdf
• Pyeloduodenal Fistula Treated By Endoscopic Ligation 144  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.14126: 186-8.,Non-OADS,/arxiv_data1/oa_pdf/e2/74/jkms-29-141.PMC3890466.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Localized Thymic Amyloidosis Presenting with Myasthenia  Gravis: Case Report A mediastinal mass was incidentally found on chest radiography in a 46-yr-old woman  who had had myasthenia gravis (MG) for 2 months.",Non-OADS,/arxiv_data1/oa_pdf/df/6d/jkms-29-145.PMC3890467.pdf
"Keywords:  Amyloidosis; Thymus; Mediastinum; Myasthenia GravisSeung-Myoung Son,1 Yong-Moon Lee,1  Si Wook Kim,2 and Ok-Jun Lee1 Departments of 1Pathology, 2Thoracic and  Cardiovascular Surgery, Chungbuk National  University College of Medicine, Cheongju, Korea Received: 30 April 2013 Accepted: 8 July 2013 Address for Correspondence: Ok-Jun Lee, MD Department of Pathology, Chungbuk National University College  of Medicine, 52 Naesudong-ro, Heungdeok-gu, Cheongju   361-763, Korea Tel: +82.43-269-6260, Fax: +82.43-269-6269 E-mail: ok5218@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.1.145  • J Korean Med Sci 2014; 29: 145-148 INTRODUCTION Amyloidosis is a large group of diseases characterized by the  deposition of misfolded extracellular fibrillar proteins in vari - ous organs and tissues.",Non-OADS,/arxiv_data1/oa_pdf/df/6d/jkms-29-145.PMC3890467.pdf
• Thymic Amyloidosis Presenting Myasthenia Gravis 146  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.145Fig.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/jkms-29-145.PMC3890467.pdf
"• Thymic Amyloidosis Presenting Myasthenia Gravis http://jkms.org   147 http://dx.doi.org/10.3346/jkms.2014.29.1.145IgG, IgA, and IgM levels were normal.",Non-OADS,/arxiv_data1/oa_pdf/df/6d/jkms-29-145.PMC3890467.pdf
• Thymic Amyloidosis Presenting Myasthenia Gravis 148  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.145thymic amyloidosis.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/jkms-29-145.PMC3890467.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357High Prevalence of Vitamin D Deficiency in Adults Aged 50 Years  and Older in Gwangju, Korea: the Dong-gu Study Vitamin D plays an important role in bone metabolism and maintaining bone health.",Non-OADS,/arxiv_data1/oa_pdf/00/c0/jkms-29-149.PMC3890468.pdf
"Keywords:  Vitamin D; Deficiency; PrevalenceHye-Rim Song,1 Sun-Seog Kweon,1,2   Jin-Su Choi,1 Jung-Ae Rhee,1   Young-Hoon Lee,3 Hae-Sung Nam,4   Seul-Ki Jeong,5 Kyeong-Soo Park,6   So-Yeon Ryu,7 Seong-Woo Choi,7   and Min-Ho Shin1 1Department of Preventive Medicine, Chonnam  National University Medical School, Gwangju;  2Jeonnam Regional Cancer Center, Chonnam  National University Hwasun Hospital, Hwasun;  3Department of Preventive Medicine & Institute of  Wonkwang Medical Science, Wonkwang University  College of Medicine, Iksan; 4Department of  Preventive Medicine, Chungnam National University  Medical School, Daejeon; 5Department of Neurology  & Research Institute of Clinical Medicine, Chonbuk  National University-Biomedical Institute of Chonbuk  National University Hospital, Jeonju; 6Department  of Preventive Medicine, Seonam University College  of Medicine, Namwon; 7Department of Preventive  Medicine, Chosun University Medical School,  Gwangju, Korea Received: 11 September 2013 Accepted: 31 October 2013 Address for Correspondence: Min-Ho Shin, MD Department of Preventive Medicine, Chonnam National  University Medical School, 160 Baekseo-ro, Dong-gu,   Gwangju 501-746, Korea Tel: +82.62-220-4166, Fax: +82.62-233-0305 E-mail: mhshinx@paran.com This study was supported by Research Institute of Medical  Sciences, Chonnam National University.http://dx.doi.org/10.3346/jkms.2014.29.1.149  • J Korean Med Sci 2014; 29: 149-152 Vitamin D is important for calcium homeostasis and bone metabolism.",Non-OADS,/arxiv_data1/oa_pdf/00/c0/jkms-29-149.PMC3890468.pdf
"• Prevalence of Vitamin D Deficiency 150  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.149merular filtration rate (eGFR) values < 30 mL/min/1.73 m2, a  total of 8,976 subjects (3,587 men and 5,389 women) were in - cluded in the present study.",Non-OADS,/arxiv_data1/oa_pdf/00/c0/jkms-29-149.PMC3890468.pdf
"• Prevalence of Vitamin D Deficiency http://jkms.org   151 http://dx.doi.org/10.3346/jkms.2014.29.1.149the month of blood collection [25(OH)D < 20 ng/mL, 75.8%;  25(OH)D < 30, 97.7%].",Non-OADS,/arxiv_data1/oa_pdf/00/c0/jkms-29-149.PMC3890468.pdf
• Prevalence of Vitamin D Deficiency 152  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.149Group.,Non-OADS,/arxiv_data1/oa_pdf/00/c0/jkms-29-149.PMC3890468.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2014.29.1.153  • J Korean Med Sci 2014; 29: 153-154 Are Soluble ST2 Levels in the  Picogram or Nanogram Range in  Serum of Healthy Subjects/Disease  Patients?",Non-OADS,/arxiv_data1/oa_pdf/ee/3e/jkms-29-153.PMC3890469.pdf
"Correspondence154  http://jkms.org  http://dx.doi.org/10.3346/jkms.2014.29.1.153 Recently, Zhao et al.",OADS,/arxiv_data1/oa_pdf/ee/3e/jkms-29-153.PMC3890469.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Peer Review in 2013: More Supports than Neglects Sung-Tae Hong Editor-in-Chief, Journal of Korean Medical Science (http://orcid.org/0000-0002-0300-1944)http://dx.doi.org/10.3346/jkms.2014.29.1.155  • J Korean Med Sci 2014; 29: 155-160 At the time of editing the first issue of 2014, Volume 29 Number  1 of the Journal of Korean Medical Science  (JKMS ), contribu - tions by all authors and peer reviewers in 2013 should be ap - preciated.",Non-OADS,/arxiv_data1/oa_pdf/00/94/jkms-29-155.PMC3890470.pdf
"Hong S-T • Peer Review in 2013: More Supports than Neglects 156  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.155Choe, Yong-Beom   Konkuk Univiersity Choi, Bo Youl   Hanyang University Choi, Chang-Min   University of Ulsan Choi, Dong-Chull   Sungkyunkwan University Choi, Dongho   Soonchunhyang University Choi, Donghoon*   Yonsei University Choi, Doo Ho   Sungkyunkwan University Choi, Eue-Keun   Seoul National University Choi, Eun Young   Seoul National University Choi, Eunhwa   Seoul National University Choi, Jae Chol   Chung-Ang University Choi, Jeong-Hee*   Hallym University Choi, Kyung Chul   Chungbuk National University Choi, Seonghoon   Hallym University Choi, Seung Ho   Seoul National University Choi, Sung Hee   Seoul National University Choi, Sung Jae*   Korea University Choi, Young Sik*   Yonsei University Chong, Semin   Chung-Ang University Choo, Eun Ju   Soonchunhyang University  Chun, Eun Ju   Seoul National University Chun, Eun Mi*   Ewha Womans University Chun, Jin-Ho   Inje University Chung, Byungha*   Yonsei University Chung, Chin Sang   Sungkyunkwan University Chung, Doo Hyun   Seoul National University Chung, Ho Yeon   Kyunghee University Chung, Hyun Woo   Konkuk University Chung, Ick-Mo   Ewha Womans University Chung, Jae-il   Inje University Chung, Jin Haeng   Seoul National UniversityChung, Ju Young   Inje University Chung, Moon Jae   Yonsei University Chung, Sochung   Konkuk University Chung, Woo Chul*   The Catholic University of Korea Chung, Woo Kyung   Gachon University Chung, Wook-Jin*   Gachon University Chung, Young-yool   Kwangju Christian Hospital Do, Jun-Young   Yeungnam University Eun, Byung Wook*   Eulji University Eun, So-Hee   Korea University Feng, Quanzhou   Chinese PLA General Hospital, China Gasparyan, Armen Yuri   The University of Birmingham, UK Goh, Choong-Won   Inje University Goo, Jin Mo   Seoul National University  Ha, Hong Koo   Pusan National University Ha, Il Soo   Seoul National University Ha, Jung Sook   Keimyung University Ha, Yong-Chan   Chung-Ang University Hahm, Jong Ryul   Gyeongsang National University Hahn, Joo-Yong*   Sungkyunkwan University Han, Dae Hee   The Catholic University of Korea Han, Dong Soo*   Hanyang University  Han, Dong Woon   Hanyang University Han, Doug Hyun   Chung-Ang University Han, Heon-Seok   Chungbuk National University Han, Jin   Inje University Han, Jung Ho   Seoul National University Han, Kye Young   Kangwon National University Han, Sang Hoon*   Yonsei University Han, Sang-Uk   Ajou University Han, Seok Joo   Yonsei UniversityHan, Seung Hwan   Gachon University Han, Seung-Yeup   Keimyung University Her, Sung-Ho   The Catholic University of Korea Hong, Joonhwa   Chung-Ang University Hong, Sae-Yong*   Soonchunhyang Univerrsity Hong, Semie   Konkuk University Hong, Seong Geun   CHA University Hong, Seong Yeon   Catholic University of Daegu Hong, Soon Cheol   Korea University Hong, Soon Jun*   Korea University Hong, Sung Jin   The Catholic University of Korea Hong, Sung Kyu   Seoul National University Hong, Yoon-Ho   Seoul National University Hong, Young Joon*   Chonnam National University Hong, Young Jun   Korea Cancer Center Hospital Huang, Yu-Shu   Chang Gung Memorial Hospital, Taiwan Huh, Chang-Hun   Seoul National University Huh, Sun   Hallym University Hur, Sooyoung   The Catholic University of Korea Hwang, Byungkwan*   Seoul National University Hwang, Eung-Soo   Seoul National University Hwang, Gyo-Seung   Ajou University Hwang, Il Tae*   Hallym University Hwang, In Gyu   Chung-Ang University Hwang, Jai-Hyun   University of Ulsan Hwang, Jin-Bok*   Keimyung University Hwang, Jun-Won   Kangwon National University Hwang, Seung-Sik   Inha University Hwang, Shin   University of Ulsan Hwang, Sung Oh*   Yonsei University  Hwang, Yoo Cheol   Kyunghee UniversityHwang, Young-Hwan   Eulji University Hwang, Young-Il*   Seoul National University Ihm, Chun-Gyoo   Kyunghee University Im, Gun-Il   Dongguk University Ito, Yasuhiro   Kuma Hospital, Japan Jang, Byoung Kuk   Keimyung University Jang, Hak Chul*   Seoul National University Jang, Jae Young*   Soonchunhyang University Jeon, Hae Myung   The Catholic University of Korea Jeon, In-Ho*   University of Ulsan Jeon, Ji Hyun   CHA University Jeong, Chang Wook   Seoul National University Jeong, In Gab   University of Ulsan Jeong, Jinwoo*   Dong-A University Jeong, Kyungah   Ewha Womans University Jeong, Myung Ho   Chonnam National University  Jeong, Seok Hoon   Yonsei University Jeong, Soung Won   Soonchunhyang University  Jeong, Young-Hoon*   Gyeongsang National University Jin, Dong Chan   The Catholic University of Korea Jin, Dong Kyu*   Sungkyunkwan University Jo, Dae Sun   Chonbuk National University Jo, Eun-Kyeong   Chungnam National University Joo, Hyung Joon   Korea University Joung, Boyoung   Yonsei University Ju, Woong   Ewha Womans University Jun, Jae-Bum*   Hanyang University Jun, Jong Kwan*   Seoul National University Jung, Da-Eun   Ajou University Jung, Eui Dal   Catholic University of Daegu Jung, Hye Seung*   Seoul National University",Non-OADS,/arxiv_data1/oa_pdf/00/94/jkms-29-155.PMC3890470.pdf
"Hong S-T • Peer Review in 2013: More Supports than Neglects http://jkms.org   157 http://dx.doi.org/10.3346/jkms.2014.29.1.155Jung, Hye-kyung   Ewha Womans University Jung, Hyun Chae*   Seoul National University Jung, Ki-Young*   Korea University Jung, Kyeong Cheon   Seoul National University Jung, Kyu Won   National Cancer Center Jung, Seung Eun   The Catholic University of Korea Kang, Cheol-In   Sungkyunkwan University Kang, Eun Ho   Sungkyunkwan University Kang, Hee Gyung   Seoul National University Kang, Hye Ryun   Hallym University Kang, Hyoung Jin   Seoul National University Kang, Jung Hun   Gyeongsang National University Kang, Jung Oak   Hanyang University Kang, Min-Kyung   Hallym University Kang, Seong-Kyu   Occupational Safety and Health Research  Institute, KOSHA Kang, Seung Gul   Gachon University Kang, Shinae   Yonsei University Kang, Ung Gu*   Seoul National University Kang, Young Ae*   Yonsei University Kasahara, Mureo   National Center for Child Health and  Development, Japan Khwarg, Sang In   Seoul National University Kim Jin Cheon   University of Ulsan Kim, Beom Seok   Yonsei University Kim, Bong Seog   VHS Medical Center Kim, Byung Jin*   Sungkyunkwan University  Kim, Byung-Jo   Korea University Kim, Chae-Yong   Seoul National University Kim, Chan Duck   Kyungpook National University Kim, Chan Jong   Chonnam National University Kim, Chang-Ki   Korean Institute of TuberculosisKim, Chul Han   Soonchunhyang University Kim, Chul Sik   Hallym University  Kim, Chun-Bae   Yonsei University Kim, Dae Joon   Yonsei University Kim, Dae Jung   Ajou University Kim, Dae Yong*   National Cancer Center Kim, Dae-Hee   University of Ulsan Kim, Dae-Seong   Pusan National University Kim, Dong Ho   Korea Cancer Center Hospital Kim, Dong Uk   Pusan National University Kim, Dong-Jun   Inje University Kim, Dongsun*   Hanyang University Kim, Eun Young   Inha University Kim, Gaabsoo   Sungkyunkwan University Kim, Geun-Tae   Kosin University Kim, Gheun-Ho   Hanyang University Kim, Gwang Ha   Pusan National University Kim, Heon   Chungbuk National University Kim, Hojoong   Sungkyunkwan University Kim, Hong Bin*   Seoul National University Kim, Hong Kyun   Kyungpook National University Kim, Hye Soo   The Catholic University of Korea Kim, Hyeon Chang   Yonsei University Kim, Hyo-Soo   Seoul National University Kim, Hyun A*   Hallym University Kim, Hyun Kyung   Seoul National University Kim, Hyun Soo*   Chonnam National University  Kim, Hyung Hun*   The Catholic University of Korea Kim, Hyung Jin   Chonbuk National University Kim, Hyung-Kwan   Seoul National University  Kim, Hyun-Sook*   Chosun UniversityKim, In Kyeom   Kyungpook National University Kim, Jae Hyoung*   Seoul National University Kim, Jae Min*   The Catholic University of Korea Kim, Jae Weon   Seoul National University Kim, Jae Yeol   Chung-Ang University Kim, Jae-Joong   University of Ulsan Kim, Jae-Ryong   Yeungnam University Kim, Jae-Seok   Hallym University Kim, Je Kyuna   Chung-Ang University Kim, Jeong Hwan   Konkuk University Kim, Ji Eun*   Seoul National University Kim, Ji Won   Seoul National University Kim, Jong Gwang   Kyungpook National University Kim, Jong-Hyun   The Catholic University of Korea Kim, JoongGon   Seoul National Unversity Kim, Ju hang   Yonsei University  Kim, Jun hyung   Kyemyung University Kim, June Myung   Yonsei University Kim, June Soo   Sungkyunkwan University Kim, Jung-Sun*   Yonsei University Kim, Jun-Su   Inje university Kim, Ki Hwan   Yonsei University Kim, Ki Woong   Seoul National University Kim, Kiho   Dong-A University Kim, Kihyun   Sungkyunkwan University Kim, Ki-Jeong   Seoul National University Kim, Ki-Seok   Jeju National University Kim, Koon Soon   Chungnam National University Kim, Kwang-il   Seoul National University Kim, Kyosun   Konkuk University Kim, Kyoung Tae   Chung-Ang UniversityKim, Kyung Jong   Chosun University Kim, Kyung Mo   University of Ulsan Kim, Kyung-Ah   Inje University Kim, Kyuseok   Seoul National University Kim, Lucia*   Inha University Kim, Mi-Na   University of Ulsan Kim, Min-Wook   The Catholic University of Korea Kim, Myoung Soo*   Yonsei University Kim, Na Young   Salk Institute of Biological Studies, USA Kim, Nam Joong*   Seoul National University  Kim, Namhee   Dongguk University Kim, Ock-Joo   Seoul National University Kim, Sang Hyun   Seoul National University Kim, Sang Soo   Pusan National University Kim, Sang Wook   Chonbuk National University Kim, Sang-Hyon   Keimyung University Kim, Sang-Wan*   Seoul National University Kim, Sejoong   Seoul National University Kim, Seog Ju   Seoul National University Kim, Seok Jin   Sungkyunkwan University Kim, Seong Hwan*   Korea University Kim, Seonmee   Korea University Kim, Seung Up*   Yonsei University Kim, So Hun   Inha University Kim, Soo Wan*   Chonnam National University Kim, Soon Bae   University of Ulsan Kim, Soon Ki*   Inha University Kim, Soo-Youl   National Cancer Center Kim, Sooyoung   Hallym University Kim, Sun Young   University of Pittsburgh Medical Center Kim, Sung Hoon   University of Ulsan",Non-OADS,/arxiv_data1/oa_pdf/00/94/jkms-29-155.PMC3890470.pdf
"Hong S-T • Peer Review in 2013: More Supports than Neglects 158  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.155Kim, Sung Huhn   Yonsei University Kim, Sungeun   Korea University Kim, Sungjoo   Sungkyunkwan University  Kim, Weon   Kyunghee University Kim, Won-Jang   University of Ulsan Kim, Wook   The Catholic University of Korea Kim, Yangho*   University of Ulsan Kim, Yang-Ki   Soonchunhyang University Kim, Yeojoo*   Soonchunhyang University Kim, Yong Beom*   Seoul National University Kim, Yong Chul   Seoul National University Kim, Yong Joo   Hanyang University Kim, Yong-Jin*   Seoul National Univeristy  Kim, You Chan   Ajou University Kim, Young Seok   Soonchunhyang University Kim, Young-Hak*   University of Ulsan Kim, Young-Kyun   Seoul National University Kim, Yun kyung   Korea University Ko, Jae Sung*   Seoul National University Ko, Jaekon   University of Ulsan Ko, Kyung Soo   Inje University Koh, Jong Hoon   Kwandong University Koh, Jung-Min*   University of Ulsan Koo, Bon-Kwon   Seoul National University Koo, Hong Hoe   Sungkyunkwan University Koo, Kyung-Hoi*   Seoul National University Koyl, Martin   Hospital for Sick Children, Canada Ku, Ja Hyeon   Seoul National University Kwak, Ihm Soo   Pusan National University Kwon, Joong Goo   Catholic University of Daegu Kwon, Kun-Young   Keimyung UniversityKwon, Ohsang   Seoul National University Kwon, Young-Jun   Hallym University Lee, Ai-Young*   Dongguk University Lee, Bae Young*   The Catholic University of Korea Lee, Beom Hee   University of Ulsan Lee, Bong Hwa   Hallym University Lee, Byung Seok   Chungnam National University Lee, Byung-Wan   Yonsei University Lee, Chang-Hoon   Wonkwang University Lee, Cheol Whan   University of Ulsan Lee, Choon-Taek   Seoul National University Lee, Dae Ho*   Jeju National University Lee, Dong Ho   Seoul National University Lee, Dong Hyup   Yeungnam University Lee, Dong-Sup   Seoul National University  Lee, Duk-Hee   Kyungpook National University Lee, Eun Bong*   Seoul National University Lee, Eun jung   Soonchunhyang University Lee, Hae-Young*   Seoul National University  Lee, Hoan Jong*   Seoul National University Lee, Hwa Mu   University of California, USA Lee, Hye Seung   Seoul National University Lee, Hyukmin   Kwandong University Lee, Hyun Woong*   Chung-Ang University Lee, Jae Hyup*   Seoul National University Lee, JaeHo   University of Ulsan Lee, Jae-Ho*   The Catholic University of Korea Lee, Jaejoon   Sungkyunkwan University Lee, Jaemin   The Catholic University of Korea Lee, Jaewon   University of Ulsan Lee, Jeong Hun   Dongguk UniversityLee, Jeung-Hoon   Chungnam National University Lee, Ji Eun   Pusan National University Lee, Jin Bae   Catholic University of Daegu Lee, Jin Yong   Seoul National University Lee, Jin-Seok   Seoul National University Lee, Jin-Woo   Inha University Lee, Jong hwa   Dong-A University  Lee, Jong-In   Korea Cancer Center Hospital Lee, Jong-Min*   Kyunghee University Lee, Jung Ryeol   Seoul National University Lee, Jung-Il*   Sungkyunkwan University  Lee, Jungkwon   Sungkyunkwan University Lee, Kang Wook   Chungnam National University Lee, Kee-Hyoung   Korea University  Lee, Keun Ho   The Catholic University of Korea Lee, Kwang-Beom   Gachon University Lee, Kwang-Bok   Chonbuk National University Lee, Kyeong-Seok   Soonchunhyang University Lee, Kyu-Beck   Sungkyunkwan University Lee, Kyung Bok   Soonchunhyang University Lee, Kyung-Mi   Korea University Lee, Kyung-Yil   The Catholic University of Korea Lee, Mi Suk   Kyunghee University Lee, Mi-Kyung   Chung-Ang University Lee, Moo-Song*   University of Ulsan Lee, Myung Ah   The Catholic University of Korea Lee, Oh Young   Hanyang University Lee, Sang Don   Pusan National University Lee, Sang Haak*   The Catholic University of Korea Lee, Sangho*   Kyunghee University Lee, Sang-il*   Gyeongsang National University Lee, Sang-Il*   University of Ulsan Lee, Sang-Min   Seoul National University Lee, Sang-Oh*   University of Ulsan Lee, Seo-Young   Kangwon National University Lee, Seung Heon   Korea University Lee, Shin-Seok   Chonnam National University Lee, So Yeong   Seoul National University Lee, Soo Bong   Pusan National Univeristy  Lee, Soo-Young   Ajou University Lee, So-Yeon   Hallym University Lee, Su Jin   Pusan National University Lee, Sung Koo*   University of Ulsan Lee, Sung Woo*   Korea University Lee, Wang Jae   Seoul National University Lee, Yeon-Ah   Kyunghee University Lee, Young Ho   Korea University Lee, Young Ki   Hallym University Lee, Young Kyung   Hallym University Lee, Young-Kyun*   Seoul National University Li, Kapsok   Chung-Ang University Lim, Cheong   Seoul National University Lim, Dae Hyun   Inha University Lim, Do Sun   Korea University Lim, Jae-Young   Seoul National University Lim, Myungho   Dankook University Lim, Soo   Seoul National University Lin, Shuan-Pei*   Mackay Memorial Hospital, Taiwan Ma, Matthew   National Taiwan University, Taiwan McKiernan, Fergus E   Marshfield Clinic, USA Min, Seung-Kee   Seoul National University Min, Young Gi*   Ajou University",Non-OADS,/arxiv_data1/oa_pdf/00/94/jkms-29-155.PMC3890470.pdf
"Hong S-T • Peer Review in 2013: More Supports than Neglects http://jkms.org   159 http://dx.doi.org/10.3346/jkms.2014.29.1.155Minami, Yasunori   Kinki University, Japan Moon, Kyung Chul   Seoul National University Moon, Seong-Hwan   Yonsei University Moon, Young Lae   Chosun University Moon, Young-Eun*   The Catholic University of Korea Mortellaro, Alessandra   Singapore Immunology Network (SIgN),  Agency for Science, Technology and  Research (A*STAR), Singapore Nam, Chang-Wook*   Keimyung Univeristy Nam, Gi-Byoung*   University of Ulsan Oh, Byung-Mo   Seoul National University Oh, Doyeun   CHA University Oh, Jaeryung   Korea University Oh, Jee-Young   Ewha Womans University Oh, Jongjin*   CHA University Oh, Jung-Tak   Yonsei University Oh, Kook-Hwan   Seoul National University Oh, Mee-Hye   Soonchunhyang University Oh, Myoung-Don   Seoul National University Oh, Seil   Seoul National University Oh, Seung Ha   Seoul National University Oh, Seungjoon   Kyunghee University Oh, Sewon   Korea University Oh, Yong-Seog   The Catholic University of Korea On, Young Keun   Sungkyunkwan University Paek, Sun Ha   Seoul National University Paeng Jin Chul*   Seoul National University Pai, Hyunjoo   Hanyang University  Park Jeong Youp   Yonsei University Park, Bongjin   Kyunghee University Park, Byung Joo   Seoul National University Park, Chan Hong   Wooridul Spine HospitalPark, Chung-Gyu   Seoul National University Park, Dae Won   Korea University Park, Eun-Cheol   Yonsei University Park, Hochul   Kyunghee University Park, Hye-Kyung   Pusan National University Park, Hyun Soo   Dongguk University Park, Hyung-Wook   Chonnam National University Park, Ie Byung   Gachon University Park, In Won   Chung-Ang University Park, Jae Berm*   Sungkyunkwan University Park, Jae Myung   The Catholic University of Korea Park, Jae Young   Korea University Park, Jae-Hyeong*   Chungnam National University Park, Jeonghyun   Inje University Park, Ji Sook   Gyeongsang National University Park, Ji Wan   Hallym University Park, Ji-Young*   Korea Universitiy Park, Jong Yeon   University of Ulsan Park, Jong-Seon   Yeungnam University Park, Joon Seong   Ajou University Park, Jun Eun   Ajou University Park, Jun Yong   Yonsei University Park, Jung-Hwan   Konkuk University Park, Jung-Won   Yonsei University Park, Kay-Hyun   Seoul National University Park, Keun-Ho   Chonnam National University Park, Kyoung Chan   Seoul National University Park, Kyoung Ho   The Catholic University of Korea Park, Kyung Hwa   Chonnam National University Park, Kyung Sik   Keimyung University Park, Kyung Woo   Seoul National UniversityPark, Kyung-Su   The Catholic University of Korea Park, Min Su   Yeungnam University  Park, Min-Hyun   Seoul National University Park, Moo In   Kosin University Park, Moo Suk   Yonsei University Park, Pyo Won   Sungkyunkwan University Park, Sangho   Soonchunhyang University  Park, Sue Kyung*   Seoul National University Park, Sung Bin*   Chung-Ang University Park, Sungha   Yonsei University Park, Sunghoon   Hallym University Park, Won Hee*   Inha University Park, Won Il   Eulji University Park, Won*   Inha University Park, Yong Mean   Konkuk University Park, Yongsoo   Hanyang University Park, Yoonhyung   Soonchunhyang University Pyun, Sung-Bom   Korea University Pyun, Wook Bum   Ewha Womans University Rhee, Chae-Seo*   Seoul National University Rhee, Joon Haeng   Chonnam National University Rhee, Moo-Yong   Dongguk University Rhyu, Kee Hyung   Kyunghee University Roh, Cheong-Rae   Sungkyunkwan University Roh, Jong-Lyel   University of Ulsan Rosenberger, Jaroslav   Nephrology and Dialysis Center  Fresenius Kosice, Slovak Republic Ryu, Hoon   Boston University School of Medicine,  USA Ryu, Jae-Sook   Hanyang University Ryu, Ji Kon   Seoul National University Sakhuja, Ankit   Medical College of Wisconsin, USASakong, Joon   Yeungnam University Seo, Geom Seog   Wonkwang University Seo, Hye-Sun   Soonchunhyang University Seo, Hyo Jung   Seoul National University Seo, Jeong Seok*   Konkuk University Seo, Jeong Wan*   Ewha Womans University  Seo, Min*   Dankook University Seo, Yeon Seok   Korea University Sheen, Seung Hun   Hallym University Shim, Chi Young*   Yonsei University Shim, Ki-Nam   Ewha Womans University Shin, Aesun*   National Cancer Center Shin, Bo-Moon*   Inje University Shin, Chol   Korea University Shin, Choong Ho   Seoul National University Shin, Dong Il   The Catholic University of Korea Shin, Dong Min   Yonsei University Shin, Donghyeok   Konkuk University Shin, Hae-Won   Chung-Ang University Shin, Hyung-Ik*   Seoul National University Shin, Jinho*   Hanyang University Shin, Joon-Han   Ajou University Shin, Kichul   Seoul National University Shin, Min-Ho   Chonnam National University Shin, Min-Sup   Seoul National University Shin, Mi-Seung*   Gachon University Shin, Sang Do*   Seoul National University Shin, Seon Hee   Hallym University Shin, Sue   Seoul National University Shin, Sung Joon*   Dongguk University Shin, Yoo Seob*   Ajou University",Non-OADS,/arxiv_data1/oa_pdf/00/94/jkms-29-155.PMC3890470.pdf
"Hong S-T • Peer Review in 2013: More Supports than Neglects 160  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.155Sim, Min seob   Sungkyunkwan University Sim, Woo-Young   Kyunghee University Son ,Daegu   Keimyung University Son, Ji Woong*   Konyang University Son, Jungwoo   Chungbuk National University Song, Ho-Taek   Yonsei University Song, Jae-Kwan   University of Ulsan Song, Jong-Min   University of Ulsan Song, Jong-Suk   Korea University Song, Joon Young   Korea University Song, Jungsoo*   Chung-Ang University Song, Suk-Won   Yonsei UniversitySuh, Chang-Hee   Ajou University Suh, DongIn   Seoul National University Suk, Ki Tae*   Hallym University Sung, Jung-Joon   Seoul National University Sung, Ki Woong   Sungkyunkwan University Suraokar, Milind   University of Texas M. D. Anderson  Cancer Center, USA Tahk, Seung-Jea   Ajou University Won, Jong-Chul   Inje University Woo, Jun Hee   University of Ulsan Yang, Chen-Chang   National Yang-Ming University, Taiwan Yang, Hyeon Jong*   Soonchunhyang UniversityYang, Sei Won   Seoul National University  Ye Sang-Kyu   Seoul National University Ye, Byong Duk   University of Ulsan Yeom, Joon Sup   Sungkyunkwan University Yeom, Seokran   Pusan National University Yoo, Bin   University of Ulsan Yoo, Hee-Jeong   Seoul National University Yoo, Jin-Hong*   The Catholic Univeristy of Korea Yoon Myung Ha   Chonnam National University Yoon, Byung-Woo   Seoul National University Yoon, Chang-Hwan*   Seoul National UniversityYoon, Hwi-Joong   Kyunghee University Yoon, Hyun Koo*   Kwandong University Yoon, Moon Soo*   CHA University Yoon, Pil Whan*   Seoul National University  Youn, Hee-Shang*   Gyeongsang National University  Youn, Hong-Duk*   Seoul Naitonal University  Youn, Young-Nam*   Yonsei University Yu, Jeesuk*   Dankook University Yu, Kyung-Sang   Seoul National University Yun, Seok Joong   Chungbuk National University",Non-OADS,/arxiv_data1/oa_pdf/00/94/jkms-29-155.PMC3890470.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Role of Endoplasmic Reticulum Stress in Rheumatoid Arthritis  Pathogenesis Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by abnormal  proliferation of synoviocytes, leukocyte infiltration, and angiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
"A092258), and National Research Foundation  of Korea (NRF) funded by the Ministry of Education, Science and  Technology 2009-0080087).http://dx.doi.org/10.3346/jkms.2014.29.1.2  • J Korean Med Sci 2014; 29: 2-11 INTRODUCTION Rheumatoid arthritis (RA) is characterized by a tumor-like ex - pansion of the synovium, which is composed of proliferating  synoviocytes and infiltrating leukocytes, including T cells and B  cells; these are likely activated by autoantigens (1).",Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
"• ER Stress and Rheumatoid Arthritis http://jkms.org   3 http://dx.doi.org/10.3346/jkms.2014.29.1.2tant UPR then initiates programmed cell death, such as apop - tosis and autophagy (12, 13).",Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
• ER Stress and Rheumatoid Arthritis 4  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.2ROLE OF ER STRESS RESPONSE IN LYMPHOCYTE  ACTIVATION GRP78 and B cell activation  B cells are directly or indirectly involved in the pathogenesis of  RA.,Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
• ER Stress and Rheumatoid Arthritis http://jkms.org   5 http://dx.doi.org/10.3346/jkms.2014.29.1.2ACPA.,Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
"• ER Stress and Rheumatoid Arthritis 6  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.2flammatory NF- κB signal pathway, and protects mice from en - dotoxic lethality and CIA (71).",Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
"• ER Stress and Rheumatoid Arthritis http://jkms.org   7 http://dx.doi.org/10.3346/jkms.2014.29.1.2at times of acute or chronic physiological stress as a form of exo- some, necrotic or apoptotic debris, can contribute to immune- modulating signals within the immune network through a vari - ety of mechanisms (73).",Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
• ER Stress and Rheumatoid Arthritis 8  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.2can cause dramatic reduction of tumor angiogenesis (76).,Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
"• ER Stress and Rheumatoid Arthritis http://jkms.org   9 http://dx.doi.org/10.3346/jkms.2014.29.1.2cells (e.g., DCs and FLS) and adaptive immune cells (e.g., T and  B cells) in inflamed joints.",Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
• ER Stress and Rheumatoid Arthritis 10  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.2intermolecular disulfide bond formation (dimerization) in the endo - plasmic reticulum.,Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
• ER Stress and Rheumatoid Arthritis http://jkms.org   11 http://dx.doi.org/10.3346/jkms.2014.29.1.2al immune tolerance: suppression of organ-specific autoimmune diseas - es by oral administration of autoantigens.,Non-OADS,/arxiv_data1/oa_pdf/8f/b0/jkms-29-2.PMC3890471.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Randomized, Open-Label, Multicenter Trial for the Safety and  Efficacy of Adult Mesenchymal Stem Cells after Acute Myocardial  Infarction Recent studies suggest that the intracoronary administration of bone marrow (BM)-derived  mesenchymal stem cells (MSCs) may improve left ventricular function in patients with  acute myocardial infarction (AMI).",Non-OADS,/arxiv_data1/oa_pdf/b4/01/jkms-29-23.PMC3890472.pdf
"(ClinicalTrials.gov  registration number: NCT01392105) Keywords:  Mesenchymal Stem Cells; Myocardial Infarction; Ventricular Dysfunction, LeftJun-Won Lee,1 Seung-Hwan Lee,1  Young-Jin Youn,1 Min-Soo Ahn,1   Jang-Young Kim,1 Byung-Su Yoo,1  Junghan Yoon,1 Woocheol Kwon,2   In-Soo Hong,2 Kyounghoon Lee,3   Jun Kwan,4 Keum Soo Park,4   Donghoon Choi,5 Yang Soo Jang,5   and Mun K. Hong6 1Division of Cardiology, and 2Department of  Radiology, Yonsei University Wonju College of  Medicine, Wonju; 3Department of Cardiology,  Gachon Medical School, Gil Medical Center,  Incheon; 4Division of Cardiology, Department of  Internal Medicine, Inha University Hospital, Incheon;  5Yonsei Cardiovascular Center and Cardiovascular  Research Institute, Yonsei University College of  Medicine, Seoul, Korea; 6Division of Cardiology,  Department of Medicine, St. Luke’s Roosevelt  Hospital, Columbia University College of Physicians  and Surgeons, New York, NY, USA Received: 9 July 2013 Accepted: 6 November 2013 Address for Correspondence: Seung-Hwan Lee, MD Division of Cardiology, Department of Internal Medicine, Yonsei  University Wonju College of Medicine, 20 Ilsan-ro,   Wonju 220-701, Korea Tel: +82.33-741-0907, Fax: +82.33-741-1219 E-mail: carshlee@yonsei.ac.kr This study was funded by FCB-Pharmicell Company Limited  (Seongnam, Korea).http://dx.doi.org/10.3346/jkms.2014.29.1.23  • J Korean Med Sci 2014; 29: 23-31 INTRODUCTION Remarkable advances of early reperfusion therapy in acute myocardial infarction (AMI)  have contributed to a reduction of early mortality as well as complications of post-AMI  (1-3).",Non-OADS,/arxiv_data1/oa_pdf/b4/01/jkms-29-23.PMC3890472.pdf
"• SEED-MSC Trial 24  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.23We designed a randomized, multicenter, pilot study to deter - mine whether intracoronary infusion of autologous BM-derived  MSCs at 1 month is safe and effective in patients with AMI.",Non-OADS,/arxiv_data1/oa_pdf/b4/01/jkms-29-23.PMC3890472.pdf
"• SEED-MSC Trial http://jkms.org   25 http://dx.doi.org/10.3346/jkms.2014.29.1.23maximum contact time of MSCs with the microcirculation of  the IRA, the balloon was inflated inside the stent at a low pres - sure to transiently interrupt antegrade blood flow during infu - sions.",Non-OADS,/arxiv_data1/oa_pdf/b4/01/jkms-29-23.PMC3890472.pdf
"• SEED-MSC Trial 26  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.23rean Food and Drug Administration (KFDA) and registered with  clinicaltrials.gov, number NCT01392105.",Non-OADS,/arxiv_data1/oa_pdf/b4/01/jkms-29-23.PMC3890472.pdf
• SEED-MSC Trial http://jkms.org   27 http://dx.doi.org/10.3346/jkms.2014.29.1.23ng/mL (reference range < 5 ng/mL) and 2.848 ng/mL (refer - ence range < 0.078 ng/mL) in one patient and 38.36 ng/mL and  5.304 ng/mL in the other.,Non-OADS,/arxiv_data1/oa_pdf/b4/01/jkms-29-23.PMC3890472.pdf
• SEED-MSC Trial 28  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.23Fig.,Non-OADS,/arxiv_data1/oa_pdf/b4/01/jkms-29-23.PMC3890472.pdf
• SEED-MSC Trial http://jkms.org   29 http://dx.doi.org/10.3346/jkms.2014.29.1.23and invasion through the extracellular matrix (26).,Non-OADS,/arxiv_data1/oa_pdf/b4/01/jkms-29-23.PMC3890472.pdf
• SEED-MSC Trial 30  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.23Circulation 2011; 123: e18-209.,Non-OADS,/arxiv_data1/oa_pdf/b4/01/jkms-29-23.PMC3890472.pdf
• SEED-MSC Trial http://jkms.org   31 http://dx.doi.org/10.3346/jkms.2014.29.1.23ing time?,Non-OADS,/arxiv_data1/oa_pdf/b4/01/jkms-29-23.PMC3890472.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Human Papillomavirus Prevalence and Genotype Distribution  among HIV-Infected Women in Korea The epidemiology on human papillomavirus (HPV) among human immunodeficiency virus  (HIV)-infected women in Korea is not well established.",Non-OADS,/arxiv_data1/oa_pdf/68/07/jkms-29-32.PMC3890473.pdf
"Keywords:  HIV; Women; Human Papillomavirus; Prevalence; GenotypeEun Kyoung Park,1 Heerim Cho,1   Sun Hee Lee,1 Seung Geun Lee,1   Sang Yeup Lee,2 Ki Hyung Kim,3   Chang Hun Lee,4 Joo Seop Chung,1   and Ihm Soo Kwak1 1Deparment of Internal Medicine, Pusan National  University School of Medicine, Medical Research  Institute, Pusan National University Hospital, Busan;  2Deparment of Family Medicine, Yangsan Pusan  National University Hospital, Yangsan; 3Deparment  of Obstetrics & Gynecology, Pusan National  University Hospital, Busan; 4Deparment of Pathology,  Pusan National University Hospital, Busan, Korea Received: 22 August 2013 Accepted: 8 November 2013 Address for Correspondence: Sun Hee Lee, MD Division of Infectious Diseases, Department of Internal Medicine,  Pusan National University Hospital, 179 Gudeok-ro, Seo-gu,  Busan 602-739, Korea  Tel: +82.51-240-7673, Fax: +82.51-247-3213 E-mail: zzanmery@gmail.com This study was supported by Medical Research Institute Grant  (2005-5), Pusan National University.http://dx.doi.org/10.3346/jkms.2014.29.1.32  • J Korean Med Sci 2014; 29: 32-37 INTRODUCTION  Human immunodeficiency virus (HIV)-infected women have  higher rates of human papillomavirus (HPV) infection than  HIV-uninfected women, and are also at higher risk for persis - tent infection and progression to malignancy (1-4).",Non-OADS,/arxiv_data1/oa_pdf/68/07/jkms-29-32.PMC3890473.pdf
• HPV Prevalence and Genotypes of HIV Patients in Korea http://jkms.org   33 http://dx.doi.org/10.3346/jkms.2014.29.1.32HIV-infected women in Korea.,Non-OADS,/arxiv_data1/oa_pdf/68/07/jkms-29-32.PMC3890473.pdf
• HPV Prevalence and Genotypes of HIV Patients in Korea 34  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.32Table 2.,Non-OADS,/arxiv_data1/oa_pdf/68/07/jkms-29-32.PMC3890473.pdf
"• HPV Prevalence and Genotypes of HIV Patients in Korea http://jkms.org   35 http://dx.doi.org/10.3346/jkms.2014.29.1.32tween hr-HPV positive and hr-HPV negative HIV-infected wom - en, age was a significant risk factor for hr-HPV infection ( P=  0.039).",OADS,/arxiv_data1/oa_pdf/68/07/jkms-29-32.PMC3890473.pdf
"• HPV Prevalence and Genotypes of HIV Patients in Korea 36  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.32gram, and 8.6% in female university students (22-25).",Non-OADS,/arxiv_data1/oa_pdf/68/07/jkms-29-32.PMC3890473.pdf
• HPV Prevalence and Genotypes of HIV Patients in Korea http://jkms.org   37 http://dx.doi.org/10.3346/jkms.2014.29.1.32405-13.,Non-OADS,/arxiv_data1/oa_pdf/68/07/jkms-29-32.PMC3890473.pdf
Available at http://stat.mw.go.kr [ac - cessed on 1 July 2013].,OADS,/arxiv_data1/oa_pdf/68/07/jkms-29-32.PMC3890473.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Safe Re-administration of Tumor Necrosis Factor-alpha (TNF α)  Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing  Spondylitis Who Developed Active Tuberculosis on Previous  Anti-TNF α Therapy There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha  (TNFα) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS)  flared after withdrawal of TNF α inhibitors due to active tuberculosis (TB).",Non-OADS,/arxiv_data1/oa_pdf/e6/98/jkms-29-38.PMC3890474.pdf
"Keywords:  TNFα Inhibitor; Tuberculosis; Arthritis, Rheumatoid; Spondylitis, Ankylosing Young Sun Suh, Seung-ki Kwok,   Ji Hyeon Ju, Kyung-Su Park,   Sung-Hwan Park, and Chong-Hyeon Yoon Division of Rheumatology, Department of Internal  Medicine, College of Medicine, The Catholic  University of Korea, Seoul, Korea  Received: 3 September 2013 Accepted: 31 October 2013 Address for Correspondence: Chong-Hyeon Yoon, MD Division of Rheumatology, Department of Internal Medicine,  Uijeongbu St. Mary’s Hospital, The Catholic University of Korea  School of Medicine, 271 Cheonbo-ro, Uijeongbu 480-717, Korea Tel: +82.31-820-3653, Fax: +82.31-820-3653 E-mail: chyoon@catholic.ac.kr http://dx.doi.org/10.3346/jkms.2014.29.1.38  • J Korean Med Sci 2014; 29: 38-42 INTRODUCTION Tumor necrosis factor-alpha (TNF α) inhibitors have demon - strated a significant effectiveness in patients with rheumatoid  arthritis refractory to DMARDs (disease modifying anti-rheu - matic drugs).",Non-OADS,/arxiv_data1/oa_pdf/e6/98/jkms-29-38.PMC3890474.pdf
"• Safe Re-administration of TNF a Inhibitors to RA with Tuberculosis http://jkms.org   39 http://dx.doi.org/10.3346/jkms.2014.29.1.38Mary’s Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e6/98/jkms-29-38.PMC3890474.pdf
• Safe Re-administration of TNF a Inhibitors to RA with Tuberculosis 40  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.38sation of anti-TNF α therapy to re-introduction was 3 (range 2-7)  months in RA and 12 (range 6-29) months in AS.,Non-OADS,/arxiv_data1/oa_pdf/e6/98/jkms-29-38.PMC3890474.pdf
"• Safe Re-administration of TNF a Inhibitors to RA with Tuberculosis http://jkms.org   41 http://dx.doi.org/10.3346/jkms.2014.29.1.38those with RA and 600.2/100,000 (PYs) for those with AS (18).",Non-OADS,/arxiv_data1/oa_pdf/e6/98/jkms-29-38.PMC3890474.pdf
"• Safe Re-administration of TNF a Inhibitors to RA with Tuberculosis 42  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.38 In conclusion, this study results suggests that re-administra - tion of TNF α inhibitors could be safe and should be considered  to control RA or AS flares for patients with anti-TNF α therapy- associated TB.",Non-OADS,/arxiv_data1/oa_pdf/e6/98/jkms-29-38.PMC3890474.pdf
Available at http://www.knta.or.kr  [accessed on 1 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/e6/98/jkms-29-38.PMC3890474.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Increased Level of Basophil CD203c Expression Predicts Severe Chronic Urticaria Increased Fc εR1α expression with upregulated CD203c expression on peripheral basophils is  seen in patients with chronic urticaria (CU).",Non-OADS,/arxiv_data1/oa_pdf/f0/c1/jkms-29-43.PMC3890475.pdf
http://dx.doi.org/10.3346/jkms.2014.29.1.43  • J Korean Med Sci 2014; 29: 43-47 INTRODUCTION Chronic urticaria (CU) is a common skin disorder character - ized by persistent or recurrent itchy wheals that last for at least 6  weeks.,Non-OADS,/arxiv_data1/oa_pdf/f0/c1/jkms-29-43.PMC3890475.pdf
• Increased Basophil CD203c Expression Predicts Severe Chronic Urticaria 44  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.43report of the clinical relevance of CD203c-BAT in CU patients.,Non-OADS,/arxiv_data1/oa_pdf/f0/c1/jkms-29-43.PMC3890475.pdf
"• Increased Basophil CD203c Expression Predicts Severe Chronic Urticaria http://jkms.org   45 http://dx.doi.org/10.3346/jkms.2014.29.1.430.5% ± 0.2%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/f0/c1/jkms-29-43.PMC3890475.pdf
• Increased Basophil CD203c Expression Predicts Severe Chronic Urticaria 46  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.43been demonstrated that serum IgE upregulates the expression  of FcεRI on human basophils both in vitro and in vivo (24).,Non-OADS,/arxiv_data1/oa_pdf/f0/c1/jkms-29-43.PMC3890475.pdf
• Increased Basophil CD203c Expression Predicts Severe Chronic Urticaria http://jkms.org   47 http://dx.doi.org/10.3346/jkms.2014.29.1.43leads to interleukin-3 hyper-responsiveness and enhancement of hista - mine release induced by anti-IgE stimulus.,Non-OADS,/arxiv_data1/oa_pdf/f0/c1/jkms-29-43.PMC3890475.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Central Lymph Node Metastasis Is an Important Prognostic  Factor in Patients with Papillary Thyroid Microcarcinoma Papillary thyroid microcarcinoma (PTMC) has been increasing, without a consensus for the  management of this condition.",Non-OADS,/arxiv_data1/oa_pdf/f0/23/jkms-29-48.PMC3890476.pdf
"Keywords:  Papillary Thyroid Carcinoma, Lymph Node Metastasis, Recurrence Jeonghun Lee, Yeongpeck Song,   and Euy Young Soh Department of Surgery, Ajou University School of  Medicine, Suwon, Korea Received: 20 May 2013 Accepted: 22 October 2013 Address for Correspondence: Jeonghun Lee, MD Department of Surgery, Ajou University School of Medicine, 164 Worldcup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: +82.31-219-5200, Fax: +82.31-219-5755 E-mail: servent-lee@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.1.48  • J Korean Med Sci 2014; 29: 48-52 INTRODUCTION Papillary thyroid cancer (PTC) is the most common endocrine  malignancy (1) and accounts for about 80% of thyroid cancers  (2).",Non-OADS,/arxiv_data1/oa_pdf/f0/23/jkms-29-48.PMC3890476.pdf
• Central Lymph Node Metastasis as a Prognostic Factor http://jkms.org   49 http://dx.doi.org/10.3346/jkms.2014.29.1.48Ethics statement This study was approved by the institutional review board at  Ajou University Hospital (IRB No.,Non-OADS,/arxiv_data1/oa_pdf/f0/23/jkms-29-48.PMC3890476.pdf
• Central Lymph Node Metastasis as a Prognostic Factor 50  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.48Table 2.,Non-OADS,/arxiv_data1/oa_pdf/f0/23/jkms-29-48.PMC3890476.pdf
"• Central Lymph Node Metastasis as a Prognostic Factor http://jkms.org   51 http://dx.doi.org/10.3346/jkms.2014.29.1.48compared with those treated with subtotal thyroidectomy (13,  14).",Non-OADS,/arxiv_data1/oa_pdf/f0/23/jkms-29-48.PMC3890476.pdf
Available at http://www.nccn.org/ professionals/physician_gls/pdf/thyroid.pdf [accessed on 28 November  2013].,Non-OADS,/arxiv_data1/oa_pdf/f0/23/jkms-29-48.PMC3890476.pdf
• Central Lymph Node Metastasis as a Prognostic Factor 52  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.48patients with AMES low-risk papillary thyroid carcinoma?,Non-OADS,/arxiv_data1/oa_pdf/f0/23/jkms-29-48.PMC3890476.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Intestinal Diffuse Large B-Cell Lymphoma: An Evaluation of  Different Staging Systems  The gastrointestinal tract is the most common primary extranodal site for diffuse large  B-cell lymphoma (DLBCL).",Non-OADS,/arxiv_data1/oa_pdf/d4/4c/jkms-29-53.PMC3890477.pdf
"Keywords:  Lymphoma, Large B-Cell, Diffuse; Intestines; Stage; RituximabHee Sang Hwang,1 Dok Hyun Yoon,2  Cheolwon Suh,2 Chan-Sik Park,1   and Jooryung Huh1 Departments of 1Pathology and 2Oncology,  University of Ulsan College of Medicine, Asan  Medical Center, Seoul, Korea  Received: 18 August 2013 Accepted: 6 November 2013 Address for Correspondence: Jooryung Huh, MD Department of Pathology, University of Ulsan College of  Medicine, Asan Medical Center, 88 Olympic-ro 43-gil,   Songpa-gu, Seoul 138-736, Korea Tel: +82.2-3010-4553, Fax: +82.2-472-7898 E-mail: jrhuh@amc.seoul.kr This study was partly supported by a grant (2011-090) from the  Asan Institute for Life Sciences, Seoul, Korea.http://dx.doi.org/10.3346/jkms.2014.29.1.53  • J Korean Med Sci 2014; 29: 53-60 INTRODUCTION The gastrointestinal tract is the most common site of extranodal  involvement for diffuse large B-cell lymphoma (DLBCL) (1).",Non-OADS,/arxiv_data1/oa_pdf/d4/4c/jkms-29-53.PMC3890477.pdf
"• Staging of Intestinal Diffuse Large B-Cell Lymphoma 54  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.53MATERIALS AND METHODS Case selection  From January 1996 to March 2011, a total of 106 cases of intesti - nal DLBCL, not otherwise specified (NOS) satisfied the defini - tion of primary gastrointestinal lymphoma of Lewin et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/4c/jkms-29-53.PMC3890477.pdf
• Staging of Intestinal Diffuse Large B-Cell Lymphoma http://jkms.org   55 http://dx.doi.org/10.3346/jkms.2014.29.1.53two-sided P value of less than 0.05.,Non-OADS,/arxiv_data1/oa_pdf/d4/4c/jkms-29-53.PMC3890477.pdf
"• Staging of Intestinal Diffuse Large B-Cell Lymphoma 56  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.53immunohistochemical expression data, nine (17.6%) were GCB  type and 42 (82.4%) were non-GCB, according to the algorithm  of Hans et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/4c/jkms-29-53.PMC3890477.pdf
• Staging of Intestinal Diffuse Large B-Cell Lymphoma http://jkms.org   57 http://dx.doi.org/10.3346/jkms.2014.29.1.53imab ( P< 0.05).,Non-OADS,/arxiv_data1/oa_pdf/d4/4c/jkms-29-53.PMC3890477.pdf
• Staging of Intestinal Diffuse Large B-Cell Lymphoma 58  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.53Fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/4c/jkms-29-53.PMC3890477.pdf
• Staging of Intestinal Diffuse Large B-Cell Lymphoma http://jkms.org   59 http://dx.doi.org/10.3346/jkms.2014.29.1.53Paris system can also be useful for staging intestinal DLBCL.,Non-OADS,/arxiv_data1/oa_pdf/d4/4c/jkms-29-53.PMC3890477.pdf
• Staging of Intestinal Diffuse Large B-Cell Lymphoma 60  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.53Gut 2003; 52: 912-3.,Non-OADS,/arxiv_data1/oa_pdf/d4/4c/jkms-29-53.PMC3890477.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Success Rate and Risk Factors for Failure of Empirical Antifungal  Therapy with Itraconazole in Patients with Hematological  Malignancies: A Multicenter, Prospective, Open-Label,  Observational Study in Korea We assessed the success rate of empirical antifungal therapy with itraconazole and  evaluated risk factors for predicting the failure of empirical antifungal therapy.",Non-OADS,/arxiv_data1/oa_pdf/85/9e/jkms-29-61.PMC3890478.pdf
"(Clinical Trial Registration on National Cancer Institute website,  NCT01060462) Keywords:  Hematological Malignancy; Itraconazole; Empirical Antifungal Therapy;  Galactomannan TestSoo-Jeong Kim,1 June-Won Cheong,1   Yoo Hong Min,1 Young Jin Choi,2   Dong-Gun Lee,3 Je-Hwan Lee,4   Deok-Hwan Yang,5 Sang Min Lee,6   Sung-Hyun Kim,7 Yang Soo Kim,8   Jae-Yong Kwak,9 Jinny Park,10 Jin Young Kim,11  Hoon-Gu Kim,12 Byung Soo Kim,13   Hun-Mo Ryoo,14 Jun Ho Jang,15   Min Kyoung Kim,16 Hye Jin Kang,17   In Sung Cho,18 Yeung Chul Mun,19   Deog-Yeon Jo,20 Ho Young Kim,21   Byeong-Bae Park,22 and Jin Seok Kim1 1Division of Hematology, Department of Internal  Medicine, Yonsei University College of Medicine,  Severance Hospital, Seoul; 2Department of Hematology/ Oncology, Pusan National University Hospital, Pusan  National University School of Medicine, Busan;  3Department of Internal Medicine, Seoul St. Mary’s  Hospital, The Catholic University of Korea, Seoul;  4Department of Hematology, Asan Medical Center,  University of Ulsan College of Medicine, Seoul;  5Department of Hematology/Oncology, Chonnam  National University Hwasun Hospital, Hwasun;  6Department of Internal Medicine, Busan Paik Hospital,  Inje University, Busan; 7Department of Internal Medicine,  Dong-A University College of Medicine, Busan;  8Department of Internal Medicine, Kosin University  Gospel Hospital, Busan; 9Department of Internal  Medicine, Chonbuk National University Medical School,  Jeonju; 10Department of Internal Medicine, Gachon  University Gil Medical Center, Incheon; 11Department of  Internal Medicine, Dongsan Medical Center, Keimyung  University School of Medicine, Daegu; 12Department of  Internal Medicine, Gyeongsang National University  Hospital, Gyeongsang National University School of  Medicine, Jinju; 13Department of Internal Medicine,  Korea University Medical Center, Seoul; 14Department of  Internal Medicine, Daegu Catholic University Medical  Center, Daegu; 15Department of Medicine, Samsung  Medical Center, Sungkyunkwan University School of  Medicine, Seoul; 16Department of Internal Medicine,  Yeungnam University College of Medicine, Daegu;  17Department of Internal Medicine, Korea Cancer Center  Hospital, Korea Institute of Radiological and Medical  Sciences, Seoul; 18Department of Internal Medicine, Eulji  University Hospital, Daejeon; 19Department of Internal  Medicine, Ewha Womans University School of Medicine,  Seoul; 20Department of Internal Medicine, Chungnam  National University Hospital, Chungnam National  University College of Medicine, Daejeon; 21Department  of Internal Medicine, Hallym University Sacred Heart  Hospital, Anyang; 22Department of Internal Medicine,  Hanyang University College of Medicine, Seoul, Korea Received: 11 August 2013 Accepted: 22 October 2013 Address for Correspondence: Jin Seok Kim, MD Department of Internal Medicine, Yonsei University College of  Medicine, Severance Hospital, 50 Yonsei-ro, Seodaemun-gu, Seoul  120-752, Korea  Tel +82.2-2228-1972, Fax: +82.2-393-6884  E-mail: hemakim@yuhs.ac This work was supported in part by a grant from the Janssen Korea  (2008, ITR-KOR-5083), Seoul, Korea.http://dx.doi.org/10.3346/jkms.2014.29.1.61  • J Korean Med Sci 2014; 29: 61-68 INTRODUCTION Most patients with hematological malignancies belong to the intermediate-to-high  risk group of infection (1).",Non-OADS,/arxiv_data1/oa_pdf/85/9e/jkms-29-61.PMC3890478.pdf
"• Risk Factors for Empirical Itraconazole Therapy 62  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.61similar (13-17), we could generalize the results of this study  with itraconazole.",Non-OADS,/arxiv_data1/oa_pdf/85/9e/jkms-29-61.PMC3890478.pdf
• Risk Factors for Empirical Itraconazole Therapy http://jkms.org   63 http://dx.doi.org/10.3346/jkms.2014.29.1.61toxicities were defined as 2 or more grade toxicity and an incre - ment of one or more grades above the baseline grade level.,Non-OADS,/arxiv_data1/oa_pdf/85/9e/jkms-29-61.PMC3890478.pdf
• Risk Factors for Empirical Itraconazole Therapy 64  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.61serum galactomannan tests and 4 patients showed a positive  galactomannan test.,Non-OADS,/arxiv_data1/oa_pdf/85/9e/jkms-29-61.PMC3890478.pdf
• Risk Factors for Empirical Itraconazole Therapy http://jkms.org   65 http://dx.doi.org/10.3346/jkms.2014.29.1.61gal infections were candidiasis (n = 1) and coccidioidomycosis  (n = 1).,Non-OADS,/arxiv_data1/oa_pdf/85/9e/jkms-29-61.PMC3890478.pdf
• Risk Factors for Empirical Itraconazole Therapy 66  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.61tests were risk factors for failure of empirical antifungal therapy  with itraconazole.,Non-OADS,/arxiv_data1/oa_pdf/85/9e/jkms-29-61.PMC3890478.pdf
"• Risk Factors for Empirical Itraconazole Therapy http://jkms.org   67 http://dx.doi.org/10.3346/jkms.2014.29.1.61P< 0.001), these results might be analyzed with caution because  there were relatively few patients who performed CT (n = 95,  24.3%) and few patients with definite evidence of fungal infec - tion on CT (n = 22, 5.6%).",Non-OADS,/arxiv_data1/oa_pdf/85/9e/jkms-29-61.PMC3890478.pdf
• Risk Factors for Empirical Itraconazole Therapy 68  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.61tients with neutropenia and persistent fever.,Non-OADS,/arxiv_data1/oa_pdf/85/9e/jkms-29-61.PMC3890478.pdf
Available at http://ctep.cancer.gov/protocolDevel - opment/electronic_applications/docs/ctcaev3.pdf [accessed on 10 Au - gust 2013].,Non-OADS,/arxiv_data1/oa_pdf/85/9e/jkms-29-61.PMC3890478.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Outcomes of Off-Pump Coronary Bypass Grafting with the  Bilateral Internal Thoracic Artery for Left Ventricular Dysfunction  This study evaluated the outcomes of off-pump coronary artery bypass surgery (OPCAB)  with severe left ventricular dysfunction using composite bilateral internal thoracic artery  grafting.",Non-OADS,/arxiv_data1/oa_pdf/db/c4/jkms-29-69.PMC3890479.pdf
"Keywords:  Coronary Artery Bypass, Off-Pump; Ventricular Dysfunction; Internal  Mammary ArterySuryeun Chung,1 Wook Sung Kim,1   Dong Seop Jeong,1 Jaejin Lee,2   and Young Tak Lee1  1Department of Thoracic and Cardiovascular  Surgery, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul; 2Department  of Thoracic and Cardiovascular Surgery, Seoul  Adventist Hospital, Seoul, Korea  Received: 28 June 2013 Accepted: 12 November 2013 Address for Correspondence: Wook Sung Kim, MD Department of Thoracic and Cardiovascular Surgery, Samsung  Medical Center, Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-3486, Fax: +82.2-3410-0089 E-mail: opheart1@gmail.comhttp://dx.doi.org/10.3346/jkms.2014.29.1.69  • J Korean Med Sci 2014; 29: 69-75 INTRODUCTION  Coronary artery bypass surgery in patients with severe left ven - tricular (LV) dysfunction remains challenging to cardiac sur - geons.",Non-OADS,/arxiv_data1/oa_pdf/db/c4/jkms-29-69.PMC3890479.pdf
"• Coronary Revascularization in Left Ventricular Dysfunction  70  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.69However, the right coronary arteries were bypassed with the  distal extension of right internal thoracic artery grafts in 666 pa - tients, in-situ right gastroepiploic arterial grafts in 418 patients,  saphenous venous grafts in 286 patients and radial arterial grafts  in 38 patients (Fig.",Non-OADS,/arxiv_data1/oa_pdf/db/c4/jkms-29-69.PMC3890479.pdf
"• Coronary Revascularization in Left Ventricular Dysfunction   http://jkms.org   71 http://dx.doi.org/10.3346/jkms.2014.29.1.69Ethics statement  The study was approved by the Samsung Medical Center insti - tutional review board on March 17, 2010.",Non-OADS,/arxiv_data1/oa_pdf/db/c4/jkms-29-69.PMC3890479.pdf
"• Coronary Revascularization in Left Ventricular Dysfunction  72  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.69four patients, cerebral hemorrhage in three patients, stroke in  one patient and other causes in three patients.",Non-OADS,/arxiv_data1/oa_pdf/db/c4/jkms-29-69.PMC3890479.pdf
"• Coronary Revascularization in Left Ventricular Dysfunction   http://jkms.org   73 http://dx.doi.org/10.3346/jkms.2014.29.1.69postoperative new arrhythmia, neurologic complication and  chronic obstructive pulmonary disease (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/db/c4/jkms-29-69.PMC3890479.pdf
• Coronary Revascularization in Left Ventricular Dysfunction  74  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.69with diabetes mellitus.,Non-OADS,/arxiv_data1/oa_pdf/db/c4/jkms-29-69.PMC3890479.pdf
• Coronary Revascularization in Left Ventricular Dysfunction   http://jkms.org   75 http://dx.doi.org/10.3346/jkms.2014.29.1.69bypass surgery with or without surgical ventricular reconstruction.,Non-OADS,/arxiv_data1/oa_pdf/db/c4/jkms-29-69.PMC3890479.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Correction of Anemia with Continuous Erythropoietin Receptor  Activator in Korean Patients on Long-Term Hemodialysis Continuous erythropoietin receptor activator (CERA) is an erythropoietin with a long-half  life.",Non-OADS,/arxiv_data1/oa_pdf/51/a5/jkms-29-76.PMC3890480.pdf
"Received: 16 September 2013 Accepted: 12 November 2013 Address for Correspondence: Suhnggwon Kim, MD Department of Internal Medicine, Seoul National University  Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82.2-2072-2214, Fax: +82.2-762-9662,  E-mail: skimim@snu.ac.kr  The study was sponsored by Roche, Korea Co., Ltd. (2007-2010)  (No.INV07-59 and No.INV10-26).http://dx.doi.org/10.3346/jkms.2014.29.1.76  • J Korean Med Sci 2014; 29: 76-83 INTRODUCTION Most patients with chronic kidney disease (CKD) develop anemia along with progres - sive loss of renal function.",Non-OADS,/arxiv_data1/oa_pdf/51/a5/jkms-29-76.PMC3890480.pdf
"• Anemia Correction with Continuous Erythropoietin Receptor Activator http://jkms.org   77 http://dx.doi.org/10.3346/jkms.2014.29.1.76MATERIALS AND METHODS Study design and parameters This was a multi-center, phase III, open-label, randomized, pro - spective study with parallel group during 24-week correction  phase; patients with once every 2 weeks IV CERA versus pa - tients with three times per week IV epoetin beta.",Non-OADS,/arxiv_data1/oa_pdf/51/a5/jkms-29-76.PMC3890480.pdf
"• Anemia Correction with Continuous Erythropoietin Receptor Activator 78  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.76at weeks 25, 37 and at the final visit.",Non-OADS,/arxiv_data1/oa_pdf/51/a5/jkms-29-76.PMC3890480.pdf
• Anemia Correction with Continuous Erythropoietin Receptor Activator http://jkms.org   79 http://dx.doi.org/10.3346/jkms.2014.29.1.76Major protocol violation (n = 8)    RBC transfusion* (n = 6)    Wrong or missed doses (n = 2)Protocol violation (n = 1)  : no study drugWithdrew consent (n = 1)  RBC transfusion* (n = 1) : no study drug Major protocol violation (n = 5)    RBC transfusion* (n = 2)    Wrong or missed doses (n = 3) Refused treatment (n = 2) Withdrawal (n = 4)    Withdrew consent  (n = 2)    Kidney transplantation (n = 1)    Other (n = 1)Randomization (n = 80) Maintenance phase (n = 54) CERA IV 1×/4 weeks Completion of  maintenance phase (n = 50)25 patientsCompletion of correction phase (n = 33)Received allocated study drug (n = 38) Withdrawal (n = 5)§ Withdrew consent* (n = 1) Insufficient therapeutic response * (n = 1) Kidney transplantation (n = 2) Lost to follow-up (n = 1)CERA IV  1×/2 weeks group (n = 39) 29 patientsReceived allocated study drug (n = 39) Withdrawal (n = 3)§ Withdrew consent (n = 2) Lost to follow-up (n = 1)Epoetin beta group IV 3×/week (n = 41) Completion of correction phase (n = 36) Fig.,Non-OADS,/arxiv_data1/oa_pdf/51/a5/jkms-29-76.PMC3890480.pdf
• Anemia Correction with Continuous Erythropoietin Receptor Activator 80  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.76Table 1.,Non-OADS,/arxiv_data1/oa_pdf/51/a5/jkms-29-76.PMC3890480.pdf
• Anemia Correction with Continuous Erythropoietin Receptor Activator http://jkms.org   81 http://dx.doi.org/10.3346/jkms.2014.29.1.76Table 3.,Non-OADS,/arxiv_data1/oa_pdf/51/a5/jkms-29-76.PMC3890480.pdf
• Anemia Correction with Continuous Erythropoietin Receptor Activator 82  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.76degree at the end of the correction phase.,Non-OADS,/arxiv_data1/oa_pdf/51/a5/jkms-29-76.PMC3890480.pdf
• Anemia Correction with Continuous Erythropoietin Receptor Activator http://jkms.org   83 http://dx.doi.org/10.3346/jkms.2014.29.1.763.,Non-OADS,/arxiv_data1/oa_pdf/51/a5/jkms-29-76.PMC3890480.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Serum Magnesium Level Is Associated with Type 2 Diabetes in  Women with a History of Gestational Diabetes Mellitus:   The Korea National Diabetes Program Study Gestational diabetes mellitus (GDM) is a strong predictor of postpartum prediabetes and  transition to overt type 2 diabetes (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/95/1d/jkms-29-84.PMC3890481.pdf
"A102065).http://dx.doi.org/10.3346/jkms.2014.29.1.84  • J Korean Med Sci 2014; 29: 84-89 INTRODUCTION Gestational diabetes mellitus (GDM), defined as glucose intolerance during pregnan - cy, is a risk factor not only for adverse perinatal outcome, but also for postpartum pre - diabetes and development of type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/95/1d/jkms-29-84.PMC3890481.pdf
"• Serum Magnesium Level and Glucose Tolerance in Women with a History of GDM http://jkms.org   85 http://dx.doi.org/10.3346/jkms.2014.29.1.84systemic inflammation, insulin resistance, and T2DM (2-5).",Non-OADS,/arxiv_data1/oa_pdf/95/1d/jkms-29-84.PMC3890481.pdf
• Serum Magnesium Level and Glucose Tolerance in Women with a History of GDM 86  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.84Table 1.,Non-OADS,/arxiv_data1/oa_pdf/95/1d/jkms-29-84.PMC3890481.pdf
• Serum Magnesium Level and Glucose Tolerance in Women with a History of GDM http://jkms.org   87 http://dx.doi.org/10.3346/jkms.2014.29.1.84DISCUSSION This is the first study to demonstrate an association between  postpartum serum magnesium level and development of T2DM.,Non-OADS,/arxiv_data1/oa_pdf/95/1d/jkms-29-84.PMC3890481.pdf
"• Serum Magnesium Level and Glucose Tolerance in Women with a History of GDM 88  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.84mal range, and serum magnesium level after delivery is within  lower normal range.",Non-OADS,/arxiv_data1/oa_pdf/95/1d/jkms-29-84.PMC3890481.pdf
"• Serum Magnesium Level and Glucose Tolerance in Women with a History of GDM http://jkms.org   89 http://dx.doi.org/10.3346/jkms.2014.29.1.84subjects - a double-blind, placebo-controlled, randomized trial.",Non-OADS,/arxiv_data1/oa_pdf/95/1d/jkms-29-84.PMC3890481.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparison of Acarbose and Voglibose in Diabetes Patients Who  Are Inadequately Controlled with Basal Insulin Treatment:  Randomized, Parallel, Open-Label, Active-Controlled Study We studied the efficacy and safety of acarbose in comparison with voglibose in type 2  diabetes patients whose blood glucose levels were inadequately controlled with basal  insulin alone or in combination with metformin (or a sulfonylurea).",Non-OADS,/arxiv_data1/oa_pdf/c4/35/jkms-29-90.PMC3890482.pdf
"(ClinicalTrials.gov number, NCT00970528) Keywords:  Diabetes Mellitus, Type 2; Acarbose; VogliboseMi Young Lee,1 Dong Seop Choi,2   Moon Kyu Lee,3 Hyoung Woo Lee,4   Tae Sun Park,5 Doo Man Kim,6   Choon Hee Chung,1 Duk Kyu Kim,7   In Joo Kim,8 Hak Chul Jang,9   Yong Soo Park,10 Hyuk Sang Kwon,11  Seung Hun Lee,12 and Hee Kang Shin12 1Division of Endocrinology & Metabolism,  Department of Internal Medicine, Yonsei University  Wonju College of Medicine, Wonju; 2Division of  Endocrinology & Metabolism, Department of  Internal Medicine, Korea University College of  Medicine, Seoul; 3Division of Endocrinology &  Metabolism, Department of Internal Medicine,  Samsung Medical Center, Sungkyunkwan University  School of Medicine, Seoul; 4Division of  Endocrinology & Metabolism, Department of  Internal Medicine, Yeungnam University College of  Medicine, Daegu; 5Division of Endocrinology &  Metabolism, Department of Internal Medicine,  Chonbuk National University Medical School,  Jeonju; 6Division of Endocrinology & Metabolism,  Department of Internal Medicine, Hallym University  College of Medicine, Seoul; 7Division of  Endocrinology & Metabolism, Department of  Internal Medicine, Dong-A University College of  Medicine, Busan; 8Division of Endocrinology &  Metabolism, Department of Internal Medicine,  Pusan National University College of Medicine,  Busan; 9Division of Endocrinology & Metabolism,  Department of Internal Medicine, Seoul National  University Bundang Hospital, Seoul National  University College of Medicine, Seongnam;  10Division of Endocrinology & Metabolism,  Department of Internal Medicine, Hanyang  University College of Medicine, Seoul; 11Division of  Endocrinology & Metabolism, Department of  Internal Medicine, The Catholic University of Korea,  Seoul; 12Bayer Korea Ltd., Seoul, Korea Received: 1 August 2013 Accepted: 31 October 2013 Address for Correspondence: Dong Seop Choi, MD Division of Endocrinology & Metabolism, Department of Internal  Medicine, Korea University Anam Hospital, 73 Inchon-ro,  Seongbuk-gu, Seoul 136-705, Korea  Tel: +82.2-920-5114, Fax: +82.2-953-9355 E-mail: cdongs@kumc.or.kr The work was funded by a research grant from the Bayer Korea  Ltd (2009.09.22-2012.09.18).http://dx.doi.org/10.3346/jkms.2014.29.1.90  • J Korean Med Sci 2014; 29: 90-97 INTRODUCTION Given the progressive nature of diabetes and the substantial evidence supporting the  beneficial effects of insulin regimens, it is imperative that patients utilize insulin thera - py to maintain glycemic control as well as reduce morbidity and mortality rates associ - ated with diabetes and its related complications (1-3).",Non-OADS,/arxiv_data1/oa_pdf/c4/35/jkms-29-90.PMC3890482.pdf
"• Acarbose and Voglibose in Diabetes Patients Treated with Basal Insulin http://jkms.org   91 http://dx.doi.org/10.3346/jkms.2014.29.1.90dial glucose concentrations by delaying carbohydrate digestion  and therefore absorption in the gut, and can be a useful first- line treatment in the patients who have a combination of slight - ly raised basal glucose concentrations and marked postprandi - al hyperglycemia (10-14).",Non-OADS,/arxiv_data1/oa_pdf/c4/35/jkms-29-90.PMC3890482.pdf
"• Acarbose and Voglibose in Diabetes Patients Treated with Basal Insulin 92  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.90Statistical methods The primary efficacy variable was mean HbA 1c change from  baseline to week 24 in the modified intent to treat (mITT) pop - ulation with last observation carried forward for the patients  who discontinued prematurely, comparing acarbose group  with voglibose group.",OADS,/arxiv_data1/oa_pdf/c4/35/jkms-29-90.PMC3890482.pdf
• Acarbose and Voglibose in Diabetes Patients Treated with Basal Insulin http://jkms.org   93 http://dx.doi.org/10.3346/jkms.2014.29.1.90Fig.,Non-OADS,/arxiv_data1/oa_pdf/c4/35/jkms-29-90.PMC3890482.pdf
• Acarbose and Voglibose in Diabetes Patients Treated with Basal Insulin 94  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.90Table 4.,Non-OADS,/arxiv_data1/oa_pdf/c4/35/jkms-29-90.PMC3890482.pdf
• Acarbose and Voglibose in Diabetes Patients Treated with Basal Insulin http://jkms.org   95 http://dx.doi.org/10.3346/jkms.2014.29.1.90 No deaths occurred during the study.,Non-OADS,/arxiv_data1/oa_pdf/c4/35/jkms-29-90.PMC3890482.pdf
• Acarbose and Voglibose in Diabetes Patients Treated with Basal Insulin 96  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.90stock in the Bayer group.,Non-OADS,/arxiv_data1/oa_pdf/c4/35/jkms-29-90.PMC3890482.pdf
Available at http://www.idf.org/global-guideline-type-2-diabetes-2012  [accessed on 19 February 2013].,Non-OADS,/arxiv_data1/oa_pdf/c4/35/jkms-29-90.PMC3890482.pdf
• Acarbose and Voglibose in Diabetes Patients Treated with Basal Insulin http://jkms.org   97 http://dx.doi.org/10.3346/jkms.2014.29.1.90ential response of plasma lipoprotein(a) and apolipoprotein B in NID - DM subjects treated with acarbose.,Non-OADS,/arxiv_data1/oa_pdf/c4/35/jkms-29-90.PMC3890482.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Randomized Controlled Trial of Comparison on Time and Rate  of Cecal and Termianl Ileal Intubation according to Adult- Colonoscope Length: Intermediate versus Long For a complete colonoscopic examination, a high intubation rate and a short intubation  time have been demanded to colonoscopists, if possible.",Non-OADS,/arxiv_data1/oa_pdf/ef/7f/jkms-29-98.PMC3890483.pdf
"Keywords:  Colonoscopy; Intubation Time; Intubation Rate; Colonoscope LengthKwang-Min Kim,1 Seung-Hwa Lee,1  Duck-Joo Lee,1 Kyu-Nam Kim,1   Sang-Wook Seo,1 Hyung-Suk Lee,2   and Dong-Ryul Lee3 1Health Promotion Center, and 2Department of  Gastroenterology, Ajou University School of  Medicine, Suwon; 3Health Promotion Center,  Wonkwang University College of Medicine, Gunpo,  Korea Received: 8 August 2013 Accepted: 30 October 2013 Address for Correspondence: Seung-Hwa Lee, MD Health Promotion Center, Ajou University School of Medicine,  164 Worldcup-ro, Youngtong-gu, Suwon 443-721, Korea  Tel: +82.31-219-7164, Fax: +82.31-219-5218 E-mail: drhwa@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.1.98  • J Korean Med Sci 2014; 29: 98-105 INTRODUCTION Colorectal cancer (CRC) is the most common malignant tumor  in the developed parts of the world, such as North America and  Europe (1), and the incidence of CRC appears to be increasing  in East Asian countries including Korea (2).",Non-OADS,/arxiv_data1/oa_pdf/ef/7f/jkms-29-98.PMC3890483.pdf
"• Intubation Time and Rate according to Colonoscope Length http://jkms.org   99 http://dx.doi.org/10.3346/jkms.2014.29.1.98withdrawal time, and total procedure time, between the two  groups.",OADS,/arxiv_data1/oa_pdf/ef/7f/jkms-29-98.PMC3890483.pdf
• Intubation Time and Rate according to Colonoscope Length 100  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.98 A Fig.,Non-OADS,/arxiv_data1/oa_pdf/ef/7f/jkms-29-98.PMC3890483.pdf
• Intubation Time and Rate according to Colonoscope Length http://jkms.org   101 http://dx.doi.org/10.3346/jkms.2014.29.1.98 A CB D Fig.,Non-OADS,/arxiv_data1/oa_pdf/ef/7f/jkms-29-98.PMC3890483.pdf
• Intubation Time and Rate according to Colonoscope Length 102  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.98Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/7f/jkms-29-98.PMC3890483.pdf
• Intubation Time and Rate according to Colonoscope Length http://jkms.org   103 http://dx.doi.org/10.3346/jkms.2014.29.1.98Fig.,OADS,/arxiv_data1/oa_pdf/ef/7f/jkms-29-98.PMC3890483.pdf
"• Intubation Time and Rate according to Colonoscope Length 104  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.1.98factors (variable stiffness and trasparent hood) and intubation  time revealed that the difference of intubation time was promi - nent in beginners (11, 29-31).",OADS,/arxiv_data1/oa_pdf/ef/7f/jkms-29-98.PMC3890483.pdf
• Intubation Time and Rate according to Colonoscope Length http://jkms.org   105 http://dx.doi.org/10.3346/jkms.2014.29.1.984.,Non-OADS,/arxiv_data1/oa_pdf/ef/7f/jkms-29-98.PMC3890483.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/8a/eht409.PMC3890694.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2f/bd/srep03679.PMC3890905.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3679 | DOI: 10.1038/srep03679 9",Non-OADS,/arxiv_data1/oa_pdf/2f/bd/srep03679.PMC3890905.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3680 | DOI: 10.1038/srep03680 6",Non-OADS,/arxiv_data1/oa_pdf/20/e3/srep03680.PMC3890906.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3685 | DOI: 10.1038/srep03685 4",Non-OADS,/arxiv_data1/oa_pdf/f2/b7/srep03685.PMC3890939.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/21/ef/srep03681.PMC3890941.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3681 | DOI: 10.1038/srep03681 6",Non-OADS,/arxiv_data1/oa_pdf/21/ef/srep03681.PMC3890941.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7c/9f/srep03682.PMC3890943.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3682 | DOI: 10.1038/srep03682 9",Non-OADS,/arxiv_data1/oa_pdf/7c/9f/srep03682.PMC3890943.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/42/jir-6-129.PMC3890964.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Inflammation Research 2013:6 129–137Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  129RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S3590 1Clinical utility of the oral JAK inhibitor tofacitinib  in the treatment of rheumatoid arthritis Maurizio Cutolo Marianna Meroni Research Laboratories and Academic  Division of Clinical Rheumatology,   Department of Internal Medicine,   University of Genova, Genova, Italy Correspondence: Maurizio Cutolo   Research Laboratories and Academic  Division of Clinical Rheumatology,  Department of Internal Medicine,  University of Genova, viale Benedetto  Xv, 6, 16132 Genova, Italy   Tel +39 010 353 7994   Fax +39 010 353 8885   email mcutolo@unige.i tAbstract:  Immune/inflammatory cells act in rheumatoid arthritis (RA)-affected patients by  synthesizing several inflammatory mediators, including cytokines that initiate intracellular  signaling.",Non-OADS,/arxiv_data1/oa_pdf/ff/42/jir-6-129.PMC3890964.pdf
Available from http://www.ema.europa.eu/docs/ en_GB/document_library/Summary_of_opinion_-_Initial_authorisa - tion/human/002542/WC500146629.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/42/jir-6-129.PMC3890964.pdf
Available  from: http://www.medpagetoday.com/Rheumatology/Arthritis/35799 .,Non-OADS,/arxiv_data1/oa_pdf/ff/42/jir-6-129.PMC3890964.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/ff/42/jir-6-129.PMC3890964.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/42/jir-6-129.PMC3890964.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/b9/ndt-9-1803.PMC3890965.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1803–1810Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1803OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5385 3effectiveness and safety of Nintendo Wii Fit PlusTM  training in children with migraine without aura:   a preliminary study Maria esposito1 Maria ruberto2 Francesca gimigliano1,2 rosa Marotta3 Beatrice gallai4 lucia Parisi5 serena Marianna lavano3 Michele roccella5 Marco carotenuto1 1center for childhood  headache, child and adolescent  Neuropsychiatry clinic, Department  of Mental health, Physical and  Preventive Medicine, 2Department of  Odonto-stomathologic Disciplines,  Pathology – Orthopedic sciences,  second University of Naples, Naples,  italy; 3Department of Psychiatry,  “Magna graecia” University of  catanzaro, catanzaro, italy;  4Unit of child and adolescent  Neuropsychiatry, University of  Perugia, Perugia, italy; 5child  Neuropsychiatry, Department of  Psychology, University of Palermo,  Palermo, italy correspondence: Maria esposito   center for childhood headache,   child and adolescent Neuropsychiatry  clinic, Department of Mental health,  Physical and Preventive Medicine,   second University of Naples, Via sergio  Pansini 5 PaD Xi, 80131, Naples, italy   Tel +0039 815 666 988   Fax +0039 815 666 694   email maria.esposito2@unina2.i tBackground:  Migraine without aura (MoA) is a painful syndrome, particularly in childhood;  it is often accompanied by severe impairments, including emotional dysfunction, absenteeism  from school, and poor aca demic performance, as well as issues relating to poor cognitive func - tion, sleep habits, and motor coordination.",Non-OADS,/arxiv_data1/oa_pdf/6b/b9/ndt-9-1803.PMC3890965.pdf
Available  from: http://www.wma.net/en/30publications/10policies/b3 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/b9/ndt-9-1803.PMC3890965.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6b/b9/ndt-9-1803.PMC3890965.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/b9/ndt-9-1803.PMC3890965.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/d4/ijn-9-351.PMC3890966.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 351–362International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  351OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5384 7Novel kojic acid-polymer-based magnetic  nanocomposites for medical applications samer hasan hussein-al- ali1 Mohamed ezzat el  Zowalaty2,5 Mohd Zobir hussein3 Maznah Ismail1,4 Dena Dorniani3 Thomas J Webster6,7 1laboratory of Molecular  Biomedicine, 2laboratory of Vaccines  and Immunotherapeutics, Institute of  Bioscience, 3Materials synthesis and  characterization laboratory, Institute  of advanced T echnology, 4Department  of Nutrition and Dietetics, Faculty  of Medicine and health science,   Universiti Putra Malaysia, serdang,   selangor, Malaysia; 5Faculty of Public  health and Tropical Medicine, Jazan  University, Jazan, saudi arabia;   6Department of chemical engineering  and Program in Bioengineering,   Northeastern University, Boston,   Ma, Usa; 7center of excellence for  advanced Materials research, King  abdulaziz University, Jeddah, saudi  arabia correspondence: Mohd Zobir hussein   Materials synthesis and characterization   laboratory, Institute of advanced   Technology, Universiti Putra Malaysia,   serdang, selangor 43400, Malaysia   Tel +603 8946 6801   Fax +603 8943 5380   email mzobir@upm.edu.m yAbstract:  Iron oxide magnetic nanoparticles (MNPs) were synthesized by the coprecipitation of  iron salts in sodium hydroxide followed by coating separately with chitosan (CS) and polyethylene  glycol (PEG) to form CS-MNPs and PEG-MNPs nanoparticles, respectively.",Non-OADS,/arxiv_data1/oa_pdf/ab/d4/ijn-9-351.PMC3890966.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ab/d4/ijn-9-351.PMC3890966.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/d4/ijn-9-351.PMC3890966.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/fd/ijn-9-363.PMC3890967.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 363–377International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  363ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5353 8Ginkgo biloba : a natural reducing agent   for the synthesis of cytocompatible graphene Sangiliyandi Gurunathan Jae Woong Han Jung Hyun Park Vasuki Eppakayala Jin-Hoi Kim Department of Animal Biotechnology,   Konkuk University, Seoul, South Korea Correspondence: Sangiliyandi Gurunathan;  Jin-Hoi Kim   Department of Animal Biotechnology,  Konkuk University, 1 Hwayang-dong,  Gwangin-gu, Seoul 143-701, South Korea   Email gsangiliyandi@yahoo.co m;  jhkim541@konkuk.ac.k rBackground:  Graphene is a novel two-dimensional planar nanocomposite material consisting  of rings of carbon atoms with a hexagonal lattice structure.",Non-OADS,/arxiv_data1/oa_pdf/fa/fd/ijn-9-363.PMC3890967.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fa/fd/ijn-9-363.PMC3890967.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/fd/ijn-9-363.PMC3890967.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Bhargava, V., Head, S.R., Ordoukhanian, P., Mercola, M. & Subramaniam, S. Technical Variations in Low-Input RNA-seq Methodologies.",Non-OADS,/arxiv_data1/oa_pdf/a2/c5/srep03678.PMC3890974.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3678 | DOI: 10.1038/srep03678 10",Non-OADS,/arxiv_data1/oa_pdf/a2/c5/srep03678.PMC3890974.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/42/53/srep03675.PMC3891018.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3675 | DOI: 10.1038/srep03675 12",Non-OADS,/arxiv_data1/oa_pdf/42/53/srep03675.PMC3891018.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/58/8a/srep03674.PMC3891019.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3674 | DOI: 10.1038/srep03674 12",Non-OADS,/arxiv_data1/oa_pdf/58/8a/srep03674.PMC3891019.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3684 | DOI: 10.1038/srep03684 7",Non-OADS,/arxiv_data1/oa_pdf/49/f8/srep03684.PMC3891020.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ed/0e/srep03683.PMC3891023.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3683 | DOI: 10.1038/srep03683 6",Non-OADS,/arxiv_data1/oa_pdf/ed/0e/srep03683.PMC3891023.pdf
Available from: http://www.kr.cimap.res.in/bitstream/123  456789/122/1/NIM%202008-39.pdf.,OADS,/arxiv_data1/oa_pdf/98/f9/JAIM-4-193.PMC3891173.pdf
Available from: https://www.biosynth.com/index.asp?topic_ id=139 and g=19 and m=182.,OADS,/arxiv_data1/oa_pdf/98/f9/JAIM-4-193.PMC3891173.pdf
Available from: http://www.en.wikipedia.org/wiki/Circadian_ rhythm.,Non-OADS,/arxiv_data1/oa_pdf/98/f9/JAIM-4-193.PMC3891173.pdf
Available from: http://www.openthemagazine.com/article/living/ayurveda-hoax-or-science [Last cited in 2013 Mar 11].,Non-OADS,/arxiv_data1/oa_pdf/d5/cb/JAIM-4-198.PMC3891174.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/78/6a/JAIM-4-211.PMC3891176.pdf
Available from: http://www.ilo.org/wcmsp5/groups/ public/---ed_protect/---protrav/---ilo_aids/documents/legaldocument/wcms_117313.pdf [Last updated on 2013 Jan 15; Last cited on 2012 Jan 23].,OADS,/arxiv_data1/oa_pdf/e7/b9/JAIM-4-224.PMC3891178.pdf
"Philadelphia, PA: Wolters Kluwer Health; 2012 Feb. (Monograph on the Internet) Available from: http://www.uptodate.com/contents/hepatotoxicity-associated-with-chronic-oral-methotrex ate-for-nonmalignant-disease [Last cited Mar 2013].Dr.",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JAIM-4-229.PMC3891179.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/7b/c3/JAIM-4-237.PMC3891180.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/93/3d/JAIM-4-241.PMC3891181.pdf
Available from:  http://cdsco.nic.in/listofdrugapprovedmain.html [Last  accessed on 2013 Dec 10].,OADS,/arxiv_data1/oa_pdf/a8/7a/JAIM-4-245.PMC3891182.pdf
511abstractwww.scielo.br/jaos http://dx.doi.org/10.1590/1679-775720130203 Stress distribution on dentin-cement-post  interface varying root canal and glass fiber post diameters.,Non-OADS,/arxiv_data1/oa_pdf/a0/3e/jaos-21-06-0511.PMC3891274.pdf
"/g06/g80/g81/g8./g74/g0 /g87/g75/g71/g0 /g90/g71/g69/g86/g76/g87/g71/g86/g0 /g70/g81/g88/g8./g7./g.5/g0 /g87/g75/g71/g85/g71/g0 /g90/g71/g85/g71/g0 /g08/g75/g76/g79/g7./g0 Health, Ministry of Health Portal (http://portal.saude.gov.br/portal/saude/area.cfm?id_area=1251), /g90/g75/g76/g70/g75/g0/g71/g8./g68/g69/g79/g71/g7./g0/g87/g75/g71/g0/g86/g71/g79/g71/g70/g87/g76/g81/g8./g0/g81/g70/g0/g76/g8./g70/g81/g85/g80/g68/g87/g76/g81/g8./g0/g70/g81/g85/g0availability in the links of Babies Portal, using the /g71/g9./g76/g86/g87/g76/g8./g74/g0/g84/g88/g68/g79/g76/g87/g91/g0/g68/g8./g7./g0/g85/g71/g79/g76/g68/g69/g76/g79/g76/g87/g91/g0/g80/g68/g87/g71/g85/g76/g68/g79/g.5/g0/g90/g75/g76/g70/g75/g0/g70/g81/g8./g8./g71/g70/g87/g71/g7./g0/g87/g75/g71/g0/g07/g68/g69/g76/g71/g86/g0/g5./g81/g85/g87/g68/g79/g0/g90/g71/g69/g86/g76/g87/g71/g0/g90/g76/g87/g75/g0/g87/g75/g71/g0/g80/g68/g87/g71/g85/g76/g68/g79/g86/g0/g70/g85/g81/g80/g0/g87/g75/g71/g0/g48/g76/g8./g76/g86/g87/g85/g91/g0/g81/g70/g0/g40/g71/g68/g79/g87/g75/g.7/g0/g58/g71/g0/g70/g81/g79/g79/g81/g90/g71/g7./g0the guidelines recommended by the Ministry of /g40/g71/g68/g79/g87/g75/g.5/g0/g80/g85/g81/g89/g76/g7./g76/g8./g74/g0/g87/g75/g71/g0/g76/g8./g70/g81/g85/g80/g68/g87/g76/g81/g8./g0/g85/g71/g74/g68/g85/g7./g76/g8./g74/g0/g75/g81/g90/g0long the mother should breastfeed her child, for example.",Non-OADS,/arxiv_data1/oa_pdf/95/88/jaos-21-06-0581.PMC3891284.pdf
585improve the management mechanisms for the  distribution of video services on the Internet) channel of the series Breastfeeding (http://iptv.usp.br/portal/videos.jsp?_contexto=grupo&_/g76/g7./g08/g81/g8./g87/g71/g9./g87/g81/g01/g17/g10/g.1/g.7/g0/g4./g76/g74/g88/g85/g71/g0/g1./g.5/g0/g69/g71/g79/g81/g90/g.5/g0/g71/g9./g71/g80/g80/g79/g76/g.9./g71/g86/g0/g87/g75/g71/g0availability of the static images and videos.,Non-OADS,/arxiv_data1/oa_pdf/95/88/jaos-21-06-0581.PMC3891284.pdf
"Upon the suggestion of the inclusion of the  /g86/g80/g71/g70/g76/g.9./g70/g0/g76/g8./g86/g87/g85/g88/g70/g87/g76/g81/g8./g86/g0/g81/g8./g0/g87/g75/g71/g0/g71/g79/g76/g80/g76/g8./g68/g87/g76/g81/g8./g0/g81/g70/g0/g75/g68/g85/g80/g70/g88/g79/g0habits (comment 4 of Figure 5), the construction /g81/g70/g0/g68/g0/g8./g71/g90/g0/g86/g71/g70/g87/g76/g81/g8./g0/g90/g68/g86/g0/g70/g68/g85/g85/g76/g71/g7./g0/g81/g88/g87/g0/g90/g76/g87/g75/g0/g10/g.9/g0/g86/g87/g71/g80/g86/g0/g70/g81/g85/g0/g87/g75/g71/g0/g85/g71/g80/g81/g89/g68/g79/g0/g81/g70/g0/g.9./g8./g74/g71/g85/g0/g86/g88/g70/g78/g76/g8./g74/g0/g68/g8./g7./g0/g80/g68/g70/g76/g.9./g71/g85/g0/g75/g68/g69/g76/g87/g86/g0(http://portaldosbebes.fob.usp.br/portaldosbebes/Portugues/detInstitucional.php?codcategoria_site=1&codinstitucional_fono=76).Regarding the evaluation of the quality of the  /g87/g71/g70/g75/g8./g76/g70/g68/g79/g0/g76/g8./g70/g81/g85/g80/g68/g87/g76/g81/g8./g0/g70/g85/g81/g80/g0/g87/g75/g71/g0/g90/g71/g69/g86/g76/g87/g71/g.5/g0/g87/g75/g71/g0/g85/g71/g86/g88/g79/g87/g86/g0/g81/g69/g87/g68/g76/g8./g71/g7./g0/g70/g85/g81/g80/g0/g87/g75/g71/g0/g68/g80/g80/g79/g76/g70/g68/g87/g76/g81/g8./g0/g81/g70/g0/g87/g75/g71/g0/g80/g81/g7./g76/g.9./g70/g68/g87/g76/g81/g8./g0of Health on the Net Code 2 are presented in Figure  6.",Non-OADS,/arxiv_data1/oa_pdf/95/88/jaos-21-06-0581.PMC3891284.pdf
"/g55/g75/g88/g86/g.5/g0/g87/g75/g71/g0/g07/g68/g69/g76/g71/g86/g0/g5./g81/g85/g87/g68/g79/g0/g90/g71/g69/g86/g76/g87/g71/g0/g70/g68/g8./g0/g69/g71/g0/g70/g81/g8./g86/g76/g7./g71/g85/g71/g7./g0 an important tool for providing information regarding the proper stimulation of orofacial functions, early diagnosis and prevention of orofacial myofunctional /g70/g75/g68/g8./g74/g71/g86/g0/g7./g88/g85/g76/g8./g74/g0/g71/g68/g85/g79/g91/g0/g70/g75/g76/g79/g7./g75/g81/g81/g7./g.5/g0/g90/g75/g76/g70/g75/g0/g70/g68/g8./g0/g70/g68/g88/g86/g71/g0/g68/g0/g86/g76/g74/g8./g76/g.9./g70/g68/g8./g87/g0/g76/g80/g80/g68/g70/g87/g0/g81/g8./g0/g87/g75/g71/g0/g7./g71/g89/g71/g79/g81/g80/g80/g71/g8./g87/g0/g81/g70/g0/g87/g75/g71/g0/g70/g75/g76/g79/g7./g.7 CONCLUSION The sections “The Oral Functions”, “Breastfeeding”,  /g.79/g4./g81/g81/g7./g.80/g.5/g0/g.79/g5./g68/g70/g76/g.9./g71/g85/g.5/g0/g69/g68/g69/g91/g0/g69/g81/g87/g87/g79/g71/g0/g68/g8./g7./g0/g.9./g8./g74/g71/g85/g0/g86/g88/g70/g78/g76/g8./g74/g.80/g0and “Breath” have been prepared and structured, /g68/g8./g7./g0/g87/g75/g71/g91/g0/g68/g85/g71/g0/g8./g81/g90/g0/g68/g89/g68/g76/g79/g68/g69/g79/g71/g0/g68/g87/g0/g87/g75/g71/g0/g07/g68/g69/g76/g71/g86/g0/g5./g81/g85/g87/g68/g79/g0(http://portaldosbebes.fob.usp.br/portaldosbebes/Portugues/detSubCategoriaInstitucional.php?codsubcategoria_fono=73&codcategoria_/g86/g76/g87/g71/g01/g10/g.1/g0/g90/g76/g87/g75/g0/g68/g8./g0/g68/g7./g71/g84/g88/g68/g87/g71/g0/g79/g71/g89/g71/g79/g0/g81/g70/g0/g85/g71/g68/g7./g68/g69/g76/g79/g76/g87/g91/g0/g70/g81/g85/g0the target public.",Non-OADS,/arxiv_data1/oa_pdf/95/88/jaos-21-06-0581.PMC3891284.pdf
"Avaliable from: http://portal.saude.gov.br/portal/arquivos/pdf/caderneta_crianca_2007_14.pdf 15- Montaldo L, Montaldo P, Cuccaro P, Caramico N, Minervini G. Effects of feeding on non-nutritive sucking habits and implications on occlusion in mixed dentition.",Non-OADS,/arxiv_data1/oa_pdf/95/88/jaos-21-06-0581.PMC3891284.pdf
Available at: http://www.gesetze-im-internet.de/bundesrecht/mpg/gesamt.pdf; last accessed 7 March 2013.,Non-OADS,/arxiv_data1/oa_pdf/31/5d/S1041610213001786a.PMC3891295.pdf
S-3 Leitlinie “Demenzen.” Available at: http://www.dgppn.de/ ﬁleadmin/user_upload/_medien/download/pdf/ kurzversion-leitlinien/s3-leitlinie-demenz-lf.pdf; last accessed 7 March 2013.,Non-OADS,/arxiv_data1/oa_pdf/31/5d/S1041610213001786a.PMC3891295.pdf
Available at: http://www.evidence.de/Leitlinien/leitlinien-intern/Demenz_Start/demenz_start.,Non-OADS,/arxiv_data1/oa_pdf/31/5d/S1041610213001786a.PMC3891295.pdf
Available at: http://www.euro.,Non-OADS,/arxiv_data1/oa_pdf/31/5d/S1041610213001786a.PMC3891295.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cb/5a/srep03665.PMC3891318.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3665 | DOI: 10.1038/srep03665 8",Non-OADS,/arxiv_data1/oa_pdf/cb/5a/srep03665.PMC3891318.pdf
"we used ImageJ (http://rsb.info.nih.gov/ij; developed by Wayne Rasband, NIH) to manually edit each z-slice and remove autofluorescence and background fluorescence, taking care always to spare nearby axons.",OADS,/arxiv_data1/oa_pdf/bf/cf/srep03676.PMC3891355.pdf
Movies were made with Fluorender software (http://www.sci.utah.edu/software/46-documentation/137- fluorender.html).,Non-OADS,/arxiv_data1/oa_pdf/bf/cf/srep03676.PMC3891355.pdf
wrote the manuscript and all authors discussed the results and commented on the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bf/cf/srep03676.PMC3891355.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3676 | DOI: 10.1038/srep03676 11",Non-OADS,/arxiv_data1/oa_pdf/bf/cf/srep03676.PMC3891355.pdf
"The movie frame rate was set to 5 3normal speed, was encoded using the Xvid codec and can be played using the free VLC Media Player (available athttp://www.videolan.org/vlc/).",Non-OADS,/arxiv_data1/oa_pdf/d2/22/srep03689.PMC3891397.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: RCB is a co-founder and Chairman of the Board of Parion Sciences Inc.,Non-OADS,/arxiv_data1/oa_pdf/d2/22/srep03689.PMC3891397.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3689 | DOI: 10.1038/srep03689 6",Non-OADS,/arxiv_data1/oa_pdf/d2/22/srep03689.PMC3891397.pdf
"CFH  resequencing revealed  a polymorphism in linkage disequilibrium (LD) with the Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> Received 8 October 2013 | Accepted 11 January 2014 | Published 14 January 2014© 2014 Molecular Vision 105CFH  haplotypes and ARMS2 , C2, C3, and CFB alleles show  association with susceptibility to age-related macular  degeneration in Mexicans Alejandra V .",Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
"Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  106risk allele representing an amino acid change, Tyr402His  (rs1061170) [ 7].",Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
"Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  107probes (Applied Biosystems, Foster City, CA), following the  manufacturer’s protocol.",Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
"Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  108individuals, and the eight haplotypes that had a frequency  greater than 4% are shown in Table 2.",Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  109Table  2. f requencies  of haplo Types iDenTifie D in CFH  gene  in Mexicans  aMD paTienTs anD con Trols .,Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
"Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  110AMD susceptibility alleles in CFH , C3, C2, CFB,  and ARMS2   genes: Seven SNPs previously associated with AMD in the  CFH , C3, C2, CFB, and ARMS2  genes were analyzed in 273  unrelated patients with advanced AMD (geographic atrophy  or choroidal neovascularization) and 201 healthy controls.",Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
"Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  111Table  3. a llelic  associa Tion of snp s in CFH , ARMS2 , C2, CFB  anD C3 genes  To aMD in Mexicans .",Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
"Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  112the seven genotyped SNPs in our control population group  with two Mexican Amerindian groups (Zapotecos and Mayas)  and individuals from three continental groups included in the  HapMap International Project, Caucasians, Asians (Chinese  and Japanese population), and individuals from a Nigerian  region, we observed significant differences for rs1061170   (Tyr402His) in CFH  between Mexican Mestizos and those  populations (Appendix 5).",Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  113APPENDIX 1.,Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  114Complement factor H polymorphism in age-related macular  degeneration.,Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  11529.,Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
"Molecular Vision  2014; 20:105-116 <http://www.molvis.org/molvis/v 20/105> © 2014 Molecular Vision  116Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/58/0f/mv-v20-105.PMC3891434.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/94/awt179.PMC3891441.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/29/awt311.PMC3891446.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/fb/awt325.PMC3891449.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813000952 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/7e/bf/S0950268813000952a.PMC3891473.pdf
"Hepatitis C Information for Health Professionals, 2012 (http://www.cdc.gov/hepatitis/HCV/index.htm).Accessed 19 March 2012.",Non-OADS,/arxiv_data1/oa_pdf/7e/bf/S0950268813000952a.PMC3891473.pdf
"Signal to cut-off ratios for commercially avail- able assays, 2012 (http://www.cdc.gov/hepatitis/HCV/LabTesting.htm).",Non-OADS,/arxiv_data1/oa_pdf/7e/bf/S0950268813000952a.PMC3891473.pdf
"Hepatitis A, B and C surveillance report (http://www.nyc.gov/html/doh/dow nloads/pdf/cd/cd-hepabc- surveillance-report-08 –09.pdf).",Non-OADS,/arxiv_data1/oa_pdf/7e/bf/S0950268813000952a.PMC3891473.pdf
(http://www.irs.gov/uac/SOI-Tax-Stats- County-to-County-Migration-Data-Files).,OADS,/arxiv_data1/oa_pdf/7e/bf/S0950268813000952a.PMC3891473.pdf
(http://nychepbc.org/checkhepc/).,Non-OADS,/arxiv_data1/oa_pdf/7e/bf/S0950268813000952a.PMC3891473.pdf
"The health care law and you (http://www.healthcare.gov/law/index.html), 2012.",Non-OADS,/arxiv_data1/oa_pdf/7e/bf/S0950268813000952a.PMC3891473.pdf
doi:10.1017/S0950268813000940 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution- NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ee/9a/S0950268813000940a.PMC3891474.pdf
SUPPLEMENTARY MATERIAL For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0950268813000940.,Non-OADS,/arxiv_data1/oa_pdf/ee/9a/S0950268813000940a.PMC3891474.pdf
Geneva: WHO; 12 November2009: http://apps.who.int/gb/ebwha/pdf_ ﬁles/EB126/ B126_15-en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/9a/S0950268813000940a.PMC3891474.pdf
"Geneva: WHO, 21 May 2010 (http://apps.who.int/gb/ebwha/pdf_ ﬁles/WHA63/A63_R18-en.",Non-OADS,/arxiv_data1/oa_pdf/ee/9a/S0950268813000940a.PMC3891474.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813001088 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/01/c7/S0950268813001088a.PMC3891475.pdf
SUPPLEMENTARY MATERIAL For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0950268813001088.,Non-OADS,/arxiv_data1/oa_pdf/01/c7/S0950268813001088a.PMC3891475.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/cc/clep-6-037.PMC3891487.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2014:6 37–48Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  37REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S3792 9Clinical epidemiology of Alzheimer’s disease:  assessing sex and gender differences Michelle M Mielke1,2 Prashanthi vemuri3 walter A Rocca1,2 1Department of Health Sciences  Research, 2Department of Neurology,   3Department of Radiology, Mayo  Clinic, Rochester, MN, USA Correspondence: Michelle M Mielke   Department of Health Sciences Research,  Mayo Clinic, 200 First Street Sw,  Rochester, MN, USA 55905   Tel +1 507 284 5545   Fax +1 507 284 1516   Email m ielke.",Non-OADS,/arxiv_data1/oa_pdf/49/cc/clep-6-037.PMC3891487.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/49/cc/clep-6-037.PMC3891487.pdf
PDF  available from http://www.lung.org/finding-cures/our-research/trend- reports/Tobacco-Trend-Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/cc/clep-6-037.PMC3891487.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/67/ccid-7-023.PMC3891488.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 23–34Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  23RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S3955 9Utilization of biodegradable polymeric materials  as delivery agents in dermatology Fiorenza Rancan Ulrike Blume-Peytavi Annika vogt Clinical Research Center for Hair  and Skin Science, Department of  Dermatology and Allergy, Charité –  Universitätsmedizin Berlin, Germany Correspondence: Fiorenza Rancan   Clinical Research Center for Hair  and Skin Science, Department  of Dermatology and Allergy,  Charité – Universitätsmedizin Berlin,  Chariteplatz 1, 10117 Berlin, Germany   Tel +49 30 450 518 347   Fax +49 30 450 518 952   email fiorenza.rancan@charite.d eAbstract:  Biodegradable polymeric materials are ideal carrier systems for biomedical   applications.",Non-OADS,/arxiv_data1/oa_pdf/21/67/ccid-7-023.PMC3891488.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/21/67/ccid-7-023.PMC3891488.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/67/ccid-7-023.PMC3891488.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dc/eb/ce-9-001.PMC3891489.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCore Evidence 2014:9 1–11Core Evidence Dove press submit your manuscript | www.dovepress.co m Dove press  1REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S5219 7Targeted therapy in triple-negative metastatic  breast cancer: a systematic review   and meta-analysis Otávio Clark1 T obias Engel Ayer Botrel1 Luciano Paladini1 Mariana Bhering Andrade  Ferreira2 1Evidências Consulting, Campinas,   Brazil; 2Roche do Brasil, São Paulo,   Brazil Correspondence: Otávio Clark   Evidências Consulting, 143 Tranquillo  Prosperi, Campinas, São Paulo   13084-778, Brazil   Tel +55 19 9 8149 5375   Fax +55 19 3287 8310   Email otavio.clark@evidencias.com.b rObjective:  To perform a systematic review and meta-analysis of randomized controlled trials  that compared the efficacy of targeted therapy to conventional chemotherapy (CT) in patients  with metastatic triple-negative breast cancer (TNBC).",Non-OADS,/arxiv_data1/oa_pdf/dc/eb/ce-9-001.PMC3891489.pdf
"Core Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/dc/eb/ce-9-001.PMC3891489.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/eb/ce-9-001.PMC3891489.pdf
http://dx.doi.org/10.1016/j.nicl.2013.12.003 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/87/7a/main.PMC3891492.pdf
"Data preprocessing MRI data were analyzed using FMRIB Software Library (FSL) 4.1.8 (http://www.fmrib.ox.ac.uk/fsl )(Jenkinson et al., 2012 ), developed by the Centre for Functional Magnetic Resonance Imaging of the Brain, Oxford, UK.",OADS,/arxiv_data1/oa_pdf/87/7a/main.PMC3891492.pdf
S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/7a/main.PMC3891492.pdf
http://dx.doi.org/10.1177/1073858413491147 (in press).,Non-OADS,/arxiv_data1/oa_pdf/87/7a/main.PMC3891492.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/d1/ijn-9-337.PMC3891565.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 337–350International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  337OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5329 9Umbilical cord mesenchymal stem cells labeled  with multimodal iron oxide nanoparticles   with fluorescent and magnetic properties:  application for in vivo cell tracking Tatiana T sibov1,2 lorena F Pavon1,2 liza a Miyaki1 Javier B Mamani1 leopoldo P Nucci1,2 larissa T alvarim1,3 Paulo h silveira1 luciana c Marti1 lF gamarra1–3 1hospital Israelita albert einstein,    são Paulo, Brazil; 2Departamento  de Neurologia e Neurociências,   Universidade Federal de são Paulo,   são Paulo, Brazil; 3Faculdade de  Ciências Médicas da Santa Casa de  são Paulo, são Paulo, Brazil correspondence: lF gamarra   Instituto do Cérebro, Instituto Israelita  de ensino e Pesquisa albert einstein,  hospital Israelita albert einstein,   avenida albert einstein,   627/701 Morumbi, são Paulo,   Brazil, ceP 05651-901   Tel +55 11 2151 3727   Fax +55 11 2151 0208   email lgamarra@einstein.b rAbstract:  Here we describe multimodal iron oxide nanoparticles conjugated to Rhodamine-B  (MION-Rh), their s tability in culture medium, and subsequent validation of an in vitro protocol  to label mesenchymal stem cells from umbilical cord blood (UC-MSC) with MION-Rh.",Non-OADS,/arxiv_data1/oa_pdf/e4/d1/ijn-9-337.PMC3891565.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e4/d1/ijn-9-337.PMC3891565.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/d1/ijn-9-337.PMC3891565.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/0f/ijwh-6-059.PMC3891566.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 59–74International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  59RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S4141 0Cesarean section in the People’s Republic   of China: current perspectives Xing Lin Feng1 Ying Wang1 Lin An2 Carine Ronsmans3 1Department of Health Policy  and Administration, School of  Public Health, Peking University,  Beijing, People’s Republic of China;  2Department of Women, Children  and Adolescent Health, School of  Public Health, Peking University,  Beijing, People’s Republic of China;  3Department of Infectious Disease  epidemiology, London School of  Hygiene and Tropical Medicine,  London, england Correspondence: Xing Lin Feng   Department of Health Policy and  Administration, School of Public   Health, Peking University,   38 Xueyuan Rd, Beijing, People’s   Republic of China 100191   Tel +86 10 8280 5394   email fxl@bjmu.edu.c nObjective:  To review the current knowledge on the prevalence, reasons, and consequences of  cesarean sections in the People’ s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/ijwh-6-059.PMC3891566.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/ijwh-6-059.PMC3891566.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/0f/ijwh-6-059.PMC3891566.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/bd/ijn-9-437.PMC3891567.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 437–459International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  437OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4988 2curcumin and 5-Fluorouracil-loaded,   folate- and transferrin-decorated polymeric   magnetic nanoformulation:   a synergistic cancer therapeutic approach,  accelerated by magnetic hyperthermia sivakumar Balasubramanian1 aswathy ravindran girija1 Yutaka Nagaoka1 seiki Iwai1 Masashi suzuki1 Venugopal Kizhikkilot2 Yasuhiko Y oshida1 T oru Maekawa1 sakthikumar Dasappan  Nair1 1Bio Nano electronics research  center, graduate school of  Interdisciplinary New science,   T oyo University, Kawagoe, Japan;   2Department of respiratory Medicine,   sooriya hospital, chennai, India correspondence: Dasappan Nair  sakthikumar   Toyo University, 2100, Kujirai, Kawagoe,  saitama, 350 – 8585, Japan   Tel +81 492 391 636   Fax +81 492 342 502   email sakthi@toyo.j pAbstract:  The efficient targeting and therapeutic efficacy of a combination of drugs (curcumin  and 5-Fluorouracil [5FU]) and magnetic nanoparticles encapsulated poly(D,L- lactic-co-glycolic  acid) nanoparticles, functionalized with two cancer-specific ligands are discussed in our work.",Non-OADS,/arxiv_data1/oa_pdf/50/bd/ijn-9-437.PMC3891567.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/50/bd/ijn-9-437.PMC3891567.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/bd/ijn-9-437.PMC3891567.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/87/opth-8-177.PMC3891580.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 177–185Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  177Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5475 3reliable intraocular pressure measurement   using automated radio-wave telemetry eleftherios i Paschalis* Fabiano Cade* samir Melki louis r Pasquale Claes h Dohlman Joseph B Ciolino Massachusetts eye and ear infirmary,   harvard Medical school, Boston, M a,   Usa *These authors contributed equally   to this work Correspondence: Joseph B Ciolino   Massachusetts Eye and Ear Infirmary,   243 Charles street, Boston,   Ma, 02114, Usa   email Joseph_Ciolino@Meei.har VarD.",Non-OADS,/arxiv_data1/oa_pdf/27/87/opth-8-177.PMC3891580.pdf
"Available  from: http://www.seedtest.org/upload/cms/user/Variance.pd f. Accessed  February 6, 2013.",OADS,/arxiv_data1/oa_pdf/27/87/opth-8-177.PMC3891580.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/27/87/opth-8-177.PMC3891580.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/87/opth-8-177.PMC3891580.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/38/56/ppa-8-063.PMC3891581.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 63–72Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  63OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5350 4Mobile phone-based asthma self-management aid  for adolescents (mAsMAA): a feasibility study hyekyun rhee1 James Allen2 Jennifer Mammen1 Mary swift2 1school of n ursing, 2Department   of computer science, University   of rochester, rochester, nY, UsA correspondence: hyekyun rhee   school of nursing, University of   rochester, 601 elmwood Avenue,   Box sOn, rochester, nY 14642, UsA   Tel +1 585 276 3775   Fax +1 585 273 1270   email hyekyun_rhee@urmc.rochester.ed uPurpose:  Adolescents report high asthma-related morbidity that can be prevented by adequate  self-management of the disease.",Non-OADS,/arxiv_data1/oa_pdf/38/56/ppa-8-063.PMC3891581.pdf
Available from: http://www.cdc.gov/healthyyouth/asthma/data.htm .,Non-OADS,/arxiv_data1/oa_pdf/38/56/ppa-8-063.PMC3891581.pdf
Available  from: http://www.pewinternet.org/ ~/media/Files/Reports/2013/ PIP_TeensandTechnology2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/38/56/ppa-8-063.PMC3891581.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/38/56/ppa-8-063.PMC3891581.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/56/ppa-8-063.PMC3891581.pdf
"OncoImmunology 2013; 2:e26529; http://dx.doi.org/10.4161/onci.26529NK-cell fratricide Dynamic crosstalk between NK and cancer cells Kyohei Nakamura1,2, Masafumi Nakayama1, Mitsuko Kawano1, Tomonori Ishii2, hideo h arigae2, and Kouetsu Ogasawara1,* 1Department of Immunobiology; Institute of Development; a ging and Cancer; Tohoku u niversity; s endai, Japan;   2Department of h ematology and r heumatology; Tohoku u niversity Graduate s chool of Medicine; s endai, Japan;  Keywords: NK cells, NKG2D, trogocytosis The intercellular transfer of plasma membrane patches, also known as trogocytosis, has a strong impact on the func - tion and fate of immune cells.",Non-OADS,/arxiv_data1/oa_pdf/74/9c/onci-2-e26529.PMC3891629.pdf
Immunity 2008; 28:571- 80; PMID:18394936 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/74/9c/onci-2-e26529.PMC3891629.pdf
Nature  2002 ; 419:734-8;  PMID:12384702 ; http://dx.doi.org/10.1038/ nature01112Figure 1.,OADS,/arxiv_data1/oa_pdf/74/9c/onci-2-e26529.PMC3891629.pdf
Proc Natl Acad Sci U S A 2013 ; 110:9421 - 6; PMID:23690625 ; http://dx.doi.org/10.1073/ pnas.1300140110 6.,OADS,/arxiv_data1/oa_pdf/74/9c/onci-2-e26529.PMC3891629.pdf
Science  1999 ; 286:952-4;  PMID:10542149 ; http://dx.doi.org/10.1126/ science.286.5441.9527.,OADS,/arxiv_data1/oa_pdf/74/9c/onci-2-e26529.PMC3891629.pdf
Nature  2011 ; 471:629-32;  PMID:21455179 ; http://dx.doi.org/10.1038/ nature09863 8.,Non-OADS,/arxiv_data1/oa_pdf/74/9c/onci-2-e26529.PMC3891629.pdf
Proc Natl Acad Sci U S A  2011 ; 108:18360 -5; PMID:22042851 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/9c/onci-2-e26529.PMC3891629.pdf
PLoS  One 2008 ; 3:e3894 ; PMID:19079610 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/9c/onci-2-e26529.PMC3891629.pdf
Cancer Res 2012 ; 72:3125 -30; PMID:22721837 ;  http://dx.doi.org/10.1158/0008-5472.CAN-11-4094,Non-OADS,/arxiv_data1/oa_pdf/74/9c/onci-2-e26529.PMC3891629.pdf
"Cancer Cell 2012; 22:796-811; PMID:23238015; http://dx.doi.org/10.1016/j.ccr.2012.10.023Keywords:  breast cancer, signal trans - duction, targeted therapy, transcription  factors, kinases Submitted: 03/29/13Revised: 04/09/13Accepted: 04/10/13 Citation: Yeh JE, Toniolo PA, Frank DA.",OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
JAK-STAT 2013; 2:e24635 ; http://dx.doi.org/10.4161/jkst.24635*Correspondence to: David A. Frank;  Email: david_frank@dfci.harvard.eduA recent article published by Britschgi   et al.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Cancer Res  2008; 68:6084-91; PMID:18676830; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
J Clin Invest 2011; 121:1231-41; PMID:21490404;  http://dx.doi.org/10.1172/JCI44145 5.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Eur J Cancer  2010; 46:1132-43; PMID:20156674; http://dx.doi.org/10.1016/j.ejca.2010.01.014 6.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Cancer Res 2006; 66:1500-8; PMID:16452206;  http://dx.doi.org/10.1158/0008-5472.CAN-05-2925 7.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
J  Mammary Gland Biol Neoplasia 2006; 11:75-87;  PMID:16947086; http://dx.doi.org/10.1007/s10911- 006-9014-4 9.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Mol Cancer  Res 2009; 7:966-76; PMID:19491198; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
N Engl J Med 2010; 363:1938- 48; PMID:21067385; http://dx.doi.org/10.1056/ NEJMra1001389 2.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Oncogene 2012; In press;  PMID:23246963; http://dx.doi.org/10.1038/ onc.2012.572pro-metastatic chemokine that induces  positive feedback on JAK2/STAT5 ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Front Biosci 2012; 17:1232-50; PMID:22201800; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Clin Cancer Res 2008; 14:6735-41;  PMID:18980965; http://dx.doi.org/10.1158/1078- 0432.CCR-07-484314.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Cancer Lett 2006; 243:160-9;  PMID:16530327; http://dx.doi.org/10.1016/j.can - let.2006.01.032 15.,OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
J  Mammary Gland Biol Neoplasia 2008; 13:41-53;  PMID:18246319; http://dx.doi.org/10.1007/s10911- 008-9063-y 16.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Cancer Cell 2004; 6:241- 9; PMID:15380515; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
J Clin Invest 2011; 121:2723- 35; PMID:21633165; http://dx.doi.org/10.1172/ JCI4474510.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
J Clin Oncol  2011; 29:2448-58; PMID:21576635; http://dx.doi.org/10.1200/JCO.2010.30.3552 11.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Cancer Res 2006; 66:1824-32; PMID:16452244;  http://dx.doi.org/10.1158/0008-5472.CAN-05- 2292 13.,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
Oncogene 2005; 24:746-60;  PMID:15592524; http://dx.doi.org/10.1038/ sj.onc.1208203,Non-OADS,/arxiv_data1/oa_pdf/76/d3/jkst-2-e24635.PMC3891630.pdf
"15 *Correspondence to: M Cecilia Larocca; Email: larocca@ifise-conicet.gov.ar Submitted: 07/22/2013; Revised: 08/29/2013; Accepted: 08/31/2013http://dx.doi.org/10.4161/cl.26331Centrosomal AKAP350 modulates   the G1/S transition stella M Mattaloni1,†, anabela c  Ferretti1,†, Facundo M Tonucci1, cristián Favre1, James R Goldenring2, and M c ecilia Larocca1,* 1Instituto de Fisiología e xperimental; c onsejo de Investigaciones c ientíficas y Técnicas ( cONI ceT); Facultad de c iencias Bioquímicas y Farmacéuticas;   Universidad Nacional de Rosario; Rosario, a rgentina; 2Departments of s urgery and c ell and Developmental Biology; e pithelial Biology c enter;   Vanderbilt University s chool of Medicine; Vanderbilt-Ingram c ancer c enter and the Nashville V a Medical c enter; Nashville, TN U sa †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
J Biol Chem 1999; 274:3055-66; PMID :9915845 ;  http://dx.doi.org/10.1074/jbc.274.5.3055 2.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
J Biol Chem 1999 ; 274:17267 - 74; PMID:10358086 ; http://dx.doi.org/10.1074/ jbc.274.24.172673.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
EMBO J 1999 ; 18:1858 - 68; PMID:10202149 ; http://dx.doi.org/10.1093/ emboj/18.7.1858 4.,Non-OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Curr Biol  2012 ;  22:R281 -3; PMID:22537634 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Nat  Rev Mol Cell Biol 2001 ; 2:688-98; PMID:11533726 ;  http://dx.doi.org/10.1038/350895756.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Genes Cells   2005 ; 10:75-86; PMID :15670215 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Mol Biol Cell  2003 ; 14:4260 -71;  PMID:14517334 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Mol Biol Cell  2002 ;  13:3235 -45; PMID:12221128 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
EMBO J  2009 ; 28:1016 -28; PMID:19242490 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
J Cell Physiol 2012 ; 227:160- 71; PMID:21374596 ; http://dx.doi.org/10.1002/ jcp.22713 11.,Non-OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Mol Biol Cell  2003 ; 14:2436 -46;  PMID:12808041 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
J Cell Biol  2012 ; 197:11-8; PMID:22472437 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Curr Biol  2010 ; 20:856-60;  PMID:20399658 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Nat Cell Biol  2007 ; 9:160-70; PMID:17330329 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Oncogene   2001 ; 20:5111-7; PMID :11526499 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Circ Res 2006 ; 98:1273 -81;  PMID:16627785 ; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
J Biol Chem 2002 ; 277:27449 - 67; PMID:11956189 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
J Biol Chem 2001 ;  276:20774 -80; PMID:11279195 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
Apoptosis  2012 ; 17:475- 91; PMID:22270152 ; http://dx.doi.org/10.1007/ s10495-012-0697-2 24.,Non-OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
J Cell Biol 1995 ; 130:1149 - 59; PMID:7657699 ; http://dx.doi.org/10.1083/ jcb.130.5.1149,Non-OADS,/arxiv_data1/oa_pdf/a6/74/cl-3-e26331.PMC3891632.pdf
"Sci Signal 2013; 6:ra8; PMID:23386745; http://dx.doi.org/10.1126/scisignal.2003638Keywords:  mitochondrial metabolism,  ATP, reactive oxygen species, TFAM,  cellular differentiation Submitted: 06/06/13Accepted: 06/18/13 Citation: Hamanaka RB, Chandel NS.",OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
"Cell Logist 2013; 3:e25456; http://dx.doi.org/10.4161/cl.25456*Correspondence to: Navdeep S Chandel;  Email: nav@northwestern.eduMitochondrial metabolism as a regulator of keratinocyte differentiation Robert B Hamanaka and Navdeep S Chandel* Department of Medicine, Division of Pulmonary and Critical Care Medicine and Department of Cell and Molecular Biology;   Northwestern University Medical School; Chicago, IL USA Mitochondrial metabolism has tra - ditionally been thought of as a  source of cellular energy in the form of  ATP.",Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Science 2009;  324:1029-33; PMID:19460998; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Nat Rev Cancer 2011; 11:85- 95; PMID:21258394; http://dx.doi.org/10.1038/ nrc2981 4.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Cell Stem Cell 2012; 11:596-606; PMID:23122287;  http://dx.doi.org/10.1016/j.stem.2012.10.002 5.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Trends Biochem Sci  2010; 35:505-13; PMID:20430626; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Sci Signal 2013; 6:ra8; PMID:23386745; http://dx.doi.org/10.1126/scisig - nal.2003638 7.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
J Physiol 2003; 552:335-44; PMID:14561818; http://dx.doi.org/10.1113/jphysi - ol.2003.049478 8.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Free Radic Biol  Med 2008; 45:1-17; PMID:18423411; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Proc Natl Acad Sci U S A  2010; 107:8788-93; PMID:20421486; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Cell  2012; 149:1269-83; PMID:22682249; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Cancer Cell 2010; 17:41- 52; PMID:20129246; http://dx.doi.org/10.1016/j.ccr.2009.11.023 13.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Nature 2011; 469:221-5; PMID:21124315; http://dx.doi.org/10.1038/nature09663 14.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Nat Immunol 2011; 12:222- 30; PMID:21151103; http://dx.doi.org/10.1038/ ni.1980 15.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Immunity 2013; 38:225- 36; PMID:23415911; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Cell Metab 2005; 1:409-14; PMID:16054090;  http://dx.doi.org/10.1016/j.cmet.2005.05.002 18.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Cell Metab 2005; 1:401- 8; PMID:16054089; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Cell Metab 2005; 1:393-9; PMID:16054088; http://dx.doi.org/10.1016/j.cmet.2005.05.003 20.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
J Cell Sci 2007; 120:4025-34; PMID:17971411;  http://dx.doi.org/10.1242/jcs.016972 21.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
J Mol Cell Cardiol 2010; 48:725-34;  PMID:20045004; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Nat Clin Pract Cardiovasc Med 2007;  4(Suppl 1):S60-7; PMID:17230217; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Stem Cells 2010; 28:721-33; PMID:20201066; http://dx.doi.org/10.1002/ stem.404 24.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Stem Cells 2008; 26:960-8; PMID:18218821; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Nat Chem Biol 2010; 6:411-7; PMID:20436487; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Stem Cells  2010; 28:661-73; PMID:20073085; http://dx.doi.org/10.1002/stem.307 27.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Nature  2009; 458:780-3; PMID:19194462; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Proc Natl Acad Sci U S A 2000; 97:10032-7; PMID:10944195; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Brain Res 2005; 1040:137-50; PMID:15804435; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Cell 2007; 128:325-39; PMID:17254970; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Nat Med 2006; 12:446- 51; PMID:16565722; http://dx.doi.org/10.1038/ nm1388 33.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Nature 2009; 461:537-41; PMID:19727075; http://dx.doi.org/10.1038/ nature08313 34.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Blood 2010; 115:4030-8; PMID:20354168; http://dx.doi.org/10.1182/blood- 2009-09-241000 35.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
J Cell Sci 2006; 119:391-3; PMID:16443746; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Nat Genet 1998; 18:231-6; PMID:9500544; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Nat Cell Biol 2006; 8:501- 8; PMID:16604061; http://dx.doi.org/10.1038/ ncb1405 40.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Crit Rev Oral Biol Med 1999; 10:442-57; PMID:10634582; http://dx.doi.org/10.1177/10454411990100040201 41.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
J Physiol  2000; 529:37-47; PMID:11080249; http://dx.doi.org/10.1111/j.1469-7793.2000.00037.x 42.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
EMBO J 2011; 30:4860-73; PMID:22085932; http://dx.doi.org/10.1038/ emboj.2011.40143.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
J Biol Chem 2007; 282:6696-706; PMID:17204470; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
J Biol Chem 2006; 281:6608-15; PMID:16407282; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
PLoS  One 2007; 2:e763; PMID:17712411; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Exp Dermatol 2002; 11:406-12; PMID:12366693; http://dx.doi.org/10.1034/j.1600-0625.2002.110503.x48.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Science  2009; 324:1076-80; PMID:19461003; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Genes Dev 2008; 22:1865- 70; PMID:18628393; http://dx.doi.org/10.1101/ gad.1673508 50.,Non-OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Cell 2013; 153:56- 69; PMID:23540690; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
Cell Metab 2012; 16:9-17; PMID:22768835;  http://dx.doi.org/10.1016/j.cmet.2012.06.001,OADS,/arxiv_data1/oa_pdf/2c/6e/cl-3-e25456.PMC3891634.pdf
"OncoImmunology 2013; 2:e26757; http://dx.doi.org/10.4161/onci.26757Regulatory T cells are redirected   to kill glioblastoma by an EGFRvIII-targeted  bispecific antibody Bryan D Choi1, Patrick C Gedeon1, Luis s anchez-Perez1, Darell D Bigner2, and John h s ampson1,2,* 1Duke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of s urgery; Duke u niversity Medical Center; Durham, NC usa ;   2The Preston r obert Tisch Brain Tumor Center at Duke, Duke u niversity Medical Center, Durham, NC usa Keywords:  bispecific antibodies, central nervous system neoplasms, epidermal growth factor receptor,   glioblastoma, granzymes, regulatory T cells regulatory T cells (Tregs) play a central role in in tumor escape from immunosurveillance.",Non-OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
N Engl J Med 2005; 352:987-96; PMID:15758009 ; http://dx.doi.org/10.1056/ NEJMoa043330 2.,OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
N Engl J Med  2006; 355:1018-28;  PMID:16908486 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
Expert Opin Biol Ther  2011; 11:843-53;  PMID:21449821 ; http://dx.doi.org /10.1517/14712598.2011.5728744.,Non-OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
J Immunol Methods 2013; 395:14-20; PMID:23806556 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
Brain Pathol 2009; 19:713-23; PMID:19744042 ;  http://dx.doi.org/10.1111/j.1750-3639.2009.00318.x 6.,Non-OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
Proc Natl Acad Sci U S  A 2013; 110:270-5; PMID:23248284 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
Expert Rev  Clin Pharmacol 2013; 6:375-86; PMID:23927666 ;  http://dx.doi.org/10.1586/17512433.2013.8118068.,Non-OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
Oncoimmunology 2013; 2:e23639;   PMID:23734318 ; http://dx.doi.org/10.4161/ onci.23639 9.,Non-OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
Cancer Immunol Res 2013;  1:163-7; http://dx.doi.org/10.1158/2326-6066.,Non-OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
Immunity 2004; 21:589-601;  PMID :15485635 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
Cancer Res 2006;  66:3294-302;  PMID:16540683 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/0d/onci-2-e26757.PMC3891636.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/b3/ppa-8-073.PMC3891638.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 73–81Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  73OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5492 2Efficacy of a reduced pill burden on therapeutic  adherence to calcineurin inhibitors in renal  transplant recipients: an observational study Massimo Sabbatini1 gianluca garofalo1 silvio Borrelli2 sossio Vitale1 Massimiliano T orino1 Domenico capone3 luigi russo3 Antonio Pisani1 rosa carrano1 riccardo gallo1 stefano Federico1 1Nephrology, Department of Public  Health, University Federico II of  Naples, 2Department of Nephrology,   Second University of Naples,   3Department of Neurosciences, Unit  of Clinical Pharmacology, University  Federico II of Naples, Naples, Italy Correspondence: Massimo Sabbatini   Medical Therapy of Renal  Transplantation, Department   of Public Health, University Federico II,   50 Via Alessandro Manzoni, Naples,  Campania 80123, Italy   Tel/fax +39 081 746 2614   email sabbatin@unina.i tPurpose:  The aim of this study was to determine the prevalence of nonadherence in a cohort of  renal transplant recipients (RTRs) and to evaluate prospectively whether more intense clinical  surveillance and reduced pill number enhanced adherence.",Non-OADS,/arxiv_data1/oa_pdf/65/b3/ppa-8-073.PMC3891638.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/65/b3/ppa-8-073.PMC3891638.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/b3/ppa-8-073.PMC3891638.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/b5/dddt-8-113.PMC3891639.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 113–119Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  113Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S4003 2Does fesoterodine have a role in the treatment of  poorly managed patients with overactive bladder?",Non-OADS,/arxiv_data1/oa_pdf/93/b5/dddt-8-113.PMC3891639.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/93/b5/dddt-8-113.PMC3891639.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/b5/dddt-8-113.PMC3891639.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/10/ott-7-111.PMC3891640.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 111–116OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  111Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5320 4Clear cell carcinoma of the uterine cervix:   clinical characteristics and feasibility   of fertility-preserving treatment Xiang Jiang Ying Jin Yan Li Hui-Fang Huang Ming Wu Keng shen Ling-Ya Pan Department of Obstetrics and  Gynecology, Peking Union Medical  College Hospital, Chinese academy  of Medical sciences and Peking Union  Medical College, Beijing, People’s  republic of China Correspondence: Ying Jin   Department of Obstetrics and  Gynecology, Peking Union Medical  College Hospital, Chinese academy  of Medical sciences and Peking Union  Medical College, 1 shuai Fu Yuan, Wang  Fu Jing street, Beijing 100730, People’s  republic of China   Tel +86 10 6529 6218   Fax +86 10 6512 4875   email jinypumc@aliyun.co mAbstract:  The objective of this retrospective study was to analyze the clinical characteristics  and prognosis of clear cell adenocarcinoma (CCA) in the post-diethylstilbestrol (DES) era  and to evaluate the feasibility of fertility-preserving treatment.",Non-OADS,/arxiv_data1/oa_pdf/9f/10/ott-7-111.PMC3891640.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9f/10/ott-7-111.PMC3891640.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/10/ott-7-111.PMC3891640.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/ndt-10-071.PMC3891647.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 71–81Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  71OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S56404identifying the affected hemisphere with a  multimodal approach in Mri-positive or negative,  unilateral or bilateral temporal lobe epilepsy Jing Zhang1 Qingzhu liu2 shanshan Mei2 Xiaoming Zhang2 Weifang liu1 hui chen1 hong Xia1 Zhen Zhou1 Xiaofei Wang2 Yunlin li2 1school of Biomedical engineering,   capital Medical University, Beijing,   People’s republic of china;   2Department of Functional Neurology  and Neurosurgery, Beijing haidian  hospital, Beijing, People’s republic of  china correspondence: Jing Zhang   school of Biomedical engineering,   capital Medical University, Beijing  100069, People’s republic of china   Tel +86 10 8391 1543   Fax +86 10 8391 1544   email jzhang0000@163.co mAbstract:  Patients with non-lesional or bilateral temporal-lobe epilepsy (TLE) are often  excluded from surgical treatment.",Non-OADS,/arxiv_data1/oa_pdf/8d/b3/ndt-10-071.PMC3891647.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8d/b3/ndt-10-071.PMC3891647.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/ndt-10-071.PMC3891647.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ac/3f/ott-7-101.PMC3891649.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 101–110OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  101Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5183 5Effect of onion flavonoids on colorectal cancer  with hyperlipidemia: an in vivo study Y ongshan he1,* heiying Jin1,* Wei gong2,* chunxia Zhang1 acheng Zhou1 1national center of colorectal  surgery, Third affiliated hospital  of nanjing University of Traditional  chinese Medicine, nanjing, People’s  republic of china; 2Department  of surgery, Jiangyin hospital of  Traditional chinese Medicine,  Jiangyin, People’s republic of china *These authors contributed equally   to this work correspondence: heiying Jin   national center of colorectal surgery,  Third Affiliated Hospital of Nanjing  University of Traditional chinese  Medicine, 1 Jinling road, nanjing, Jiangsu  210001, People’s republic of china   Tel +86 133 8279 3886   email jinheiying@hotmail.co mObjectives:  This study aims to find the effect of onion’ s extraction on the colorectal cancer  with hyperlipidemia.",Non-OADS,/arxiv_data1/oa_pdf/ac/3f/ott-7-101.PMC3891649.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ac/3f/ott-7-101.PMC3891649.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/3f/ott-7-101.PMC3891649.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/fb/dddt-8-101.PMC3891651.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 101–112Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  101Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S4347 5Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/94/fb/dddt-8-101.PMC3891651.pdf
"Or use: http://dvpr.es/1g7Ywh 9Transdermal testosterone replacement   therapy in men M iftekhar Ullah1 Daniel M Riche1,2 Christian A Koch1,3 1Department of Medicine, University  of Mississippi Medical Center,    2Department of Pharmacy Practice,   The University of Mississippi,   3Gv (Sonny) Montgomery vA   Medical Center, Jackson, MS, USA Correspondence: CA Koch; M iftekhar  Ullah  Department of Medicine, University   of Mississippi Medical Center, 2500 N   State Street, Jackson, MS 39216, USA   email ck och@umc.ed u;   mullah@umc.ed uAbstract:  Androgen deficiency syndrome in men is a frequently diagnosed condition associated  with clinical symptoms including fatigue, decreased libido, erectile dysfunction, and metabolic  syndrome.",Non-OADS,/arxiv_data1/oa_pdf/94/fb/dddt-8-101.PMC3891651.pdf
"Available from: https://www.endocrine.org/ ∼/media/ endosociety/Files/Publications/Clinical%20Practice%20 Guidelines/FINAL-Androgens-in-Men-Standalone.pd f.  Accessed November 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/94/fb/dddt-8-101.PMC3891651.pdf
Available at: http://www.accessdata.fda.gov/drug - satfda_docs/label/2002/21454 lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/94/fb/dddt-8-101.PMC3891651.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/94/fb/dddt-8-101.PMC3891651.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/fb/dddt-8-101.PMC3891651.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d2/07/opth-8-187.PMC3891663.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 187–190Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  187Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5492 9acute anterior uveitis after discontinuation   of tocilizumab in a patient with rheumatoid  arthritis tomohito sato1 shinya Minakuchi1 Manabu Mochizuki2 Masaru takeuchi1 1Department of Ophthalmology,   National Defense Medical College,   saitama, Japan; 2Department of  Ophthalmology and Visual science,   tokyo Medical and Dental University  Graduate school of Medicine,    tokyo, Japan Correspondence: Masaru takeuchi   Department of Ophthalmology,   National Defense Medical College,  3-2 Namiki, tokorozawa, saitama,   359-8513, Japan   tel +81 4 2995 1683   Fax +81 4 2993 5332   email masatake@ndmc.ac.j pBackground:  Tocilizumab is a humanized monoclonal anti-interleukin-6 (IL-6) receptor  antibody and has been approved in Japan for the treatment of Castleman’ s disease, rheumatoid  arthritis (RA), and systemic juvenile idiopathic arthritis.",Non-OADS,/arxiv_data1/oa_pdf/d2/07/opth-8-187.PMC3891663.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d2/07/opth-8-187.PMC3891663.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/07/opth-8-187.PMC3891663.pdf
Available from: http://chugai-pharm.jp/hc/di/scholar/item/ drug_data/act/if/act_if.pd f. Accessed Nov 2013.,OADS,/arxiv_data1/oa_pdf/d2/07/opth-8-187.PMC3891663.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/70/opth-8-191.PMC3891666.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 191–197Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  191Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5454 6association of electroretinogram   and morphological findings in central   retinal vein occlusion with macular edema hidetaka noma1 Tatsuya Mimura2 Manami Kuse3,4 Katsunori shimada5 1Department of Ophthalmology,   Yachiyo Medical Center, Tokyo  Women’s Medical University, Chiba,   Japan; 2Department of Ophthalmology,   Medical Center east, T okyo Women’s  Medical University, T okyo, Japan;   3Department of Ophthalmology,   national hospital Organization, Mie  Central Medical Center, Tsu, Japan;   4Department of Ophthalmology,   Mie University graduate school of  Medicine, Tsu, Japan; 5Department  of Biostatistics, sTaTZ institute inc.,   T okyo, Japan Correspondence hidetaka noma   Department of Ophthalmology,   Yachiyo Medical Center, Tokyo   Women’s Medical University,   477-96, Owada-shinden, Yachiyo,   Chiba 276-8524, Japan   Tel +81 47 450 6000   Fax +81 47 458 7047   email noma-hide@umin.ac.j pAbstract:  The objective of this study was to evaluate the relations among electroretinogram  (ERG) parameters (cone a-wave, cone b-wave, and 30 Hz flicker), retinal thickness, and retinal  volume in 16 patients with central retinal vein occlusion and macular edema.",Non-OADS,/arxiv_data1/oa_pdf/f2/70/opth-8-191.PMC3891666.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f2/70/opth-8-191.PMC3891666.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/70/opth-8-191.PMC3891666.pdf
"The identi - fication of potentially reversible aberrant DNA methylation events that initiate and promote bladder cancer development may highlight biological markers for early diagnosis, effective therapy, and accurate prognosis of this malignancy.In this issue of Epigenetics Barbara P r attner Landes Bioscience; s an d iego, CA U sA Correspondence to: Barbara P Rattner; Email: barbara@landesbioscience.com Submitted: 09/12/13; Accepted: 09/12/13http://dx.doi.org/10.4161/epi.26480miRNAs in Speech   and Language Disorders  pp.",Non-OADS,/arxiv_data1/oa_pdf/01/9b/epi-8-1005.PMC3891679.pdf
"www.landesbioscience.com Epigenetics 1053Epigenetics 8:10, 1053–1060; October 2013; © 2013 Landes Bioscience REsEaR ch papER REsEaR ch papER *Correspondence to: Monica Miozzo; Email: monica.miozzo@unimi.it Submitted: 06/12/13; Revised: 07/16/13; Accepted: 07/13/13http://dx.doi.org/10.4161/epi.25812Introduction Beckwith-Wiedemann syndrome (BWS; OMIM 130650) is a  rare overgrowth syndrome that is characterized by prenatal and postnatal macrosomia, macroglossia, abdominal wall defects, and predisposition to embryonal tumors.",Non-OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
"Frequencies of the different methylation defects (I cR1 hyper - methylation, I cR2 hypomethylation, and both I cR1 and I cR2 methyla - tion anomalies) in the cohort of the current study (left) and in cohorts of  previous studies (http://www.ncbi.nlm.nih.gov/books/NBK1394/#bws.summary) (right).",Non-OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Am J Med Genet C Semin  Med Genet 2010; 154C:343-54; PMID:20803657;  http://dx.doi.org/10.1002/ajmg.c.30267 17.,OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
PLoS One 2012; 7:e33449; PMID:22428052; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Am J Med Genet A 2013; 161A:993- 1001; PMID:23532898; http://dx.doi.org/10.1002/ ajmg.a.358318.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Ultrasound Obstet Gynecol  2010; 36:687-92; PMID:20509138; http://dx.doi.org/10.1002/uog.7698 11.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Placenta 2010; 31:197-202;  PMID:20060582; http://dx.doi.org/10.1016/j.placen- ta.2009.12.003 12.,OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Epigenetics 2010; 5:313-24; PMID:20418667; http://dx.doi.org/10.4161/ epi.5.4.11637 14.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Eur J Hum Genet 2001; 9:409-18;  PMID:11436121; http://dx.doi.org/10.1038/ sj.ejhg.5200649References 1.,OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Eur J Hum Genet 2010;  18:8-14; PMID:19550435; http://dx.doi.org/10.1038/ ejhg.2009.106 2.,OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Clin Genet  2012; 81:350-61; PMID:22150955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Am J  Med Genet C Semin Med Genet 2013; 163:131- 40; PMID:23592339; http://dx.doi.org/10.1002/ ajmg.c.31363 4.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Eur J Hum Genet 2012; 20:240- 3; PMID:21863054; http://dx.doi.org/10.1038/ejhg.2011.166 5.,OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Am J Med Genet 1998; 79:347- 53; PMID:9779800; http://dx.doi.org/10.1002/ (SICI)1096-8628(19981012)79:5<347::AID- AJMG4>3.0.CO;2-G 7.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
Proc Natl Acad Sci U S A 2005; 102:4085- 90; PMID:15743916; http://dx.doi.org/10.1073/ pnas.0500037102,OADS,/arxiv_data1/oa_pdf/d0/23/epi-8-1053.PMC3891686.pdf
"www.landesbioscience.com  Epigenetics  1061Epigenetics 8:10, 1061–1068; O ctober 2013; © 2013 Landes Bioscience REsEaRch  pap ER REsEaRch  pap ER *Correspondence to: Lavinia Casati; Email: lavinia.casati@unimi.it Submitted: 06/03/13; Revised: 07/15/13; Accepted: 07/18/13http://dx.doi.org/10.4161/epi.25811Introduction Epigenetic marks, including DNA methylation, histone modifi - cations and small inhibitory RNAs, are heritable and provide crit - ical layers of gene regulatory control; however, they are dynamic  and can be influenced by environmental exposures.",Non-OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Toxicol Appl Pharmacol 2002; 179:185-94; PMID:11906248; http://dx.doi.org/10.1006/taap.2002.9371 28.,Non-OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
J Androl 2012; 33:210-5; PMID:21597087; http://dx.doi.org/10.2164/jandrol.111.013391 29.,Non-OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Genomics 1992; 12:241-53; PMID:1740333; http://dx.doi.org/10.1016/0888-7543(92)90371-X 30.,OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Hum Mol Genet 1995; 4:523-7; PMID:7633399; http://dx.doi.org/10.1093/hmg/4.4.523 31.,Non-OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Mol Endocrinol 1996; 10:1527-35; PMID:8961263; http://dx.doi.org/10.1210/me.10.12.1527 32.,Non-OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Hum Mol Genet 2004; 13:1677-92; PMID:15198988; http://dx.doi.org/10.1093/hmg/ddh181 33.,OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Reprod Toxicol 2011; 32:293-7; PMID:21729750; http://dx.doi.org/10.1016/j.reprotox.2011.06.075 34.,OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Science 2005; 310:819-23; PMID:16272115; http://dx.doi.org/10.1126/science.1115455 35.,Non-OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Soc Sci Med 2012; 74:1738-44; PMID:21962724; http://dx.doi.org/10.1016/j.socs-cimed.2011.08.026 36.,OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Psychoneuroendocrinology 2009; 34:752-61; PMID:19167832; http://dx.doi.org/10.1016/j.psyneuen.2008.12.007 37.,Non-OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Toxicology 2005; 215:115-25; PMID:16125295; http://dx.doi.org/10.1016/j.tox.2005.07.00316.,OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Reprod Toxicol 2006; 22:738-45; PMID:16938428; http://dx.doi.org/10.1016/j.reprotox.2006.07.002 17.,OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Int J Toxicol 2009; 28:294-307; PMID:19636072; http://dx.doi.org/10.1177/1091581809337918 18.,OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Epigenomics 2012; 4:101-12; PMID:22332662; http://dx.doi.org/10.2217/epi.11.110 19.,Non-OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
PLoS Genet 2013; 9:e1003461; PMID:23637629; http://dx.doi.org/10.1371/journal.pgen.1003461 20.,Non-OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Neurobiol Dis 2009; 33:395-404; PMID:19100835; http://dx.doi.org/10.1016/j.nbd.2008.11.007 21.,OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
Acta Crystallogr Sect F Struct Biol Cryst Commun 2011; 67:907-10; PMID:21821892; http://dx.doi.org/10.1107/S1744309111021981 22.,OADS,/arxiv_data1/oa_pdf/2e/e6/epi-8-1061.PMC3891687.pdf
